merrell moc speed streak

Transcription

Final Program
TARGETING
CANCER:
Technology
Biology
A S T R O ’S 56 T H
A N N UA L
M E E T I N G
Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
oad
Downl mobile –
ASTRO cial
the offing app.
meeti
s.
S e e pa
www.astro.org/annualmeeting
#ASTRO14
ge 22 f
or deta
il
Final Program
TARGETING
CANCER:
Technology
Biology
A S T R O ’S 56 T H
A N N UA L
M E E T I N G
Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
load
DownOmobile –
ASTR fficial
the o ing app.
meet
tails.
S e e pa
www.astro.org/annualmeeting
HELD IN CONJUNCTION WITH:
#ASTRO14
AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT)
ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO)
Held in(SROA)
conjunction with:
SOCIETY FOR RADIATION ONCOLOGY ADMINISTRATORS
American Society of Radiologic Technologists (ASRT)
Association of Residents in Radiation Oncology (ARRO)
#ASTRO13
Society for Radiation Oncology Administrators (SROA)
ge 22
for de
Welcome
TO THE 56TH ANNUAL MEETING OF
THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
“Targeting Cancer: Technology and Biology”
Dear Colleagues,
It is my honor to welcome you to the vibrant city of San Francisco and ASTRO’s 56th Annual
Meeting. We are confident that the meeting will provide ample opportunity for professional
networking, exchange of new ideas and knowledge in clinical, basic and translational research as
we continue our mission to move the field of radiation oncology forward and improve the quality
of life for the patients we serve.
The theme of this year’s meeting is “Targeting Cancer: Technology and Biology.” The Annual
Meeting Scientific Program Committee, led by Lynn D. Wilson, MD, MPH, FASTRO, along with a
dedicated group of volunteers, has assembled an inspiring and exciting program from a
record-breaking number of abstract submissions. Novel developments in biology and
cutting-edge technology will be highlighted in a broad spectrum of educational sessions, panel
discussions, oral presentations, poster presentations and digital posters. The popular Plenary
Session and Clinical Trials Session will both be unopposed to allow the entire membership to
attend these highly rated and important sessions.
The meeting officially begins with the Presidential Symposium, “Local-regional Management of
Breast Cancer: A Changing Paradigm. ”Moderated by Jay R. Harris, MD, FASTRO, and Thomas A.
Buchholz, MD, FASTRO, the symposium will highlight recent practice-changing landmark studies
and current developments in the local-regional management of breast cancer.
Our keynote speakers, Hedvig Hricak, MD, PhD, Frank McCormick, PhD, FRS, and Sidney Dekker,
PhD, MA, MSc, will address a range of topics, including oncologic imaging, biology and targeting
in oncology, and human error and safety concerns (see page 45 for more details).
I invite you to join me in congratulating our 2014 ASTRO Gold Medalists, Fellows and Honorary
Member during the Awards Ceremony on Tuesday at 10:15 a.m. in the Esplanade Ballroom.
I also extend a very warm welcome and note of appreciation to our industry colleagues for their
support and contributions to our specialty. I encourage you to visit the Exhibit Hall to learn about
their latest developments.
I hope the Annual Meeting will provide you with new insights, ideas and inspiration to bring back
to your practice and your patients. Enjoy the meeting and all that San Francisco has to offer.
Bruce G. Haffty, MD, FASTRO
President, ASTRO
Chair, Annual Meeting Steering Committee
2
ASTRO 2014 / 56TH ANNUAL MEE TING
Table of Contents
WELCOME TO THE 56TH ANNUAL MEETING
Board of Directors
Continuing Medical Education
Annual Meeting Committee Members
Abstract Reviewers
Session Reviewers
Gold Medal Recipients
Fellow Recipients
Honorary Member Recipient
Annual Meeting Abstract Awards
2
4
5
8
10
12
13
14
15
16
GENERAL INFORMATION
ASTROmobile
Concessions
Industry-Expert Theater
Industry Satellite Symposia
Posters
Shuttle Service
Moscone Center Floor Plans
19
22
24
26
27
29
31
34
SCHEDULE OF EVENTS
eContouring Learning Lab
Live Self-Assessment CME Sessions (SA-CME)
Presidential Symposium
Keynote Speakers
Meeting Highlights
ARRO Program
Young Physicians’ Workshop
Nurses’ Program
International Program
APEx
RO-ILS: Radiation Oncology Incident Learning System
Schedule by Day
Saturday
Sunday
Monday
Tuesday
Wednesday
POSTER PRESENTATIONS
INDEXES
By Author
By Topic
EXHIBITOR LISTINGS
Exhibitor List
Exhibitor List by Product/Service Category
Exhibit Hall Floor Plan
41
42
44
45
47
48
51
52
54
57
58
61
63
75
88
103
123
185
194
207
215
218
Board of Directors
2014 Officers and Board of Directors
Colleen A.F. Lawton, MD, FASTRO, Chair
Bruce G. Haffty, MD, FASTRO, President
Bruce D. Minsky, MD, President-elect
Phillip M. Devlin, MD, FASTRO, Secretary/Treasurer
Jeff Michalski, MD, MBA, FASTRO, Secretary/
Treasurer-elect
Michael L. Steinberg, MD, FASTRO, Immediate Past
Chair
Council Chairs and Vice-chairs
Carol H. Hahn, MD, Clinical Affairs and Quality
Council Chair
Lawrence Marks, MD, FASTRO, Clinical Affairs and
Quality Council Vice-chair
Laura A. Dawson, MD, Education Council Chair
Paul M. Harari, MD, FASTRO, Education Council
Vice-chair
Bharat B. Mittal, MD, FASTRO, Government
Relations Council Chair
Geraldine M. Jacobson, MD, MBA, MPH, FASTRO
Government Relations Council Vice-chair
Brian Kavanagh, MD, Health Policy Council Chair
Thomas J. Eichler, MD, FASTRO, Health Policy
Vice-chair
Mary K. Martel, PhD, FASTRO, Science Council Chair
Theodore L. DeWeese, MD, Science Council
Vice-chair
Laura I. Thevenot, Chief Executive Officer
4
Continuing Medical Education
NEEDS STATEMENT
Cancer is a leading cause of death worldwide.
According to the World Health Organization (WHO),
cancer deaths worldwide are projected to continue
to rise to more than 11 million in 2030. The American
Cancer Society estimates that in 2014 1.6 million new
cases of cancer will be diagnosed. Nearly two-thirds
of these patients will receive radiation therapy
during their illness – most with the intent to cure the
cancer. Advances in the applications, technologies
and methodologies of radiation oncology continue
to evolve rapidly and the delivery of radiation therapy
has become more complex, making it imperative that
the radiation oncology professional remain current in
the state-of-the-art techniques. The American Society
for Radiation Oncology is committed to providing
educational programming that creates a forum for
global collaboration on issues in radiation oncology
to improve professional practice by increasing level
of knowledge, as required to improve competency in
the field of oncology.
PROGRAM DESCRIPTION AND OBJECTIVES
The scientific program will continue to be the ideal
platform to bring together clinicians, scientists and
researchers from all of the oncologic disciplines to
exchange ideas, promote multidisciplinary care and
address the educational and professional
development interests of our attendees. Scientific and
educational sessions will cover specific clinical areas
including breast, central nervous system,
gastrointestinal, genitourinary, gynecological, head
and neck, lymphoma, musculoskeletal, pediatric,
sarcoma and thoracic cancers. Radiation biology and
radiation physics concepts will also be explored.
During the 2014 Annual Meeting, we will highlight
science that showcases how technology and biology
advance the field and improve patient outcomes and
quality of life. Significant advances in both
technology and biology continue to move our field
forward, improving our ability to target cancer
through both technologic and biologic approaches.
At this year’s meeting, we will bring together the
latest developments in basic, translational, applied
technology and clinical sciences as they relate to our
multidisciplinary efforts to improve the quality of
life and outcomes of our patients. Scientific sessions
will highlight science that improves quality of care,
outcomes and quality of life of our patients, and paves
the way for future directions, with an emphasis on the
clinical, translational, biological and technical research
helping us to “target cancer.”
The Annual Meeting, a live, four-day, interactive
meeting, will feature a continued emphasis on patient
quality and safety issues in the delivery of radiation
therapy in the areas of treatment techniques,
equipment, terminology and professional
responsibilities. Program content has been designed
to address specific documented and clinically
important practice gaps in physician knowledge and
competence. We will continue to emphasize quality
and safety issues in the delivery of radiation therapy
in the areas of treatment techniques, equipment,
terminology and professional responsibilities.
Upon completion of this live activity, attendees should
be able to do the following:
1.
2.
3.
Examine the advances in technology and biology
that help improve patient outcomes and quality
of life.
Determine the value of combining novel
strategies in technology and biology to radiation
therapy in the treatment of cancer.
Employ quality and safety measures in the
delivery of radiation therapy.
ELEMENTS OF COMPETENCE
The Annual Meeting program has been designed to
narrow the competency gaps of patient/
patient-centered care, medical knowledge,
practice-based learning and improvement,
interpersonal skills and communication,
professionalism, work in interdisciplinary teams,
evidence-based practice, quality improvement,
utilization of informatics, professional standing and
commitment to lifelong learning, 12 of the 15 core
competencies embraced by the American Board of
Medical Specialties, the Accreditation Council for
Graduate Medical Education and the Institute of
Medicine.
TARGET AUDIENCE
The Annual Meeting program is intended for all
health professionals in the field of oncology, with
particular emphasis on radiation oncologists,
radiation oncology residents, radiation biologists,
radiation physicists, medical dosimetrists, radiation
therapists, radiation oncology nurses, medical
oncologists, oncological surgeons and pathologists.
CONTINUING MEDICAL EDUCATION
PHYSICIANS
The American Society for Radiation Oncology (ASTRO)
is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
ASTRO designates this live activity for a maximum of
37 AMA PRA Category 1 Credits™. Physicians should
claim only the credit commensurate with the extent
of their participation in the activity.
5
PHYSICISTS
CAMPEP has approved this activity for 37 medical
physics continuing education credit (MPCEC) hours.
DOSIMETRISTS
An application has been submitted to the Medical
Dosimetrist Certification Board for designation of
MDCB credit.
NURSES
This activity has been submitted to the Oncology
Nursing Society (ONS) for approval to award contact
hours. ONS is accredited as an approver of continuing
nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
PROGRAM EVALUATION PROCESS AND
CONTINUING EDUCATION CREDITS
All attendees are encouraged to complete the online
evaluation. However, you must be a full-conference or
one-day only registrant to receive continuing
education credit. To receive continuing education
credits, you must evaluate each of the sessions you
attended using the online evaluation form no later
than October 17, 2014.
On-site Computer Stations
•
The evaluation can be completed on-site at
either the CE Central Booth or a Cyber Café. The
CE Central Booth is located outside Hall E, and
the Cyber Cafés are located in the North and
South Lobbies.
•
Attendees can log in and out of the evaluation
system throughout the meeting, allowing you to
save your progress as you go.
•
Attendees will be able to print or email their
certificate after the evaluation has been
submitted.
Post-meeting or Mobile Device During Meeting
•
Attendees wishing to complete the evaluation
using a mobile device or post-meeting should
access the evaluation at www.astro.org/2014eval.
•
You will need your badge number to complete
the evaluation form. Please write your badge
number here for future reference: ____________
•
Attendees will be able to print or email their
certificate after the evaluation has been
submitted.
For questions regarding continuing education credits,
please visit the CE Central Booth located outside Hall
E at Moscone Center.
6
DISCLOSURE OF VESTED INTEREST
ASTRO is an accredited provider of continuing
medical education. Since our accreditation is
important to us, we plan activities that are compliant
with the Accreditation Council for Continuing Medical
Education (ACCME) and the content or format of CME
activities and related materials will promote
improvements or quality in health care and not a
specific proprietary business interest or commercial
bias. Planning Committee members and speakers are
required to disclose the existence of any financial or
other relationship with the manufacturer(s) of any
commercial product(s) or provider(s) of any
commercial services discussed in an educational
presentation.
Any conflicts of interest are resolved prior to
participation. In addition to written disclosure,
presenters will disclose any vested interest or their
intention to discuss off-label use of pharmaceuticals
or devices, if applicable, to the audience at the
beginning of their presentation and in accordance
with ACCME standards and the Food and Drug
Administration requirements.
In an effort to increase transparency and easy access
to all disclosures, ASTRO’s Faculty, Committee and
Planner disclosure information will be available online
for the 2014 Annual Meeting. Go to the ASTRO
Annual Meeting Program Web page at
www.astro.org/soe14. In addition, disclosure slides
will be shown at the beginning of each session,
and every presenter is also required to display their
disclosure. Disclosure information will not be printed
in paper versions of the meeting materials.
DISCLAIMER
ASTRO is committed to the free exchange of
medical education. Inclusion of any presentation in
this program, including presentations of off-label
uses, does not imply an endorsement by ASTRO of the
uses, products or techniques presented.
The information contained in this program is current
as of August 12, 2014, and is subject to change.
Program changes will be provided in an addendum
and posted online.
UPCOMING
ASTRO MEETINGS
Mark Your Calendars!
2015
ASTRO ANNUAL REFRESHER COURSE
March 6-8, 2015
The Roosevelt New Orleans
New Orleans
12TH ANNUAL ADVOCACY DAY
March 23-24, 2015
Renaissance Washington
Washington, D.C.
STATE OF THE ART RADIATION THERAPY
April 2015
Las Vegas
EXPLORING OPPORTUNITIES FOR RADIATION ONCOLOGY IN THE ERA OF BIG DATA
August 13-14, 2015
NIH Campus
Bethesda, Maryland
ASTRO 57TH ANNUAL MEETING
October 18-21, 2015
Henry B. Gonzalez Convention Center
San Antonio
BEST OF ASTRO
November 2015
San Diego
2016
MULTIDISCIPLINARY HEAD AND NECK CANCER SYMPOSIUM
February 18-20, 2016
JW Marriott Camelback Inn
Resort and Spa
Scottsdale, Arizona
7
2014 Committee Members
2014 Annual Meeting Steering Committee
ASTRO President
Bruce D. Minsky, MD
ASTRO President-elect
Lynn D. Wilson, MD, MPH, FASTRO
Annual Meeting Scientific Committee Chair
Benjamin Movsas, MD, FASTRO
Annual Meeting Scientific Committee Vice-chair
Catherine C. Park, MD
Annual Meeting Education Committee Chair
Brian G. Czito, MD
Annual Meeting Education Committee Vice-chair
Laura A. Dawson, MD
Education Council Chair
Theodore L. DeWeese, MD
Best of ASTRO Chair
8
2014 Annual Meeting Scientific Committee
Lynn D. Wilson, MD, MPH,
FASTRO, Chair
Benjamin Movsas, MD, FASTRO,
Vice-chair*
Kevin V. Albuquerque, MD
Kaled M. Alektiar, MD*
Jonathan Ashman, MD, PhD
Elizabeth H. Baldini, MD, MPH
Beth M. Beadle, MD, MPH
Justin E. Bekelman, MD*
Jennifer R. Bellon, MD*
Lawrence B. Berk, MD, PhD
Ramesh S. Bilimagga, MD
Kevin A. Camphausen, MD
A. Bapsi Chakravarthy, MD*
Allen M. Chen, MD
Ronald C. Chen, MD*
Indrin J. Chetty, PhD*
Deborah E. Citrin, MD
Louis S. Constine, MD, FASTRO
Bouthaina Dabaja, MD*
Shari Damast, MD*
Indra J. Das, PhD, FASTRO
Roy H. Decker, MD, PhD
Jun Deng, PhD
Lorraine Drapek, MSN, NP
Jason A. Efstathiou, MD, PhD*
Suzanne B. Evans, MD
Felix Y. Feng, MD*
Gary M. Freedman, MD
James Alan Hayman, MD, MBA*
Alice Y. Ho, MD
Rojyman Jacob, MD
Salma Jabbour, MD
David A. Jaffray, PhD
Lisa A. Kachnic, MD
Jonathan P.S. Knisely, MD
Alexander Lin, MD*
Bo Lu, MD, PhD
Stephen Thomas Lutz, MD
Anand Mahadevan, MD*
Anita Mahajan, MD
Robert C. Miller, MD, MS
Drew Moghanaki, MD
Aswatha Narayana, MD
Harald Paganetti, PhD
Arnold C. Paulino, MD*
Kenneth Rosenzweig, MD*
Lakshmi Santanam, PhD
Farzan Siddiqui, MD, PhD
Ben J. Slotman, MD, PhD
Benjamin D. Smith, MD
Alexander Spektor, MD, PhD
Akila N. Viswanathan, MD*
Stephanie E. Weiss, MD*
Maria Werner-Wasik, MD
* Track Chair
2014 Annual Meeting Education Committee
Catherine C. Park, MD, Chair*
Brian Czito, MD, Vice-chair*
James Balter, PhD*
Changhu Chen, MD
Robert B. Den, MD
Thomas J. Dilling, MD
B. Ashleigh Guadagnolo, MD,
MPH*
Daniel A. Hamstra, MD, PhD
David Hodgson, MD
Alice Y. Ho, MD
Janet K. Horton, MD
Kun (Kim) Huang, MD*
Jordan R. Kharofa, MD
Krystyna D. Kiel, MD
Patrick A. Kupelian, MD*
Joshua D. Lawson, MD*
Harvey J. Mamon, MD, PhD
Martha M. Matuszak, PhD
Karen J. Marcus, MD
Brian Marples, PhD
Loren K. Mell, MD
Arno J. Mundt III, MD, FASTRO
Andrea K. Ng, MD, MPH*
Christopher F. Njeh, PhD
George Rodrigues, MD, PhD
Narayan Sahoo, PhD
Roy B. Tishler, MD, PhD*
Christina Irene Tsien, MD
Akila Viswanathan, MD, MPH*
Michelle Wallace, OCN, BSN,
RN, CCRP
George D. Wilson, PhD
Suzanne L. Wolden, MD*
Min Yao, MD, PhD
James B. Yu, MD*
*Track Chair
2014 Annual Meeting Press Planning Team
David C. Beyer, MD, FASTRO
Brian Czito, MD
Laura A. Dawson, MD
Paul M. Harari, MD, FASTRO
Bruce D. Minsky, MD
9
2014 Abstract Reviewers
Thank You
May Abdel-Wahab, MD, PhD
Nzhde Agazaryan, PhD
Salahuddin Ahmad, PhD
Peter Ahn, MD
Parham Alaei, PhD
Kevin V. Albuquerque, MD**
Kaled M. Alektiar, MD*
Berthe Aleman, MD, PhD
Brian M. Alexander, MD
Ozer Algan, MD
Penny R. Anderson, MD
Christopher J. Anker, MD
Jonathan Ashman, MD, PhD**
Richard L. Bakst, MD
Elizabeth H. Baldini, MD, MPH
Peter Balter, PhD
Voichita Bar Ad, MD
Christopher Barker, MD
Beth Beadle, MD, PhD
Clair Beard, MD
Jonathan Beitler, MD, MBA, FASTRO
Justin Bekelman, MD*
Jennifer R. Bellon, MD*
Ross Berbeco, PhD
Sushil Beriwal, MD
Lawrence Berk, MD, PhD**
Matthew Biagioli, MD, MS
Ramesh Bilimagga, MD
Ranjit Bindra, MD, PhD
Jean-Pierre Bissonnette, PhD
Seth Blacksburg, MD, MBA
James Bonner, MD, FASTRO
Alberto Bossi, MD
J. Daniel Bourland, PhD
Kristin Bradley, MD
Kristy Brock, PhD
Michael Buckstein, MD, PhD
Kevin Camphausen, MD
David Carlson, PhD
Jimmy Caudell, MD, PhD
Keith Cengel, MD, PhD
Laura Cervino, PhD
A. Bapsi Chakravarthy, MD*
Daniel Chamberlain, MD
Brian W. Chang, MD
Eric Lin Chang, MD
Joe Y. Chang, MD, PhD, MS
Aileen Chen, MD
Lili Chen, PhD
Peter Y. Chen, MD
Ronald C. Chen, MD*
Bhisham Chera, MD
Indrin J. Chetty, PhD*
Junzo Chino, MD
Seungtaek Choi, MD
Ananya Choudhury, MD, MB, PhD
Peter Chung, MBChB
Jay P. Ciezki, MD
Deborah E. Citrin, MD**
John J. Coen, MD
C. Norman Coleman, MD, FASTRO
10
Louis S. Constine, MD, FASTRO
Brett W. Cox, MD
Gilles Crehange, MD, PhD
Bruce H. Curran, MS
Bouthaina Dabaja, MD*
Megan E. Daly, MD
Shari Damast, MD*
Parima Daroui, MD, PhD
Indra J. Das, PhD, FASTRO
Prajnan Das, MD, MS
Laura A. Dawson, MD
Ellen E. Day, PhD
Joseph O. Deasy, PhD
Alicia DeCaria, BSN, RN, NE-BC
Roy H. Decker, MD, PhD
Andre Dekker, PhD
John DeMarco, PhD
Sonja Dieterich, PhD
Thomas A. DiPetrillo, MD
Nesrin Dogan, PhD
Jadranka Dragovic, MD
Lorraine C. Drapek, MSN, NP*
Warren D’Souza, PhD, MBA
Cheryl R. Duzenli, PhD
Jason A. Efstathiou, MD, PhD*
John P. Einck, MD
Rodney J. Ellis, MD
Mohamed A. Elshaikh, MD
Natia Esiashvili, MD
Andrew J. Evans, MD
Suzanne B. Evans, MD**
Bruce A. Faddegon, PhD
Alysa M. Fairchild, MD
Steven J. Feigenberg, MD
Felix Y. Feng, MD*
Steven E. Finkelstein, MD
Robert L. Foote, MD, FASTRO
Eric C. Ford, PhD
Kenneth M. Forster, PhD
Barbara L. Fowble, MD, FASTRO
Benedick A. Fraass, PhD, FASTRO
Steven J. Frank, MD
David Kassler Gaffney, MD, PhD
Thomas J. Galloway, MD
Yolanda Garces, MD
Hiram A. Gay, MD
John P. Gibbons, PhD
Carri Glide-Hurst, PhD
Daniel R. Gomez, MD
Alexander R. Gottschalk, MD, PhD
Phillip J. Gray, MD
Katherine L. Griem, MD
Inga S. Grills, MD
B. Ashleigh Guadagnolo, MD, MPH
Thomas M. Guerrero, MD, PhD
Vishal Gupta, MD
Marilyn L. Haas, PhD
Daphne A. Haas-Kogan, MD
Michael G. Haddock, MD
Karl E. Haglund, MD, PhD
to the 2014
Abstract Reviewers
Stephen M. Hahn, MD, FASTRO
Lia M. Halasz, MD
Christopher L. Hallemeier, MD
Michele Yvette Halyard, MD
Daniel A. Hamstra, MD, PhD
James E. Hansen, MD
Paul M. Harari, MD, FASTRO
James Alan Hayman, MD, MBA*
Mark A. Henderson, MD
Joseph M. Herman, MD, MS
Michael G. Herman, PhD
Susan M. Higgins, MD, MS
Alice Y. Ho, MD**
David Hodgson, MD
Karen E. Hoffman, MD
Theodore S. Hong, MD
Bradford S. Hoppe, MD
Dimitre H. Hristov, PhD
I-Chow Joe Hsu, MD
Arthur Y. Hung, MD
Margie A. Hunt, MS
Mark David Hurwitz, MD
Zain A. Husain, MD
Geoffrey S. Ibbott, PhD, FASTRO
Timothy Illidge, MD, PhD
Daniel J. Indelicato, MD
Salma K. Jabbour, MD**
Rojymon Jacob, MD
Jian-Yue Jin, PhD
Ellen L. Jones, MD, PhD
Mitchell Kamrava, MD
Christopher R. Kelsey, MD
Atif J. Khan, MD
Krystyna D. Kiel, MD
Catherine S. Kim, MD
Jinkoo Kim, PhD
Randall J. Kimple, MD, PhD
Christopher R. King, MD, PhD
David G. Kirsch, MD, PhD
Eric E. Klein, PhD, FASTRO
Jonathan P.S. Knisely, MD**
Albert C. Koong, MD, PhD
David E. Kozono, MD, PhD
Matthew Krasin, MD
Daniel J. Krauss, MD
Jon J. Kruse, PhD
Gregory J. Kubicek, MD
Patrick A. Kupelian, MD
Marikki Laiho, MD, PhD
Brian E. Lally, MD
Jerome C. Landry, MD, MBA
Joshua D. Lawson, MD
Andrew K. Lee, MD, MPH
Larissa J. Lee, MD
Nancy Lee, MD
Percy Lee, MD
W. Robert Lee, MD, MS, MEd
Zuofeng Li, DSc
Jay J. Liao, MD
Zhongxing Liao, MD
Alexander Lin, MD*
Lilie Lin, MD
Steven Lin, MD, PhD
Holly Lincoln, MS
Dale W. Litzenberg, PhD
Arthur K. Liu, MD, PhD
Chihray Liu, PhD
Fei-Fei Liu, MD
Simon S. Lo, MBChB
Daniel Low, PhD
John N. Lukens, MD
Stephen Thomas Lutz, MD
Gary Luxton, PhD
C.M. Charlie Ma, PhD
Anand Mahadevan, MD*
Anita Mahajan, MD
Raymond H. Mak, MD
Harvey J. Mamon, MD, PhD
Sheida Mani, MD
Karen J. Marcus, MD
Danielle N. Margalit, MD, MPH
Rufus J. Mark, MD
Mary K. Martel, PhD, FASTRO
Neil E. Martin, MD
Malcolm D. Mason, MD
Jyoti S. Mayadev, MD
Susan McCloskey, MD, MSHS
Beryl McCormick, MD, FASTRO
Todd R. McNutt, PhD
Sanford Meeks, PhD
William M. Mendenhall, MD
Joshua E. Meyer, MD
Dimitris N. Mihailidis, PhD
N. George Mikhaeel, MD, MBChB
Michael T. Milano, MD, PhD
Robert C. Miller, MD, MS
James B. Mitchell, PhD, FASTRO
Drew Moghanaki, MD**
Gerard Morton, MD
Sabin B. Motwani, MD
Benjamin Movsas, MD, FASTRO*
Michael T. Munley, PhD
Jean L. Nakamura, MD
Ashwatha Narayana, MD**
Christopher F. Njeh, PhD
Mark Oldham, PhD
Michael O’Neill, MD
Harald Paganetti, PhD**
David A. Palma, MD, PhD
Jatinder R. Palta, PhD, FASTRO
Bhupesh Parashar, MD
William Parker, MS
Upendra Parvathaneni, MD
Abhijit A. Patel, MD, PhD
Shilpen A. Patel, MD
Arnold C. Paulino, MD*
Todd Pawlicki, PhD
Charles A. Pelizzari, PhD
Stephanie M. Perkins, MD
Ivy A. Petersen, MD
Mark H. Phillips, PhD
Jean-Philippe Pignol, MD, PhD
Matthew B. Podgorsak, PhD
Alan Pollack, MD, PhD
Richard Popple, PhD
Louis Potters, MD, FASTRO
Jean Pouliot, PhD
Deepak G. Pradhan, MD
Robert A. Price, PhD
Rinaa S. Punglia, MD, MPH
David Raben, MD
Dirk Rades, MD
Abram Recht, MD, FASTRO
Lei Ren, PhD
Ramesh Rengan, MD, PhD
Nadeem Riaz, MD, MS
Andreas Rimner, MD
Mark J. Rivard, PhD
Mack Roach, MD
Kenneth B. Roberts, MD
George Rodrigues, MD, PhD
Kenneth Rosenzweig, MD*
Mihaela Rosu, PhD
Christian Rube, MD
Samuel Ryu, MD
Bill J. Salter, PhD
Lakshmi Santanam, PhD
Amit Sawant, PhD
Tracey Schefter, MD
Julie K. Schwarz, MD, PhD
Joao Seco, PhD
Jan Seuntjens, PhD
Simona Shaitelman, MD
Renu Sharma, MS
Michael B. Sharpe, PhD
Nathan C. Sheets, MD, MS
Xinglei Shen, MD
Ke Sheng, PhD
David J. Sher, MD, MPH
Helen A. Shih, MD, MS, MPH
Timothy N. Showalter, MD
Hui-Kuo George Shu, MD, PhD
Farzan Siddiqui, MD, PhD**
Jeffrey Siebers, PhD
Charles B. Simone, MD
Ramon Alfredo Siochi, PhD
Heath D. Skinner, MD, PhD
Ben J. Slotman, MD, PhD
William Small, MD, FASTRO
DeeDee K. Smart, MD, PhD
Grace L. Smith, MD, PhD, MPH
Danny Song, MD
William Y. Song, PhD
Luis Souhami, MD, FASTRO
Lena Specht, MD, PhD
Corey Speers, MD, PhD
Sharon A. Spencer, MD
Matthew H. Stenmark, MD
Kevin Stephans, MD
Robin L. Stern, PhD
Gita Suneja, MD
Mohan Suntharalingam, MD, MBA
Samuel D. Swisher-McClure, MD
Alphonse G. Taghian, MD, PhD
James A. Tanyi, PhD
Randall K. Ten Haken, PhD, FASTRO
Joel E. Tepper, MD, FASTRO
Welela Tereffe, MD
Stephanie A. Terezakis, MD
Juliette O. Thariat, MD, PhD, MS
Charles R. Thomas, MD
Wade L. Thorstad, MD
Wolfgang A. Tome, PhD
Mylin Torres, MD
Minh Tam Truong, MD
Christina Irene Tsien, MD
Katherine S. Tzou, MD
James J. Urbanic, MD
Riccardo Valdagni, MD, PhD
Neha Vapiwala, MD
Andrew D. Vassil, MD
Akila N. Viswanathan, MD, MPH*
Sujay Vora, MD
Eleanor M. Walker, MD
Michelle Wallace, OCN, BSN, RN, CCRP
Andrew Z. Wang, MD
Brian Wang, PhD
Dian Wang, MD, PhD
David E. Wazer, MD, FASTRO
Joanne B. Weidhaas, MD, PhD
Stephanie E. Weiss, MD*
Maria Werner-Wasik, MD**
Julia R. White, MD
Henning Willers, MD
Christopher G. Willett, MD, FASTRO
Karen M. Winkfield, MD, PhD
Jennifer Y. Wo, MD
Julia S. Wong, MD
Rebecca Wong, MBChB
Wendy A. Woodward, MD, PhD
Jean L. Wright, MD
Qiuwen Wu, PhD
Ping Xia, PhD
Ying Xiao, PhD
Lei Xing, PhD
Theodore E. Yaeger, MD
Di Yan, DSc
Gary Y. Yang, MD
Johnny Yap, MD
Catheryn M. Yashar, MD, OCN
Torunn I. Yock, MD, MCH
Sue S. Yom, MD, PhD
Ellen D. Yorke, PhD
David S. Yu, MD, PhD
James Yu, MD
Jennifer B. Yu, MD, PhD
Yan Yu, PhD, MBA
Almudena Zapatero, MD, PhD
Richard Cedric Zellars, MD, DO
Tiezhi Zhang, PhD
Timothy C. Zhu, PhD
Key
* Track chair
** Track co-chair/vice-chair
2014 Session Reviewers
Thank You
Kaled M. Alektiar, MD
James Balter, PhD
Justin Bekelman, MD
Jennifer R. Bellon, MD
A. Bapsi Chakravarthy, MD
Ronald C. Chen, MD
Indrin J. Chetty, PhD
Brian Czito, MD
Bouthaina Dabaja, MD
Shari Damast, MD
Laura A. Dawson, MD
Jason A. Efstathiou, MD, PhD
Thomas J. Eichler, MD, FASTRO
Felix Y. Feng, MD
B. Ashleigh Guadagnolo, MD
12
Carol A. Hahn, MD
James Alan Hayman, MD, MBA
Kun (Kim) Huang, MD
Geraldine Jacobson, MD, MBA, MPH,
FASTRO
Brian Kavanagh, MD
Patrick A. Kupelian, MD
Joshua Lawson, MD
Alexander Lin, MD
Anand Mahadevan, MD
Lawrence B. Marks, MD, FASTRO
Brian Marples, PhD
Mary K. Martel, PhD, FASTRO
Bruce D. Minsky, MD
to the 2014
Session Reviewers
Bharat B. Mittal, MD, FASTRO
Andrea K. Ng, MD, MPH
Arnold C. Paulino, MD
Ken Rosenzweig, MD
Roy B. Tishler, MD, PhD
Akila N. Viswanathan, MD, MPH
Michelle Wallace, OCN, BSN, RN
Joanne B. Weidhaas, MD, PhD
Stephanie E. Weiss, MD
George D. Wilson, PhD
Suzanne L. Wolden, MD
Ying Xiao, PhD
James B. Yu, MD
Gold Medal Recipients
Join us in honoring
the distinguished
leaders in our field at the
2014 ASTRO
The Gold Medal is ASTRO’s highest honor
bestowed on revered members who have made
outstanding contributions to the field of
radiation oncology.
Awards
Ceremony
Tuesday, September 16
10:15 a.m. – 11:30 a.m.
2014 GOLD MEDALISTS
MARY K. GOSPODAROWICZ, MD, FASTRO
Dr. Gospodarowicz is the medical director of the Princess Margaret
Cancer Centre at the University Health Network in Toronto and professor
of radiation oncology at the University of Toronto. She has had a major
impact on several areas of radiation oncology, including the treatment
of malignant lymphomas and genitourinary cancers, global health and
the use of radiation therapy treatment worldwide, and the mentoring
of trainees. She is currently the president of the Union for International
Cancer Control (UICC), an international organization dedicated to
helping the global health community reduce the worldwide cancer
burden.
LEONARD L. GUNDERSON, MD, MS, FASTRO
Dr. Gunderson is an emeritus professor and consultant in the
department of radiation oncology at the Mayo Clinic, as well as a former
Chair of ASTRO’s Board of Directors. He has made significant
contributions to radiation oncology through research and clinical
practice in gastrointestinal cancers (colorectal, gastric/GE junction,
biliary, pancreas and anal) and soft tissue sarcomas (extremity,
retroperitoneal). His research has focused on defining the indications for
and results of external bean irradiation as a component of
multi-modality treatment, alone or in conjunction with surgical
resection and systemic therapy.
NANCY J. TARBELL, MD, FASTRO
Dr. Tarbell is the dean for academic and clinical affairs at Harvard Medical
School in Boston and the C.C. Wang Professor of Radiation Oncology at
Harvard Medical School and Massachusetts General Hospital in Boston. She
is an internationally recognized expert in pediatric oncology and radiation
therapy. Her research has examined ways to provide curative treatment
programs for children with malignant disease and to develop effective
strategies to decrease the late effects of treatment.
13
Fellow Recipients
The ASTRO Fellow designation honors those who have been an Active or Emeritus Member of
ASTRO for at least 15 years, have given the equivalent of 10 years of service to ASTRO and have
made significant contributions to the field of radiation oncology.
ASTRO PROUDLY RECOGNIZES THE 2014 CLASS OF FELLOWS
•
John M. Buatti, MD, University of Iowa, Iowa City, Iowa
•
Thomas F. DeLaney, MD, Massachusetts General Hospital, Boston
•
Adam Dicker, MD, PhD, Thomas Jefferson University, Philadelphia
•
Avraham Eisbruch, MD, University of Michigan, Ann Arbor, Michigan
•
Eduardo Fernandez, MD, PhD, 21st Century Oncology, Plantation, Florida
•
David Gaffney, MD, PhD, University of Utah/Huntsman Cancer Hospital, Salt Lake City
•
Adam S. Garden, MD, MD Anderson Cancer Center, Houston
•
Katherine L. Griem, MD, Rush University Medical Center, Chicago
•
William F. Hartsell, MD, Radiation Oncology Consultants Ltd., Warrenville, llIinois
•
James Alan Hayman, MD, MBA, University of Michigan, Ann Arbor, Michigan
•
I-Chow Joe Hsu, MD, University of California, San Francisco
•
Lisa Kachnic, MD, Boston Medical Center, Boston
•
Brian Kavanagh, MD, MPH, University of Colorado Cancer Center, Aurora, Colorado
•
Timothy Kinsella, MD, MS, MA (ad eundem), Warren Alpert Medical School of Brown University,
Providence, Rhode Island
•
Andre Konski, MD, MBA, MA, University of Pennsylvania, West Chester, Pennsylvania
•
Patrick Kupelian, MD, University of California, Los Angeles
•
Quynh-Thu Le, MD, Stanford University, Stanford, California
•
W. Robert Lee, MD, MS, MEd, Duke University School of Medicine, Durham, North Carolina
•
Stephen Lutz, MD, Blanchard Valley Regional Cancer Center, Findlay, Ohio
•
Chang Ming Charlie Ma, PhD, Fox Chase Cancer Center, Philadelphia
•
Bruce D. Minsky, MD, MD Anderson Cancer Center, Houston
•
Najeeb Mohideen, MD, Northwest Community Hospital, Arlington Heights, llIinois
•
Simon N. Powell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
•
Mack Roach III, MD, University of California, San Francisco
•
Kenneth E. Rosenzweig, MD, Icahn School of Medicine at Mount Sinai, New York
•
Christopher J. Schultz, MD, Medical College of Wisconsin, Milwaukee
•
Dennis C. Shrieve, MD, PhD, University of Utah School of Medicine, Salt Lake City
•
Paul W. Sperduto, MD, MPP, Minneapolis Radiation Oncology, Waconia, Minnesota
•
Maria Werner-Wasik, MD, Thomas Jefferson University Hospital, Philadelphia
•
Jeffrey F. Williamson, PhD, Virginia Commonwealth University, Richmond, Virginia
Class of 2013 Fellows
Silvia Chiara Formenti, MD, Phillip M. Devlin, MD, Peter B. Schiff, MD, PhD, Bhudatt R. Paliwal, PhD,
Jonathan J. Beitler, MD, MBA, Geraldine M. Jacobson, MD, MPH, MBA, Seth Rosenthal, MD, Tariq A. Mian, PhD,
Thomas J. Eichler, MD, and Stephen M. Hahn, MD
Honorary Member Recipient
Honorary Membership is awarded annually to a distinguished cancer researcher
or leader in a discipline other than radiation oncology, radiation physics or
radiobiology.
2014 HONORARY MEMBER
ANGELITA HABR-GAMA, MD, PHD
Dr. Habr-Gama is internationally recognized for her work in
developing and supporting selective nonoperative treatment
approaches for rectal cancer. She founded the Division of
Coloproctology at the University of Sao Paulo School of Medicine, and
has been a member of the Board of the Oncology Foundation of Sao
Paulo since 1990. Dr. Habr-Gama is a strong advocate for the role of
radiation therapy in rectal cancer treatment. Dr. Habr-Gama is
professor of surgery at the University of Sao Paulo School of Medicine
and staff surgeon of coloproctological surgery at Hospital Alemao
Oswaldo Cruz in Sao Paulo, Brazil.
15
Annual Meeting Abstract Awards
2014 ASTRO ANNUAL MEETING AWARD RECIPIENTS
RESIDENT CLINICAL/BASIC SCIENCE RESEARCH AWARD
Andrew Sharabi, MD, PhD (Radiation and Cancer Biology)
Madhu Sudhan Reddy Gudur, PhD (Radiation Physics)
Stephanie Markovina, MD, PhD (Clinical)
RESIDENT DIGITAL POSTER RECOGNITION AWARD
Pranshu Mohindra, MD (Radiation and Cancer Biology)
Adam Gladwish, MD (Radiation Physics)
Kim Cao, MD (Clinical)
RESIDENT POSTER VIEWING RECOGNITION AWARD
Clinical
Steven Sckolnik, MD (1st place)
Jessica Zhou, MD (2nd place)
Thomas Mullen, MD, PhD (3rd place)
Radiation and Cancer Biology
Nils Nicolay, MD, PhD (1st place)
Kate Barrett, MD, BS (2nd place)
Chi Zhang, MD, PhD (3rd place)
Radiation Physics
Paul Romesser, MD (1st place)
Roohi Gupta, PhD (2nd place)
Ziad Simon Fawaz, MD (3rd place)
BASIC SCIENCE ABSTRACT AWARD
Masayuki Matsuo, MD, PhD
Everett Moding, BS
Ngoc Pham, BS
Corey Speers, MD, PhD
Daniel Spratt, MD, BS
Radiation Physics
Ganiyu Asuni, PhD
Jeremy Booth, PhD
Fiona Hegi-Johnson, MBBS
Xia Li, PhD
Yana Zlateva, MS
ANNUAL MEETING TRAVEL AWARD
Clinical
Kamran Ahmed, MD
Ben Creelan, MD
Clement Ho, MD, MS
Anthony Paravati, MD, MBA
John Vargo, MD
Miran Blanchard, MD
Nevine Hanna, MD, MPH
Amanda Walker, MD
Christopher Wright, BS
Zachary Zumsteg, MD
Radiation Physics
Olivia Kelada, MS, BS
Yilin Liu, PhD
Jan Schuemann, PhD
Almut Troeller, MS
Stephen Yip, PhD
INTERNATIONAL – U.S. ANNUAL MEETING SCIENTIFIC ABSTRACT AWARD
Yun Chiang, MD
ANNUAL MEETING NURSE ABSTRACT AWARD
Chiaki Fujioka, RN
Diane Serra, MS, RN
General Information
ASTROmobile – Official Meeting App
Concessions
Industry-Expert Theater
Posters
Shuttle Bus Schedule
Moscone Center Floor Plans
General Information
INSIDE:
General Information
,ZDVWROG,ZRXOG
QHYHUJRWRXQLYHUVLW\«
Thanks to PROTON THERAPY, Mary, physics graduate, is living a normal life
in Oxford, UK. She was diagnosed with a medulloblastoma in 1997.
More about Proton Therapy treatment for Medulloblastoma
With the support of
Article: St. Clair et al, Int. J. Radiation Oncology Biol. Phys.,
Vol. 58, No. 3, pp. 727–734, 2004
Clinical trial: Proton Beam Radiotherapy for Medulloblastoma
and Pineoblastoma/ NCT01063114 - http://clinicaltrials.gov
www.iba-protontherapy.com/why-proton-therapy
The clinical information provided is indicative and is not intended to replace medical advice offered by
physicians. The publishers make no representations or warranties with respect to any treatment or action,
by any person following the information offered or provided. The publishers will not be liable for any direct,
indirect, consequential, special, exemplary, or other damages arising therefrom.
Although inspired from real cancer patient stories, characters appearing in this work are fictitious. Any
resemblance to real persons, living or dead, is purely coincidental.
General Information
MOSCONE CENTER NORTH AND SOUTH
747 Howard St.
San Francisco, CA 94103
www.moscone.com
All activities take place in Moscone Center North and
South unless otherwise stated. All information is
correct as of August 14, 2014, and is subject to change.
ATTENDEE REGISTRATION
North Lobby
ATTENDEE REGISTRATION HOURS
Saturday, September 13
Sunday, September 14
Monday, September 15
Wednesday, September 17
8:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 2:00 p.m.
ABSTRACTS AND EMBARGO POLICY
The full text of the abstracts selected for oral and
poster presentation are available on the Annual
Meeting Online Conference Planner and
ASTROmobile beginning Saturday, September 13.
All abstracts are published in a supplement of
the September 1, 2014, issue of the International
Journal of Radiation Oncology • Biology • Physics
(www.redjournal.org).
All abstracts are embargoed and remain
confidential until the date and time of
presentation at the Annual Meeting. If you have
any questions about the embargo policy, please
contact ASTRO’s Media Relations Manager,
Michelle Kirkwood, at 703-286-1600 or
press@astro.org.
EXHIBITOR REGISTRATION
South Lobby
EXHIBITOR REGISTRATION HOURS
Thursday, September 11
Friday, September 12
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
19
AFFILIATE MEETINGS
38TH ASRT RADIATION THERAPY CONFERENCE
September 14-16, 2014
Hilton San Francisco Union Square
The 38th Annual ASRT Radiation Therapy Conference will take place
at the Hilton San Francisco Union Square. ASTRO registered attendees may attend
ASRT sessions by paying a reduced registration fee of $195. Proof of registration
(registration confirmation or badge) is required to receive this reduced rate. If you
have not registered to attend the ASRT conference but would like to do so, please
register on-site at the Hilton San Francisco Union Square.
31ST SROA ANNUAL MEETING
September 14-17, 2014
Hyatt Regency San Francisco
The 31st SROA Annual Meeting will take place at the Hyatt Regency San Francisco.
ASTRO registered attendees may attend the SROA general sessions by paying a
reduced registration fee of $210. Proof of registration (registration confirmation or
badge) is required to receive this reduced rate. If you have not registered to attend
the SROA conference but would like to do so, please register on-site at the
Hyatt Regency San Francisco.
C NNECT
South Lobby
ASTRO Connect is the perfect place to RECHARGE, RELAX
and REVIVE. This networking lounge offers an area to
charge your devices, network with colleagues, have
informal meetings, make new connections within the
radiation oncology community and check in on social
media sites.
Funded in part by Elekta
20
Connect with attendees.
Tweet
#ASTRO14
ASTRO CAREER FAIR
ASTRO RESOURCE CENTER
Rooms 250-262
Take advantage of the ASTRO Career Fair to connect
with candidates for employment. Equipped with
computers and printers for your convenience, the
Career Fair is available for employers to conduct
interviews with job applicants. Employers and
applicants must register through the online ASTRO
Career Center in order to schedule interviews at the
on-site Career Fair.
North Lower Lobby, Outside Hall D
Visit the ASTRO Resource Center, located outside Hall
D. Here you can learn about ASTRO member benefits
and get information on new programs such as APEx:
Accreditation Program for Excellence and RO-ILS:
Radiation Oncology Incident Learning SystemTM. You
can also pick up materials on upcoming educational
meetings and webinars, patient advocacy and more.
ASTRO’s knowledgeable staff will be on hand to
answer any questions about ASTRO membership. A
professional photographer will be available during
designated hours so that you can get your picture
taken and uploaded to the ASTRO membership
directory. The Survivor Circle is also located in the
Resource Center.
Hours of Operation:
3:00 p.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
Private interview rooms are also available. These
rooms are ideal if you have multiple interviews to
conduct or just need more privacy. A limited
number of meeting rooms are available for
three-hour periods Saturday, September 13 through
Tuesday, September 16. For more information,
contact Todd Karstaedt at toddk@astro.org.
Hours of Operation:
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 12:00 p.m.
ASTRO PAC LOUNGE
North Lower Lobby, Across from CE Central
ASTRO’s political action committee (PAC) is offering
access to an exclusive lounge for all ASTRO members
who have donated to the ASTRO PAC in 2014. The
PAC lounge will feature Internet access, coffee and
beverages, food and a place to rest between
sessions. Members who have not made their
contribution yet will be able to donate on-site.
ASTRO PAC provides ASTRO with the opportunity to
more fully participate in government and ensure our
members’ voices are being heard by key policy
makers on Capitol Hill. Be sure to stop by the lounge
to get the most recent legislative and election
updates. For more information, please email
shandib@astro.org or visit
www.astro.org/ASTROPAC.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:30 p.m.
Happy Hour and Legislative Issue Forum (Room 114)
4:30 p.m. - 5:30 p.m.
10:00 a.m. - 5:00 p.m.
21
ASTROmobile – Your Annual Meeting Guide
ASTROmobile gives you access to the meeting
program and the ability to customize your meeting
experience with personalized maps and planners.










Search sessions by day, track or speaker.
Search exhibitors by name, booth number or product/service
category.
Locate sessions and exhibitors with customized maps.
Search and view the full abstracts.
Preview general meeting information.
Access “MyPlan” – your personal Annual Meeting schedule.
View convention center maps.
Take notes on a session or exhibitor and access your notes from
your mobile device.
Exchange messages with colleagues attending the meeting
using Find-a-Friend.
Integrates with the Online Conference Planner.
Please note that all information in the final program is available
on ASTROmobile.
ASTROmobile Login Instructions
An account has been created for all registered attendees. Please log in as follows:
iPhone Users
Droid Users
Smartphone Users
1. Download
“ASTROmobile14” from the
App Store.
1. Download
“ASTROmobile14” from the
Google Play store.
1. Go to www.astro.org/
ASTROmobile in your mobile
web browser.
2. Log in with the following
credentials:
credentials:
credentials:
Registration ID: Badge Number
Password: Last Name
Email ID: Email Address
Password: Last Name
Email ID: Email Address
Password: Last Name
Smartphone users can also access ASTROmobile using a QR Code reader and the QR Code to the right.
Login Tips
Your badge number is located on the front of your badge. Your email address is the email that you
provided at the time of registration. Your last name must match the spelling on your badge.
22
BUSINESS CENTER
CE CENTRAL
South Lower Lobby
The business center is conveniently located in the
South Lower Lobby of Moscone Center. The business
center offers a variety of services including packing
and shipping, sign production, copying and office
supplies.
Outside Hall E
Staff from ASTRO and the ABR will be on hand
during the meeting to answer your individual
questions about continuing education and MOC
requirements.
Hours of Operation:
8:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
BUSINESS MEETING
Tuesday, September 16, 2014
11:30 a.m. - 1:00 p.m.
Room 102/103
ASTRO voting members (Active, Affiliate, Allied or
International members) are invited to attend the
Business Meeting on Tuesday, September 14 from
11:30 a.m. - 1:00 p.m. Leaders of the Society will
discuss topics of interest to ASTRO members. You
should not miss this important meeting. Lunch will
be served.
CE Central computer stations allow you to:
•
Complete your continuing education and
meeting evaluation.
•
View/print a session tracking form.
•
Search abstracts.
•
Search exhibitors.
•
Update your Online Conference Planner.
Hours of Operation:
8:30 a.m. - 6:00 p.m.
7:30 a.m. - 6:30 p.m.
7:30 a.m. - 6:00 p.m.
7:30 a.m. - 6:30 p.m.
7:30 a.m. - 5:00 p.m.
Great Meeting?
Tweet
#ASTRO14
23
CONCESSIONS
A number of food concession outlets are located in
the Exhibit Hall and in the North and South Lower
Lobbies so that attendees can grab a cup of coffee,
sandwich or salad. The electronic food and
beverage card that you received with your
registration materials can only be used at the food
outlets in the Exhibit Hall.
MC COFFEE
South Lower Lobby
MC Coffee offers a variety food and beverage items
such as coffee, soft drinks and grab and go breakfast
and lunch meals.
Hours of Operation:
7:00 a.m. - 3:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 3:00 p.m.
SAVOR EXPRESS
South Lower Lobby
Savor Express offers a variety of beverages, grab and
go lunch and snack items.
Hours of Operation:
Hours of Operation:
7:00 a.m. - 3:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 3:00 p.m.
EXHIBIT HALL CONCESSIONS
Halls A-C
A number of concessions stands will be located
thoughout the Exhibit Hall. A variety of sandwiches,
salads, snacks and hot and cold beverages will be
available.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
ELECTRONIC FOOD AND BEVERAGE CARD
9:00 a.m. - 3:00 p.m.
MARKET SQUARE
South Lower Lobby
Market Square offers a variety of different grab and
go salads, sandwiches, beverages and snacks.
Hours of Operation:
CONCOURSE EXPRESSO
North Concourse
Concourse Expresso offers a variety of coffee, soft
drinks and grab and go breakfast and lunch items.
Attendees receive a $10 electronic food and
beverage card with their registration materials. This
card can be used for coffee and beverages as well
as food items located at concession stands in the
Exhibit Hall. This card will not be accepted at food
outlets outside of the Exhibit Hall. Lost cards will
not be replaced.
8:00 a.m. - 4:00 p.m.
8:00 a.m. - 4:00 p.m.
8:00 a.m. - 4:00 p.m.
ESPLANADE COFFEE CART
Esplanade Level, South Building
Located near the General Session, the Esplanade
Coffee Cart offers coffee and other hot beverages
and grab and go snacks.
Hours of Operation:
24
7:00 a.m. - 3:00 p.m.
7:00 a.m. - 3:00 p.m.
7:00 a.m. - 3:00 p.m.
Tweet
#ASTRO14
CYBER CAFÉ
FACULTY/VIP OFFICE
North and South Lobbies
ASTRO attendees can check email, browse the
Internet, print a boarding pass and registration
receipt, and much more at one of several computer
stations located in the North and South Lobbies.
Room 120
Faculty members and VIPs should check in at the
Faculty/VIP Office to pick up registration
materials and receive last-minute updates and
program changes. The Faculty/VIP Office is
conveniently located next to the Speaker Ready
Room. Faculty and VIPs are welcome in the
Faculty/VIP Office throughout the meeting.
Hours of Operation:
8:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
EXHIBIT HALL
Halls A-C
Learn about the latest products in cancer treatment
and care in the Exhibit Hall.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
EXHIBITOR PRODUCT INFORMATION
New this year, your registration badge will include
an Aztec code that contains your contact
information. This code can be scanned by
exhibitors in the Exhibit Hall so that you may request
information on products and services offered by the
company. Your contact information will include your
email address, unless you opted not to include it
during the registration process. Please stop by
Attendee Registration in the North Lobby if you
would like to change your contact information.
Faculty members include:
•
Educational session speakers.
•
Panel moderators and presenters.
•
Scientific program moderators and discussants.
•
eContouring Learning Lab presenters.
•
Presidential Symposium speakers.
•
Keynote speakers and introducers.
•
Nurses’ Program speakers.
•
International Symposium speakers.
Note: Presenters of abstracts are not classified as
faculty and should follow attendee registration
instructions.
Hours of Operation:
6:45 a.m. - 6:00 p.m.
6:45 a.m. - 6:15 p.m.
6:45 a.m. - 5:45 p.m.
6:45 a.m. - 6:15 p.m.
6:45 a.m. - 4:30 p.m.
FIRST AID
Across from Room 106
First Aid: 415-974-4090 or ext. 4090 from a
house phone
Building Emergency: Ext. 5111 from a house
phone
First aid is located across from Room 106 in Moscone
Center South. In an emergency, please dial ext.
5111 from a house phone, contact First Aid or go to
ASTRO Registration and have a staff person contact
security.
Sample Badge
Number
Aztec code
Hours of Operation:
Monday, September 8
Friday, September 12
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 8:00 p.m.
8:00 a.m. - 8:00 p.m.
7:00 a.m. - 8:00 p.m.
6:30 a.m. - 6:00 p.m.
7:00 a.m. - 7:00 p.m.
7:00 a.m. - 10:00 p.m.
7:00 a.m. - 8:00 p.m.
8:00 a.m. - 12:00 p.m.
INDUSTRY-EXPERT THEATER*
Exhibit Hall, Room 100
This activity allows companies to present their noteworthy products and
services through a live presentation in the Industry-Expert Theater located
in the Exhibit Hall. Seating is available on a first-come, first-served basis. The
Industry-Expert Theater content and views expressed therein are those of the
exhibitor and not of ASTRO.
*Industry-Expert Theaters are not accredited for continuing medical education credits.
SUNDAY, SEPTEMBER 14
Time: 12:15 p.m. – 1:15 p.m.
Precision in Practice: Optimizing
Outcomes and Expanding Applications
with Accuray
Company: Accuray
Contact: Rebecca Byrne
Phone: 408-334-7950
Box lunch provided.
MONDAY, SEPTEMBER 15
Time: 6:45 a.m. – 7:45 a.m.
Perirectal Spacers: Emerging
Technology and Impact on Future
Prostate RT Utilization
Company: Augmenix
Contact: Eileen Gardner
Phone: 508-944-8015
Box breakfast provided.
Time: 12:30 p.m. – 1:30 p.m.
The Therapeutic Application of Xofigo®
(radium Ra 223 dichloride) Injection
Company: Bayer HealthCare
Contact: Michelle Noyes
Phone: 862-404-5478
Box lunch provided.
Time: 10:15 a.m. – 10:45 a.m.
Exclusive: Pre-release screening
footage from the upcoming series
“Cancer: The Emperor of All Maladies”
by Award-Winning Executive Producer
Ken Burns
Company: Siemens
Contact: Jeffrey Bell, Sr. Manager, Media
Relations - Imaging and Therapy Systems
Phone: 484-868-8346
Refreshments provided.
TUESDAY, SEPTEMBER 16
6:45 a.m. – 7:45 a.m.
Clinical Advancements in
Electronic Brachytherapy for
Breast, Skin and Gynecological
Cancers
Company: Xoft Inc.
11:45 a.m. – 12:45 p.m.
Patient QA and Safety in
Modern Radiation Therapy
Company: ScandiDos
Contact: Marni Brown
Phone: 608-630-9415
Box lunch provided.
INDUSTRY SATELLITE SYMPOSIUM
6:00 p.m. – 9:30 p.m.
Proton Therapy:
Clinical Applications and Outcomes,
Delivery Methods and
Biologic Parameters
San Francisco Jazz Center
(Registration from 6:00 to 7:00 p.m.; reception to follow the conclusion of the program at 9:00 p.m.)
Accreditation: The University of Florida
College of Medicine is accredited by the
Accreditation Council for Continuing
Medical Education to provide continuing
medical education for physicians.
CME Credits: The University of Florida
College of Medicine designates this live
activity for a maximum of 2.0 AMA PRA
Category 1 Credits™. Physicians should
claim only the credit commensurate with
the extent of their participation in the
activity.
Target Audience: Radiation oncologists
actively involved in the management of
patients with cancer, physicists involved
in clinical medical physics, allied health
care professionals including but not
limited to nurses, therapists, dosimetrists,
and administrators.
This activity is hosted by the University of
Florida and is supported by a grant from IBA.
SEARCHING FOR QUALIFIED RADIATION
ONCOLOGY PROFESSIONALS?
Find them online on the ASTRO Career Center and
in San Francisco at the ASTRO Career Fair
Find the right people for your practice when
you use the ASTRO Career Center. Advance
features allow you to search our resume
database by education, title, location and more.
e.
Located in Rooms 250-262 at the Moscone
Center, the ASTRO Career Fair is a great
opportunity to interview qualified
candidates. Employer interview space at the
Career Fair is free for ASTRO members with
the purchase of an online Career Center
posting at www.astro.org/careercenter.
JOB SEEKERS
Indicate your availability
for an interview at the
Annual Meeting by selecting
the Career Fair option
on “MyAccount”
in Career Center.
INFORMATION DESK
Have a question? Stop by the Information Desk to
get your questions answered.
Hours of Operation:
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
Hearst Parking Center
45 Third Street
Entrance on Stevenson, two blocks from Moscone
North and South.
415-989-4000
Moscone Center Garage
255 Third Street
Folsom and Howard, across the street from Moscone
South’s Esplanade Ballroom.
415-777-2782 (garage)
415-538-7888 (office)
LOST AND FOUND
To report a missing item, to check to see if an item
has been turned into security or to turn in a lost
item, please stop by one of the Information Desks
located in the North and South Lobbies.
Museum Parc Garage
300 Third Street
Entrance on Third and Folsom Streets.
415-348-0304
Hours of Operation:
Rooms 110-111
Accredited journalists are provided with a press kit
and access to cover ASTRO’s 56th Annual Meeting.
For more information on-site about ASTRO’s Press
Program and Policies, please contact ASTRO’s on-site
Press Office at 415-978-3503 or email
press@astro.org.
PRESS OFFICE AND NEWS BRIEFINGS
8:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
LUGGAGE/COAT CHECK
North Lobby
Luggage and coat check will be available in the
North Lobby at Moscone Center for $2 per coat and
small handbag and $3 per luggage item.
Hours of Operation:
7:30 a.m. - 6:00 p.m.
6:00 a.m. - 6:30 p.m.
7:00 a.m. - 7:00 p.m.
7:00 a.m. - 6:30 p.m.
7:00 a.m. - 5:00 p.m.
PARKING
Moscone Center does not have a public parking
facility on the premises. Listed below are public
parking garages in close proximity to the facility,
each of which provide spaces reserved for use by
authorized, handicapped individuals.
Please note ASTRO does not validate for parking.
Fifth and Mission Parking Garage
833 Mission Street
Located between Fourth and Fifth Streets, adjacent
to Moscone West.
415-982-8522, ext. 18
28
Hours of Operation:
8:00 a.m. - 4:00 p.m.
8:00 a.m. - 4:00 p.m.
8:00 a.m. - 4:00 p.m.
8:00 a.m. - 12:00 p.m.
For ASTRO press information and policies, please
visit www.astro.org/AMpress.
REGISTRANT LOCATOR – FIND-A-FRIEND
Looking to connect with an attendee at the Annual
Meeting? You can now use our Find-a-Friend service
with ASTROmobile, the official Annual Meeting app.
Find-a-Friend allows you to search for an attendee
and send messages while at the Annual Meeting.
Posters
POSTER SETUP AND REMOVAL
POSTER VIEWING RECEPTION
Hall D
Poster Setup Hours
Hall D
12:00 p.m. - 5:00 p.m.
7:30 a.m. - 10:00 a.m.
Poster Removal Hours
5:00 p.m. - 7:00 p.m.
POSTER VIEWING
Hall D
New this year, digital posters and paper posters
will be on display during the poster viewing hours
below. Please note that digital posters will not be
available for viewing during digital poster discussion
session times as the screens will be used for these
sessions. See the schedule of events or use the
Online Conference Planner or ASTROmobile for the
digital poster session schedule.
Poster Viewing Hours
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 6:45 p.m.
10:00 a.m. - 5:00 p.m.
POSTER PICKUP OFFICE
Hall D
For those poster presenters who chose to use
ASTRO’s poster printing service, there is a special
pickup location in Hall D.
Hours of Operation:
12:00 p.m. - 5:00 p.m.
7:30 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
5:30 p.m. - 6:45 p.m.
All conference attendees are invited to attend this
poster viewing session and reception. During this
time, poster presenters are available by their poster
to answer questions and discuss their research.
Poster award winners are presented their awards
at the beginning of this session, and will provide
a short oral presentation of their abstract in the
poster presentation area within the hall. Each full
conference attendee, exhibitor and Monday one-day
conference attendee will receive one drink ticket
that can be used for one complimentary beverage at the Poster Viewing Session and Reception.
After your ticket has been redeemed, drinks will be
available for purchase. You must be 21 years of age
to consume alcoholic beverages. Your drink ticket
will be included with your badge in your registration
materials.
Poster Categories:
Biology
Breast
CNS
Gastrointestinal
Genitourinary
Gynecologic
Head and Neck
Health Services Research
History/Education
Informatics/Bioinformatics
Lung
Lymphoma/Hematologic/
Leukemia
Non-malignant
Nursing
Palliative Care
Patient-reported
Outcomes
Patient Safety
Pediatrics
Physics
Quality of Life
Sarcoma/Cutaneous
Tumors
DIGITAL POSTER SESSIONS
*NEW* Digital Poster Format
New this year, the Digital Poster Discussion sessions
will have a new format and sessions will be held in
the Poster Hall. Sessions will begin with 15 minutes of
poster viewing on monitors located outside of the session room. Attendees and presenters will then move
into the session room to hear brief four-minute oral
presentations from each poster presenter. The session
will end with discussant presentations that compare,
contrast and tie the abstracts together. The sessions
will take advantage of touch-screen technology to
present more in-depth information, and the monitor
structure has been redesigned to allow for easier
viewing and discussion with colleagues.
Digital Poster Presenters
Digital Poster Presenters must check-in at the Digital
Poster Discussion Check-in booth located in the
Poster Hall between the digital poster session rooms
at least two hours prior to your presentation.
Staff will be available to assist you with uploading any
last-minute changes and to help you prepare for your
oral presentation. Presenters are required to stand
by their poster for the first 15 minutes of the session.
Once the session begins presenters should sit in the
front row and wait for the Discussant to call you up to
the podium for your presentation.
PASSPORT PROGRAM
(As of July 31, 2014)
A special thank you to our Survivor Circle Passport Program Participants. Through their
generous donations, the Breast and Gyn Health Project and Kids Konnected received grants
to help support their initiatives helping California cancer survivors.
RADIATION ONCOLOGY INSTITUTE (ROI) BOOTH
North Lower Lobby, across from the ASTRO Resource Center
All Annual Meeting attendees are invited to visit the Radiation Oncology Institute (ROI) booth,
located near Hall D at Moscone Center. Learn more about ROI’s research initiatives and current projects.
Our mascot, “ROI” the gorilla, will also be on hand for those wishing to accept our
Gorilla Challenge. Don’t miss out on this great opportunity and show your support of the Institute!
Hours of Operation:
30
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 12:00 p.m.
Shuttle Service
SHUTTLE SERVICE TO MOSCONE CENTER
This is preliminary information only, which is subject to change at any time without notice.
HOURS OF OPERATION
SATURDAY, SEPTEMBER 13
8:00 a.m. – 6:30 p.m.
6:30 a.m. – 7:00 p.m.
6:15 a.m. – 7:30 p.m.
6:15 a.m. – 7:00 p.m.
WEDNESDAY, SEPTEMBER 17
6:30 a.m. – 5:00 p.m.
HOTELS AND BOARDING LOCATIONS
All travel times are approximate pending time of day, day of week and traffic conditions.
Route
Hotel
Boarding location at hotel
Hotel Abri
Parc 55 Wyndham San Francisco
On Cyril Magnin, across the street from
the Parc 55
2
Clift Hotel
Hilton San Francisco Union Square*
Hotel Monaco (a Kimpton property)
Hotel Nikko San Francisco
Serrano Hotel San Francisco
At Hilton San Francisco
Curbside on Taylor
3
Handlery Union Square Hotel
JW Marriott San Francisco Union Square
Prescott Hotel (a Kimpton property)
Villa Florence Hotel
Westin St. Francis
At Westin St. Francis
Curbside on Post
Grand Hyatt San Francisco
Hotel Triton (a Kimpton property)
Marriott Union Square San Francisco
Sir Francis Drake Hotel (a Kimpton property)
Check the sign in your hotel lobby upon
arrival in San Francisco for boarding
location.
1
4
WALK
Courtyard by Marriott San Francisco Downtown
Hotel Palomar (a Kimpton property)
InterContinental San Francisco
Marriott Marquis SanFrancisco
Mosser Hotel, The
Palace Hotel, A Luxury Collection Hotel
St. Regis Hotel San Francisco
W Hotel San Francisco
Westin San Francisco Market Street
Approximate
one-way
travel time
Frequency
in minutes
7-10
MINUTES
10-15 PEAK
15-20 NONPEAK
8-12
MINUTES
10-15 PEAK
15-20 NONPEAK
9-13
MINUTES
1015 PEAK
1520 NONPEAK
10-14
MINUTES
10-15 PEAK
15-20 NONPEAK
NO SHUTTLE SERVICE PROVIDED.
*ASRT is being held at the Hilton San Francisco Union Square. Attendees must ride Route #2 and from Moscone Center
to access the Hilton San Francisco Union Square. Transfer point for all routes is at Moscone Center.
Funded in part by Elekta
31
SAN FRANCISCO TRAVEL INFORMATION
South Lobby
Attendees can stop by the San Francisco travel
information desk located in the South Lobby at
Moscone Center to receive restaurant
recommendations, San Francisco visitor guides,
maps, destination information and local directions.
organizations featured in the Survivor Circle. Since
its inception, the Survivor Circle has raised nearly
$200,000 for our partner organizations. Stop by the
Survivor Circle to learn more about this year’s
Survivor Circle Grant Recipients: Breast and Gyn
Health Project and Kids Konnected.
TRANSPORTATION
Hours of Operation:
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:00 p.m.
SMOKING
Moscone Center is a non-smoking facility.
SPEAKER READY ROOM
Room 121
Faculty members and abstract presenters should
upload their PowerPoint presentation in advance of
their session in order to have it pre-loaded onto the
ASTRO conference network. To ensure presentations
have been properly uploaded, faculty members
and abstract presenters are asked to check in at the
Speaker Ready Room to review the information and
make any last-minute edits.
Speakers should plan to save their presentation on
a portable device and bring it to the Speaker Ready
Room at least 24 hours in advance of their
presentation or upon arrival at Moscone Center.
Hours of Operation:
6:45 a.m. - 6:00 p.m.
6:45 a.m. - 6:15 p.m.
6:45 a.m. - 5:45 p.m.
6:45 a.m. - 6:15 p.m.
6:45 a.m. - 4:30 p.m.
SURVIVOR CIRCLE
ASTRO Resource Center, Outside Hall D
In 2003, ASTRO created the Survivor Circle as a way
to honor cancer survivors. Each year, ASTRO partners
with two local patient support organizations and
features them at the Survivor Circle at the Annual
Meeting. It was our hope that by partnering with
local organizations in the cities that host our
meeting, we would be able to not only give back to
the cities we visit, but also help raise awareness of
these important organizations among our members.
Through generous donations from exhibitors and
attendees, ASTRO raises funds for the two
32
San Francisco offers a number of convenient
transportation options to help attendees easily get
around the city.
Airport
The San Francisco International Airport (SFO) is
approximately 14 miles from Moscone Center and
Union Square. Buses, shared ride and long-distance
vans, taxis, and hotel and rental car courtesy vans are
located in the arrival area of each terminal.
Taxi
On average, a one-way taxi ride from the San
Francisco International Airport (SFO) to Moscone
Center and Union Square is approximately $45
one-way (gratuity not included).
SFMTA
SFMTA is San Francisco’s public transportation
system that provides light rail and bus services
throughout downtown and to and from the airport.
The fare for rail and bus is $2 and for cable car is $6.
For more information on rates and schedules, visit
www.sfmta.com.
BART/CALTRAIN
BART (Bay Area Rapid Transit) is a fast, easy and
inexpensive way to get to San Francisco and around
the Bay area. Trains arrive at the San Francisco
International Airport (SFO) terminal every 15
minutes. It is 30 minutes to downtown San Francisco,
and a one-way ticket from the airport to downtown
is $8.65.
Tweet
#ASTRO14
VIRTUAL MEETING
WIRELESS INTERNET ACCESS
Extend your learning experience with access to
the 2014 ASTRO sessions long after the meeting is
over. All full conference attendees receive the
Virtual Meeting with their registration at no
additional cost. You will receive streaming content
that has been digitally recorded live and published
as audio synchronized to the speaker presentations.*
Within two weeks after the meeting, full conference
attendees will receive an email with a link providing
access to the Virtual Meeting.
Complimentary wireless Internet access is provided
in all common areas and session rooms throughout
Moscone Center. Please note that this does not
include the Exhibit Hall. Attendees can bring their
laptop to check email, complete the evaluation or
surf the Internet. Laptops must have a Wi-Fi card to
connect.
*Presentations are included in the Virtual Meeting
as approved per faculty.
Funded in part by Varian.
33
34

 Restrooms
E Elevator
CYBER CAFE
Escalator
 Shuttle Bus
SHUTTLE DROP-OFF/PICKUP FOR ROUTES 1 AND 2
ASTRO INFORMATION
AND HOUSING DESK
ATTENDEE REGISTRATION
E
Office/Other
Session Room
Floor Plans
North Lobby
Luggage/Coat Check
Floor Plans
South Lobby
GENERAL SESSION
Esplanade Ballroom
SAN FRANCISCO TRAVEL DESK
E
E
Cyber Café
ASTRO Information
ASTRO Connect
Lead Retrieval
Exhibitor Registration
SHUTTLE DROP-OFF/PICKUP FOR ROUTES 3 AND 4


E
Restrooms
Elevator

Escalator
Shuttle Bus
Session Room
Office/Other

 Restrooms
228/230
220-226
E Elevator
200-212
Escalator
Office/Other
Session Room
ASTRO Career Fair
(250-262)
ASTRO Job
Interview Rooms
Floor Plans
Mezzanine Level
Floor Plans
Exhibit Level
Exhibit Hall
Halls A-C
First Aid
Industry-Expert
Theater
ASTRO
Press
Office
130/131
132/133
125
121
Speaker
Ready Room
Faculty/ VIP
Office
123/124
ASTRO Resource
Center
ROI Lounge
122
Escalator
ASTRO
Radio
News
Interview Briefing
Room
Room
ASTRO PAC Lounge
CE Central

Office/Other
Session Room
Telephone
Poster Pickup
Poster Information
Poster Discussion
Room D-1
Poster Hall D
E Elevator

 Restrooms
Poster Discussion
Room D-2
37
RO ILS
TM
RADIATION ONCOLOGY
INCIDENT LEARNING SYSTEM
Sponsored by ASTRO and AAPM
The only medical specialty
society-sponsored incident learning
system for radiation oncology.
Why participate?
Submit patient safety information in a confidential,
non-punitive environment.
Track and analyze internal incidents while contributing
to a national database.
Receive summary reports, including aggregate data on
events entered throughout the United States.
Opportunity to satisfy Maintenance of Certification
requirements.
Become a
champion of
safety –
ENROLL NOW!
www.astro.org/ROILS
INSIDE:
Schedule of Events
Live SAM Sessions
Meeting Highlights
ARRO Program
Nurses’ Program
APEx: ASTRO Accreditation Program for Excellence
RO-ILS: Radiation Oncology Incident Learning System
Schedule of Events by Day
2014 Corporate Ambassadors
Schedule of Events
(Promotional Supporters)
These hands-on sessions are designed to provide crucial contouring education and experience. Attendees will
have an opportunity to learn about and discuss issues such as imaging, target delineation, quality assurance
and accuracy. Each attendee receives access to the online cases for practice and reference. Learn more about
earning MOC PQI credit for your participation at the CE Central Booth.
After this session, attendees will be able to:
•
Identify basic anatomy in the cases presented.
•
Evaluate normal tissue dose constraints versus target dose constraints.
•
Demonstrate improvement in contouring skills in the cases presented between pre- and post-activity.
•
Self-assess where additional contouring skills training may be needed.
•
Apply newly acquired contouring skills to his/her own practice.
Sarah Hoffe, MD, Program Chair
Steven Finkelstein, MD, Program Vice-chair
Room: 102
Schedule
9:00 a.m. - 10:30 a.m.
8:00 a.m. - 9:30 a.m.
eContouring for Gynecologic Cancers
eContouring for Lymphoma
Beth Erickson, MD, FASTRO, Medical College of
Wisconsin
Arno J. Mundt III, MD, FASTRO, University of
California San Diego
Stephanie Terezakis, MD, Johns Hopkins University
Joachim Yahalom, MD, FASTRO, Memorial Sloan
Kettering Cancer Center
10:15 a.m. - 11:45 a.m.
11:00 a.m. - 12:30 p.m.
eContouring for Breast Cancer
eContouring for Sarcoma
Steven Finkelstein, MD, 21st Century Oncology
Amalia DeComas, MD, The Core Institute
Frank Vicini, MD, 21st Century Oncology
Julia White, MD, Ohio State University
Philip Poortmans, MD, PhD, President, ESTRO
1:00 p.m. - 2:30 p.m.
1:15 p.m. - 2:45 p.m.
eContouring for Lung Cancer
eContouring for Head and Neck –
Intermediate
Billy Loo, MD, PhD, Stanford University
2:45 p.m. - 4:15 p.m.
eContouring for GI Cancer I
Ravi Shridhar, MD, Moffitt Cancer Center
Ken Meredith, MD, University of Wisconsin School of
Medicine and Public Health
Avraham Eisbruch, MD, University of Michigan
Health Systems
Matthew Stenmark, MD, University of Michigan
Health Systems
Mary Beth Cunanne, MD, Massachusetts Eye and Ear
3:00 p.m. - 4:30 p.m.
4:30 p.m. - 6:00 p.m.
eContouring for GI Cancer II
Karyn Goodman, MD, Memorial Sloan Kettering
Cancer Center
Corinne Winston, MD, Memorial Sloan Kettering
Cancer Center
eContouring for Head and Neck –
Advanced
Avraham Eisbruch, MD, University of Michigan
Health Systems
Matthew Stenmark, MD, University of Michigan
Health Systems
Mary Beth Cunanne, MD, Massachusetts Eye and Ear
4:45 p.m. - 6:15 p.m.
eContouring for Prostate Cancer
Michael Zelefsky, MD, Memorial Sloan Kettering
Cancer Center
Live Self-Assessment Module Sessions
Special sessions have been designated as Live Self-Assessment Modules (SAMs) to help physician and
physicist attendees meet the requirements of the American Board of Radiology’s Maintenance of
Certification (MOC) program. Attendance at the Live SAM sessions is open to all attendees, but only Live
SAM ticket holders are eligible to earn SA-CME credit. On-site registration is available at the registration
desk if seats are still available (a $35 preregistration fee for each ticketed SAM session is required).
How to Participate On-site
Live SAM registrants have two ways to participate: a personal mobile device (smartphone, tablet or laptop)
or a paper assessment. All registrants will receive the same assessment and evaluation questions regardless
of the method they use to participate.
1.
2.
3.
4.
5.
Visit the Live SAM table outside the designated session room 15 minutes prior to the start of the
session.
Give your Live SAM ticket to ASTRO staff at the Live SAM table. In return for your ticket, ASTRO staff will
give you a two-sided handout. One side of the handout contains the Live SAM Participant Directions for
both the paper and mobile options and the other side contains the required assessment and evaluation
questions for those registrants wishing to use the paper method of participation.
Find any available seat in the session room and attend the entire session (required to earn credit).
At the conclusion of the session, follow the directions to complete the assessment and evaluation
questions on paper or via your personal mobile device. A minimum score of 70 percent must be
achieved on the assessment in order to earn credit, and the evaluation questions must be completed as
well.
ASTRO staff will email you approximately 30 days post-meeting with your individual score and
directions on how to print your certificate of completion from the ASTRO website.
Live SAM Policy
•
•
•
•
Live SAM registrants MUST be in the designated Live SAM room 15 minutes prior to the start of the
session. If you are not in the room at this time, your seat may be given away to another attendee.
Registrants interested in using the mobile device option will need to bring their own mobile device
and are responsible for ensuring that it is charged and can connect to the Internet via Wi-Fi or a cellular
network connection.
No refunds, extensions or substitutions will be made for those registrants who, for any reason, were
unable to attend or were tardy for the session. Attendees who are more than 10 minutes late to the
session will not be able to participate in the Live SAM component.
Registrants must earn a minimum score of 70 percent on the assessment and complete the evaluation
questions to earn credit. Participants who do not earn a minimum of 70 percent on the assessment
questions will NOT receive SA-CME credit and will NOT receive a refund.
If you have any questions about the Live SAM sessions, SA-CME requirements or MOC, please visit CE
Central located outside Hall E.
Tweet
#ASTRO14
42
Live SAM Sessions
1:15 p.m. - 2:45 p.m.
Educational Session 101: Knowledge Modeling for Treatment Planning and Its Clinical
Implementation
Room: 104
4:45 p.m. - 6:15 p.m.
Educational Session 105: Challenging Cases in Cervical and Endometrial Cancer
Room: 104
7:45 a.m. - 9:00 a.m.
Educational Session 206: Esophagus and Gastric Cancer: Contemporary Treatment
Approaches
Room: 104
7:45 a.m. - 9:00 a.m.
Educational Session 208: Extranodal Non-Hodgkin’s Lymphoma: Recent Advances in the
Management of CNS, Orbital and Cutaneous Lymphomas
Room: 103
7:45 a.m. - 9:00 a.m.
Educational Session 304: Cancer of the Colon, Rectum, Anus
Room: 104
7:45 a.m. - 9:00 a.m.
Educational Session 310: Pediatric Sarcomas and Hodgkin Lymphoma
Room: 132/133
1:00 p.m. - 2:30 p.m.
Educational Session 311: Challenging Cases in the Management of Newly Diagnosed and
Recurrent Prostate Cancer
Room: 104
7:45 a.m. - 9:00 a.m.
Educational Session 403: Imaging Brain Tumors: Practical Primer for the Radiation Oncologist
Room: 104
7:45 a.m. - 9:00 a.m.
Educational Session 406: Recent Advances in Endometrial Cancer
Room: 103
3:00 p.m. - 4:30 p.m.
Educational Session 415: Optimizing Outcomes in Breast Cancer Patients Receiving
Reconstruction and Radiation Therapy in 2014
Room: 104
43
Local-regional Management of Breast Cancer:
A Changing Paradigm
September 14, 2014
8:00 a.m. - 12:15 p.m. |
Room: Esplanade Ballroom
8:00 a.m. - 8:10 a.m.
Welcome
8:10 a.m. - 8:15 a.m.
Presidential Symposium – Introduction
Richard T. Hoppe, MD, FASTRO
Speaker: Bruce G. Haffty, MD, FASTRO
8:15 a.m. - 10:00 a.m.
Presidential Symposium – Session I – Local Management of Breast Cancer
Moderators: Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO
Julia White, MD – Partial Breast Irradiation
John Yarnold, BSc, MBBS, MRCP – Hypofractionation, Rationale, Current Status and Future
Directions
Reshma Jagsi, MD, DPhil – Low Risk Luminal A Tumors/Low Oncotype: Less Aggressive
Treatment After Lumpectomy or Mastectomy?
Jennifer R. Bellon, MD – Triple Negative: More Aggressive Treatment After Lumpectomy or
Mastectomy?
David E. Wazer, MD, FASTRO – Cardiac Issues in Breast Irradiation
10:00 a.m. - 10:15 a.m.
Break – Exhibit Hall Opens
10:15 a.m. - 11:15 a.m.
Presidential Symposium – Session II – Local-regional Treatment after
Preoperative Systemic Therapy (PST)
Eric P. Winer, MD – PST: Why and When?
Judy C. Boughey, MD – Surgical Issues after PST?
Lori J. Pierce, MD, FASTRO – Radiation Issues after PST
Wendy Woodward, MD, PhD – Inflammatory Breast Cancer: Biologic and Other Special
Considerations
11:15 a.m. - 12:15 p.m.
Presidential Symposium – Session III – Regional Management of Breast Cancer
Henry Kuerer, MD, PhD, vs. Timothy Whelan, MSc, BM, BCh, FASTRO – Debate: Tangents
Only or Regional Nodal Irradiation for Sentinel Node + Disease
Sarah C. Darby, PhD – Update on EBCTCG for Node Positive Disease
Panel Discussion:
Henry Kuerer, MD, PhD
Timothy Whelan, MSc, BM, BCh, FASTRO
Sarah C. Darby, PhD
Lawrence B. Marks, MD, FASTRO
Don’t miss the ASTRO
Guidelines Highlight
Session on Breast Margins
on Monday
See page 47 for more
information.
44
Keynote Speakers
9:15 a.m. - 10:15 a.m.
Keynote Address I – New Horizons in Oncologic Imaging –
Unraveling Pathways to Synergy
Hedvig Hricak MD, PhD, Chair, Department of Radiology, Memorial
Sloan Kettering Cancer Center
Introduced by Sarah S. Donaldson, MD, FASTRO, Stanford Cancer Center
Dr. Hedvig Hricak is chair of the Department of Radiology at Memorial Sloan Kettering Cancer Center. She
is a member of the Molecular Pharmacology and Chemistry Program at the Sloan Kettering Institute, and is
a professor at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Her publication record
includes more than 380 peer-reviewed original research articles and more than 135 monographs and book
chapters. Dr. Hricak has held numerous leadership positions in professional societies and has served as
president of numerous societies including the Society of Uroradiology (2001-2003) and the Radiological
Society of North America (2010). Dr. Hricak will speak on the topic of oncologic imaging and radiogenomics.
Imaging has always been an essential component of treatment planning and follow-up for patients
undergoing radiation treatment. Increasingly, opportunities are arising to enhance the sophistication of
cross-sectional imaging with molecular imaging, making possible a new level of precision in tumor targeting
and the ability to tailor the treatment dose to the tumor’s biology. In addition, the capacity for very early
assessment of tumor response by imaging is rapidly evolving. The new discipline of correlating imaging
findings with genomics – often called radiogenomics – is offering still more insights that can help to
modulate treatment planning. While the advances in these areas have been exciting, the dissemination of
new technologies has been impeded by a variety of obstacles, ranging from limited resources to lack of FDA
approval for new tracers and lack of oncologic imaging specialists. Dr. Hricak will discuss emerging areas of
potential synergy between radiology and radiation oncology and the need for interdisciplinary collaboration
in overcoming obstacles to progress.
9:15 a.m. - 10:15 a.m.
Keynote Address II – New Approaches to Targeting K-Ras
Frank McCormick, PhD, FRS, David A. Wood Distinguished Professor of Tumor
Biology and Cancer Research and Professor Emeritus, UCSF Helen Diller Family
Comprehensive Cancer Center
Introduced by Catherine C. Park, MD, University of California San Francisco
Dr. Frank McCormick is the David A. Wood Distinguished Professor of Tumor Biology and Cancer Research at
the University of California San Francisco. He recently held the position of director of the UCSF Diller Family
Comprehensive Cancer Center. Dr. McCormick will address the promise of biology and targeting in oncology,
specifically as it relates to K-Ras proteins, which play a major role in many human cancers.
K-Ras proteins have unique biochemical properties relative to other Ras proteins that offer new opportunities
for therapeutic intervention. Dr. McCormick’s lab is attempting to target K-Ras 4B, the major isoform of K-Ras,
directly and indirectly. The lab has identified compounds that bind covalently to the C-terminal CAAX box and
prevent prenylation. In his address, Dr. McCormick will discuss the strategy of modifying these compounds
through medicinal chemistry to increase specificity for K-Ras relative to other Ras proteins. He will also discuss
the work his lab has done in the various mutants of K-Ras and their different biochemical properties. Tumors
driven by the different K-Ras mutants also have different clinical outcomes that presumably relate to these
functional differences. Dr. McCormick will discuss the results from his labs exploration of these differences
using Ras-less MEFS rescued by introduction of individual Ras isoforms so that contributions of different
isoforms and different mutant alleles to signaling networks can be analyzed in isolation.
9:15 a.m. - 10:00 a.m.
Keynote Address III – Human Error and Just Culture
Sidney Dekker, PhD, MA, MSc, Professor and Director, Safety Science Innovation Lab,
Griffith University
Introduced by Lawrence B. Marks, MD, FASTRO, University of North Carolina
Dr. Dekker is currently a professor at Griffith University in Brisbane, Australia, where he is director of
the Safety Science Innovation Lab. He is also an honorary professor of psychology at The University of
Queensland. Previously, he was professor of human factors and system safety at Lund University in Sweden.
There, he learned to fly the Boeing 737, working part-time as an airline pilot out of Copenhagen. Dr. Dekker
has received worldwide acclaim for his groundbreaking work in human factors and safety, and is a
best-selling author of several books on patient safety and just culture including his latest book, “Safety
Differently” (2014). Dr. Dekker will speak on the topic of human error, safety culture and safety as it is related
to medicine and, specifically, the field of radiation oncology.
Dr. Dekker’s address will focus on several safety topics and questions, including: “When we go beyond the
technical details of a radiation oncology incident, and face a ‘human error’ problem, we may be tempted
to ask ‘Why didn’t these people watch out better?’ or ‘How could they miss that which is now so obvious
to us?’” and “Beyond the software and hardware, can we solve our safety problems by telling people to be
more careful, by reprimanding the miscreants, by issuing a new rule or procedure, by demanding
compliance?” Dr. Dekker will explain that these are all expressions of “The Bad Apple Theory,” where we
believe our system is basically safe if it were not for those few unreliable people in it. He will suggest that a
new way of dealing with a perceived “human error” problem in the field is to see “human error” as
systematically connected to features of people’s tools and tasks. To begin dealing with a “human error
problem,” Dr. Dekker will discuss the need to look more closely at how people create safety through
practice, mostly successfully, under the pressure of resource constraints and multiple conflicting goals.
46
Meeting Highlights
3:15 p.m. – 4:45 p.m.
Clinical Trials Session
Moderators:
Lynn D. Wilson, MD, MPH, FASTRO, Yale School of Medicine
Benjamin Movsas, MD, FASTRO, Henry Ford Health System
See page XX for full details.
1:30 p.m. - 2:15 p.m.
Presidential Address – Back to the Future: 30 Years in Breast Cancer
Bruce G. Haff ty, MD, FASTRO, President, ASTRO
Introduced by: Lynn Wilson, MD, MPH, FASTRO, Yale School of Medicine
Join us for the Presidential Address where ASTRO President Dr. Bruce Haff ty will discuss
the evolution in the treatment of breast cancer over the past 30 years. The informative presentation will
cover what has changed, what hasn’t changed and projections for the future.
2:15 p.m. – 3:25 p.m.
Plenary Session
Moderators:
Lynn D. Wilson, MD, MPH, FASTRO, Yale School of Medicine
Benjamin Movsas, MD, FASTRO, Henry Ford Health System
See page XX for full details.
3:25 p.m. - 3:45 p.m.
ASTRO Guidelines Highlight I – Breast Margins
Meena S. Moran, MD, Yale School of Medicine
Monica Morrow, MD, Memorial Sloan Kettering Cancer Center
10:00 a.m. - 10:30 a.m.
ASTRO Guidelines Highlight II – Endometrial and Lung Cancer
Benjamin D. Smith, MD, MD Anderson Cancer Center
Ann H. Klopp, MD, PhD, MD Anderson Cancer Center
George Rodrigues, MD, PhD, London Health Sciences Centre
Great speaker?
Tweet
#ASTRO14
47
ARRO Program
ARRO Annual Seminar*
10:00 a.m. - 5:00 p.m.
Room: 103
Box lunch provided.
Refer to page 50 for program schedule.
*This session is not accredited for continuing medical education credits.
6:30 p.m. - 8:30 p.m.
ARRO Reception
Slide
430 Mason St.
San Francisco, CA 94102
The ARRO Reception will be held at Slide, a popular nightclub ideally situated in downtown San Francisco in
the historic Theater District adjacent to Union Square. Slide is located at 430 Mason St., between Geary St.
and Post St., an approximate 15-minute walk from Moscone Center. Shuttle service will not be provided to
the ARRO Reception.
12:15 p.m. - 1:15 p.m.
ARRO Annual Luncheon
Room: 200-212
Guest Speaker: Colleen A.F. Lawton, MD, FASTRO, Chair, ASTRO Board of Directors
7:15 a.m. - 9:00 a.m.
Meet the Professor Breakfast – Leadership Part 1*
Room: 101
Join us for the newly revamped ARRO Meet the Professor breakfast! Registered attendees will hear
best-selling author and leadership expert Courtney Lynch and a panel of world-renowned radiation
oncologists speak on various aspects of leadership as it relates to residents in radiation oncology.
There will be audience interaction throughout the event with plenty of time for questions and answers.
Guest Speaker: Courtney Lynch, Lead Star
Panelists: Theodore L. DeWeese, MD, Johns Hopkins School of Medicine
Tim R. Williams, MD, FASTRO, Lynn Cancer Institute
Akila N. Viswanathan, MD, MPH, Brigham and Women’s Hospital
Andrew T. Turrisi III, MD, Locum Tenens
48
12:15 p.m. - 1:30 p.m.
ARRO Poster Walk with a Professor
Room: Poster Hall D
Box lunch provided.
12:30 p.m. - 1:30 p.m.
How to Review a Scientific Paper Workshop I*
Room: 220-222
W. Robert Lee, MD, MS, MEd, Duke University
Box lunch provided.
5:30 p.m. - 6:45 p.m.
Meet and Greet – Residents and Medical Students
Room: Poster Hall D
Please join us in the Poster Hall during the Poster Session and Reception to meet and greet the medical
students in attendance. This is a great opportunity to meet medical students and offer your help and
guidance navigating the ASTRO Annual Meeting.
12:15 p.m. - 1:15 p.m.
How to Review a Scientific Paper Workshop II*
Room: 200/212
W. Robert Lee, MD, MS, MEd, Duke University
Box lunch provided.
49
ARRO Annual Seminar*
10:00 a.m. - 4:30 p.m. | Room: 103
This year’s program combines a variety of timely topics for residents at all stages of training. Using the
audience interactive system, presentations are intended to facilitate interaction among participants
from different communities.
10:00 a.m. - 10:15 a.m.
Opening Remarks by the ARRO Executive Committee
Welcome and Reminders – Seth Miller, MD, University of North Carolina at Chapel Hill
Program Review – Nima Nabarizadeh, MD, Oregon Health and Science University
10:15 a.m. - 10:30 a.m.
Global Health Scholar Presentations
Global Health Scholar Program Awardee Presentation on Accra, Ghana –
Kosj Yamoah, MD, Thomas Jefferson University and Hospitals
How to Design a Radiation Oncology Related Project in a Developing Nation
Tracy Sherertz, MD, Case Western University Hospitals
10:30 a.m. - 11:00 a.m.
Radiation Oncologist Engagement in Quality and Safety in Leadership
Bhisham Chera, MD, University of North Carolina at Chapel Hill
11:00 a.m. - 11:10 a.m.
Break
11:10 a.m. - 12:00 p.m. Keynote Address: Physician Engagement in the Era of Value-based Health
Care: A Call to Action
Stephen Hahn, MD, FASTRO, University of Pennsylvania
12:00 p.m. - 1:00 p.m.
1:00 p.m. - 2:15 p.m.
Lunch (Box lunch provided)
Applying for Jobs: A Panel Discussion
Moderator: Lisa A. Kachnic, MD, Boston Medical Center
Panelists:
Aaron Spalding, MD, PhD, Norton Cancer Institute
Marka R. Crittenden, MD, PhD, Providence Cancer Center, The Oregon Clinic
Siavash Jabbari, MD, Scripps Health
Gautum Prasad, MD, PhD, Epic Care
2:15 p.m. - 2:30 p.m.
Break
2:30 p.m. - 3:30 p.m.
Career Development: Strategy Primer to Address Young Investigator
Skill Set Gaps for Clinical Research
Charles R. Thomas Jr., MD, Oregon Health and Science University
3:30 p.m. - 3:45 p.m.
Prospective Review: A New Form of Submission for Manuscripts to the
Red Journal
Loren Mell, MD, University of California San Diego
3:45 p.m. - 4:00 p.m.
Break
4:00 p.m. - 5:00 p.m.
Practice Entry Survey Results
Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
50
2:45 p.m. - 6:15 p.m. | Room: 123/124
This two-part workshop will address several key issues facing early career physicians and will provide an open forum
for discussion among peers. The educational focus is targeted toward young physicians with less than 10 years in
practice. Distinguished faculty will share their experiences and insights on several exciting topics.
2:45 p.m. - 4:15 p.m.
Young Physicians’ Workshop – Part 1
Welcome and Introductions
Eric D. Donnelly, MD, Northwestern University Feinberg School of Medicine
Sudha Amarnath, MD, Cleveland Clinic
Understanding What the ABR Wants from You
Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital
Negotiating a Contract When You Are Established in the Field
Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
Economics 101 – How Are Radiation Oncologists Compensated
David C. Beyer, MD, FASTRO, Arizona Oncology Services
4:45 p.m. - 6:15 p.m.
Young Physicians’ Workshop – Part 2
Welcome and Introductions – Eric D. Donnelly, MD, Northwestern University Feinberg School of
Medicine, and Sudha Amarnath, MD, Cleveland Clinic
Difficult Conversations with Patients
Moderators:
Panelists:
Nils Arvold, MD, Dana-Farber Cancer Institute, Brigham and Women’s Hospital
New Name to come soon University Name
Danielle N. Margalit, MD, MPH, Dana-Farber/Brigham and Women’s Hospital Cancer Center, Harvard
Medical School
Tim R. Williams, MD, FASTRO, Lynn Cancer Institute
Case Presentation
Moderators:
Panelists:
Patty Hardenberg, MD, Shaw Regional Cancer Center
Grant Hunter, MD, Intermountain Healthcare
Reshma Jagsi, MD, DPhil, University of Michigan
Charles R. Thomas Jr., MD, Oregon Health and Science University
How to Get Involved with Your Specialty – Shilpen Patel, MD, University of Washington
Nurses’ Program
This year’s Nurses’ Program includes 11 sessions and a luncheon designed to address the educational needs of
radiation oncology nurses. The Nurses’ Luncheon is open to all Annual Meeting nurse registrants, but the option
must have been added at the time of registration; therefore, you must have a ticket to attend.
10:00 a.m. - 11:30 a.m.
Palliative Care Panel
Room: 300
Tracy Balboni, MD, MPH, Dana-Farber Cancer Institute
Lorraine Drapek, MSN, NP, Massachusetts General Hospital
Jeannine Brant, PhD, APRN, AOCN, Billings Clinic
11:30 a.m. - 12:45 p.m.
Welcome Luncheon
Room: 104
Michelle Wallace, RN, William Beaumont Hospital
The Annual Meeting Nurse Abstract Awards will be presented during the luncheon.
12:45 p.m. - 1:45 p.m.
Room: 300
Radiation Treatment of Non-malignant Disorders
Lynn Leandro, MS, MSN, RN, GNP-BC, Emory Healthcare, Winship Cancer Institute
2:00 p.m. - 3:00 p.m.
Room: 300
Acute and Late Effects of Chemo-radiotherapy in Lung Cancer: Integrating Survivorship
Craig Stevens, MD,PhD, Beaumont Health System
Jeanne Parzuchowski, RN, William Beaumont Hospital
3:00 p.m. - 4:00 p.m.
Room: 300
Skin Care for the Radiation Oncology Patient
Dorothy Doughty, MN, RN, CWOCN, FAAN, Emory University
4:15 p.m. - 5:15 p.m.
Room: 300
To Treat or Not to Treat: Decision-making and Treatment Options in Low-risk Prostate
Cancer: Risk versus Benefit
Vanna Dest, MSN, APRN, AOCN, Yale New Haven Hospital, Smilow Cancer Hospital
Pamela Devine, MSN, RN, Philadelphia VA Medical Center
A
ARON
Ticketed Event/ Nurses’
Separate
Session
registration
required
52
Live
Interactive
SAM/
Session
Separate
registration
required
8:30 a.m. - 10:00 a.m.
Room: 220-226
Survivorship Panel
Richard Boyajian, RN, MS, NP, Dana-Farber Cancer Institute
Jeannine Brant, PhD, APRN, AOCN, Billings Clinic
Carrie Stricker, PhD, RN, On Q Health Inc.
10:15 a.m. - 11:15 a.m.
Room: 220-226
Know Your Patients’ Behaviors: Impact on Radiation Treatment and Outcomes
Emily Moore, ND, LAC, Indiana Health Goshen Center for Cancer Care
11:15 a.m. - 12:15 p.m.
Room: 220-226
Update on Protons - GI, GU and Breast
Lorraine Drapek, MSN, NP, Massachusetts General Hospital
1:15 p.m. - 2:45 p.m.
Room: 220-226
Rehab for RT Patients/Lymphedema from Radiation
Carol Parmelee, RN, Indiana University Health
3:15 p.m. - 4:45 p.m.
Room: 220-226
Revolutionary Noninvasive Surgery Procedures
Michelle Manders, RN, BScN, William Beaumont Hospital
Daniel Krauss, MD, Oakland University William Beaumont School of Medicine
4:45 p.m. - 6:15 p.m.
Room: 220-226
Sexuality – Long Term Effects from Radiation – Male and Female
Deborah Watkins Bruner, PhD, RN, Emory University
53
A series of sessions have been identified throughout the Annual Meeting Program as pertinent to our
international attendees. The International Attendee Welcome Breakfast is open to all international
attendees, and you must have an international attendee badge holder (black) to be admitted. The Foreign
Language Poster Walks are ticketed events. You must be registered for these events and have a ticket to
attend. Lunch will be provided at the Poster Walks for those who have tickets to attend.
1:00 p.m. - 2:30 p.m.
ASTRO 2014 Chinese Language Refresher Course: Multidisciplinary Approach to Improve
Quality and Safety in Radiotherapy
Room: 122
Moderator:
Zhongxing Liao, MD, MD Anderson Cancer Center
Speakers:
Yexiong Li, MD, PhD, Chinese Academy of Medical Science Cancer Hospital
Dian Wang, MD, Medical College of Wisconsin
Barbara Sims, BS, RTT, Fox Chase Cancer Center
W. Kenneth Zhen, MD, University of Nebraska Medical Center
Jinming Yu, MD, PhD, Sandong Tumor Hospital and Institute
Jinyi Lang, MD, Sichuan Tumor Hospital and Institution
Feng-Ming Kong, MD, PhD, Georgia Regents University
3:00 p.m. - 6:00 p.m.
ASTRO 2014 Spanish Language Refresher Course: Update and Review of Established and
Modern Technologies
Room: 122
Moderators:
Beatriz Amendola, MD, Innovative Cancer Institute
Higinia Cárdenes, MD, PhD, Indiana University
Speakers:
Victor Bourel, PhD, Universidad Favaloro
Naipy Perez, MS, Innovative Cancer Institute
Dante E. Roa, PhD, University of California Irvine
Roberto Diaz, MD, PhD, Moffit Cancer Center
Ferran Guedea, MD, University of Barcelona
Beatriz Amendola, MD, Innovative Cancer Institute
Juanita Crook, MD, University of British Columbia
Carlos Perez, MD, FASTRO, Washington University
Higinia Cárdenes, MD, PhD, Indiana University
A
ARON
Ticketed Event/ Nurses’
Separate
Session
registration
required
54
Live
Interactive
SAM/
Session
Separate
registration
required
6:45 a.m. – 8:00 a.m.
International Attendee Welcome Breakfast
Room: 104
The Internationals Abstract Award will be presented during the breakfast, along with remarks from the
International Education Subcommittee Chair Kenneth Hu, MD.
1:15 p.m. – 2:45 p.m.
Best of ESTRO at ASTRO*
Room: 300
Moderators:
Bruce G. Haff ty, MD, FASTRO, President, ASTRO
Philip Poortmans, MD, PhD, President of ESTRO
Speakers:
Nuria Jornet, PhD, Chair, Physics Committee, ESTRO
Brad Wouters, PhD, Chair, Radiobiology Committee, ESTRO
* This session is not accredited for continuing medical education credits
4:45 p.m. – 6:15 p.m.
UICC Panel – Inserting Radiotherapy into the Global Health Movement*
Room: 300
Moderator:
Mary Gospodarowicz, MD, FASTRO, Princess Margaret Hospital
Speakers:
David Jaffray, PhD, Princess Margaret Hospital
Rifat Atun, MBA, Harvard University
Danielle Rodin, MD, University of Toronto
Gavin Yamey, MD, MPH, MA, MRCP, University of California, San Francisco
7:45 a.m. – 9:00 a.m.
Room: 300
ASTRO/ESTRO Joint Breast Symposium - Current Challenges in Radiation Therapy for
Breast Cancer*
Speakers:
Nuria Jornet, PhD, Chair, Physics Committee, ESTRO
Lawrence B. Marks, MD, FASTRO, University of North Carolina
Atif Khan, MD, Cancer Institute of New Jersey
Connect with attendees
Tweet
#ASTRO14
55
10:45 a.m. - 12:15 p.m.
ASTRO 2014 International Symposium: Workshop on Safe Implementation of
Advanced Technologies in Radiation Oncology
PART I: Practice of Advanced Radiotherapy Techniques, Clinical Implementation of IMRT, IGRT
and IGART Programs
Room: 125
Moderator:
Jatinder Palta, PhD, FASTRO, Virginia Commonwealth University
Speakers:
Patrick Kupelian, MD, University of California Los Angeles
Jean Moran, PhD, University of Michigan
Laura Dawson, MD, Princess Margaret Hospital
12:15 p.m. – 1:30 p.m.
Foreign Language Poster Walks
Room: Poster Hall D
Foreign Language Poster Walks will be offered in Chinese and Spanish, and will review selected abstracts
based on disease site. Please note that this event is open to international attendees only. Please refer to the
details below for further information.
CHINESE POSTER WALK
Faculty: W. Kenneth Zhen, MD
Disease Site: Head and Neck
SPANISH POSTER WALK
Faculty: Adela Poitevin, MD
Disease Site: Breast, CNS and Prostate
4:15 p.m. - 5:45 p.m.
ASTRO 2014 International Symposium: Workshop on Safe Implementation of
Advanced Technologies in Radiation Oncology
PART II: Commissioning SBRT and SRS Systems; Clinical Implementation of SBRT and SRS
Programs; Moderated Interactive Discussion
Room: 125
Moderator:
Speakers:
Indrin J. Chetty, PhD, Henry Ford Hospital Center
Brian Kavanagh, MD, MPH, University of Colorado
Nina A. Mayr, MD, FASTRO, University of Washington
56
ASTRO Accreditation Program for Excellence (APEx)
TM
ASTRO’s practice accreditation program highlights the Society’s
commitment to safety and quality. The program uses
evidence-based guidelines and consensus statements on the
practice of radiation oncology to establish standards of
performance. ASTRO’s practice accreditation program will provide
an objective review by practicing radiation oncology professionals
of essential functions and processes of radiation oncology
practices, in addition to a facility visit from a multidisciplinary
team. The practice accreditation program consists of five key areas:
the process of care, the radiation oncology team, safety, quality
management and patient-centered care.
1:00 p.m. - 4:00 p.m.
ASTRO Accreditation Program for Excellence (APEx) – Surveyor Session*
Room: 200-226
Angela Nicholas, DC, MBA, ASTRO
Yan Yu, PhD, MBA, Thomas Jefferson University
Prabhakar Tripuraneni, MD, FASTRO, Scripps Health Clinic
Amy Nordeng, JD, ASTRO
This interactive session is designed to provide guidance on the surveyor’s role and an opportunity for
surveyors to take the online orientation modules*. The target audience for this session is approved
surveyors for ASTRO’s practice accreditation program.
Participants of this session will be able to:
•
Discuss the mission, vision and goals of the program.
•
Discuss the radiation oncology practice accreditation model.
•
Identify and discuss the program standards.
•
Identify the steps of the survey process.
•
Discuss corrective action steps when encountering difficult scenarios during a survey.
•
Discuss surveyor training requirements.
*Attendees must bring their own laptop to participate in taking the online modules. Internet access and power
cords will be provided.
12:30 p.m. - 1:30 p.m.
ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon
Room: 200-212
Prabhakar Tripuraneni, MD, FASTRO, Scripps Health Clinic
James Hayman, MD, MBA, University of Michigan Hospitals
Yan Yu, PhD, MBA, Thomas Jefferson University
This session will provide an overview of ASTRO’s practice accreditation program. This luncheon will provide
the necessary information needed to understand the process, from application to successful accreditation.
Those attending will be able to understand the expectations, steps, resources and tools to complete the
process.
57
RO ILS
R A D I AT I O N O N C O L O G Y TM
INCIDENT LEARNING SYSTEM
Sponsored by ASTRO and AAPM
RO-ILS: Radiation Oncology Incident Learning System™ provides a shared learning environment for
radiation oncology providers to collect and analyze patient safety events. ASTRO contracted with Clarity
PSO, a federally qualified patient safety organization (PSO), to develop and administer RO-ILS. PSOs create
a secure, non-punitive environment where providers can collect, aggregate and analyze data to identify
and reduce the risks and hazards associated with patient care, as outlined in the Patient Safety and Quality
Improvement Act of 2005. RO-ILS was also developed with the support and partnership of the American
Association of Physicists in Medicine and is the only medical specialty society-sponsored incident learning
system for radiation oncology. On June 19, 2014, RO-ILS became available to the full radiation oncology
community. Please join us at the following sessions to learn more about RO-ILS and patient safety.
RO-ILS Luncheon:
12:15 p.m. - 1:15 p.m.
RO-ILS Luncheon: Lessons Learned from Medical Specialty Patient Safety
Organizations
Room: 101
Moderator: Adam Dicker, MD, PhD, Jefferson Medical College of Thomas Jefferson University
Speakers:
Carrie Bosela, RN, CPC, CPC-I, Society for Vascular Surgery Patient Safety Organization
Donald Tyler, MD, MBA, Executitve Director, Wake up Safe
Other Sessions of Interest:
9:15 a.m. - 10:00 a.m.
Keynote Address III – Human Error and Just Culture
See page 46 for more information.
10:45 a.m. - 12:15 p.m.
Educational Session 412: Improving Patient Safety and Quality of Care with the Radiation
Oncology Incident Learning System (RO-ILS)
Room: 134
See page 104 for more information.
58
59
60
61
ASTRO 2014 / 56TH ANNUAL MEETING
62
63
65
66
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
notes
notes
notes
INSIDE:
Poster Presentations
Poster Viewing Hours
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 6:45 p.m.
10:00 a.m. - 5:00 p.m.
2014 ANNUAL MEETING
PROMOTIONAL SUPPORTERS
(AS OF AUGUST 4, 2014)
Special thanks to ASTRO’s 56th Annual Meeting Promotional Supporters
GOLD
SILVER
BRONZE
CIVCO Medical Solutions
Hologic
COPPER
Sun Nuclear
Vertual, Ltd.
Poster Presentations by Track
BREAST CANCER
2001
Naoto Shikama
Acute Toxicities Associated With
Three-Dimensional Conformal
External-Beam Accelerated Partial
Breast Irradiation in a Prospective
Phase 2 Trial
2002
Bartosz Urbanski
Effectiveness and Toxicity of
Intraoperative Radiotherapy (IORT)
Given as a Boost During Breast
Conserving Surgery (BCS) Followed by
Adjuvant Whole Breast Radiotherapy
(WBRT)
2003
Andrzej Wojcieszynski
Toxicity From Breast Cancer Treatment
Using Helical Intensity Modulated
Radiation Therapy With an
Incorporated Boost
2004
Kimberley Mak
Dosimetric Inhomogeneity Predicts
for Long-Term Breast Pain Following
Breast-Conserving Therapy
2005
Malolan Rajagopalan
Utilization of Hypofractionated
Radiation Therapy for Early Stage Breast
Cancer in the Elderly Population A National Cancer Data Base Analysis
2006
Norman Williams
Cosmetic Outcome Before and After
External Beam or Intraoperative
Radiotherapy for Early Breast Cancer
Within One Year of Breast Conserving
Surgery: An Objective Assessment of
Patients From a Randomised Controlled
Trial
2007
John Cuaron
Outcomes and Early Toxicity in Patients
Treated With Proton Therapy for Breast
Cancer
2008
Marco Trovo
Hypofractionated Radiotherapy for
Partial Breast Irradiation Based on a
Novel NTCP Model for Severe Fibrosis:
Clinical Results
2009
Edward Yu
Male Breast Cancer Prognostic Factors:
Similarity to Female Counterparts With
Propensity Scores and Matched-Pair
Analysis
2010
Delnora Erickson
Axillary Coverage During Radiation
Therapy to the Breast With Tangents
Alone
2011
Marciana-Nona Duma
Tangential Field Technique for Breast
Cancer: The Dose to the Heart and
Heart Subvolumes
2012
Chikao Sugie
Efficacy of the Dynamic Jaw Mode in
Helical Tomotherapy With Static Ports
for Breast Cancer
2013
Tamer Refaat
Hyperthermia and Radiation Therapy
for Local Advanced or Recurrent Breast
Cancer: Long Term Outcomes and
Adverse Events
2014
ZhaoZhi Yang
Age and Her-2 Subtype Predict The Risk
of Ipsilateral Breast Tumor Recurrence
After Breast Conservative Therapy in
Chinese Breast Cancer Patients
2016
Charles Leonard
Clinical Utility of the 12-Gene Ductal
Carcinoma In-Situ (DCIS) Score Assay:
Impact on Treatment (tx)
Recommendations
2017
Mariko Kawamura
Development of the Breast
Immobilization System in Prone Setup:
The Effect of Bra in Prone Position to
Eliminate the Breast Setup Error
2018
Kitwadee Saksornchai
Local Recurrence and Overall Survival
Rate After Hypofractionated Irradiation
With Concomittant Boost in Early Breast
Cancer
2019
Olga Vujovic
Comparison of Two Radiation
Schedules in The Adjuvant Treatment of
Early Stage Breast Carcinoma With Long
Term Follow-Up
2020
Miriam Knoll
Dose to Organs at Risk (OAR) When
Covering the Internal Mammary Nodes
in Breast Cancer Patients: A Quantitative
Comparison of VMAT, Partially-Wide
Tangents (PWT), and Photon-Electron
(P-E)
2021
Yun Ding
Comparison of the Volume and
Localization of Lumpectomy Cavity
Delineated by Clips and Seroma Based
on 4DCT Scan for External-Beam Partial
Breast Irradiation After Breast
Conserving Surgery
2022
Guy Jones
Are the Conclusions of Z11 Relevant to
Community Practice?
2023
Ugo de Paula
Full Local Control With Accelerated
Partial Breast Irradiation (APBI) by
Tomotherapy After Breast-Conservative
Surgery for Patients Suitable, or Not,
According to ASTRO 2009 Consensus
Statement: Interim Report After 2 Years
Follow-Up
2024
Madeera Kathpal
Deep Inspiration Breath Hold (DIBH)
With Electromagentic Surface
Transponder Confirmation of Chest Wall
Position for Adjuvant Therapy of Left
Breast Cancer
2025
Jonathan Wallach
Correlation of Pathological Features of
Ductal Carcinoma in Situ (DCIS) and
Oncotype DCIS Score
2026
Yasser Abo-Madyan
Breast Radiotherapy (RT) Using
Simultaneous Integrated Boost (SIB):
Which Is The Optimal Intensity
Modulated RT (IMRT) Technique?
2027
Aaron Falchook
Adoption of Intensity Modulated
Radiotherapy (IMRT) in Early-Stage
Breast Cancer Patients Receiving
Hypofractionated and Conventionally
Fractionated Radiation in the US
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
123
2028
Mina Shenouda
Contralateral Breast Cancer: Risk
Factors, Characteristics and Prognostic
Implications
2029
Kumiko Karasawa
Carbon Ion Radiotherapy for Stage I
Breast Cancer
2030
Ravi Chandra
Radiotherapy Risk Factors for the
Development of Lymphedema in
Patients Treated With Regional Lymph
Node Irradiation for Breast Cancer
2031
Sunpreet Rakhra
Review of Outcomes After Breast
Conserving Surgery and Intraoperative
Radiotherapy and Risk Factors Leading
to Breast Complications for Early Stage
Breast Cancer
2032
David Woolf
Biological Dosimetry With γ-H2AX Foci
Using Radiotherapy for Breast Cancer
as a Model
2033
Jason Duelge
A Simple Low Cost Deep Inhalation
Breath Hold System That Can Be
Implemented at Your Clinic
2034
Eva Ambroa Rey
Which Are the Best Dose/Volume
Constraints in 3D-CRT Breast Cancer?
2035
Li Zhang
Dose Coverage of Axillary Levels I-III and
the Sentinel Lymph Node Area With
Inverse-Planned Intensity Modulated
Radiotherapy in Patients With Breast
Conserving Surgery
2036
Paola Pinnaro
Whole Breast Hypofractionated
Radiation Therapy After Conservative
Surgery: A Phase 2 Study
2037
Sandi Bosnic
A Retrospective Study of the Prone
Breast Technique: Analysing Dosimetry,
Breast Volume, Breast Separation and
Acute Skin Toxicity
2038
Li Zhang
Dose Distribution Analysis of the
Sentinel Lymph Node Area During
Field-in-Field Forward-Planned
Intensity Modulated Radiotherapy to
Breast
2039
Merrylee McGuffin
Breast Cancer Patient Preferences for
Adjuvant Radiotherapy PostLumpectomy: Whole Breast Irradiation
Vversus Partial Breast Irradiation Preliminary Results
2040
Elisa Cordova
Polymorphic Variant TP53 (R72P) May
Suggest Acute Radiotoxicity in Breast
Cancer Patients Undergoing
Conventional Radiation Treatments
2041
Elia del Cerro Penalver
Single Fraction HDR Brachytherapy
After Conservative Surgery and Whole
Hypofractionated Breast Radiotherapy
2042
May Lin Tao
Long Term Results of Breast
Conservation Therapy for Patients With
Early Stage Breast Cancer: A Large
Community Based Experience and
National Norms
2043
Zaker Rana
Factors Improving Skin Sparing, Rib
Sparing, and D95 Coverage in
Accelerated Partial Breast Irradiation
Across Five Catheter Subtypes
2044
Erin Healy
Compliance With Hormonal Therapy in
Elderly Women With Early Breast Cancer
Who Were Not Treated With Adjuvant
Radiation Following Lumpectomy
2045
Michael Stauder
Post-Mastectomy Radiotherapy After
Positive Sentinel Lymph Node Biopsy
and Completion Axillary Lymph Node
Dissection
2046
Wei Wang
Comparison of Orthogonal Kilovolt
X-Ray Plain Film and Cone-Beam CT
Matching Results in Setup Error Assessment and Correction for EB-PBI During
Free Breathing
2047
Zeliang Shi
Radiation Increase Invasive and
Metastatic Potential of Breast Cancer
Cells Through Activating Mmp-2
2048
Gul Alco
Replacement of Tumor Bed After
Oncoplastic Breast Conserving Surgery
With Immediate Latissimus Dorsi
Mini-Flap
2049
Whitney Hitchcock
Cherenkoscopically Visualized
Superficial Dose and Radiation
Dermatitis During Breast Radiotherapy
2050
Jose Bazan
Chestwall/Breast and Regional Nodal
Irradiation: A Feasibility Study of
Achieving the Normal Tissue
Constraints on NSABP B51/RTOG 1304
2051
Rosanna Yeung
Visually Monitored Deep Inspiration
Breath Hold Technique in Left-Sided
Breast Cancer Patients Treated With
Adjuvant Radiotherapy: Reproducibility
and Reliability
2052
Dean Shumway
Development of a Photonumeric Scale
for Acute Radiation Dermatitis in Breast
Cancer Patients
2053
Michael Yassa
Regional Nodal Radiotherapy in Breast
Cancer Patients With Positive Nodes
Who Convert to Negative Nodes After
Neoadjuvant Chemotherapy
2054
Rosanna Yeung
Evaluation of Cardiac Dose Reduction
With Deep Inspiration Breath Hold in
Patients With Left-Sided Breast Cancer
Receiving Adjuvant Radiotherapy
2055
Sua Yoo
Delivered Dose for Preoperative Single
Fraction Partial Breast Radiotherapy
2056
Hadley Sharp
Extent of Regional Nodal Irradiation in
the Breast-Conservation Setting
Following a Positive Sentinel Lymph
Node Biopsy: Network Practice Patterns
in a Large Multi-Site Cancer Center
2057
Andrew Wong
A Comparative Review of Three
Methods for Scoring Late Breast
Cosmesis in Patients Treated With
Lumpectomy and Radiation Therapy
(RT)
2058
Lauren Herman
Daily Two Millimeter Chest Wall Bolus
Provides Adequate Dose Build-Up With
Acceptable Skin Toxicity for
Post-Mastectomy Radiation Therapy
124
2059
Erin Gillespie
Pathologic Response After Neoadjuvant
Chemotherapy Predicts Locoregional
Control in Patients With Triple Negative
Breast Cancer
2060
Budhi Yadav
Outcome Following Postmastectomy
Internal Mammary Node Radiation in
Patients With Breast Cancer - A Long
Term Follow Up Study
2061
Yazid Belkacemi
Tangential Fields (TGF) Breast
Radiotherapy (RT): Prospective
Evaluation of the Dose Distribution
in the Axilla and the Sentinel Lymph
Node Area (SLNA) Determined Intra
Operatively by Clip Placement
2062
Jean Wright
Black Patients Treated With PMRT Are
More Likely Than Others to Develop
Moist Desquamation in a Prospective
Skin Toxicity Study
2063
Xiaofeng Yang
Ultrasound Texture Features as
Potential Early Imaging Biomarkers for
Normal-Tissue Toxicity in Breast-Cancer
Radiotherapy
2065
Robert Mutter
Single Field Spot-Scanning (SFSS) is
Dosimetrically Superior to Two Field
Intensity Modulated Proton Therapy
(IMPT) for Proton Post-Mastectomy
Radiotherapy (PMRT)
2070
Brandi Page
Leptomeningeal Failure in Patients With
Breast Cancer Receiving Stereotactic
Radiosurgery for Brain Metastases
2071
Suzhen Wang
Comparison of Clinical Treatment Effect
Between Sib-IMRT and Late-Course
Boost-IMRT for Early Breast Cancer After
Breast-Conserving Surgery
2072
Suzhen Wang
Comparison of Acute Radiation Injury
of the Skin and Cosmetic Outcome
Between Sib-IMRT and Late-Course
Boost-IMRT for Early Breast Cancer After
Breast-Conserving Surgery
2067
Lior Braunstein
Invasive Lobular Carcinoma (ILC) of
the Breast: Local Recurrence (LR) After
Breast-Conserving Therapy (BCT) by
Subtype Approximation
2068
Yolanda Tseng
Association Between Breast Cancer
Biological Subtype and Risk of
Locoregional Recurrence After
Mastectomy in Node-Negative Patients
2069
Lu Cao
Hormone Receptor Status and TN
Stage Influence the Locoregional
Benefit From Trastuzumab in Patients
With HER2 Positive Breast Cancer After
Adjuvant Radiotherapy
2081
Lesley Jarvis
Cherenkoscopy Is a Novel Imaging
Technique With the Potential to
Improve Accuracy and Detect
Radiotherapy Misadministrations
During Whole Breast Radiotherapy
2082
Leonid Zamdborg
Dosimetric Predictors of Cosmesis
in Whole Breast Irradiation: A Novel
Clincally-Applicable Constraint
2073
Pratap Reddy
To Study Whether Curcumin and
Piperine Sensitize Breast Cancer Cells
and Breast Cancer Initiating Cells to
Radiation
2083
Jacob Shin
The Impact of Race in Male Breast
Cancer Outcome in the United States:
A Population-Based Analysis of 4,279
Patients
2074
Weiwei Li
IMRT Versus 3D-CRT for PostMastectomy Irradiation of Chest Wall
and Regional Nodes: A
Population-Based Comparison of
Normal Lung Dose
2084
Yazid Belkacemi
Patterns of Practice of Nodal
Radiotherapy in Breast Cancer: Results
of the Eortc “Nora” Survey
2075
Jiayi Chen
Outcome of Brain Metastases From
Her2-Positive Breast Cancer: Difference
in Survival Benefit From Anti-Her2
Treatment After WBRT With Regard to
Prior Targeted Therapy
2076
2066
David Wazer
A Phase 1 Trial of a Novel Photodynamic
Therapy for Chest Wall Recurrent Breast
Cancer Following Prior Radiation
Therapy
2080
Mami Ogita
Randomized, Prospective Trial of
Moisturizer Efficacy for the Treatment
of Skin Dryness Following Radiotherapy
After Breast-Conserving Surgery
WITHDRAWN
2077
Shuai Li
Risk Factors for Supraclavicular Nodal
Failure in Chinese Breast Cancer Patients
With One to Three Positive Axillary
Nodes Treated With Breast Conserving
Surgery Without Supraclavicular Nodal
Radiation
2078
Jason Ye
Triple Negative Receptor Status and
Other Predictors of Lymph Node
Positivity in Small (T1) Breast Cancers: A
National Registry Study
2079
T. Jonathan Yang
Characteristics and Outcomes of Breast
Cancer Patients Who Received
Immediate Reconstruction and
Postmastectomy Radiation Following
2085
Kristina Mirabeau-Beale
Quality of Life (QOL) in Women With
Breast Cancer Enrolled on a Prospective
Lymphedema Screening Protocol
2086
Sahaja Acharya
Ductal Carcinoma In-Situ Treated With
Accelerated Partial Breast Irradiation:
An Analysis of Ipsilateral Breast Tumor
Recurrence and Contralateral Breast
Cancer
2087
Sui Shen
Variation in Boost Dose to Breast Cancer
Tumor Bed in Deep Inspiration
Breath-Hold Radiotherapy Evaluated
With Feedback-Guided CBCT
2088
Tara Hansen
Using the Strut-Adjusted Volume
Implant: A Single Institution Review of
Toxicity and Cosmetic Outcome
2089
Mary Lopresti
Lack of Breast Cancer Screening in
Women at High Risk After Supra
Diaphragmatic Irradiation for Pediatric
Malignancies
125
2090
Qian Zhang
The Impact of Serum IL-8 Level on
Acute Radiation-Induced Skin
Toxicity in a Prospective Trial
Comparing Concomitant or Sequential
Anastrozole With Postoperative
Radiotherapy in Postmenopausal
Women With Receptor Positive Breast
Cancer
2091
Asal Rahimi
Phase 1 Dose Escalation Trial Using
Stereotactic Body Radiation Therapy
(SBRT) for Partial Breast Irradiation (PBI)
2092
Rebekah Young
Evaluation of Oncotype DX DCIS Usage
Among Minority Women: A Single
Institutional Review
2093
Linna Li
Squamous Cell Carcinoma of the Breast:
An Analysis of a Rare Tumor Type in the
SEER Database
2094
Timothy Lymberiou
Predictors of Breast Radiotherapy
Plan Modifications: Quality Assurance
Rounds in a Large Cancer Center
2095
Trang Pham
Left-Sided Breast Cancer Loco-Regional
Radiotherapy With Deep Inspiration
Breath-Hold (DIBH): Does Volumetric
Modulated Arc Therapy (VMAT) Reduce
the Cardiac Dose Further When
Compared to Tangential Intensity
Modulated Radiotherapy (T-IMRT)?
2096
Grace Lee
Identifying Anatomic Features in
Women at Risk of Cardiac Exposure in
Whole Breast Radiotherapy Treatments
2097
Yoonsun Chung
Dummy Run Study of Quality Assurance
Program in KROG 08-06 Study, Phase
3 Randomized Trial to Investigate the
Role of Internal Mammary Lymph Node
Irradiation for Breast Cancer Patients
2098
Shuai Li
Interim Analysis of 354 Breast Cancer
Patients Randomly Treated With
Hyperfractionated or Conventional
Fractionated Radiotherapy After Breast
Conserving Surgery
2099
Louis Keiler
EBRT Versus APBI: Patient Satisfaction
2100
Kristina Demas
Treatment of Ductal Carcinoma in Situ
With Adjuvant Accelerated Partial Breast
Irradiation: A Surveillance,
Epidemiology, and End Results Based
Patterns of Care Analysis
2101
Clare Suttie
Dosimetric Implications of Tissue
Expanders in Post-Mastectomy
Irradiation, and Oncoplastic
Reconstruction Outcomes
2102
Charlotte Dai Kubicky
Impact of Molecular Subtypes and
Pathologic Response on Locoregional
Recurrence (LRR) and Survival in Breast
Cancer Patients Treated With
2103
Shihfan Lai
Effect of Immunohistochemically
Biological Expression on Clinical
Outcome for Patients With Breast
Cancer and Brain Metastases After Brain
Radiotherapy
2104
Jae Myoung Noh
Prognostic Significance of Internal
Mammary Node Involvement in
Patients With Clinical Stage IIIc Breast
Cancer Who Received Neoadjuvant
Chemotherapy, Surgery, and
Radiotherapy
2105
Tao Wu
Improved Locoregional Control For
Patients With T1-2n1 Triple-negative
Breast Cancer Treated With
Radiotherapy Following Modified
Radical Mastectomy
2106
Celine Bourgier
Bilateral Cancer Breast Irradiation by
Volumetric Modulated Arc Therapy
(VMAT): Early Clinical Experience
2107
Gabriele Simontacchi
Comparison of Static Fields IMRT and
Helical IMRT for Accelerated Partial
Breast Irradiation
2110
Valentina Vanoni
Extrernal Beam Radiotherapy Versus
Intraoperative Radiotherapy for Breast
Conserving Therapy: A Large Single
Institution Matched-Pair Evaluation
2111
Masako Kato
Evaluating Radiation Dose to the Heart
and the Left Anterior Descending (LAD)
Coronary Artery With Left Whole Breast
Radiation Therapy to Japanese Women
2112
Hyunsoo No
Breast Cancer Radiotherapy (RT) in
Developing Countries: A Technique for
Simple Prone Treatment Planning
2113
Eunjin Jwa
Retrospective Analysis of Risk Factors for
Regional Recurrence for pN1 Patients
After Breast Conserving Surgery
2114
Kruti Patel
Comparison of Coronary Vessel
Contouring Using Non-Contrast Cardiac
Gated CT VersusCT Angiogram
2115
Jonathan Verma
Breast Cancer Subtype and
Locoregional Outcomes in Locally
Advanced Breast Cancer
2116
Ivy Petersen
What Is Normal? - Cooperative Pooled
Database to Establish Typical Heart and
Lung Doses for Modern Breast
Radiation Therapy
2117
Maria Almudena
Cascales Garcia
Borderline and Malignant Phylloides
Tumors of the Breast: A Retrospective
Analysis of 37 Cases
2118
Elizabeth Nichols
Prospective Evaluation of Preoperative
3d Conformal Accelerated Partial Breast
Irradiation (3dcrt-apbi) Shows
Promising Early Results
2108
Karolien Verhoeven
Boost Delineation in Breast
Radiotherapy: Isotropic Versus
Anisotropic Margin Expansion
2119
Efrat Shekel
Is Contouring the Left Anterior
Descending (LAD) Artery Necessary for
Left Breast Patients? A
Retrospective Comparison Between
Treated and Revised Plans
2109
Diana Tuano
The Impact of Contouring the Axillary
Lymph Nodal Levels in Achieving
Adequate Doses for Tangential
Chestwall Irradiation
2120
Julian Johnson
Repeat Sentinel Lymph Node Mapping
in Patients With Post Mastectomy Chest
Wall Recurrence: Influence on Radiation
Treatment Fields and Outcome
126
2121
Anna Lee
Inter- and Intra-operator Reproducibility
of Cutaneous Toxicity Measurements
Using Quantitative Ultrasound
2131
Stuti Ahlawat
Accelerated, Hypofractionated Whole
Breast Radiotherapy in Women With
Breast Cancer: A Phase II Trial
2142
Brent Rose
Effect of Involved Lymph Node Size on
Cancer-Specific Mortality in Women
With Node-Positive Breast Cancer
2122
Julia Manzerova
Predicting Potential RadiationAssociated Cardiac Risks for Left Breast
Cancer Patients Treated With
Post-Mastectomy or Breast and
Regional Nodal Radiation Therapy
2132
Carole Massabeau
Outcome of pN0 Triple Negative Breast
Cancers With and Without Lymph Node
Irradiation
2143
Daniel Petereit
The Impact of Breast Patient Navigation
on Breast Preservation Rates
2123
Daniel Trifiletti
A Comparative Analysis of 3-D
Conformal and Intensity Modulated
Radiotherapy During Deep Inspiratory
Breath Hold for Left Sided Whole Breast
Irradiation
2124
Nalini Rao
Can Tangential Fields Designed for
Whole Breast Coverage in Early Breast
Cancer Adequately Irradiate Limited
Node Positive Disease, Not Treated
With Alnd?
2133
Richard Hymas
Dosimetric Predictors of Toxicity and
Cosmesis in Women Treated With
Hypofractionated Whole Breast
Irradiation
2134
Jon Strasser
Outcomes for APBI With Strut-Based
Brachytherapy: 596 Patients With 39
Month Median Follow-Up
2135
Christy Goldsmith
Clinical Outcome of Stereotactic
Radiotherapy for the Treatment of
Oligometastatic Breast Cancer
2125
Benjamin Lok
Age, Tumor Subtype and
Locoregional Recurrence in Operable
Breast Cancer Patients Treated With
Adjuvant Therapies
2136
Jean Wright
Racial and Ethnic Disparity in Stage at
Breast Cancer Diagnosis: Changes in
Minority Populations in Florida From
1981-2009
2126
Malcolm Mattes
Breast Cancer Molecular Subtype as a
Predictor of Lymph Node Metastasis
2137
Peter Chen
Propensity-Score Matched-Pair Analysis
of Interstitial Multicatheter Versus
Balloon-Based Accelerated Partial
Breast Irradiation, Stratified by ASTRO
Guidelines
2127
Adavikolanu Kesava
Ramgopal
Postmastectomy Chest Wall Radiation
of Left Sided Breast Cancer Patients
With Single Energy Electron-beam
Versus Three Dimensional Conformal
Radiotherapy With Photons- Analysis of
Dosimetric Parameters
2128
Randy Wei
Association Between Breast Cancer and
Glioblastoma Multiforme in Women: A
California Cancer Registry
Population-Based Analysis
2129
Catheryn Yashar
Outcomes for APBI With Strut-Based
Brachytherapy: First 200 Accrued
Patients (52 Month Median Follow-Up)
2130
Melis Gultekin
Radiation Induced Hypothyroidism and
Related Dosimetric Parameters in Breast
Cancer Patients
2138
María Ríos Pozo
Locoregional Recurrence of Early Breast
Cancer According to Intrinsic Subtype
2144
Laura Warren
Inflammatory Breast Cancer: Patterns
of Failure and the Case for Aggressive
Local-Regional Management
2145
Justin Rineer
Patterns of Progression in Hormone
Receptor Positive Metastatic Breast
Cancer - An Argument for Local Therapy
2146
Richard Cedric Zellars
Two Phase 1/2 Trials of Partial Breast
Irradiation (PBI) With Concurrent
Chemotherapy Regimens: Late
Toxicity, Cosmetic Outcome and
Disease Recurrence
2147
Linda Smith
Improved Targeting of the
Lumpectomy Cavity Using a Spiral
3-D Marker
2148
Nisha Patel
Dosimetric Deviations in Partial Breast
Irradiation During the Treatment
course due to Random and Systematic
Uncertainties
2149
Nathan Tonlaar
Outcomes of African American Women
Undergoing APBI for Early Stage Breast
Cancer: A Matched Pair Analysis
2150
2139
William Hartsell
Proton Beam Therapy for Locally
Advanced Breast Cancer: Dosimetric
Results and Acute Toxicity
2140
Jessica Wobb
Comparison of Chronic Toxicities
Between Brachytherapy-Based
and Whole Breast Intensity Modulated
Radiotherapy
2141
Grant Ognibene
Three-Dimensional Conformal External
Beam Accelerated Partial Breast
Irradiation: The Stanford Experience
WITHDRAWN
2151
Jennifer Chang
Evolution of Heart Dose Over Time in
Patients Treated for Left-Sided Breast
Cancer
2152
Richard Cedric Zellars
Identification of Molecular Markers of
Radiation-Induced Toxicity in Patients
Undergoing Breast Conserving Therapy
2153
James Snider III
Theoretical Improvements in Cosmetic
Outcomes Utilizing a Novel Breast
Stereotactic Radiotherapy (BSRT)Device Compared to 3-Dimensional
Partial Breast Irradiation Using IMRT
(IMRT PBI): A Dosimetric Analysis
127
2154
Carolina Fasola
Local Recurrence Among Patients With
Early Stage Breast Cancer Treated With
Intraoperative Radiotherapy: The Effect
of Systemic Therapy
2155
Michael Eblan
Effect of Internal Mammary Vessel
Irradiation on Outcomes of Free Flap
Breast Reconstruction in Patients
Treated With Mastectomy and Radiation
Therapy for Breast Cancer
2156
Morteza Dowlatshahi
Favorable Cosmesis and Local Control
for Single-Lumen and Multi-Lumen
Applicators for Accelerated Partial
Breast Irradiation for Early Stage Breast
Cancer
CENTRAL NERVOUS SYSTEM
2157
James Marsh
Involvement of the Neural Stem Cell
Compartment by Pediatric and Adult
Gliomas: A Retrospective Review of
377 Cases
2158
Lova Sun
Next Generation Nanoparticles for
Enhanced Radiation Therapy and
Diagnostic Imaging of Brain Tumors
2159
Jimmy Caudell
Radiosensitivity Molecular Signature
is Predictive of Overall Survival in
Glioblastoma
2160
Quincey LaPlant
Radiographic Features, Patterns
of Treatment Failure, and Clinical
Outcomes in 56 Cases of Molecularly
Subtyped Glioblastoma Multiforme
Patients
2161
Toshihiko Iuchi
Risk and Benefit of Irradiation for
Subventricular Zone in the Treatment of
Patients With Glioblastoma
2162
Michelle Kim
A Phase 1 Dose-Escalation Study of
Gemcitabine Plus Standard Radiation
Therapy for Malignant High Grade
Gliomas
2163
Andrew Elson
Evaluation of Pre-Radiotherapy
Apparent Diffusion Coefficient (ADC):
Patterns of Recurrence and
Progression Free Survival Analysis in
Patients with GBM
2164
Abhilasha Patel
Population Based Analysis to Determine
Conditional Survival in Patients with
Gliomas Treated With Radiation
2165
Alin Chirindel
Multi-Reader Evaluation of Manual
Tumor Delineation for Recurrent
Glioblastoma on FET-PET Scan - Impact
of PET Windowing Settings
2166
Anthony Rizzo
Investigating the Relationship Between
Radiation Dose to Neural Stem Cell
Niches and Survival in GBM
2167
Melissa Azoulay
Hypofractionated Radiotherapy With
or Without Temozolomide Compared
to Standard of Care in the Treatment
of Glioblastoma: Results From a Single
Institution
2168
Julie Carlson
Hypofractionated-Intensity
Modulated Radiotherapy (hypo-IMRT)
and Temozolomide (TMZ) With and
Without Bevacizumab (BEV) for
Glioblastoma Multiforme (GBM): A
Comparison of Two Prospective Phase
2 Trials
2169
Julie Carlson
A Phase 2 Trial of
Hypofractionated-Intensity
Modulated Radiation Therapy
(hypo-IMRT) Combined With
Temozolomide (TMZ) and Bevacizumab
(BEV) for Patients With Newly
Diagnosed Glioblastoma Multiforme
(GBM)
2170
Dayssy Diaz Pardo
Re-irradiation for Recurrent Gliomas:
Comparison of Multiple Fractionation
Schedules
2171
Hiroshi Igaki
Patterns of Recurrence in Malignant
Glioma Patients: Association With
Neurogenic Niche and Radiotherapy
Dose
2172
Brijal Desai
Overall Survival (OS) and Toxicity
Outcomes Following Large-Volume
Re-irradiation Using Proton Therapy
(PT) for Recurrent Glioma
2173
Christopher Anker
Additional Treatment Margin Beyond
Edema Provides No Benefit in the
Radiation of Glioblastoma Multiforme
2174
Naomi Nakajima
Pretreatment Fluid-Attenuated
Inversion Recovery (FLAIR) High
Intensity Volume on Magnetic
Resonance Imaging Correlate With
Clinical Outcome in Who Grade 3
Gliomas
2175
Naomi Nakajima
High Subventricular Zone Radiation
Dose Correlates With Progression-Free
Survival in Glioblastoma Patients After
Concurrent Temozolomide
Administration and Extended Focal
Radiotherapy
2176
Naomi Nakajima
Clinical Outcomes and Prognostic
Factors in Patients With High Grade
Glioma Treated With Surgery
Followed by Concurrent Temozolomide
Administration and Extended Focal
Radiotherapy
2177
Michael Kucharczyk
Evaluation of Pseudoprogression in
Patients With Glioblastoma (EPPIG)
2178
Fen Zhao
Prognostic Value of 3’-deoxy-3’18f-fluorothymidine Pet in Patients With
Recurrent Malignant Gliomas:
Comparison With Contrast-Enhanced
MRI
2179
Joseph Bovi
Treatment of Recurrent Glioblastoma
With Bevacizumab With or Without
Re-irradiation Using a Pulsed Low Dose
Radiotherapy Technique: A Single
Institution Experience
2180
Xin Li
Extravasation Rate Constant Estimation
From Pharmacokinetic First Principles
to Improve Dynamic Susceptibility
Contrast MRI Characterization of Brain
Tumors
2181
Grace Kusumawidjaja
Dose Escalated Intensity Modulated
Radiotherapy and Increased Radiation
Doses to Subventricular Zones in
Treatment Outcomes of Patients With
Glioblastoma Multiforme
2182
Nobumasa Fujitani
Applicability of the Linear-Quadratic
Model to Radiotherapy at a High Dose
per Fraction In Vivo
128
2183
Rifaquat Rahman
Toxicity, Hospitalization Burden, and
Survival Among Glioblastoma Patients
Receiving Chemoradiation
2184
Charlotte Debus
The Battle Between Amino Acid PET
and Functional MRI: Precision of Tumor
Delineation Examined by Glioma
Progression Pattern After Radiotherapy
2185
Mekhail Anwar
Determining Voxel Response to
Radiotherapy in Glioblastoma Using
Integrated Dosimetry, Diffusion,
Perfusion and Spectra
2186
Jordan Holmes
Genomic Predictors of Infield and
Marginal Failure for Glioblastoma
Treated With Concurrent Radiotherapy
and Temozolomide: A Step Towards
Personalized Radiation Fields?
2187
Barbara Diletto
Prognostic Value of Age and
Comorbidities in Elderly Glioblastoma
Patients: Analysis From Three
Prospective Phase 2 Trials
2188
Silvia Chiesa
Including Edema or Not in
Glioblastoma? Analysis From Sequential
Prospective Phase 2 Studies
2189
Vikram Jairam
Change in Radiotherapy Treatment
Volumes With Initial Alkylating
Chemotherapy in WHO Grade 3
Gliomas
2190
John Hardie
Evaluation of RANO Response Criteria
Compared to Clinician Evaluation in
Grade 3 Anaplastic Astrocytoma (AA):
Implications for Clinical Trial Reporting
2191
Jiayi Huang
Clinical Outcomes of Small Cell
Glioblastoma or Glioblastoma With
Oligodendroglioma Component
treated With Radiotherapy and
Temozolomide
2192
Julie Jung Kang
High-Dose Radiation to the
Subventricular Zone Does Not Alter the
Patterns of Recurrence in GB
2193
Magali LecavalierBarsoum
Prognostic Factors of Survival for
Aanaplastic Gliomas
2194
Amol Narang
Mr Enhancement as a Predictor for
Malignant Degeneration in Progressive
Low-Grade Gliomas: An Update With
Survival Analysis
2195
David Randolph
Does Delay of Start of Radiation Affect
Clinical Outcomes of Glioblastoma
2196
Evan Osmundson
Relative Monocytopenia, a Proposed
Correlate of Decreased Vasculogenesis,
is Associated With Improved Survival in
Patients With Glioblastoma Multiforme
2197
Ru xin Wong
Outcome of Patients With Acoustic
Neuroma Treated With Conventionally
Fractionated Stereotactic Therapy: An
2198
Kurt Meyer
Predictors of Symptomatic Edema After
Treatment of Intracranial
Meningiomas With Single Fraction
Stereotactic Radiosurgery
2199
Ariel Marciscano
Long-term Follow Up of Adaptive
Multi-Stage Stereotactic Radiosurgery
for Treatment of High Grade
Arteriovenous Malformations
2200
Nikhil Joshi
Staged Gamma Knife Radiosurgery for
Large Volume Arteriovenous
Malformations: A Single Institution
Retrospective Review and Initial Results
2201
Xin Wang
Hypofractionated Stereotactic
Radiotherapy for Giant Cavernous Sinus
Hemangiomas in Close Proximity to
Optic Nerves and/or Optic Chiasm
2202
Gregory Russo
Evolving Trends in Stereotactic
Radiosurgical Treatment of Meningioma
2203
Jeffrey Kittel
Adjuvant Radiation May Not be Necessary Following Gross Total Resection of
an Atypical Meningioma
2204
Jillian Maclean
Simultaneous PET/MRI for Target
Volume Definition in Meningiomas:
Feasibility and Impact on Interobserver
Variability
2205
William Kennedy
Proton Therapy for Pituitary Adenoma
2206
Khusraw Sabit
Volumetric Growth Measurements of
Pituitary Macroadenomas Following
Surgical Resection and Indications for
Early Adjuvant Radiotherapy
2207
Michael Dyer
Quality of Life in Patients Treated With
Surgery Alone versus Surgery and
Radiation for Nonfunctioning Pituitary
Adenomas
2208
Ryan Rhome
Long Term Outcomes and Toxicities
of Growth Hormone (Somatotroph)Secreting Pituitary Macroadenomas
Treated With Adjuvant Fractionated
Stereotactic Radiation Therapy (FSRT)
2209
Jennifer Jefferis
Minimal Acute Toxicities Following
High-Dose Proton Therapy for Spinal
Tumors
2210
Zain Ahmed
Spine Stereotactic Radiosurgery in the
Management of Sarcoma Metastasis
2211
Clifford Robinson
Comparison of Spinal Cord Motion
Versus Vertebral Body Motion During
Magnetic-Resonance Imaging-Guided
Radiation Therapy (MR-IGRT)
2212
Michael Virk
Symptomatic Vertebral Body
Compression Fractures Requiring
Intervention Following Single Fraction
Stereotactic Radiosurgery for Spinal
Metastases
2213
Prachi Jain
Radiographic, Neurological and Clinical
Assessment of Fractionated Stereotactic
Radiosurgery in the Treatment of
Metastatic Epidural Spinal Cord
Compression at a Single Institution
2214
Eric Chang
Long-Term Outcomes after Proton
Beam Radiation Therapy for Intraocular
Vascular Tumors
2215
Gaurav Marwaha
Ruthenium Eye Plaques for Uveal
Melanoma: Long-Term Clinical
Outcomes
129
2216
Puyao Li
Radiation Tolerance of the Optic
Pathway After Fractionated Proton
Radiation Therapy
2228
Bruce Pollock
Single Fraction Stereotactic
Radiosurgery of Meningeal
Hemangiopericytomas
2217
Christopher Barker
Ruthenium-106 Plaque Brachytherapy
for Uveal Melanoma: Factors Associated
With Local Tumor Recurrence
2229
Shyamal Patel
Does Systemic Therapy Matter After
Stereotactic Radiosurgery for Brain
Metastases From Lung Cancer?
2218
Sean Szeja
Clinical Effect of UV radiation on Ocular
Melanoma: SEER Investigation
2230
Akifumi Miyakawa
Low-Dose (GK) Radiosurgery Plus
Whole-Brain Radiotherapy (WBRT)
Versus GK Alone for Multiple Brain
Metastases: a Matched Case-Control
Study
2219
Alexei Polishchuk
Tumor and Dosimetric Predictors of
Long-Term Visual Outcomes After
Proton Beam Therapy of Uveal
Melanoma
2220
Lukas Stalpers
Late Effects of Radiotherapy for Optic
Nerve Sheath Meningioma (ONSM)
2221
Samantha Price
MRI-Based Verification of Plaque
Positioning and Treatment Planning for
Episcleral Brachytherapy
2222
Bradford Perez
Uveal Melanoma Treated With
Iodine-125 Episcleral Plaque According
to the COMS Trial Is Associated With
Worsened Visual Acuity Change and
Increased Risk of Chronic Toxicity
Compared to Lower Prescription Doses
2223
Aiko Nagai
Radiotherapy Using Helical
Tomotherapy for Single or Multiple
Brain Metastases
2224
Keisuke Tamari
Non-invasive Stereotactic Radiosurgery
for Brain Metastases of Lung Cancer
2225
Prince Mathew
Alignment Accuracy & Intrafraction
Motion Analysis in Frameless Functional
Image Guided Radiosurgery
2226
James Bates
Efficacy of Stereotactic Radiosurgery
(SRS) in the Treatment of Brain
Metastases From Melanoma and Renal
Cell Carcinoma (RCC)
2231
Akihiro Hayashi
Study on the Optimal Field Width in
Helical Tomotherapy With the New
Dynamic Jaws Technology for Small
Metastatic Brain Tumors
2232
Samuel Shin
Updated Results of Involved Field
Radiation Therapy After Resection
of Single Brain Metastases - A Single
2233
Hideyuki Harada
Cranio-Spinal Irradiation for
Leptomeningeal Carcinomatosis: A
pilot study
2234
Rovel Colaco
Systemic Treatment and Radiation
Necrosis Following Gamma Knife
Radiosurgery in the Treatment of Brain
Metastases
2235
Rovel Colaco
Dose Selection Algorithm for Gamma
Knife Treatment of Cerebral
Metastases- Preliminary Results
2236
Jean-Baptiste Clavier
Delineation of Brain Metastases for
Stereotactic Radiotherapy: An
Interobserver Contour Comparison
2237
Kamran Ahmed
Fractionated Stereotactic Radiotherapy
to the Postoperative Cavity for Brain
Metastases
2238
David Shultz
Repeat Stereotactic Radiosurgery (SRS)
For New Brain Metastases Following
Initial Srs: Accumulated Tumor Volume
And Graded Prognostic Assessment
(GPA) Score Calculated at Each Course
Correlate With Overall Survival
2239
Hilary Bagshaw
Local Control of Melanoma Brain
Metastases by Metastatic Lesion
2240
Jennifer Chang
Estimation of the Incident Probability
of Brain Metastases in HippocampalSparing Whole Brain Radiation
2241
Kamran Ahmed
Outcomes Following Fractionated
Stereotactic Radiotherapy in the
Management of Radioresistant and
Radiosensitive Brain Metastases
2242
Zachary Seymour
Surgical Resection and Brain
Brachytherapy With Permanent
Iodine-125 Seeds for Brain Metastases
2243
Gerald Fogarty
Randomised Trial of Whole Brain
Radiotherapy in Melanoma Brain
Metastases- First Interim Analysis
2244
Seohee Choi
Treatment Outcome and Prognostic
Factors of Supratentorial PNET :
Follow-Up Results of a Single Institute
2245
Maria Leticia Silva
Analyses of 600 Patients With Brain
Metastases Treated With Whole Brain
Radiotherapy: Prognostic Features and
Comparison With DS-GPA Prognostic
Features - A 16-year Institutional Review
2246
Ching-Chieh Yang
Frameless Hypofractionated Robotic
Radiosurgery for Cerebral Arteriovenous
Malformations : Early Clinical Report
on Obliteration Rate, Bleeding Risk and
Toxicity
2247
Andrew Huang
Factors Associated With
Leptomeningeal Failure in Patients Who
Underwent Surgical Resection
Followed by Cavity-Directed
Metastases
2248
John Lucas
A Propensity Score Adjusted Analysis of
Patients Receiving Up-Front SRS Versus
WBRT: Does the Use of Upfront WBRT
Really Affect Neurologic Death?
2249
Jacob Raber
2227
Stefanie Lazow
Effects of Acute Radiation Exposure on
Comparison of Clinical Outcomes
Extinction of Previously Conditioned
After Intracavitary Cesium-131 (Cs-131)
Fear in Mice
Brachytherapy Versus Stereotactic
Radiosurgery for Resected Brain
Metastases
130
2250
Rebecca Levin-Epstein
Stereotactic Radiation Therapy
Demonstrates Improved Tumor Control
Versus Whole Brain Radiotherapy in
Breast Cancer Brain Metastasis for all
Receptor Subtypes
2251
Rupesh Kotecha
Management of Brain Metastasis in
Patients With Neuroendocrine
Carcinomas of the Lung
2252
Tony Wang
Lung Cancer Mutation Status and
Targeted Therapy Predict for Outcomes
in the Setting of Brain Metastasis
Treated With Stereotactic Radiosurgery
2253
Luluel Khan
Outcomes With Hypofractionated
Stereotactic Radiotherapy (hfSRT) in
Patients With Intact Brain Metastases
and Post-Operative Surgical Cavities
2254
Vinai Gondi
Real-Time Pre-Treatment Review Limits
Unacceptable Deviations: Quality
Assurance (QA) Results of RTOG 0933
2255
Paulo Moraes
Outcome of Cerebral Arteriovenous
Malformation After Linear Accelerator
Radiosurgical Retreatment
2257
Lukas Stalpers
Estimation of the Incidence of Brain
Metastases and Patterns of Care in The
Netherlands
2258
Guy Savir
Comparison of Fractionated
Stereotactic Radiosurgery and
Single-Fraction Stereotactic
Radiosurgery for the Treatment of
Brain Metastases
2259
Daniel Gorovets
Improving Patient Selection for
Stereotactic Radiosurgery as the Initial
Radiotherapy Approach for Brain
Metastases
2260
Priya Jayachandran
Repeat Stereotactic Radiosurgery (SRS)
for Brain Metastases Locally Recurrent
Following Initial SRS
2261
Jeffrey Burkeen
Lower-Dose Stereotactic Radiosurgery
for Small Brain Metastases: Local Control
and Toxicity
2262
Ashish Jani
The Effect of Energy Index on Brain
Metastases Local Control with
2274
Joel Broomfield
Stereotactic Radiosurgery for Refractory
Trigeminal Neuralgia
2275
Ryan Lanning
Clinical Outcomes of Salvage Partial
Brain Radiation Therapy for Local
Recurrence After Stereotactic
Radiosurgery in the Setting of Brain
Metastases
2263
Andrew Song
Adult Medulloblastoma: Does
Craniospinal Dose Matter?
2264
Saif Althaqfi
Use of CT Cisternograms in Target
Definition for Trigeminal Neuralgia
Radiosurgery
2265
Amandeep Taggar
Outcomes From First Three Years of
Frameless Stereotactic Radiosurgery in
Treating Brain Metastases
2266
Taro Murai
Stereotactic Radiotherapy for Brain
Metastases From Advanced Non-Small
Cell Lung Cancer With or Without
Endothelial Growth Factor Receptor
(EGFR) Mutations: Influence of Gefitinib
Treatment
2267
Yaser Hasan
Factors Affecting Post-Operative
Surgical Cavity Volume and Surface
Area Dynamics Specific to Brain
Metastases
2268
Jason Chan
Re-treatment of Brain Metastases Using
2269
Hong-Qing Zhuang
Analysis of Risk and Predictors of
Brain Radionecrosis After Robotic
Radiosurgery
2270
Eduard Schreibmann
Automated Population-Based Planning
for Whole Brain Radiation Therapy
2271
Bree Eaton
Single Fraction Radiosurgery versus
Hypofractionated Radiosurgery for
the Treatment of Resected Large Brain
Metastases: A Comparison of
Complications and Local Tumor Control
2272
Nikolai Mickevicius
Effects of Whole Brain Radiation
Therapy on Resting State Connectivity:
A Case Study
2273
Jared Giem
Evaluation of Treatment Plan Quality of
Single and Multiple Isocenter
Stereotactic IMRT for Multiple
Intracranial Tumors
2276
Karin Lindberg
Outcome After SBRT of Adrenal Gland
Metastases - A Multicenter
Retrospective Analysis of 60 Adrenal
Metastases
2277
Kyle Arneson
A Phase 1 Trial of Concurrent Sorafenib
and Stereotactic Radiosurgery for
Patients With 1-4 Brain Metastases
2278
Leslie Modlin
Repeat Resection Cavity Stereotactic
Radiosurgery (SRS) for Brain Metastases
Locally Recurrent Following Initial
Resection Cavity Boost
2279
Mira Shah
Parotid Gland Dose in Whole Brain
Radiation Therapy Patients
2280
Anthony Pham
Evaluation of Mini-Mental Status
Examination Score in a Prospective
Study of Neurosurgical Resection and
Intra-Operative Cesium-131
Radioisotope Brachytherapy in
Patients With Newly Diagnosed Brain
Metastases
2281
Reshma Munbodh
Radiation Induced Toxicity in Patients
Treated for Brain Tumors With Photon
or Proton Radiotherapy
2282
Christopher Abraham
Dosimetric Variables Predictive of Local
Control Following Stereotactic
Radiosurgery (SRS) for Non-Small Cell
Lung Cancer (NSCLC) Brain Metastasis
2283
Neil Estabrook
Quantifying the Optimum Number of
Proton Fields in Treatment of Midline
Tumors Using a Marginal Cost Analysis
2284
Matthew Johnson
Brain Metastases Treated With Surgical
Resection Followed by Frame-Based
131
2285
Colette Shen
Repeat Stereotactic Radiosurgery is an
Appropriate Approach for New/
Recurrent Brain Metastases
2286
Shahed Badiyan
Outcomes Following a Second Course
of Stereotactic Radiosurgery (SRS) for
Locally Recurrent Brain Metastases
2287
Robert Press
Clinical Predictors of Distant Brain
Failure and Early Salvage Whole Brain
Radiation Therapy after LINAC-Based
Metastases
2288
Ryan Abel
Stereotactic Radiosurgery to the
Resection Cavity for Brain Metastases:
Prognostic Factors and Outcomes
2289
Alexander Masino
Fractionated Stereotactic Radiosurgery
for the Treatment of High-Risk Brain
Metastases
2290
Jennifer Chang
Estimation of the Incident Probability
of Brain Metastases in HippocampalSparing Whole Brain Radiation
GASTROINTESTINAL CANCER
2291
Shuhei Sekii
Intrafraction Esophageal Motion for
Clinically T1 Esophageal Cancer
2292
Liu Di
Shall We Treat Small Cell Esophageal
Carcinoma (SCEC) Like Small Cell Lung
Cancer (SCLC)? Comparison of the
Expression Profiles of SCEC, SCLC and
Esophageal Carcinoma (EC)
2293
Mary Dean
Definitive Contemporary
Chemoradiation With Dose Escalation
for Esophageal Cancer
2294
Yoshiko Doi
Four-Dimensional Assessment of the
Internal Motion of Esophagus in
Early-Stage Esophageal Cancer Patients
Using Metal Markers
2295
Annemarie Fernandes
Clinical Outcomes of Proton Beam
Re-Irradiation for Esophageal Cancer
2296
Hunter Boggs
Primary Gross Tumor Volume is an
Important Prognostic Factor in Locally
Advanced Esophageal Cancer Patients
Treated With Trimodality Therapy
2306
Kazushige Atsumi
Utility of an Artificial Neural Network
for Prediction of Survival in Patients
With Esophageal Cancer Treated With
Radiotherapy
2297
Jin Wang
Detecting The Variations of the Spatial
Position and Overlap Ratio for Primary
Thoracic Esophageal Cancer Target
During Radiotherapy Based on
Repeated Four-Dimensional CT Scans
2307
Takuro Ariga
Clinical Outcomes of Definitive
Chemo-Radiotherapy for T4 Esophageal
Cancer
2298
Jin Wang
Detection of Tumour Volume
Regression and Motion Changes During
Radiotherapy for Primary Thoracic
Oesophageal Cancer Based on 4DCT
Scans
2299
Stephanie Servagi
Vernat
Chemoradiotherapy for Oesophageal
Cancer in Elderly Patients
2300
Mariko Kawamura
Safety and Efficacy of Endoscopic
Evaluation During Chemo-Proton
Therapy of Esophagus Cancer: Initial
Result of 6 Month Follow-Up
2301
Yuji Murakami
Results of Neoadjuvant
Chemoradiotherapy Followed by
Surgery for Locally Advanced
Esophageal Squamous Cell Carcinoma
2302
Melody Xuanlu Qu
Management and Outcomes of
Elderly Patients Treated for Cancer of
Esophagus
2303
Yasumasa Nishimura
Clinical Outcome of Radiotherapy for
Esophageal Cancer between 2004 and
2008: Second Survey
2304
Nima Nabavizadeh
Preoperative Carboplatin and
Paclitaxel-Based Chemoradiotherapy
for Esophageal/Gastroesophageal
Carcinoma: Results of a Modified Cross
Regimen Within a Multidisciplinary
Upper Foregut Malignancy Program at
a NCI-Designated Cancer Center
2305
Yoshinori Ito
Phase 2 Study of Neoadjuvant
Chemoradiotherapy With Cisplatin
Plus 5-Fluorouracil and Elective Nodal
Irradiation for Stage 2/3 Esophageal
Squamous Cell Carcinoma
2308
Ted Ling
Protons Offer Reduced
Cardiopulmonary Exposure for Patients
Receiving Radiation Therapy for
Esophageal Cancer
2309
Rei Umezawa
Long-Term Results of
Chemoradiotherapy for Stage 2-3
Thoracic Esophageal Cancer:
Comparison of Three Protocols
2310
Jun Tan
Suggestion on Modification of
Postoperative Radiation Therapy
Volumes for Thoracic Esophageal
Squamous Cell Carcinoma in Stage 3 or
Positive Lymph Nodes
2311
Miyako Myojin
The Significance of 3DCRT/VMAT Hybrid
Plan to Reduce Pericardial Toxicity After
Chemoradiation for Thoracic
Esophageal Cancer
2312
Jun Tan
Results and Prognostic Factors for
Esophageal Cancer Treated With
Intensity-Modulated Radiotherapy
2313
Mao-Bin Meng
Multimodality Therapy Is
Recommended for Limited-Stage
Combined Small-Cell Esophageal
Carcinoma
2314
Peng Zhang
Detection of Radiation-Induced Heart
Disease by Gated Myocardial Perfusion
Imaging in Patients With Esophageal
Cancer During-RT
2315
Yanluan Guo
Defining Target Volumes for Radiation
Treatment of Primary Esophageal
Cancer: A Comparison of Four
Dimensional CR and 18FDG PET-CT
132
2316
Yanluan Guo
Geometrical Differences in Target
Volumes Between 18FDG PET-CT and
Four Dimensional CT Mip Images of
Primary Esophageal Cancer for
Radiation Treatment
2317
Yanluan Guo
Detection of the Factors That Influence
the Correlation of Target Volumes for
Primary Esophageal Cancer Based
on Pet-CT and End-Expiration Phase
of Four-Dimensional CT in Radiation
Treatment
2318
Feng-Ming Hsu
Clinical Application of the Seventh
UICC-AJCC TNM Staging System in
Patients Treated With Trimodality
Therapy for Esophageal Squamous Cell
Carcinoma
2319
Lan Wang
The Relationships Analysis of CT Based
Gross Tumor Volume(GTV) and
Prognosis for Esophageal Carcinomas
Received 3DCRT or IMRT Treatment
2320
Dali Han
Risk Factors of Lymph Node
Micro-Metastasis in Negative Node of
Detected by Conventional Pathological
Technique, and Its Relationship With
Primary Tumor FDG PET/CT Uptake
2321
Chun Han
The Application of Volumetric
Modulated Arc Therapy(VMAT)in
Esophageal Carcinoma
2322
Melanie Machiels
Feasibility of Endoscopic Guided
Placement of Markers in Patients With
Esophageal Tumors
2323
Kazuki Ishikawa
Clinical Results of Definitive
Chemoradiotherapy for T4 Esophageal
Cancer
2324
Jinsong Yang
Dosimetric Analysis and Clinical
Outcome of Prophylactic Intensity
Modulated Radiation Therapy in
pT3N0M0R0 Esophageal Cancer
2325
Hitoshi Ishikawa
Proton Beam Therapy Combined With
Concurrent Chemotherapy for
Esophageal Cancer
2326
Ikuno Nishibuchi
Tolerability and Outcome of Definitive
Chemoradiotherapy for Elderly Patients
With Esophageal Cancer
2336
Amanda Choflet
Nutritional Factors Predict Survival in
Patients Receiving Concurrent
Chemoradiotherapy for Locally
Advanced Esophagus Cancer
2327
Junxin Wu
Treatment and Prognosis of 73 Cases
With Limited Stage Primary Esophageal
Small Cell Carcinoma
2337
Tetsuo Nonaka
Radiation Therapy for Squamous Cell
Carcinoma of the Cervical Esophagus
2328
Hui Liu
Concurrent Chemoradiotherapy
Associated With Enteral Nutrition
Support: A Radical Treatment Option for
Patients With Malignant Fistulae
2338
Arjun Sahgal
A Multi-Institutional Study Evaluating
the Reliability of the Spinal Instability
Neoplastic Score (sins) Among
Radiation Oncologists for Spinal
Metastases
2329
Tawfik Giaddui
Inter Observer Variability in Esophageal
Contours for Patients With Non-Small
Cell Lung Cancer Treated With
Definitive Chemoradiotherapy: RTOG
0617 Experience
2339
Mark Zaki
PET SUVmax as a Predictor of Pathologic
Complete Response to Neoadjuvant
Chemoradiation Therapy in Patients
With Carcinoma of the Esophagus
2330
Sarah James
Potential Presurgical Predictors for
Pathologic Response in Patients With
Advanced Esophageal Carcinoma
Treated With Trimodality Therapy
2340
Jinsong Yang
The Important Prognostic Value of
Pretreatment Stage in Patients
Achieving Pathologic Complete
Response After Neoadjuvant Therapy of
Esophageal Cancer
2331
Ethan Ludmir
Definitive Chemoradiotherapy for
Cervical Esophageal Carcinoma: A
Single-Institution Experience
2341
Judit Boda-Heggemann
Dose-Dependent Changes in Renal
1H-/23Na-MRI After Adjuvant
Radiochemotherapy for Gastric Cancer
2332
Yun Chen
Specific Lymphocytes Subsets are
Associated With Stage and Overall
Survival of Esophageal Squamous
Cell Carcinoma Patients Treated With
Radiotherapy
2342
Jessica Cheng
Radiotherapy Patterns of Care in Gastric
Adenocarcinoma: A Single Institution
Experience
2333
Talha Shaikh
Histology Predicts Response to
Chemoradiation (cRT) Regimen In
Patients Undergoing Esophagectomy
for Locally Advanced Esophageal
Cancer
2334
Takashi Kawanaka
Salvage Chemoradiation Therapy With
Triple-Drug Combination (Docetaxel,
5-FU And CDDP) for Postoperative
Locoregional Recurrence of Esophageal
Cancer
2335
Matthew Thau
Significant Weight Loss in The
Neoadjuvant Setting Is Predictive of
Whether Patients Undergo Surgery
Following Chemoradiation for Locally
Advanced Esophageal Cancer
2343
Guichao Li
An Interim Analysis of a Phase 2
Clinical Trial of Preoperative
Chemoradiotherapy Improving the
Resection Rate for Potential Resectable
Gastric Cancer Patients
2344
NingNing Lu
Prospective Phase 2 Trial of
Nimotuzumab and Concurrent
Capecitabine and Radiotherapy for
Patients With Locally Advanced
Inoperable or Relapsed/ Residual
Gastric Cancer: Final Analysis
2345
Ravi Patel
Increased Survival Associated With
Post-Operative Radiation in Gastric
Cancer Before and After MAGIC Trial: A
Population Based Study
133
2346
Kyle Cuneo
A Pilot Study of Diffusion Weighted MRI
in Patients Undergoing Neoadjuvant
Chemoradiation for Pancreatic Cancer
2358
Talha Shaikh
Defining the Optimal Sequencing of
Chemotherapy (Cx) and Radiation (RT)
in Patients (pts) With Locally Advanced
Pancreatic Cancer
2368
Ryan Lutz
Pre-treatment Neutrophil to
Lymphocyte Ratio (NLR) is Prognostic in
Resectable Pancreatic Cancer
2359
Ted Ling
Evaluation of Normal Tissue Exposure
in Patients Receiving Radiotherapy for
Pancreatic Cancer based on RTOG 0848
2369
Omar Mian
Dosimetric Parameters Predicting Late
Toxicity in Stereotactic Body
Radiotherapy (SBRT) for Pancreatic
Cancer
2348
Lauren Colbert
The Use of MRI for GTV Delineation
In Borderline and Locally Advanced
Pancreatic Cancer Increases Local
Control in Patients Treated With
Intensity Modulated Radiation Therapy
2360
Lora Wang
Dose Escalation With a Vessel Boost
in Borderline Resectable Pancreatic
Adenocarcinoma Treated With
Neoadjuvant Chemoradiation
2370
Yun Liang
Preliminary Study of Daily
Gastrointestinal Filling Impact on Tumor
Targeting During Radiotherapy for
Pancreatic Cancer Patients
2349
Takahiro Kishi
Impact of Pretreatment Modified
Glasgow Prognostic Score on Survival in
Chemoradiotherapy for Locally
Advanced Pancreatic Cancer
2361
Matthew Abrams
Safety and Efficacy of Capecitabine as a
Radiosensitizer in Adjuvant
Chemoradiotherapy for Pancreatic
Adenocarcinoma
2371
Hua Gan
Monte Carlo Dose Evaluation for
Pancreatic Stereotactic Body Radiation
Therapy
2350
Norifumi Kennoki
Preliminary Results of Feasibility and
Toxicities In Intensity Modulated
Radiotherapy With Gemcitabine And
S-1 for Pancreatic Cancer
2362
Eric Mellon
for Locally Advanced and Borderline
Resectable Pancreatic Cancer: Updated
Outcomes and Toxicity in Over 100
Patients
2347
Tobin Strom
Worse Overall Survival With
Preoperative Biliary Drainage in
Resectable Pancreatic Cancer Patients
2351
Jessica Freilich
Age and Resected Pancreatic Cancer
Outcomes
2352
Jinluan Li
Comparison of CT and MRI-Based Gross
Tumor Volume and Organ at Risk
Delineation for Pancreatic Cancer
Patients Undergoing Neoadjuvant
Stereotactic Body Radiotherapy
2353
Entesar Dalah
Delineation of Spatially-Varied High-Risk
GTV in Pancreatic Adenocarcinoma
Using MRI-ADC Maps
2354
Takeo Kasuya
Feasibility of Respiratory-Gated PET/
CT for Pancreatic Tumors: A Preliminary
Result
2355
Gang Ren
Dosimetric Study on Dose Escalation
in Internal Target of Pancreatic Cancer
With Helical Tomotherapy
2356
Antonino Romeo
Loco-Regional Hypofractionated
Radio-Chemotherapy for Unresectable
Nonmetastatic Pancreatic Cancer
2363
David Sherr
Is Marital/Partner Status Associated
With Survival in Patients With
Resectable Pancreatic Cancer Treated
With Adjuvant Post-Operative
Multi-Modality Therapy? Results of
Secondary Analysis of RTOG 97-04
2364
Andrew Baschnagel
The Effects of Neoadjuvant Chemoradiation on Gene Expression Patterns of
Pancreatic Ductal Adenocarcinoma
2365
Yong Yue
Prognostic Modeling of Locally
Advanced Pancreatic Cancer Treated
With Radiotherapy Using [18F] FDG-PET
Features and CA-19-9
2366
Thomas Hayman
Pancreatic Cancer Outcomes in
Resected Age ≥ 70 Patients Are
Comparable to Younger Patients
2367
Carla Hajj
Chemotherapy and IntensityModulated Radiation Therapy for
Locally Advanced Pancreatic Cancer
Achieves Prolonged Survival
2357
Nicolas Peguret
Individualized Gated Stereotactic Body
Radiation Therapy for Pancreatic Cancer
2372
Michael Bernstein
Chemotherapy Alone Versus
Chemoradiation for Unresectable
Pancreatic Cancer: A Meta-Analysis
2373
Roland Teboh Forbang
Patient Setup Management for
Pancreatic Stereotactic Body Radiation
Therapy: Inter-Fraction Adjustment
Between Spine Alignment and the
Pancreatic Fiducial During Breath-Hold
Kv Imaging
2374
Shalini Moningi
Interpreting Baseline and Follow-up
18Flurodeoxyglucose-PET Total Lesion
Glycolysis in Patients With Locally
Advanced and Borderline Resectable
Pancreatic Cancer
2375
Kujtim Latifi
Metabolic Tumor Volume (MTV) is
a Predictor of Survival in Borderline
Pancreatic Cancers Treated With
Neoadjuvant Therapy
2376
Esengul Kocak
Paraneoplastic Thrombocytosis is a
Significant Independent Prognostic
Factor for Overall and Progression Free
Survival in Locally Advanced Pancreatic
Cancer
2377
Joshua Palmer
Modern Clinical Outcomes of
Periampullary Cancer Following
Pancreaticoduodenectomy and
Adjuvant Chemoradiotherapy: A
Single-Institution Pancreatic Cancer
Registry
134
2378
Joshua Palmer
Patterns of Failure in Periampullary
Cancer Following
Pancreaticoduodenectomy and
Adjuvant Chemoradiotherapy With
Implications on Radiation Treatment
Planning
2379
David Horowitz
Use of Adjuvant Radiation Therapy in
the Management of Acinar Cell
Carcinoma of the Pancreas: Results
From the Survival, Epidemiology, and
End Results Database
2380
Shalini Moningi
Surgical Outcomes Following
Chemotherapy and Stereotactic Body
Radiation Therapy in Patients With
Borderline and Unresectable Pancreatic
Cancer
2381
Camille Berriochoa
Preoperative Chemoradiation for
Locally Advanced Pancreatic Cancer
Improves Margin Negativity and Nodal
Involvement at Resection
2388
Yusuke Iuzuka
Evaluation of Dose Distribution and
Tracking Accuracy in Dynamic
Tumor-Tracking Irradiation for Liver
Tumors Using a Gimbaled Linac
2389
Shigeyuki Takamatsu
Focal Liver Reaction After Proton Beam
Therapy for Hepatocellular Carcinoma
Examined With Gadoxetate
Disodium-Enhanced Hepatic MRI: Initial
Results
2390
Shigeyuki Takamatsu
Early Experience With Proton Beam
Therapy for Hepatocellular Carcinoma
2391
Shirin Sioshansi
Tolerance Dose of the Diaphragm With
Liver SBRT
2392
Jonathan Klein
Prospective Longitudinal Assessment
of Quality of Life for Liver Cancer
Patients Treated With Stereotactic Body
Radiotherapy
2382
Terence Williams
Caveolin-1 Confers a Multi-Modality
Therapy Resistance Phenotype in
Pancreatic Cancer Cells
2393
Vijay Kudithipudi
Liver Stereotactic Radiotherapy (SRT)
With Functional Treatment Planning
for Patients With Intermediate Stage
Hepatocellular Carcinoma (HCC)
2383
Yo-Liang Lai
MELD Score is a Predictor of Early
Deterioration of Liver Function and
Overall Survival in Patients With
Hepatocellular Carcinoma Receiving
Radiotherapy
2394
Smith Apisarnthanarax
Quantitative Imaging of Global
Variability and Regional Heterogeneity
in Liver Function With 99mTC-Sulfur
Colloid SPECT/CT in Hepatocellular
Carcinoma Patients
2384
Wei Huang
The Risk Factors Of HBV Reactivation
After Conformal Radiotherapy in
Patients With Hepatocellular Carcinoma
2395
Uranchimeg Tsegmed
Functional Image-Guided Stereotactic
Body Radiotherapy Planning Using the
Technique for Patients With
Hepatocellular Carcinoma
2385
Amar Kishan
Dosimetric Comparison Between an
MRI-Guided Tri-Cobalt-60 Teletherapy
System and VMAT for Liver SBRT
2386
Yaoru Huang
Risk Factors of Hepatic Failure After
Re-irradiation for Recurrent Hepatocellular Carcinoma
2387
Kimberly Keene
Followed by Sorafenib Improves
Survival Without Increasing Toxicity
2396
Tiziana Comito
Stereotactive Ablative Radiotherapy
(sabr) in Inoperable Oligometastatic
Disease From Colorectal Cancer: A Safe
and Effective Approach
2397
William Hall
Abdominal MRI Radiographic to
Pathologic Agreement in Patients With
Resected Cholangiocarcinoma
2398
Joshua Niska
Impact of Intravenous Contrast
Enhancement Phase on Target
Definition for Hepatocellular Carcinoma
(HCC) and Intrahepatic
Cholangiocarcinoma (IHC):
Observations from Patients Enrolled on
a Prospective Phase 2 Trial
2399
Ann Raldow
Tolerability of Liver Re-irradiation With
Stereotactic Radiation Therapy
2400
Iris Ernst
Detection of Target Motion for Liver
SBRT by 4 D List Mode PET/CT - an
Analysis based on Phantom
Measurements, Interfractional Cone
Beam CT Scans and 510 Clinical Data
2401
RyoongJin Oh
Tolerance of Liver as a Predictor of
Hepatic Dysfunction In Stereotactic
Body Radiotherapy
2402
Eun Kyung Paik
Stereotactic Ablative Radiotherapy
Combined With Incomplete
Transarterial Chemoembolization in
2403
Ben Goodman
Safety and Efficacy of Stereotactic Body
Radiotherapy for Hepatic
Oligometastases: 10-year Update
2404
Jenny Shaffer
Pooled Analysis of Liver Stereotactic
Body Radiotherapy for Colorectal
Metastases: Results From 5 Institutions
2405
Daniel Chang
Pooled Analysis of Liver Stereotactic
Body Radiotherapy for Hepatocellular
Carcinoma: Results From a
Multi-Institution Study
2406
Marta Scorsetti
The Challenge of Inoperable
Hepatocellular Carcinoma (HCC):
Results of a Single-Institutional
Experience on Stereotactic Body
Radiation Therapy
2407
Karin Muller
Reduced Tumor Dose Coincides With
Compromised Local Control of Liver
Metastases Treated With fSRT
2408
Taiki Takaoka
Helical Tomotherapy for
Chemo-Refractory Multiple Liver
Metastases: A Pilot Study
135
2409
Reena Engineer
Neoadjuvant Chemoradiation Can
Downstage and Improve Resectability
Rates In Locally Advanced Unresectable
Gall Bladder Cancers
2410
Mary Feng
Unexpected Geometric Changes of the
Gall Bladder During Liver Stereotactic
Body Radiation Therapy
2411
Haoming Qiu
SBRT for Hepatocellular Carcinoma:
8 Year Experience from a Regional
Transplant Center
2412
Daniel Wahl
SBRT Provides Equivalent Local Control
Compared to RFA for the Treatment of
Hepatocellular Carcinoma With Minimal
Toxicity
2413
Neha Bhooshan
Pre-Treatment Tumor Volume as a
Prognostic Factor in Metastatic
Colorectal Cancer Patients Who
Received Selective Internal Radiation
Therapy to the Liver Using Yttrium-90
Coated Resin Microspheres
2414
Michael Chuong
Radiographic Tumor Volume Change as
a Prognostic Factor for Overall Survival
in Metastatic Colorectal Cancer Patients
Who Received Selective Internal
Radiation Therapy to The Liver Using
Yttrium-90 Resin Microspheres
2415
Edward Mannina
Radiologic Versus Pathologic
Assessment of Response in
Hepatocellular Carcinoma Treated With
2416
Seth Blacksburg
Characterizing Radiographic and
Pathologic Outcomes After Stereotactic
Body Radiation Therapy (SBRT) in the
Management of Primary Hepatocellular
Carcinoma (HCC)
2417
Jenny Shaffer
Pooled Analysis of Stereotactic Body
Radiotherapy for Liver Tumors: Results
From 5 Institutions
2418
Aditya Halthore
Radiographic Outcomes of Yttrium-90
Radioembolization in Patients With
2419
Michael Chuong
Radiation Dose Versus Activity as a
Prognostic Factor in Metastatic
Colorectal Cancer Patients Who
Received Selective Internal Radiation
Therapy to the Liver Using Yttrium-90
Resin Microspheres
2420
Krista Bota
Dosimetric Comparison of Volumetric
Modulated Arc Therapy, Tomotherapy
and Intensity Modulated Radiation
Therapy for Radiation Dose Escalation
of Hepatic Malignancies
2421
Evan Osmundson
Dosimetric Modeling of Central Liver
Toxicity After SBRT to the Liver
2422
Brandon Dyer
Laboratory Evaluation of Hepatic
Synthetic Function as a Predictor of
Ethiodol Retention During Transarterial
(Chemo)Embolization in Hepatocellular
Carcinoma (HCC)
2423
Xin Wang
Adjuvant Radiotherapy May be
Necessary for High Risk Patients With
Stage 2 or 3 Upper Rectal Cancer After
Total Mesorectal Excision
2424
Virginia Morillo Macías
Surgical Interval After Neoadjuvant
Treatment in Rectal Cancer: Impact on
Response and Outcome
2425
Marzieh Lashkari
The Effect Of Neoadjuvant Intraluminal
Brachytherapy and Chemotherapy After
Conventional Neoadjuvant
Chemoradiation On Pathologic
Response In Patients With Locally
Advanced Rectal Cancer: A Phase 2
Nonrandomized Clinical Trial
2426
Shilo Lefresne
Management of Stage II and III Rectal
Cancer: Is There A Rural-urban
Difference?
2428
Chun-Ming Huang
Preoperative Image-Guided versus
Conventional Pelvic Radiation Therapy
for Locally Advanced Rectal Carcinoma:
Comparison of Clinical Outcomes and
Toxicity
2429
Esther Yu
Comparison Of EUS Versus Pelvic Mri
For Radiation Treatment Planning In
Locally Advanced Rectal Cancer
2430
Kim Ann Ung
Treatment Dilemmas for Synchronous
and Metachronous Prostate and Rectal
Cancers
2431
Ning Li
Repeated Endorectal
Ultrasonographies Predict The Tumor
Response Of Preoperative
Chemo-radiotherapy In Rectal Cancer
2432
Rafal Suwinski
Randomized Clinical Trial on
Hyperfractionated versus
Hypofractionated Preoperative
Radiotherapy for Rectal Cancer: Subset
Analysis and Evaluation of the
Prognostic Factors for Overall Survival
and Loco-regional Control
2433
Karine Benezery
The Role Of Contact Brachytherapy Xray
50 Kv (cbx) For Organ Preservation In
Rectal Cancer: A Series Of 61 Patients
2434
Ching-Chieh Yang
Importance of Tumor Regression
Grading in Predicting the Outcome
for Patients With Rectal Cancer After
Preoperative Chemoradiotherapy
2435
Esther Jimenez-Jimenez
Improvement Of Rectal Boost
Contouring By Comparing Colonoscopy
(CL) and MRI With Planning CT (PCT)
Findings
2436
Jae-Sung Kim
The Role Of Postoperative Adjuvant
Radiotherapy In Patients With Stage II
and III Upper Rectal and Recto-sigmoid
Cancer: A Propensity Score Matched
Analysis
2437
Lijun Shen
Validation of a Rectal Cancer Outcome
Prediction Model in Routine Chinese
Patients
2438
Yan Zhang
Role Of 18F-FDG PET-CT In
Postoperative Surveillance Of Colorectal
Cancer Patients With Different
Carcinoembryonic Antigen
Concentrations
2439
Lijun Shen
Baseline Neutrophil-lymphocyte
Ratio as a Prognostic Factor for Locally
Advanced Rectal Cancer Undergoing
Neoadjuvant Chemoradiation
136
2440
Daniel Glick
Gastrointestinal Toxicity in Patients With
Inflammatory Bowel Disease Treated
With Pelvic Radiotherapy
2441
Ashley Weiner
Neoadjuvant Rectal Cancer (NAR) Score
Applied to Phase II Trial of Short Course
Radiation (RT) and FOLFOX as
Preoperative Therapy for Rectal
Cancer Supports a Total Neoadjuvant
Approach
2442
Hiroo Sato
HLA class I Expression Its Alteration by
Preoperative HyperthermoChemoradiotherapy in Patients With
Rectal Cancer
2443
Hyeon Woo Lim
Is Elective Inguinal Radiotherapy
Necessary for Locally Advanced Rectal
Cancer Involving Anal Canal?
2444
Tae hyung Kim
The Effectiveness of Off-Protocol
Upfront Chemotherapy and
Preoperative Short-course
Radiotherapy followed by Delayed
Surgery for Patients With Locally
Advanced Rectal Cancer and
Synchronous Metastases
2445
Robert Weir
L5/S1 as the Superior Border of
Radiation Therapy Fields in Rectal
Cancer Misses Internal Iliac Lymph
Nodes
2446
Lucas Resende Salgado
Outcomes of Oligometastatic Rectal
Cancer Treated With Extended Course
Pelvic Irradiation
2447
Yaacov Lawrence
Severe Gastro-Intestinal Complications
Of Radiation Therapy In Rectal Cancer:
Quantifying The Effect of Age
2448
Qin Xiao
Phase II trial of Preoperative
Chemoradiotherapy With Oxaliplatin
and Capecitabine for 137 Patients With
Locally Advanced Rectal Carcinoma:
Outcome and Failure Pattern
2449
Xin Lei
The Individual Californium(cf)-252
Neutron Intracaviatry Brachytherapy
after Concurrent Chemo-radiation
Predicted the Radio-sensitivity for
Low-lying Rectal Adenocarcinoma: The
3 year result for 62 T2 and T3 patients
2450
Yu Tang
Phase I Study Of Postoperative
Capecitabine With Concurrent
Radiotherapy In Elderly Patients With
Rectal Cancer
2461
Shyam Tanguturi
Outcomes With Full Dose Re-irradiation
With Curative Intent for Secondary
Anorectal Cancers Following Prostatic
Radiotherapy
2451
Tae Ryool Koo
Prognostic Factors In Lymph Node
Positive Rectal Cancer After Surgery
Following Neoadjuvant
Chemoradiotherapy
2462
Malgorzata Kozak
The Prognostic Significance Of
Pre-treatment Hematologic Parameters
In Patients Undergoing Resection For
Colorectal Cancer
2452
Yali Shen
High Dose Hypo-fractionated
Stereotactic Body Radiotherapy (SBRT)
For Isolated Lung Metastasis from
Colorectal Cancer: Preliminary Results
2463
Benjamin Moeller
Outcomes and Quality of Care for Anal
Cancer Patients Treated With IMRT in a
Large Multi-Site Cancer Center
2453
Helen Chen
Outcomes and Prognostic Facors
of Rectal Cancer Patients Receiving
Neoadjuvant Chemoradiation With and
Without Planned Surgery
2454
Lee Jeongshim
Involved-field Radiotherapy Integrated
In The Management Of Isolated
Retroperitoneal Nodal Recurrence From
Colorectal Cancer
2464
Berardino De Bari
Helical Intensity-Modulated Radiation
Therapy With Daily Image Guidance in
the Treatment of Anal Canal Cancer
2465
John Longo
Pelvic Insufficiency Fractures in Anal
Canal Cancer Patients Treated With
Helical Tomotherapy: Can We Identify
Demographic, Clinical, or Dosimetric
Risk Factors?
2466
Jennifer Wo
Dosimetric Analysis of Proton Pencil
Beam Scanning Radiotherapy versus
Dose Painted Intensity Modulated
Radiation Therapy for Squamous Cell
Carcinoma of the Anal Canal
2455
Khinh Ranh Voong
Radiation Therapy for High Grade
Neuroendocrine Carcinoma of the
Rectum and Anal Canal
2456
Abhijeet Bhirud
Does Bladder Filling Affect Rectum
Position?
2457
Nathan Bennion
Comparing Supine vs. Prone Positioning
and Contouring Methods in Patients
Undergoing Preoperative
Chemoradiation for Rectal Cancer
2458
Zachary Morris
Increased Pathologic Complete
Response to Neo-adjuvant Radiation in
Rectal Cancer Patients Taking an
Angiotensin Converting Enzyme
Inhibitor or Angiotensin Receptor
Blocker
2459
Eric Anderson
Statin Use As A Predictor Of Outcome In
Colorectal Cancer
2460
Aman Anand
Robust Scanned Proton Treatment Plans
Provide Large Reductions In Bone
Marrow Exposure For Pelvic
Radiotherapy For Anal Cancer
2467
David Grew
Significantly Worse Colostomy-free
Survival In Human Immunodeficiency
Virus Positive Patients After Definitive
Chemoradiation For Anal Cancer
2468
Raima Amin
Impact of HIV Status and Protease
Inhibitor Use on Blood Counts During
Concurrent Chemoradiation
2469
Nadia Saeed
Pre-treatment Neutrophil-Lymphocyte
Ratio (NLR) Does Not Predict Worse
Outcomes in Anal Cancer
2470
Rebecca Muirhead
A Tumour Control Probability Model for
Anal Squamous Cell Carcinoma
2471
Craig Baden
Patterns of Failure in Squamous Cell
Carcinoma of the Anal Canal - A
Comparison between Intensity
Modulated Radiation Therapy and
3-Dimensional Conformal Radiation
Therapy
137
2472
Christopher Spencer
Outcomes After Imrt Compared To
3dcrt For Squamous Cell Carcinoma Of
The Anus
2473
Abhilasha Patel
Comparison of Conditional Survival in
Patients With Gastrointestinal
Malignancies Treated With Radiation: A
Population-based Analysis
2474
Duygu Sezen
Robotic Stereotactic Body Radiation
Therapy In Patients With Recurrent Or
Metastatic Abdominopelvic Tumors: A
Single Institute Experience
2475
Manisha Palta
Intensity Modulated Radiotherapy
Utilization in the Treatment of
Gastrointestinal Malignancies between
2000 and 2009 in the SEER Medicare
Population
GENITOURINARY CANCER
2476
John Mikell
Low-Dose Aspirin Mitigates Acute
Radiation-Induced Genitourinary
Toxicity in Patients With Prostate
Adenocarcinoma
2477
Matthew Hall
Improved Overall Survival in Prostate
Cancer With Increasing Dose
2478
James Ying
Long Term Outcome of Prostate Cancer
Patients Who Fail Salvage Radiation
Therapy and Radical Prostatectomy
2479
Minh-Phuong Huynh-Le
Discrepancies In Toxicity Grading Of
Rectal Bleeding: A Survey Of Radiation
Oncologists Who Treat Prostate Cancer
2480
John Phillips
The Impact of Differing Gleason Scores
at Biopsy on the Odds of Upgrading
and the Risk of Death from Prostate
Cancer
2481
Boris Naydich
Capricious Psa Dynamics After Prostate
Seeds Brachytherapy Complicates
Interpretation Of Outcome In Over 40%
Of Patients
2482
Yachiro Hashimoto
Hypofractionated Image-Guided-IMRT
For Clinically Localized Prostate
Cancer - A Total Dose Of 66 Gy
Delivered At 3 Gy Per Fraction Thrice
A Week
2483
Ovidiu Marina
Prognostic Value Of Diagnostic Prostate
Biopsy Percent Carcinoma Volume (pcv)
And Percent Positive Cores (ppc) On
Treatment Outcomes Following
Radiotherapy (rt): A Retrospective
Analysis Of 1731 Patients
2484
Hiroyuki Ogino
Transperineal Approach Versus
Transrectal Approach For Fiducial
Marker Placement In Proton Beam
Therapy Of Prostate Cancer: A
Prospective Comparison
2485
Joen Sveistrup
Prospective Assessment of Urinary,
Gastrointestinal and Sexual Symptoms
Before, During and After Image Guided
Intensity Modulated Radiotherapy for
Prostate Cancer
2486
Tobin Strom
A Dosimetric Study of Polyethylene
Glycol Hydrogel in 200 Prostate Cancer
Patients Treated With High-Dose-Rate
Brachytherapy ± Intensity Modulated
Radiation Therapy
2487
Benjamin Spieler
Salvage Radiation for Biochemical
Failure Following Radical
Prostatectomy: Improved Outcomes
With Early Treatment
2488
Eunpi Cho
A Phase II Trial of External Beam
Radiotherapy (RT) And Abiraterone (ABI)
In Men With Localized Prostate Cancer
(PCa): A Safety And Pharmacodynamics
Assessment
2489
Yvonne Pham
Improved Biochemical Control after
Permanent Prostate Seed Implantation
for Large Prostate Glands >60 Grams
Compared to Smaller Glands
2490
Steven Finkelstein
Impact of Prior Radiation Treatment
on Sipuleucel-T Product Parameters in
PROCEED Patients
2491
Henry Park
Effect Of Primary Treatment Modality
On The Association Between Statins
And Prostate Cancer Recurrence: An
Updated Meta-Analysis
2492
Takuma Nomiya
Phase I/II Trial of Definite Carbon Ion
Radiotherapy for Prostate Cancer:
Evaluation of hypofractionated
treatment of 12 fractions over 3 weeks
2493
Zachary Seymour
Dose-Volume Analysis of Urinary
Toxicity following SBRT Monotherapy
for Prostate Cancer
2494
Joseph Evans
Comparative Effectiveness Analysis of
Patient Reported Quality of Life (QOL)
After Stereotactic Body Radiotherapy
as Compared to Intensity Modulated
Radiotherapy or Low Dose Rate
Brachytherapy up to 2 years after
Treatment
2495
WITHDRAWN
2496
Felipe Counago
3T Multiparametric MRI (3T mMRI) With
a Phased-array Torso Coil in Staging
of Prostate Cancer Patients (PCP) Prior
to Radical Prostatectomy: Preliminary
Results
2497
Felipe Counago
Correlation between apparent diffusion
coefficient (ADC) and gleason score
(GS) in prostate cancer patients (PCP)
by using 3.0 Tesla multiparametric MRI
(3T mMRI)
2498
Amar Kishan
Pelvic Nodal Dosing With Registration
to the Prostate: Implications for
High-Risk Prostate Cancer Patients
Receiving SBRT
2499
Jim Rose
Androgen Deprivation Therapy in
Intermediate Risk Prostate Cancer
Patients Treated With Low Dose Rate
Brachytherapy: A Multi-institutional
Propensity Score Matched Pair Analysis
2500
Arpit Chhabra
Impact Of Race On Both Pathologic
Extent Of Disease And Administration Of Adjuvant Radiation Therapy
In A Cohort With Clinical Low Risk
Prostate Cancer Undergoing Radical
Prostatectomy
138
2501
Daniel Krauss
Favorable Toxicity Profiles for Low
and Intermediate Risk Prostate Cancer
Patients Treated With Single Fraction
High Dose Rate Brachytherapy
2502
Sandrine van de Pol
Low Acute Toxicity in Prostate Cancer
Patients Treated With Hypofractionated
External Beam Radiotherapy and Single
Fraction HDR Brachytherapy
2503
Colin Murphy
Identification of Groups at Increased
Risk of Prostate Cancer (PCa) Death
after Salvage Radiation Therapy (sRT)
using Recursive Partitioning Analysis
(RPA) - Results from an NCI-designated
Comprehensive Cancer Center
2504
Hyun-Cheol Kang
Whole Pelvic Irradiation for Patients
With Prostate Cancer With a
Biochemical Relapse Following Radical
Prostatectomy: The Era of Robotassisted Minimally Invasive Surgery
2505
Josh Mason
Delivering Multi-Parametric MRI-guided
High Dose Rate Brachytherapy Boost in
Non-Metastatic Prostate Cancer
2506
Amber Orman
A Phase III Randomized Trial of
MRI-Mapped Dose-Escalated Salvage
Radiotherapy Post-Prostatectomy:
The Maps Trial, An Initial Dosimetric
Assessment
2507
Gregory Warrell
Computationally-Obtained Thermal
Distributions for LDR
Thermobrachytherapy Seeds in Clinical
Implants
2508
George Rodrigues
Comparison of LDR Brachytherapy
Versus External Beam Radiation Therapy
for Low and Intermediate-Risk Prostate
Cancer: A Propensity-Score Matched
Analysis
2509
Albert Edwards
A Competing Risks Analysis of Clinical
Outcomes of Prostate LDR
Brachytherapy at a Single Institution
2510
Donald Fuller
HDR-like SBRT For Post-radiotherapy
Locally Recurrent Prostatic Carcinoma:
PSA Response, DFS And Toxicity
Assessment
2511
Joelle Helou
Stereotactic Radiotherapy Versus
External Beam + High Dose Rate
Brachytherapy Boost in the Treatment
of Localized Prostate Cancer: A Quality
of Life Analysis
2512
Lindsay Jensen
Higher Delivered Bowel Doses Due
To Lower Bladder Volumes In Patients
Receiving Post-prostatectomy Salvage
Radiotherapy
2513
Joelle Helou
Dosimetric and Patient Correlates of
Quality of Life after Prostate Stereotactic
Ablative Radiotherapy
2514
Jack Bagley
Performance Status and Comorbidities
in Patients Treated with External Beam
Radiation for Intermediate-Risk Prostate
Cancer
2515
Yutaka Shiraishi
Prostate Postimplant CT With Metal
Artifacts Reduction For Improvement
Of Seed Localization
2516
Ananya Choudhury
Simultaneous Cone Beam Computed
Tomography (CBCT) Acquisition
During Arc Radiotherapy (SCART): A
Comparison Of Volume Delineation On
Simultaneous And Standard CBCT In
Prostate Radiotherapy
2517
F. J. Pos
Introduction Of VMAT, IGRT And IMRT
Reduced Acute GI Toxicity In Prostate
Cancer Patients
2519
Benedikt Engels
Impact Of Planning Target Volume
Margins And Rectal Distention On
Biochemical Failure In Image-guided
Radiotherapy Of Prostate Cancer
2520
Haruo Inokuchi
Long-term Genitourinary Toxicity Up
To 7-years After High Dose
Intensity-modulated Radiotherapy In
Patients With Localized Prostate Cancer
2521
Tamara Smith
Impact of Change from CTCAE Version
3 to CTCAE Version 4 on Urologic
Toxicity Scores in Prostate Cancer
2522
Caitlin Gomez
Dosimetric Parameters Predict Quality
of Life Outcomes for Patients Receiving
Stereotactic Body Radiation Therapy for
Prostate Cancer
2523
Aaron Nelson
Evaluation of an Atlas-Based
Segmentation Method for Prostate MRI
2524
Jonathan Cheng
Intensity-Modulated Radiation Therapy
and Daily Image Guidance Therapy for
Localized Prostate Cancer: Clinical
Outcome and Toxicity from a
Multi-Institutional Retrospective Cohort
Study
2525
Curtis Bryant
Proton Therapy in the Management of
High-Risk Prostate Cancer
2526
Michael Hughes
The Long Term Effects of Salvage High
Dose IG-IMRT after Prostatectomy in a
Community Setting
2527
Waleed Mourad
Dose-escalated Post-prostatectomy
Salvage Radiation Therapy: Is 81 Gy Safe
And Effective?
2528
Roger Huang
Long-Term Outcome of Dose Escalated
Hypofractionated Intensity Modulated
Radiation Therapy (IMRT) for Localized
Prostate Cancer.
2529
Joshua Sifuentes
Evaluating The Distribution Of Prostate
Cancer In Prostatectomy Specimens To
Determine Eligibility For Focal Therapy
2530
Waleed Mourad
Androgen Deprivation Therapy (ADT)
With 75.6-81 Gy Conformal External
Beam Irradiation (EBRT) Improves
Biochemical Progression Free Survival
(BPFS) In Gleason Score 7 (GS7)
Intermediate Risk Prostate Cancer
2531
Christopher Straka
Early and Multiple PSA Bounces Can
Occur Following High Dose Prostate
Stereotactic Body Radiation Therapy:
Subset Analysis of a Phase I/II Trial
2532
Anusha Kalbasi
Low Rates of Adjuvant Radiation in
Non-Metastatic Prostate Cancer
Patients With Pathologic Risk Factors
2533
Rupesh Kotecha
A Comparison Of Long-term Treatmentrelated Toxicities Between Moderately
Hypofractionated And Conventionally
Fractionated Radiation Therapy For
Localized Prostate Cancer
139
2534
Nevine Hanna
Treatment of Adenocarcinoma of
Prostate Using HDR Interstitial
Brachytherapy Along With External
Beam Radiation - Long Term Follow-up
Results
2535
Andrew Loblaw
Versus Low Dose Rate Brachytherapy:
A Propensity Matched Analysis of
Canadian Data
2536
Sarah Hamilton
The Incidence Of Second Malignancies
Following Low Dose Rate
Brachytherapy For Prostate Cancer
2537
Joseph Safdieh
Long Term Tolerance and Outcomes for
Dose Escalation in Early Salvage
Post-Prostatectomy Radiation Therapy
2538
Kentaro Ishii
Comparison of Dosimetric Parameters
and Acute Toxicity after Whole-pelvis
Versus Prostate-only Volumetricmodulated Arc Therapy With Daily
Image Guidance for Prostate Cancer
2545
Jonathan Yang
Evaluation of PSA Patterns in Patients
With Localized Prostate Cancer Treated
With Radiotherapy and Androgen
Deprivation Therapy
2546
Thomas Nabhani
Biochemical Progression-Free Survival
(BPFS) for Gleason Score (GS) 7 Prostate
Adenocarcinoma Treated With External
Beam Radiation (RT) ± Prostate Seed
Implant (SI)
2547
Martin Dolezel
Interfraction Variation In Prostate
Cancer - Analysis Of 11726 Cone-beam
Ct And Implication For Treatment
Planning
2548
Shane Lloyd
Robotic Stereotactic Body Radiotherapy
for Prostate Adenocarcinoma
2549
Didem Oksuz
Seminal Vesicle Interfraction
Displacement and Dose Variations
Throughout the CBCT-guided
Radiotherapy for Prostate Cancer
2539
Seth Miller
Change in Prostate Biopsy Pathology
Reading on a Second Pathology Review
at an Academic Medical Center
2550
Christina Son
Bladder Dose-Volume Parameters
Predict for Urinary Incontinence After
Post-operative Radiation for Prostate
Cancer
2540
Dominika Hempel
Testicular Dose Contributed by
Image-Guided Intensity-Modulated
Radiotherapy (IMRT) in Prostate Cancer
Patients
2551
Harold Wallace
Transperineal Ultrasound for Image
Guidance in the Treatment of Prostate
Cancer: A Comparison to Fiducial-Based
CT Imaging
2541
Alexandra Stewart
Findings of the Royal College of
Radiologists (UK) national audit of
Prostate Cancer Brachytherapy
2552
William Jackson
A Phase II Trial of Salvage Radiation and
Concurrent Weekly Docetaxel After
Rising PSA post Radical Prostatectomy
2542
Yu-Wei Lin
The 4-Year Result of Stereotactic Body
Radiotherapy for Localized Prostate
Cancer
2553
Phillip Gray
Recent Trends in the Management of
Localized Prostate Cancer: Results from
the National Cancer Data Base
2543
Cheng Hong
Influence Of Zonal Dosimetry On
Prostate Brachytherapy Outcomes
2554
Eric Vigneault
Comparison Of Permanent Seed
Implant Monotherapy With Combined
Ebrt Plus Hdr Boost In Intermediate Risk
Prostate Cancer
2544
Daniel Shasha
Brachytherapy Boost For Gleason (GS) 7
Intermediate Risk Prostate
Adenocarcinoma Yields Excellent
Biochemical Control And May Eliminate
Therapeutic Benefit Of Hormonal
Therapy
2555
Andrew Chiang
Boost to Mimic High-Dose Rate (HDR)
Brachytherapy for Intermediate-Risk
Prostate Cancer: A Phase I Study
2556
David Crawford
CCP Score Stratifies Risk For Prostate
Cancer Patients At Biopsy: Initial
Commercial Results
2557
Yuta Shibamoto
Dose-volume Histogram Analysis for
the Urethra to Predict Urinary
Complications in Carbon-ion
Radiotherapy of Prostate Cancer
2558
Felipe Counago
Role of 3.0 Tesla multiparametric
MRI (3TmMRI) in local staging and in
decision-making for treatment planning
in prostate cancer (PC)
2559
Robert Kattevilder
Time Trends in Urinary Toxicity after
Radiotherapy Treatment for Prostate
Cancer
2560
Ferran Ferrer
External Beam Radiotherapy Plus
High Dose Rate Brachytherapy in the
Treatment of Locally Advanced Prostate
Cancer
2561
Hirofumi Asakura
Response of Pelvic Lymph Nodes to
Neoadjuvant Hormonal Therapy in
Prostate Cancer Patients: Computed
Tomography for Radiotherapy
Treatment Planning as “Second Look”
Imaging
2562
Antoine Simon
Quantification of The Differences
Between Planned and Delivered Doses
in The Bladder in Prostate IGRT
2563
Melpomeni Kountouri
Dose Escalation with Two Sequential
Twice-Weekly Hypofractionated
Schedules for Localized Prostate
Cancer: A Comparative Study of Long
Term Toxicity and Outcome
2564
Kenshiro Shiraishi
(VMAT) in the Treatment of Localized
Prostate Cancer: Initial Experience in
200 Patients
2565
Magali LecavalierBarsoum
Pelvic Lymph Nodes Displacement
in High-risk Prostate Cancer Patients
Treated With Image-guided IMRT With
Two Independent Target Volumes
140
2566
Piotr Milecki
Importance Of Psa Level Post
Neoadjuvant Androgen Deprivation
Therapy (adt) For Patients With Prostate
Cancer (pc) Treated With External Beam
Radiotherapy (ebrt) And Brachytherapy
Hdr Boost
2576
Derek McHaffie
Observations from Early Adoption
of Radium 223 (Ra-223) in Heavily
Pretreated Patients With Metastatic
Castration-Resistant Prostate Cancer
(mCRPC)
2577
2567
Xin Qi
Optimal Clinical Target Volume for the
Seminal Vesicles in Localized Prostate
Cancer Radiotherapy: Using CT to
Include the Segments Recommended
by Pathological Examination
2568
Xin Qi
Neo-adjuvant Hormonal Therapy on
Seminal Vesicles Reduction: Optimal
Clinical Target Volume for the Seminal
Vesicles in Localized Prostate Cancer
Radiotherapy
2569
Lara Hathout
Dose To The Bladder Neck Is A Strong
Predictor For Acute Toxicity After
Combined Ldr Brachytherapy And
External Beam Radiation Therapy For
Prostate Cancer: Implications For New
Dose Constraints
2570
Frederic Commandeur
Gradient Collinearity Method For
Prostate Mri To Ct Registration
2571
Cory Hogue
Optimum Frequency of Cone Beam
Computed Tomography (CBCT) for
Intact Prostate IMRT
2572
Razvan Galalae
High-Dose-Rate Brachytherapy For
Radical Dose Escalation In Patients With
Localized Prostate Cancer - A
Longitudinal Comparative Study Of
Three Historical Protocols
2573
Monica Shukla
Early Salvage Pelvic Radiotherapy For
Lymph Node Positive Prostate Cancer
Following Prostatectomy
2574
Christophe Blay
Prostate CT CBCT Registration Quality
Assessment
2575
Xiaofeng Yang
Integration of MR Images into
Ultrasound for 3D Doppler Imaging of
the Neurovascular Bundle in Prostate
Radiotherapy: A Pilot Study
Justyna ChalubinskaFendler
Impact Of Intensity Modulated
Radiotherapy And Hypofractionated
Radiotherapy On Overall Survival In
Prostate Cancer
2578
Peter Agoston
Quality of Life After Permanent
Implantation Prostate Brachytherapy
Based On Prospective Questionnaire
Data
2579
Jeff Michalski
Impact of Prior Docetaxel, Extent of
Disease (EOD), and Prior
Bisphosphonates (Bp) on Hematologic
(Heme) Safety of Radium-223 Dichloride
(Ra-223) From ALSYMPCA
2580
Paul Nguyen
Impact of a Genomic Classifier of
Metastatic Risk on Post-prostatectomy
Treatment Recommendations by
Radiation Oncologists and Urologists
2581
Steven Oh
Outcomes in Organ Transplant Patients
With Prostate Cancer Treated With
Radiotherapy
2582
Michael Lovelock
Continuous Monitoring and
Intra-Fraction Target Position
Correction during Treatment is Essential
for Patients Undergoing SBRT Prostate
Therapy With Tight Target Margins
2583
James Kavanaugh
Initial Evaluation of the First
Commercially Available
Knowledge-Based Planning Software
2584
Young Kwok
Long-Term Follow-up of a Prospective
Trial of Neoadjuvant Chemotherapy
and Androgen Deprivation Followed by
Prostatectomy and Adjuvant Radiation
in High Risk Prostate Cancer
2585
Shu-Ya Lisa Grimm
Comparison Of The Ipss Score Changes
One Year Post High Dose Radiation
Between Good Bladder Fillers And Poor
Bladder Fillers
2586
Zhiyuan Zheng
A Description Of The Failure Patterns
Of High-risk Prostate Cancer In The
United States: Useful But Incomplete
Information From The National Cancer
Database
2587
Joseph Weiner
A Novel Perineal Shield for Low-dose
Rate Prostate Brachytherapy
2588
Moshe Meister
Clinical Experience of Full-Dose External
Beam Radiation in Prostate Cancer
Patients Failing Initial Treatment With
Prostate Brachytherapy
2589
David Harris
Acute and Late Toxicity of Prostate
Radiotherapy Utilizing Fiducial versus
Cone-Beam Computed Tomography
Daily Alignment
2590
Gilles Crehange
The Relationship Between The
Occurrence Of Bone Metastases
And Dose/volume Of Prior Prostate
Radiotherapy In Patients With Localized
Prostate Cancer
2591
Brandon Mahal
Racial Disparities in the Management of
African American Men With
Intermediate to High-Risk Prostate
Cancer
2592
David Marcus
The Impact of Radiation Therapy
Oncology Group Consensus Clinical
Target Volume Guidelines on Outcomes
in Patients Undergoing PostProstatectomy Radiation Therapy
2593
James Melotek
Urinary, Bowel, and Sexual Quality of
Life Is Not Worse After Whole Pelvic
Post-Prostatectomy Radiation
2594
Hima Musunuru
Comparison of Active Surveillance, Low
Dose Rate Brachytherapy, Stereotactic Ablative Body Radiotherapy and
Standard External Beam in Low Risk
Prostate Cancer
141
2595
Dorota Kazberuk
High-Dose-Rate Interstitial
Brachytherapy As Monotherapy In
Prostate Cancer Patients
2596
Brandon Mahal
The Impact of Race on Prostate-Cancer
Specific Mortality Among Men With
Low-risk Disease: Potential Implications
for Active Surveillance
2597
Zvi Symon
Does Choline PET/CT Change the
Management of Prostate Cancer
Patients With Biochemical Failure?
2598
Albert Chang
Long-Term Outcomes of Patients With
High-Risk Prostate Cancer Treated With
HDR Brachytherapy Boost
2599
Florian Sterzing
Impact of 68Ga-PSMA PET/CT in
Staging of Prostate Cancer Patient Prior
to Radiotherapy
2600
Thirupandiyur
Udayakumar
Radiation Mediated Inhibition of IFN
Signaling Sensitizes VSV Resistant
Prostate Cancer Cells
2601
Abhishek Solanki
Biochemical and Survival Outcomes in
Patients With T3 Prostate
Adenocarcinoma Treated With
Brachytherapy
2602
Ann Henry
Impact of D90 on PSA outcomes in men
treated With Low Dose Rate Prostate
I125 Monotherapy
2603
John Lukens
Oncologic and Toxicity Outcomes after
Prostate Brachytherapy for HIV-Positive
Patients: A Matched Cohort Analysis
2604
George Yang
Prostate Volumes >50 cc Do Not
Preclude Dosimetric Coverage of the
Prostate With High-Dose-Rate
Brachytherapy
2605
Fabio Ynoe Moraes
Trial Sponsorship, Self-reported
Conflicts Of Interest Of Authors (coi)
And Non-drug Related Randomized
Clinical Trial (rct) In Prostate Cancer
2606
Fan Ye
Comparison of Patient versus Physician
Reporting of Comorbidities in Localized
Prostate Cancer Patients, Results from
the Population-Based NC ProCESS
Cohort
2607
Alfredo Urdaneta
Long-term Follow-up after
MRI-Directed Regional Salvage
Brachytherapy for Locally Recurrent
Adenocarcinoma of the Prostate
2608
David Ziehr
Exogenous Insulin Therapy Is
Associated With Increased Prostate
Cancer Mortality in Men With Type 2
Diabetes Mellitus
2609
Alexander Engelman
The Efficacy and Toxicity Outcomes
of HIV-Infected Patients With Prostate
Cancer Treated With Definitive
Radiation Therapy
2610
Ross Zeitlin
The Dosimetric Impact of Small
Smearing and PTV Margin Reductions
on DVH Values for OAR in
Imaged-Guided Therapy for Localized
Prostate Cancer
2611
Hardev Singh
Impact of Endorectal Balloon and Saline
on Translational Shift in Prostate Cancer
Patients Treated With Proton Therapy
2612
Kevin Blas
Long-Term Clinical Outcomes for
Patients Treated With Adjuvant Versus
Early Versus Delayed Salvage
Radiotherapy in the Post-Prostatectomy
Setting
2613
Ashwin Ram
Multiple Intermediate-Risk Factors as a
Prognostic Tool For Men With
2614
Amol Narang
End of Treatment PSA as a Novel
Prognostic Factor in Patients
Undergoing Definitive Radiation for
Prostate Cancer
2615
Atchar Sudhyadhom
IPIP: A Planner Independent Approach
to HDR Prostate Brachytherapy
2616
Alan Pollack
Prostate Cancer Phase I Lattice
Extreme Ablative Dose (LEAD) Trial:
Feasibility and Acute Toxicity
2618
Ashwin Ram
Prognostic Value Of Psa Nadir In
Patients Undergoing Definitive
Radiation For Prostate Cancer
2619
Garrett Green
Dose Volume Relationship of Acute
and Late Small Bowel Toxicity From
Radiation Therapy for Prostate Cancer:
a Veteran Affairs Study
2620
David Asher
The Emergence Of New Late Radiation
Toxicities Beyond The Traditional 5
Years Of Follow-up After Low-dose
Rate Prostate Brachytherapy
2621
Sergio Faria
Radiotherapy-induced Castration In
Men With Advanced Prostate Cancer.
Results Of A Prospective Phase I Study
2622
Parvesh Kumar
Recently Updated Preliminary Results
Of An On-Going Phase I/II Trial Using
Tri-modality Therapy In Patients With
Post-prostatectomy High Risk
Pathologic (p) T2-3N0M0 Prostate
Cancer
2623
Moses Arunsingh
Dosimetric Correlates for Acute
Toxicity in Prostate Cancer Treated
With Hypofractionated
Radiotherapy - Absolute Volumes
are Better Predictors than Relative
Volumes
2624
William Hartsell
Multi-institutional Prospective
Evaluation Of Quality Of Life
Outcomes In Patients Treated With
Proton Therapy For Prostate Cancer
2625
Samuel Cooper
Comparison of Intraoperatively Built
Custom Linked (IBCL) Seeds to Free
Seeds for LDR Prostate Brachytherapy
2626
Sindy Magnan
Androgen Deprivation Therapy for
Patients With Localized Prostate
Cancer Treated With High-Dose-Rate
Brachytherapy Boost
142
2627
Donald Fuller
Factors That Predict Gu, Gi And Sexual
Quality Of Life (QoL) Outcomes 3 Years
After Stereotactic Body Radiation
Therapy (SBRT) For Early Prostate
Cancer, Results From A Multiinstitutional Phase 2 Trial
2628
Magali Quivrin
Post-implant Multiparametric Mri-based
Dosimetry After Permanent Iodine Seed
Prostate Brachytherapy: The Impact Of
The Dose Delivered To The Dominant
Intra-prostatic Lesion On Prostate
Specific Antigen Bounce
2629
Scott Robertson
Prognostic and Therapeutic
Implications of PNI in Prostate Cancer
Patients Undergoing Definitive
Radiation
2630
Skyler Johnson
A Comprehensive Assessment Of The
Prognostic Utility Of The Stephenson
Nomogram For Salvage Radiotherapy
Post-prostatectomy
2631
Dean Shumway
Is the Fear of Post-Prostatectomy
Radiotherapy Justified? An Analysis of
Patient-reported Quality of Life
Following Adjuvant or Salvage
Radiation
2632
Amber Orman
Automated Prostate Bed Lesion
Detection: The Next Step in Salvage
Radiotherapy Dose Escalation
2633
Nirdosh Gogna
USANZ And TROG Inter-group Phase III
Trial (TROG 02.03) Concurrent Weekly
Cisplatin Plus Radiation Therapy In
Localised Muscle Invasive Bladder
Cancer: Compliance< Toxicity< Quality
Of Life And Overall Results
2634
BaoQing Li
The Role Of Post-cystectomy Radiation
In Treatment Of Squamous Cell
Carcinoma Of The Bladder: A Seer
Analysis
2635
Tim Lautenschlaeger
Novel Predictive Micro-RNA Signature
In The Setting Of Selective Trimodality
Bladder Preservation Therapy
2636
Khaled Zaza
Patterns of Referral to Radiation
Oncology Among Patients Who
Undergo Cystectomy for Invasive
Bladder Cancer in Ontario: A Population-Based Study
2637
Marisa Kollmeier
Image-guided Intensity-modulated
Radiation Therapy (IMRT) for Bladder
Cancer: Toxicity and Early Outcomes
2638
Deborah Whalley
Accelerated IMRT With Image Guidance
For Bladder Cancer
2639
Catherine Thompson
Tolerability Of Neoadjuvant
Chemotherapy And Concurrent
Chemoradiotherapy With Gemcitabine
In Muscle Invasive Bladder Cancer:
Physician And Patient Reported
Outcomes
2640
Fulya Agaoglu
Bladder Preservation Therapy for
Muscle Invasive Bladder Cancer
2647
Norio Katoh
Japanese Multi-institutional Study of
Stereotactic Body Radiation Therapy For
Renal and Adrenal Tumors
2648
Christopher Tinkle
Comparison of Stereotactic Body
Radiotherapy and Conventional
External Beam Radiotherapy in Renal
Cell Carcinoma
2649
Fabio Cury
Renal Tolerance to Stereotactic Body
Radiotherapy - an Assessment of
Volume and Anatomical Site Irradiated
2650
Sophia Kamran
Risk of Testicular Cancer Following
Childhood Cancer Testicular Radiation
2651
Clair Beard
Variation in patterns of care in the
United States for clinical Stage I
seminoma - Results from the National
Cancer Data Base (1998-2011)
2652
Marco Carlone
CT Imaging for Penile Brachytherapy
2641
David Raleigh
Gold Fiducial Marker Tracking To
Optimize Radiotherapy For
Organ-Preserving Treatment Of
Muscle-Invasive Bladder Cancer
2653
Abhilasha Patel
Conditional Survival in Patients With
Genitourinary Malignancies Treated
With Radiation: A SEER Based Analysis
2642
Paula Doyle
In Vivo Assessment Of Radiation
Damage To Murine Urothelium Using
Chondroitin Sulfate Labeled With Texas
Red
2654
Brett Cox
Single Institution Experience With
Radium-223 Dichloride (Ra-223) for
Metastatic Castrate-Resistant Prostate
Cancer (mCRPC)
2643
William MacKillop
The Outcomes of Radiotherapy and
Surgery for Bladder Cancer: A
Population-Based Study
2644
Ariel Lederman
Treatment of Adrenal Metastases Using
Hypofractionated Stereotactic Body
Radiosurgery
2645
Ryan Hughes
Predictors of Locoregional and
Intravesical Recurrence Among Patients
Treated With Nephroureterectomy for
Urothelial Tract Carcinoma
2646
Aaron Sabolch
Toxicity of Concurrent Radiotherapy
With Mitotane Compared to
Radiotherapy Alone in the Adjuvant
Treatment of Adrenocortical Carcinoma
GYNECOLOGIC CANCER
2655
Ying Zhang
Rethinking For Pathological Risk-factors
Of Patients With Figo Stage I And Ii
Cervical Cancer
2656
Fei Yang
Standardized Spatial Heterogeneity
Of Baseline Intratumoral 18F-FDG
Accumulation For Outcome Prediction
Of Concurrent Chemoradiotherapy in
Cervical Cancer
2657
Lauren Tait
The Difference in Dose to the
Parametria Using Image Guided
Brachytherapy As We Move Away from
Point A
143
2658
Grant Clark
Quantifying Organ-at-Risk and
Applicator Movement During the Time
Between Treatment Planning and
Delivery of 3-D Image Guided High
Dose Rate Intracavitary Brachytherapy
for Cervical Cancer
2659
John Ma
The Impact of Total External Beam
Radiation Therapy and Brachytherapy
Package Duration on the Outcome of
Cervical Cancer Treated with Radiation
alone or with Concomitant
Chemotherapy
2660
Karen Xu
Extended Field Intensity-Modulated
Radiation Therapy for Gynecologic
Cancers: Is the Risk of Duodenal Toxicity
High?
2661
Marc Mahe
Early Clinical Outcomes In Cervical
Cancer Treated With Extended Field
Helical Tomotherapy To Paraaortic
Lymph Nodes
2662
Hanmanth Neboori
Is Quantifying the D2cc to Bowel
Necessary During Definitive HDR
Brachytherapy for Patients with Invasive
Cervical Carcinoma?
2663
Kawngwoo Park
Clinical Outcome of Isolated Para-aortic
Lymph Node Recurrence Treated With
Salvage Chemoradiotherapy for Uterine
Cervical Cancer
2664
Goro Kasuya
Impact Of Bladder Volume And Uterine
And Vaginal Geometric Factors On
The Irradiated Dose To The Bladder
And Small Intestine In Cervical Cancer
Patients Treated With Image-guided
Brachytherapy
2665
Yusung Kim
Overall Rectum and Bladder doses
(D2cc and D0.1cc) when integrated
EBRT and HDR Brachytherapy Doses
for Cervical Cancer by Accounting for
Organ Deformations
2666
Shira Felder
The Addition Of Brachytherapy To
Adjuvant External Beam Radiation
Improves Survival In Cervical Cancer
Patients Following Surgery
2667
Elizabeth Kidd
Comparison of Outcomes for Cervical
Cancer Patients Treated with Radiation
and Concurrent Weekly Cisplatin versus
Cisplatin and 5-Fluorouracil
2668
Matthew McKeever
Radioablative Dose for Pelvic and
Paraaortic Lymph Node Metastases
from Cervical Cancer
2669
Seok Ho Lee
Assessment Of Tumor Volume And
Serum Tumor Marker Levels During
Chemoradiation Therapy For Cervix
Cancer
2670
Primoz Petric
A Tool For Pre-treatment Estimation Of
Brachytherapy Dose Contribution To
Pelvic Lymph Nodes In Cervix Cancer
2671
Sean Quinlan-Davidson
A Prospective Comparative Analysis Of
Three Methods Of Rectal Retraction For
High-dose-rate Brachytherapy In
Cervical Carcinoma: Effect On Organs
At Risk
2672
Claire Dempsey
The Changing Nature Of HDR
Brachytherapy For Cervix Cancer: How
The Clinical Target Volume Affects The
Historical Prescription Dose
2673
Gamze Ugurluer
Bone Complications after Pelvic
Radiation Therapy: Evaluation With MRI
2674
Yongsook Lee
Variation In High Dose Rate
Brachytherapy Dose Contribution
Among Pelvic Lymph Node Groups In
Locally Advanced Cervical Cancer
2675
Francesco Cellini
FDG-PET Can Predict Overall
Recurrence And Disease Free Survival
After Definitive Irradiation And
Mri-guided Adaptive Brachytherapy In
Uterine Cervix Cancer
2676
Jun-ichi Saitoh
Effectiveness of Bisphosphonate
against Radiation-induced Decrease of
Bone Mineral Densities in Irradiated and
Non-irradiated Bone after Pelvic
Radiation Therapy in Patients with
Uterine Cervical Cancer
2677
Hong In Yoon
The Long-term Follow-up Result Of
Extended-field Radiotherapy For
Uterine Cervical Cancer With Positive
Para-aortic Lymph Nodes: Does The Addition Of Chemotherapy Have Survival
Benefit?
2678
Fumiaki Isohashi
Dose-volume Analysis Of Predictors For
Acute Hematologic Toxicity In Patients
With Cervical Cancer Treated With
Postoperative Pelvic Radiation Therapy
And Concurrent Nedaplatin-based
Chemotherapy
2679
Vinita Takiar
PD-1 Levels Correlate with Lymph Node
Positivity in Patients with Squamous
Cell Carcinoma of the Cervix
2680
Mitchell Kamrava
Clinical Outcomes Of High-dose-rate
Interstitial Gynecologic Brachytherapy
For Primary Locally Advanced Cervical
Cancer
2681
Kazuhiko Hayashi
Total Rectal Dose Estimated From
Radical External Beam And
Intracavitary Radiotherapy For Uterine
Cervical Cancer Using Deformable
Image Registration Method
2682
Keiko Murofushi
Early Outcomes And Dose-volume
Parameters For CT Based Treatment
Planning In Brachytherapy For Cervical
Cancer With Severe Vaginal Invasion Or
Vaginal Cancer
2683
Henrik Hansen
Introducing PET/CT in Cervical Cancer
Staging Procedures Leads to Stage
Migration and Selection Bias
2684
Akiko Kubo
Contribution Of Imaging In Diagnosis
Of Local Recurrence After Radiation
Therapy For Cervical Cancer
2685
Cameron Swanick
Impact of Normal Tissue Motion on
Dose to Critical Structures during
Intracavitary Brachytherapy
2686
John Boyle
Simultaneous Integrated Boost to Pelvic
and Paraaortic Nodes from Cervical
Cancer Improves the Dosimetric
Therapeutic Ratio
144
2687
Emily Dunn
PET/CT and MRI After Chemoradiation
for Cervical Cancer: Comparing the
Predictive Value for Recurrence
2688
Valentine Guimas
Trendelenburg Position Can Reduce
Small Bowel Dose In Brachytherapy Of
Cervix Carcinoma
2689
Lilie Lin
Initial Report of the Clinical Feasibility
and Acute Toxicities Associated with
Pencil Beam Scanning Whole Pelvis
Proton Therapy for Gynecologic
Cancers
2690
Mei Li
The Comparison between Reporting
Doses per GEC ESTRO and Estimation
from Deformable Dose Accumulation
2691
Henrik Hansen
Radiotherapy without Cisplatin for
Elderly Cervical Cancer Patients
2692
Tony Eng
Treatment Outcome of Patients With
Advanced Cervical Carcinoma After
Concurrent Chemotherapy and External
Beam Radiation Therapy Plus
High-Dose-Rate (HDR) Brachytherapy
2693
Gregory Treharne
Cervical Cancer Patients Presenting
with Para-aortic Lymph Node
Involvement have Distinctly Different
Survival Compared to Patients
Presenting with Metastatic Disease
2694
Ryan Best
Dosimetric Study Of Two Utrecht-style
Applicators For Cervical Brachytherapy
2695
Ebru Karakaya
Is Pretreatment Neutrophil To
Lymphosite Ratio A Predictive Factor
For Cervical Cancer Control?
2696
Jihoon Lim
The Impact of Substance Use on
Incidence and Survival in Locally
Advanced Cervical Cancer Treated with
Radiation Therapy
2697
Feng Mei
Prognostic Factors For Toxicity And
Survival In Advanced Cervical Cancer
Patients Treated With High Dose Rate
(hdr)-intracavitary Brachytherapy
(icbt) Combined With Complementary
Intensity Modulated Radiotherapy (imrt)
2698
Dominique Rash
Prospective Evaluation of Patient
Satisfaction Following the Use of
Education Materials for Cervical Cancer
Brachytherapy
2699
Anthony Michaud
Prospective Analysis of the Treatment
Planning Process for Gynecologic Image
Guided High Dose Rate Brachytherapy
2700
Rajni Sethi
A Multi-Institutional Study of Lymph
Node Positive Cervical Cancer Patients
Treated in the Modern Era of
Chemoradiation
2701
Xin Wang
Long-term Follow-up Results Of
Simultaneous Integrated Or Late
Course Accelerated Boost With Ebrt
To Vaginal Stump In Intermediate Risk
Cervical Cancer Patients After Radical
Hysterectomy
2702
Jennifer Croke
Vaginal Dose And Patient Reported
Sexual Adjustment With MR-guided
Brachytherapy For Cervical Cancer
2703
Angela Lin
A Retrospective Review Of Patient
Outcomes Following High-Dose-Rate
Brachytherapy In The Treatment Of
Cervical Cancer
2704
Baozhou Sun
3d Dose Accumulation In Pseudo-splitfield Imrt And Bt For Locally Advanced
Cervical Cancer
2705
Rebekah Young
Is Point A Still Relevant?: Does
Prescribing to Tumor Volume Vs Point A
Correspond to Equivalent Outcomes
Among Cervical Cancer Patients
Undergoing T&O Brachytherapy?
2706
Alex Herskovic
Is There A Difference In Cause Specific
Survival And Overall Survival In 1b1
Squamous Cell Carcinoma And
Adenocarcinoma Of The Uterine Cervix?
Seer Database: 2004-2008
2707
Puja Venkat
Outcome Assessment of Dose
Adaptation of MRI-Guided Cervical
Cancer Brachytherapy
2708
Chris McClinton
Comparison of Four Different
Optimization Methods for Cervical
Brachytherapy in the Era of 3D Planning
2709
Puja Venkat
F18-FDG PET/CT as a Prognostic
Indicator of Clinical Outcomes for
Cervical Cancer Treated With
MRI-Guided Brachytherapy
2710
Himanshu Nagar
Treatment with Adjuvant Pelvic
Radiation Therapy ± Vaginal
Brachytherapy in Patients with
High-Risk Stage I or Stage II Uterine
Papillary Serous, Clear Cell, and
High-Grade Endometrioid Carcinoma
2711
Christine ChangHalpenny
Early Stage Pure and Mixed Endometrial
Clear Cell Carcinoma: Outcomes and
Patterns of Recurrence
2712
Angeles Rovirosa
Comparative Results of Vaginal Relapses
and Toxicity of Two Protracted 192-Ir
HDR brachytherapy (BT) Schedules in
Postoperative Endometrial Carcinoma
(EC)
2713
Gustavo Ferraris
Ki-67 Expression as a Prognostic Factor
of Outcome After Adjuvant Irradiation
in Endometrial Carcinoma
2714
Lucas Sapienza
Isolated Brachytherapy for
Endometrial Cancer with Disease
Restricted to Uterus - Oncologic Results
and Toxicity Analysis
2715
Sebastia Sabater
Body Mass Index And Doses At Organs
At Risk Evaluated By CT In A
Mediterranean Postoperative Vaginal
Cuff Brachytherapy (VCB) Cancer
Population
2716
Himanshu Nagar
Tolerability of Concurrent
Chemotherapy and Vaginal
Brachytherapy for Treatment of Early
Stage High Grade Endometrial Cancer
2717
Sharon Lu
Single Institution Comparison of
“Sandwich” versus Sequential Adjuvant
Chemotherapy and Radiation for Stage
III Endometrioid Uterine Carcinoma
145
2718
Mohamed Elshaikh
Quantification of the Air Gaps Around
High-Dose Rate Brachytherapy Cylinder.
A Prospective Study to Correlate Air
Gaps with Optimal Cylinder Size
2719
Sean Vance
Failure Patterns of Type II Endometrial
Cancer With and Without Adjuvant RT
2720
Nicolas Bauer
Vaginal Vault High-dose-rate
Brachytherapy Alone as Adjuvant
Treatment of Early-stage Endometrial
Cancer: a Retrospective Study on 119
Patients
2721
Mehmet Ufuk Abacioglu
Comparison of Target Volume and
Organ At Risk Doses With Multi-channel
vs. Single Channel Cylinder for Vaginal
Brachytherapy
2722
Christina Chapman
Assessing the Need for Dose
Calculations to Organs at Risk Using MRI
Planning in Vaginal Brachytherapy
2723
Josephine Chen
Comparing the Use of the Full
Dose-Volume Histogram (DVH) Curves
with Point Dosimetric Indices to
Characterize External-Beam Treatment
Plans for Endometrial Cancer
2724
Neil Desai
Comparison Of Early Stage Uterine
Papillary Serous Carcinoma (upsc) And
Carcinosarcoma Treated With Adjuvant
Carboplatin/taxane Chemotherapy And
Intravaginal Radiotherapy (ivrt)
2725
Vikram Velker
Adjuvant Treatment of Stage IA Type II
Endometrial Cancers: Is Observation a
Valid Strategy?
2726
Philip Poorvu
“Loops” Versus “Bowel Bag”: Which Is
Better For Bowel Contouring In
Gynecologic Cancer Patients Receiving
IMRT To The Paraaortic Nodes?
2727
Julia Manzerova
Treatment Regimens Incorporating
Adjuvant Radiation Therapy Improve
Survival of Patients with Carcinosarcoma of the Uterus: a SEER Study
2728
Arya Amini
Should we customize PTV expansions
for BMI? Daily Cone Beam
Computerized Tomography to Assess
Organ Motion in Postoperative
Endometrial and Cervical Cancer
Patients
2729
Joseph Dise
Development and Evaluation of an
Automatic Interstitial Catheter
Digitization Tool for HDR Brachytherapy
of Gynecologic Cancers
2730
Jennifer Ma
Lymphovascular Invasion as a Poor
Prognostic Factor in Uterine Cancer
2731
Thatcher Heumann
Survival Outcomes and the Role of
Adjuvant Therapy Sequencing in Type II
Uterine Cancer After Definitive Surgery
2732
Kaveh Maghsoudi
Salvage Radiation Therapy Including
High Dose Rate Brachytherapy for
Isolated Vaginal Recurrences of
Endometrial Cancer
2733
Joseph Syh
A Dosimetric Study by Using a
Multichannel Cylinder in High Dose
Rate Brachytherapy Treatment of the
Vaginal Cuff
2734
Sang-June Park
Is It Better to Treat from Inside Out or
Outside In for Vaginal Cuff
Radiotherapy?
2735
Rebekah Maymani
Vaginal Cancer: Importance of
Response to EBRT and Medical
Contraindications to Interstitial
Brachytherapy
2736
Jim Rose
Transvaginal Ultrasound-Guided
Interstitial Brachytherapy For Vaginal
Tumors: A Fixed Template Technique
2737
Yuan Rao
Analysis of Survival after
Brachytherapy for Vulvar Cancer Using
the SEER Registry
2738
Kathy Han
What Is The Optimal Treatment For
Patients With Sentinel Node-positive
Vulvar Cancer?
2739
Larissa Lee
Local-Regional Recurrence in Node
Positive Vulvar Cancer: Clinical Factors,
RT Fields and Dose
2740
Carminia Lapuz
Determination of Standardized
Objective and Constraint Settings for
Inverse Planning using IPSA and HIPO
for HDR Brachytherapy Multi-channel
Vaginal Cylinders
2741
Megan Mezera
Utilizing Dose-Escalated Integrated
Simultaneous Boost to PET Avid Gross
Nodal Disease in Gynecologic
Malignancies: Analysis of Disease
Response and Toxicity
2742
Sujith Baliga
Stereotactic Body Radiation Therapy in
Recurrent, Persistent, or Oligometastatic
Gynecological Tumors
2743
Jessica Zhou
Radiation Dosimetry of Pelvic Floor and
Non-Reproductive Sexual Organs in
External Beam Radiation Therapy for
Gynecologic Cancers
2744
Ryan Bair
Radiopaque Polymer Hydrogel used
as a Fiducial Marker in Gynecologic
Brachytherapy
2745
Melis Gultekin
Determination of Optimal Planning
Target Volume Margins in Patients with
Gynecologic Cancer
2746
Nicolette Taku
Quantifying Vaginal Motion Associated
With Daily Endorectal Balloon During
Whole Pelvis Radiotherapy For
Gynecologic Cancers
HEAD AND NECK CANCER
2747
Rangarajan Ramya
Comparison of Clinical Profile of Oral
Cancers in Young And Elderly - A Single
Institution Series From a Developing
country
2748
Ryuji Murakami
Prognostic Impact of the Nodal Level
Involvement in Advanced Oral Cancer
Treated with Preoperative Concurrent
Chemoradiation Therapy
146
2749
Zachary Nicholas
A Dosimetric Evaluation of Oral Tongue
Sparing to Reduce Dysgeusia in Head
and Neck Cancers
2750
Eli Scher
Evaluation Of Primary Treatment
Technique For Squamous Cell
Carcinoma Of The Buccal Mucosa: A
Single Center Experience
2751
Sean Quinlan-Davidson
Postoperative IMRT for Patients with
Oral Cavity Carcinoma
2752
Kathryn Hitchcock
Retromolar Trigone Squamous Cell
Carcinoma Treated with Radiotherapy
Alone or Combined with Surgery: A
10-Year Update
2753
Richard Cassidy
Squamous Cell Carcinoma of the Oral
Tongue: Exploring New Trends
2754
Jeffrey Vainshtein
Matted Lymph Nodes: An Indication
for Intensification of Chemotherapy in
Human Papillomavirus-Related (HPV+)
Oropharyngeal Cancer (OPC)?
2755
Jerry Liu
Prognostic Value Of Radiographic
Extracapsular Extension In Locally
Advanced Head And Neck Squamous
Cell Cancers
2756
Moein Alizadeh-Kashani
Phase I-ii Study Evaluating Reduced
Radiation Volume And Dosage Using
Comprehensive Tomotherapy And
Concurrent Chemotherapy For
Oropharyngeal Carcinoma
2757
John Ma
Three-year Clinical Outcome and
Quality of Life Interim Analysis of a
Phase II Trial to Examine Use of
Post-Chemotherapy Volumes after
Neo-adjuvant Treatment of Squamous
Cell Carcinomas of the Head and Neck
2758
Pirus Ghadjar
Impact Of Weight Loss On Survival After
Chemoradiation For Locally Advanced
Head And Neck Cancer. Secondary
Results Of A Randomized Phase 3 Trial
(SAKK 10/94)
2759
Ken Takeda
Clinical Factors with respect to Cervical
Body Volume Reduction During
Definitive External Beam Radiation
Therapy for Oropharyngeal Squamous
Cell Carcinoma
2771
Shlomo Koyfman
(IMRT) Reduces Late Toxicity in Patients
with Human Papillomavirus Associated
(HPV+) Oropharyngeal Carcinoma
Treated with Chemoradiotherapy (CRT)
2760
Omar Gayar
Compliance with Quality Assurance
Measures for Improving Oropharyngeal
Cancer Patient Care
2772
Sophia Kamran
Weekly On-treatment MRIs During
Radiotherapy (RT) In Head And Neck
Squamous Cell Carcinoma (HNSCC)
Patients To Monitor Treatment
Response
2761
Esengul Kocak
Beam Path Toxicity In Candidate
Organs at Risk: Assessment Of Radiation
Emetogenesis For Patients Receiving
Head And Neck Intensity Modulated
Radiotherapy
2762
Daniel Yeung
Reducing Toxicity from Oropharyngeal
Cancer Therapy with IMPT: A Dosimetric
Analysis
2763
Francesco Ricchetti
Parotid Gland Shrinkage during IMRT for
Oropharyngeal Cancer and Xerostomia
2765
Florence Keane
The Prognostic Significance Of T-stage
And N-stage In Patients With Squamous
Cell Carcinoma Of The Oropharynx
(OPSCC) In The HPV Era
2766
Mauricio Gamez
Unilateral Radiotherapy for
Node-Positive HPV-Positive Squamous
Cell Carcinoma of the Tonsil: Analysis of
a Prospective Cohort
2767
Jerry Liu
Is Radiographic Extracapsular
Extension Prognostic In Human
Papillomavirus-related Oropharyngeal
Cancers?
2768
Jacob Rasmussen
Temporal Stability And
Reproducibility Of FDG-PET-based Dose
Painting Targets In Head And Neck
Cancer
2769
Ganesh Narayanasamy
Radiobiological Evaluation of IMRT
Treatment Of Head And Neck Patients:
Multi-Institutional Study
2770
Stephen Rosenberg
HPV Positive Oropharyngeal Cancers:
Mid-treatment PET During
Radiotherapy And Implications For
Treatment De-escalation
2773
William Magnuson
Potential Influence of ACE Inhibitors
and Angiotensin Receptor Blockers on
Outcome in Patients with Oropharynx
Cancer Treated with Radiotherapy
2774
Anthony Pham
Significantly Improved Local Control
With The Use Of Cesium-131
Brachytherapy In High Risk And
Recurrent Head And Neck (hn) Cancers:
Long Term Results Of A Pilot Study
2775
Marianne Feen Roenjom
A Validation Study Of Normal Tissue
Complication Probability (NTCP)
Models For Radiation-induced
Hypothyroidism (HT)
2776
Scott Glaser
A Dosimetric Analysis of Adjuvant
Radiation Therapy Following Transoral
Robotic Surgery (TORS) for Oropharyngeal Cancer Compared to Definitive
Chemoradiation (CRT)
2777
Enrique Izaguirre
Dose Dependent Response of Tonsil
Cancers to Radiation Therapy and
Concurrent Chemotherapy: A
Retrospective Analysis of Change of
Gross Tumor Volume
2778
Philip Schaner
Decreases the Risk of Long Term
Gastrostomy Tube Dependence in
Curative Intent Treatment for Squamous
Cell Carcinoma of the Oropharynx
2779
Natalie Logie
The Impact Of Treatment Delays In
Oropharyngeal Cancer Patients Treated
With Surgery Followed By (chemo)
radiation
147
2780
Joshua Weir
Reduced Toxicity of Induction
Chemotherapy with Omission of 5FU
and Response Rates by RTOG 0129 Risk
Group
2781
Susie Chen
Use of 18-FDG PET in Determination of
Disease Extent in HPV/p16 Positive
Oropharyngeal Squamous Cell
Carcinoma
2782
Takeshi Kodaira
Clinical Efficacy Of Helical Tomotherapy
For Nasopharyngeal Cancer Treated
With Definite Concurrent
Chemoradiotherapy
2783
Vincent Wu
Radiation Induced Changes On
Temporo-Mandibular Joint In
Nasopharyngeal Cancer Patients After
External Beam Radiotherapy - A
Preliminary Study
2784
Yong Chen
Prognostic Significance of Maximum
Primary Tumor Diameter in
Nasopharyngeal Carcinoma
2785
Ning Zhang
Primary Tumor Regression Speed After
Radiotherapy And Its Prognostic
Significance In Nasopharyngeal
Carcinoma: A Retrospective Study
2786
Tsung Min Hung
The Dose of Elective Neck Irradiation
as 46 Gy is Feasible in Nasopharyngeal
Carcinoma treated by IntensityModulated Radiotherapy
2787
Hongmei Ying
Effectiveness And Toxicities Of
Intensity-modulated Radiation Therapy
For Patients With T4 Nasopharyngeal
Carcinoma
2788
Ryo Toya
Radiotherapy For Nasopharyngeal
Carcinoma: Predictability Of Treatment
Outcomes At Interim Re-assessment
2789
Lin Ma
Replanning Criteria and Timing
Definition for Parotid Protection-based
Adaptive Radiation Therapy in
2790
Irene Karam
Outcomes Following Re-irradiation For
Recurrent Nasopharyngeal Carcinoma:
A Single Institutional Experience
2791
Musa Altun
Radiation Infield Second Tumors in
Nasopharyngeal Carcinoma Patients
2792
Rafael Manon
Retrospective Study Of Hippocampal
Sparing In The Treatment Of
Nasopharyngeal Cancer
2793
Faqiang Ma
Efficacy and Factor Affecting Outcome
of Induction Chemotherapy Combined
Concurrent Chemoradiation Therapy in
263 Patients with locally
advancednasopharyngeal carcinoma
2794
Chan Woo Wee
A Single Physician Experience of
Intensity-Modulated Radiotherapy for
Locoregionally Advanced
Nasopharyngeal Carcinoma Treated
with Concurrent Chemoradiation
2795
Lai Tan
Quality of Life in Nasopharyngeal
Cancer (NPC) Patients: Study of Salivary
Flow Recovery Pattern on
Xerostomia Improvement for IMRT
(Intensity Modulated Radiation Therapy)
vs VMAT (Volumetric Modulated Arc
Therapy)
2796
Weixin Liu
Nasopharyngeal Carcinoma in
Childhood and Adolescence: A Single
Institution’s Experience of 158 Patients
2797
Qichao Zhou
Prognostic Factors Of Local Control
After Re-irradiation With
Intensity-modulated Radiotherapy
Of Locally Recurred Nasopharyngeal
Carcinoma
2798
Xiyin Guan
Induction Chemotherapy With
Docetaxel And Nedaplatin Followed
By Concurrent IMRT And Nedaplatin
For Locally Advanced Nasopharyngeal
Carcinoma
2799
Ramesh Bilimagga
Role Of Stereotactic Radiosurgery In
Recurrent Head And Neck Cancers: A
Single Institution’s Experience
2800
Niranjan Bhandare
Association Between Location of
Nasopharyngeal Carcinoma, Pre- and
Postradiotherapy Otitis Media with
Effusion, and Sensory Neural Hearing
Loss
2801
Wing Lun Mui
Dosimetric Effect of Binary Multi-leaf
Collimator in Helical Tomotherapy to
Optic System in Treating
2802
Emily Tanzler
Are Blind Biopsies of the Nasopharynx,
Pyriform Sinus, and Contralateral Tonsil
Necessary in the Work-Up of Unknown
Primary Squamous Cell Carcinoma of
the Head and Neck?
2803
Chengtao Wang
Metabolic Tumor Volume (MTV) and
Maximum Standardized Uptake Value
(SUVmax) as Predictive Factors in
Locally Advanced Nasopharyngeal
Cancer Treated with Definitive
Chemoradiotherapy
2804
Ozlem Ozkaya
Akagunduz
Evaluation of the Radiotherapy Induced
Optic Nerve and Chiasm Injuries by
Electrophysiological Tests and Optic
Coherence Tomography in the Patients
with Nasopharyngeal Carcinoma
2805
Emma Holliday
Gastrostomy Tube Rates Decrease by
Over 50% in Patients with
Nasopharyngeal Cancer Treated with
(IMPT): A Case-Control Study
2806
Miranda Kim
Sequential Versus Concurrent
Chemotherapy For Locally Advanced
Nasopharyngeal Carcinoma: A
US-based Study
2807
Wei-Hsien Hou
The Ratio Of Weight Loss To Planning
Target Volume Significantly Impacts
Setup Errors In Nasopharyngeal Cancer
Patients Undergoing Helical
Tomotherapy With Daily MVCT
2808
WeiWei Xiao
Delineation Of the Clinical Target
Volume in Early-stage Nasopharyngeal
Carcinoma Treated With
Intensity-modulated Radiotherapy:
Long-term Follow-up Of A Phase 2
Study
2809
Annie Chan
Refinement and Individualization of
Clinical Target Volume Delineation in
Nasopharyngeal Carcinoma: A 22-Year
Clinical Experience
148
2810
Ayal Aizer
Assessment Of Trismus After
Chemoradiation For Nasopharyngeal
Cancer: A Prospective, Phase 2 Trial
2819
Mark Edson
IMRT For Organ Preservation In
Hypopharynx Cancer Provides Good
Locoregional Control
2811
Aron Popovtzer
Organ Preservation for Patients with
Advanced Laryngeal Cancer Who
Responded to Induction Chemotherapy
with Docetaxel, Cisplatin, and 5Fluorouracil (TPF) Followed by Cisplatin
Concomitant with Radiation Therapy: A
Phase 2 trial
2820
Jacob Shin
Racial Disparities In Laryngeal Cancer
Treatment And Outcome In The United
States: A Population-Based SEER
Analysis Of 24,069 Patients
2812
Keiichi Takehana
Retrospective Analysis of Clinical
Efficacy of IMRT Using Helical
Tomotherapy among Patients Treated
with Definitive Chemoradiotherapy for
Hypopharyngeal Cancer
2813
Ken Takeda
Clinical Factors with respect to Cervical
Body Volume Reduction During
Definitive External Beam Radiation
Therapy for Hypopharyngeal Squamous
Cell Carcinoma
2814
Zhibin Huang
Tumor Volume Delineation in Head and
Neck Cancer with Imaging Modalities:
CT, PET, MRI, Compared with
Pathological Tumor Volume
2815
Naoyuki Kanayama
Patterns of Cervical Lymph Node
Metastasis in Definitive Radiotherapy
for Hypopharyngeal Cancer:
Implications for the Elective Target
Volume Delineation
2816
Jonathan Chen
Differences in Survival Outcome
Between Stage 1 and Stage 2 Glottic
Cancer: A SEER-Based Analysis
2817
Esat Mahmut Ozsahin
Carotid Dose Sparing in Definitive
Irradiation of Early-Stage Glottic Cancer
Using Helical Tomotherapy-Based
Image-Guided Intensity-Modulated
Radiotherapy
2818
Joseph Tung-Chieh
Chang
Outcome Of Residual Disease At The
End Of Radiotherapy For
Pharyngo-laryngeal Cancer Patients
Received Definite Chemotherapy And
Intensity Modulation Radiotherapy
2821
Matthew Ward
Reduction of Severe Late Toxicity After
Definitive Chemoradiotherapy (CRT)
using Intensity Modulated Radiation
Therapy (IMRT) in Non-HPV Associated
Head and Neck Squamous Cell
Carcinoma (HNSCC): More than
Xerostomia
2822
Elise Anne Jager
Improved GTV Delineation Of
Laryngeal/Hypopharyngeal Carcinoma
On MRI By The Use Of Delineation
Guidelines
2823
Joana Caldas Magalhaes
FDG-PET Semi-automatic
Segmentation Methods For GTV
Delineation In Laryngeal And
Hypopharyngeal Cancer
2824
Newton Hurst
Pretreatment Computed Tomographic
Gross Tumor Volume (CT-GTV) Is
Prognostic for Poor Functional
Outcomes in Patients Undergoing
Larynx Preservation
2825
Shahrokh Iganej
Triweekly Carboplatin Alone Instead of
Cisplatin in the Definitive Treatment of
Locally Advanced Laryngeal Carcinoma
With Concurrent Chemoradiation: One
Institution’s Experience and a
Comparison to RTOG 91-11 Results
2826
Lucas Sapienza
Long-term Experience With
Radiotherapy Alone For Early Stage
Squamous Cells Glottic Carcinoma:
Impact Of Technological Incorporation
2827
Bhaswanth Dhanireddy
The Impact of Different Radiation
Therapy Techniques on Oncologic
and Functional Outcomes of Locally
Advanced Laryngeal Cancer
2828
Kristin Plichta
The Prognostic Value of Pretreatment
FDG-PET scans in Head and Neck
Squamous Cell Cancers Treated with
Definitive Chemoradiation
2829
Kenneth Shung Hu
Pre-Treatment PET Metabolic Tumor
Volume (MTV) and Maximum
Standardized Uptake Value (SUVmax)
Predict for Organ Preservation and
Disease-Free Survival in Larynx Cancer
Patients Treated with Concurrent
Chemoradiation
2830
Yae-eun Suh
Single Institution Outcomes Of Stage 3
And 4 Laryngeal Squamous Cell
Carcinoma Treated With Primary
(Chemo)radiation
2831
Jeppe Friborg
Loco-regional Control And Survival
After Primary Radiotherapy Of
Hypoharyngeal Carcinoma - A
Population-based Study
2832
Lauren Kropp
Radiation Therapy following Total
Laryngectomy for High-Risk Larynx
and Hypopharynx Squamous Cell
Carcinoma
2833
Bhaswanth Dhanireddy
The Impact of Smoking on Laryngeal
Preservation in Locally Advanced
Laryngeal Cancer Treated with
Definitive Chemoradiotherapy
2834
Stephen Lai
Identification and Management of
Laryngeal Carcinoma Patients with
Risk Factors for Gastrostomy Tube
Placement
2835
Ozlem Ozkaya
Akagunduz
Dose-Volume Effects of Radiation to
Swallowing Function in the
Radiotherapy of Head and Neck Cancers
2836
Michael Scott
Comparison of Toxicity and Tumor
Response in Early Glottic Cancer Treated
with Conventionally Fractionated (CRT)
vs. Hypofractionated Radiotherapy
(HRT): Retrospective Analysis of a Single
2837
Cole Kreofsky
Larynx-Preserving Intensity Modulated
Radiation Therapy for Laryngeal and
Hypopharyngeal Carcinoma
149
2838
Priyanka Bhateja
Definitive Chemoradiation (CRT) For
Organ Preservation In Locally Advanced
Squamous Cell Carcinoma Of The
Hypopharynx (SCC-HP): Oncological
Outcomes And Late Toxicity
2839
Samir Patel
Charged Particle Therapy for Nasal
Cavity and Paranasal Sinus
Malignancies: A Systematic review and
Meta-analysis
2840
Nadya Shusharina
Evaluation of Proton Therapy for
Advanced Head and Neck Cancer with
Respect to Changing Heterogeneity
2841
Issa Mohamad
Role of Radiotherapy in Management
of Nasal and Sinonasal Squamous Cell
Carcinomas
2842
Yang-Gun Suh
Treatment Outcomes of
Intensity-Modulated Radiotherapy
versus Three-Dimensional Conformal
Radiotherapy for Patients With
Maxillary Sinus Cancer in the
Postoperative Setting
2848
Jin Ho Kim
Impact Of Radiotherapy Volumes On
Skull Base Recurrence In Adenoid Cystic
Carcinoma In The Head And Neck
2859
Juliette Thariat
Prognosis Of Irradiated Anaplastic
Thyroid Carcinomas, A Rare Cancer
Network Study
2849
Waleed Mourad
Durable cosmetic control with radiation
therapy for HIV-associated Parotid
Benign Lymphoepithelial Cysts
2860
Alan Monroe
Dorsal Vagal Complex of the Brainstem:
Conformal Avoidance to Reduce
Nausea
2850
Cheng-En Hsieh
Postoperative Radiotherapy for
Submandibular Gland Carcinomas:
What is the Optimal Elective Nodal
Irradiation Volume?
2861
Srinivas Chilukuri
Two Prescription Dose Levels As Safe As
3-4 Prescription Dose Levels In IMRT For
The Treatment Of Neck Nodal Regions
In Head Neck Cancers
2851
Alexandra Jensen
High-let Radiotherapy For Adenoid
Cystic Carcinoma Of The Head And
Neck: 15 Years’ Experience With
Raster-scanned Carbon Ion Therapy
2862
Beth Beadle
Differential Feeding Tube Placement
and Duration with IMRT for Head and
Neck Cancer: A SEER-Medicare Analysis
2852
Petra Stegmaier
Identification of Differences in the
whole Saliva Baseline Proteome Profile
that are Associated with Development
of Oral Mucositis in Head and Neck
Cancer Patients during Treatment with
IMRT
2843
Daisuke Miyawaki
Result of Multimodal Treatment
Including Radiotherapy for Squamous
Cell Carcinomas of Maxillary Sinus: A
Retrospective Study
2853
James Han
Weekly On-treatment MRIs During
Radiotherapy (RT) In Head And Neck
Squamous Cell Carcinoma (HNSCC)
Patients To Monitor Normal Tissue
Response
2844
Lawrence Younan
Influence of Time Factors on Local
Control and Survival Following
Radiotherapy for Paranasal Sinus Cancer
2854
Darwin Yip
Proton Beam Therapy for
Unresectable Adenoid Cystic
Carcinoma of the Nasopharynx
2845
Jay Liao
Management and Long-Term
Outcomes of Sinonasal Undifferentiated
Carcinoma: 20-year Experience at a
Single Insitution
2855
Aleksandra Kuczmarska
Markedly Increased Incidence of
Thyroid Cancer in Northeast Pennsylvania: A Clinical-Epidemiological
Investigation
2846
Shyamal Patel
Postoperative Radiation Therapy For
Parotid Pleomorphic Adenoma With
Close Or Positive Margins: Treatment
Outcomes And Toxicities
2856
Mu-Hung Tsai
A Dose-Effect Relationship and
Estimated Parameters for the
Lyman-Kutcher-Burman (LKB) Model of
Normal Tissue Complication
Probability (NTCP) for Radiation Induced
Hypothyroidism
2847
Jin Ho Kim
Significance Of Postoperative
Radiotherapy On Locoregional Control
In T1/t2 Adenoid Cystic Carcinoma In
The Head And Neck
2857
Peter Zavitsanos
Hürthle Cell Carcinoma of the Thyroid
2863
John Cuaron
Patterns of Failure in Patients with Head
and Neck Carcinoma of Unknown
Primary Treated with Radiation Therapy
2864
Masaru Takagi
Treatment Outcomes of Proton or
Carbon Ion Radiotherapy for Chordoma
of the Skull Base
2865
Re-I Chin
Prognostic Significance of Metabolic
Tumor Volume after Induction
Chemotherapy in Squamous Cell
Carcinoma of the Head and Neck
2866
Jon Cacicedo
Utility Of 18F-fluorodeoxyglucose
Positron Emission Tomography (PET/
CT) In The Staging And Treatment Plan
Evaluation Of Head And Neck
2867
Madhava Kanakamedala
Outcome Analysis Of Extracapsular
Extension In Cervical Lymph Nodes
For Locally Advanced Squamous Cell
Carcinomas Of Head And Neck
2868
Hugo van der Heide
Radiation-induced Volumetric Changes
Of Salivary Glands In Relation With
Mean Dose And Saliva Production In
Head-and-neck Cancer Patients
2869
Dayssy Diaz Pardo
Head And Neck Second Primary Cancer
Rates In The HPV Era: A SEER Analysis
2858
Sean Sachdev
Thyroid V50 Predicts Hypothyroidism in
Head-and-Neck Cancer Patients Treated
with IMRT
150
2870
Niranjan Bhandare
The Effect of Preexisting Diabetes
on the Incidence of Post-Radiation
Retinopathy in Head and Neck Cancer
Patients
2881
Sonam Sharma
Risk Factors for Prolonged Diagnosis to
Treatment Interval (DTI) Among Patients
with Head and Neck Squamous Cell
Carcinoma (HNSCC)
2871
Jessica Freilich
Outcomes of Mucosal Melanoma of the
Head and Neck
2882
Sean Sachdev
Age Most Significant Predictor of
Requiring Enteral Feeding in Head-andNeck Cancer Patients
2872
Paolo Antognoni
FDG PET SUV-based Segmentation
Method for Biological GTV (BTV)
Delineation in Pharyngeal Cancer
Dose-Painted IMRT: Preliminary
Retrospective Evaluation of Patterns of
Local Relapse
2873
Jesse Shulman
Long Term Follow-up of Patients
treated with Radiation Therapy for
Merkel Cell Carcinoma of the Head
and Neck
2874
Philip Gilbo
Radiotherapy for Benign Head and Neck
Paragangliomas: A 45-year Experience
2875
Michael Cheung
Optimal Timing of Initial PET/CT
Surveillance Scan after Radiotherapy for
Head and Neck Cancers
2883
Lanting Gao
The Role of Adjuvant Radiotherapy in
the Treatment of Type B3 Thymoma
2884
Timothy Waxweiler
Safety and Feasibility Update of
Olaparib, an Orally Bioavailable PARP
Inhibitor, With Concurrent Cetuximab
and Radiotherapy in Heavy Smokers
with Stage 3-IVB Squamous Cell
Carcinoma of the Head/Neck: A Phase
1 Trial
2885
Harry Quon
Effective Pain Management of Mucositis
with Prophylactic Gabapentin in the
Irradiated Head and Neck Cancer
Patient Is Associated with Functional
Benefits
2891
Stephanie Rice
Skin Cancers of the Head and Neck: A 21
Year Single Institution Experience
2892
Vikram Manoor Maiya
The Use of Xylitol for the Prevention
of Xerostomia in Patients Receiving
Intensity Modulated Radiotherapy for
Head and Neck Cancers
2893
Ali Hosni
IMRT with Selective Target Volume
Approach in Head and Neck Squamous
Cell Carcinoma of Unknown Primary
Site
2894
Michael Spiotto
Ace Inhibitors Predict For Acute Kidney
Injury During Chemoradiation For Head
And Neck Cancer
2895
Michael Spiotto
Unplanned Hospitalizations Greater
Than Five Days Predict For Worse
Outcomes After Radiotherapy For Head
And Neck Cancer
2896
Aleksandra Napieralska
Cancerogenic Wind Blows Through
the Pipe - Rare Carcinoma of Trachea as
Primary or Secondary Neoplasm
2876
Rex Hoffman
Multi-site Review Of Osteoradionecrosis
in the Posterior Aspect of the Mandible
Following Radiotherapy
2886
Yvonne Mowery
Changes in Tumor Volumes and
18F-FDG PET characteristics during
Radiotherapy for HPV+ and HPV- Head
and Neck Squamous Cell Carcinoma
(HNSCC)
2877
Jean-Claude Rwigema
4π Noncoplanar Stereotactic Body
Radiation Therapy (SBRT) for Head and
Neck Cancer: Potential to Improve Local
Control and Late Toxicity
2887
Yutaka Toyomasu
Treatment Outcomes of Particle
Therapy using Protons or Carbon Ions
for Locally Advanced Head and Neck
2878
Jakub Cvek
Hyperfractionated Accelerated
Radiotherapy 70-75Gy in 5 weeks for
Advanced Head and Neck
Cancer - Single Institution Experiences
2888
Satish Kondaveeti
Therapeutic Benefit Of Concurrent
Radiation With Single Agent
Nimotuzumab In Locally Advanced
And Recurrent Hnscc - A Retrospective
Analysis
2899
Madhava Kanakamedala
Comparison Of Cisplatin Versus
Cetuximab With Intensity Modulated
Radiation Therapy In Locally Advanced
Squamous Cell Carcinomas Of Head
And Neck-Toxicity, Patterns Of Failure
And Survival Analysis
2889
Isabel Prieto
Tapentadol To Alleviate Chronic Pain
Secondary to Neck Fibrosis in Head
and Neck Cancer Patients Treated With
Surgery Plus Chemo-Radiotherapy
2900
Shea Wilcox
Cyclical Hypofractionated IMRT For
Effective Palliation Of Head And Neck
Cancers: Can Modern Techniques Offer
Improved Outcomes?
2879
Meredith Giuliani
Elderly Patients With Advanced Head
And Neck Cancer Less Likely To Receive
Radiation Therapy
2880
Neal Dunlap
Cyclical Hypofractionated Radiotherapy
For Palliative Treatment Of Locally
Advanced Head And Neck Cancer
2897
Beibei Xu
Aspiration Pneumonia After
Chemoradiotherapy for Head-and-Neck
Cancer
2898
Huaising Ko
Lhermitte’s Sign After VMAT-based
Radiation of Head-and-Neck Cancer:
Incidence, Clinical Features and
Dosimetry
2890
Taro Murai
Radiotherapy For Auditory Canal Or
Middle Ear Cancer: 2-year Results In 30
Patients
151
2901
Rejnish Kumar
Phase IIb Randomized Trial Comparing
Concurrent Chemoradiation with
Weekly versus Three Weekly
Cisplatinum in Locally Advanced Head
and Neck Squamous Cell Carcinoma
2910
Olgun Elicin
Volumetric Regression Ratio of Tumor
and Involved Lymph Nodes after
Induction Chemotherapy Predicts
the Overall Survival in Head and Neck
Cancer
2902
Yeona Cho
Clinical Outcome Of Eye-conserving
Treatment With Ruthenium-106
Brachytherapy For Choroidal
Melanoma: Experience with the first 88
Korean patients
2911
Abdallah Mohamed
Methods for Analysis and Reporting the
Patterns of Loco-regional Failure in the
Era of IMRT for Head and Neck Cancer:
Deformable Image Registration Based
Quality Assurance Workflow
2903
Nigel Anderson
Gross Tumor Volume Size and Oral
Cavity Dose Drive Dysphagia in
Definitive (Chemo) IMRT for Head &
Neck Cancer
2912
Nhu Tram Nguyen
Head And Neck Squamous Cell
Carcinoma Of Unknown Primary: Is
There A Better Treatment?
2904
Maureen Rolfo
Association of 18F-FDG Metabolic
Tumour Volume and Dysphagia in Head
and Neck IMRT as a Prophylactic
Feeding Predictor
2905
Matthew Bertke
HPV Status May Alter the Significance
of Extranodal Extension as a Negative
Prognostic Factor in Post-Operative
Squamous Cell Carcinoma of the Head
and Neck
2906
Matthew Ward
Nasogastric Enteral Feeding is Superior
to Percutaneous Gastrostomy in
Preventing Late Pharyngeal
Dysfunction in Long-term Survivors of
Locoregionally Advanced Head and
Neck Squamous Cell Cancer (HNSCC)
treated with Definitive
Chemoradiotherapy (CRT)
2907
David Grew
Disease Outcomes In Human
Immunodeficiency Positive Patients
Treated With Primary Or Adjuvant
Radiotherapy For Head And Neck
Cancer
2908
Vasanthan Sakthivel
Secondary Cancer Risk Analysis:
Evaluation Of VMAT Vs Dynamic IMRT
Planning In Treatment Of Head And
Neck Cancer By Simultaneously
Integrated Boost Technique
2909
Andrew Hoover
Head and Neck Cancer Patients with
False Negative Surveillance FDG PET/CT
Scans Show Unique Clinical
Characteristics and Disease Recurrence
Patterns
2913
Marielle Philippens
Advances in MRI for Elective Treatment
of Lymph Nodes and Cranial Nerves in
Head and Neck Cancer
2914
Shaakir Hasan
Simultaneous Integrated Boost (SIB) for
Advanced Head and Neck (H&N) Cancer
May Accelerate Muscle Loss in
Concurrent Chemoradiation as
Assessed By A Validated CT-based Tool
2915
Canhua Xiao
Increased Fatigue is Associated with
TNF and NFκB-Regulated Inflammatory
Signaling in Patients with Head and
Neck Cancer Receiving IMRT
2916
Abdallah Mohamed
Biological and Dosimetric Analysis of
Loco-regional Failure after IMRT for
Head and Neck Cancer
2917
Daniel Grossi Marconi
Head And Neck Non-melanoma Skin
Cancer Treated By Orthovoltage
Radiation: An Analysis Of 1021 Cases
2918
Ahmed Chaudhary
Trismus after Chemoradiotherapy for
Locoregionally Advanced Head and
Neck Cancer: A Prospective Study of the
Dose Effect Relationship in Accelerated
Fractionation by Concomitant Boost
with Cisplatin and Cetuximab from the
EPIC Trial
2919
Peter Ahn
Comparison Of The Effect Of Full-neck
Rapidarc IMRT Versus Split-field IMRT
Techniques On Radiation Dose To Low
Neck Structures
2920
Junjian Huang
Low Baseline Lymphocyte Count
May Predict Poorer Overall Survival In
Patients With Head And Neck Cancer
Treated With Radiation Therapy
2921
Kaleigh Doke
Lymphedema Therapy Improves Neck
Circumference, Range of Motion and
Pain Scores in Head and Neck
Radiotherapy Patients
2922
Ahmad Al-Basheer
Correlation Of Integral Does, White
Blood Cell Counts, And Radiotherapy
Techniques For Head And Neck Cancer
Patients Under Radiotherapy
2923
Scott Robertson
Routine Capture of Structured Data
Elements (SDEs) Provides Insight into
Unique Dose-Toxicity Relationships in
Irradiated Head and Neck (HN) Cancer
Patients
HEALTH SERVICES RESEARCH
2924
Yu Yang Soon
Impact Of Adoption Of Prophylactic
Cranial Irradiation On The Outcome Of
Extensive Stage Small Cell Lung Cancer:
A Single Institution Retrospective Study
2925
Nitesh Paryani
Referral Patterns for Pediatric Proton
Therapy in Florida
2926
Christopher Corso
Demographic Disparities in SBRT
Utilization for Stage I NSCLC
2927
Lili Goh
A Survey Of The Asian Patients’
Expectations And Beliefs About The
Effectiveness Of Radiotherapy For
Incurable Cancers
2928
Alexander Rand
Demographic Disparities in Time from
Prostate Cancer Diagnosis to Definitive
Treatment in Patients at a Diverse
Academic Medical Center
2929
Guy Jones
Initial Results of a Pilot Program for
Low-Dose CT Lung Cancer Screening
in a Community Radiation Oncology
Practice
152
2930
Leslie Ballas
Radiation Therapy Utilization in
Adolescent and Young Adult Oncology
Patients
2931
Rishabh Kapoor
Report on the Veteran Health
Administration - Radiation Oncology
Quality and Safety Monitoring
(VHA-ROQSM) Program
2932
Joan Ryoo
Assessing Quality of Care (QC) Near
End-Of-Life (EOL): Use of Natural
Language Processing (NLP) to Identify
Brain Metastasis (BM) Cases for
Evaluation of Radiotherapy (RT) Receipt
2933
Alexander Rand
Impact of Breast Cancer Patient
Demographics and Treatment Type on
Time from Diagnosis to Adjuvant
Treatment at a Diverse Academic
Medical Center
2934
Mark Waddle
Which Prostate Cancer Patients Receive
Multidisciplinary Consultation? Findings
from the Population-Based NC Process
Cohort
2935
Amy Harrison
Radiation Quality and Safety: A Patient’s
Perspective
2940
Terence Sio
Temporal and Geographic Variation
of Intensity Modulated Radiation
Therapy (IMRT) Utilization in Patients
with Colorectal Cancer: A SEERMedicare Based Analysis
2941
Sean Maroongroge
The Impact of New EMR Adoption
on the Number of Radiology Exams
Ordered in a Busy Radiation Oncology
Clinic
2942
Nikola Cihoric
Analysis of Clinical Trials in Radiation
Oncology: A Systematic
Characterization of the Clinicaltrials.gov
Database
2943
Michaela Dinan
Association between Diagnostic CT
Utilization and Radiation Therapy at the
End of Life (EOL) in Elderly Breast and
Prostate Cancer Patients, 2002-2007
2944
Usama Mahmood
Impact Of Insurance Status On
Treatment Selection For Localized
Prostate Cancer In The United States
2945
Kimberley Foley
Measuring The Quality Of Personal
Care In Prostate Cancer Radiotherapy:
What Aspects Of Care Are Important
To Patients?
2952
Raymond Mailhot Vega
Cost-effectiveness Analysis Of Proton
Versus Photon Therapy With Respect To
Risk Of Growth Hormone Deficiency
2953
Nataniel Lester-Coll
Cost Effectiveness Analysis of
Stereotactic Body Radiotherapy for
Pulmonary Oligometastases
2954
Tongming He
Personalized Radiation Therapy of
Breast Cancers May Not Incur
Substantial Increase in Treatment
Delivery Time
2955
Merrylee McGuffin
The Cost Of Convenience: A
Cost-Effectiveness Analysis Comparing
External Beam Radiation Therapy,
High-dose Rate Brachytherapy And
Permanent Seed Implants For Early
Stage Breast Cancer
2956
Hayeon Kim
Cost-effectiveness Analysis of 3D
Image-Guided Brachytherapy
Compared to 2D Brachytherapy in the
Treatment of Locally Advanced Cervical
Cancer
2957
Matthew Schutzer
Time Driven Activity Based Costing:
an Economic Analysis of Whole Breast
Radiotherapy versus Balloon-Based
Brachytherapy in the Management of
Early Stage Breast Cancer
2936
Gaurav Bahl
A National Analysis of Gender and
Ethnocultural Diversity Within the
Canadian Radiation Oncology Physician
Workforce
2946
Arash Naghavi
Outcomes Following Radiotherapy
For Head And Neck Cancer Of A High
Volume Center Vs Low Volume Center
2937
Daniel Yang
Impact Of Three Decades Of Screening
On Racial Disparities In Cervical Cancer
Incidence
2947
Naichang Yu
Automatic Monitoring of Patient Chart
Status Improves Workflow for External
Beam Radiotherapy
2958
Thomas Lanni
Comparing the Cost Effectiveness of
Low Dose Rate Brachytherapy, High
Dose Rate Brachytherapy and
Hypofactionated Intensity-Modulated
Radiation Therapy for the Treatment of
Low/Intermediate Risk Prostate Cancer
2938
Jeremy Harris
Factors Contributing to the Use of
Intensity Modulated versus 3D
Conformal Radiation Therapy for Stage
III Non-Small-Cell Lung Cancer: A
SEER-Medicare Study
2948
David Schreiber
Comparative Effectiveness of Radical
Prostatectomy versus Dose Escalated
Radiation Therapy in a predominantly
African American Population
2959
Alexander Louie
Estimating the Population Impact of
Introducing Stereotactic Ablative
Radiotherapy for Stage I NSCLC in
Canada
2949
Daniel Grossi Marconi
The Reliability Of Automatic
Segmentation For Lung Volumes In
Breast, Lung And Esophageal Cancers
2960
Anand Shah
Cost-Effectiveness Analysis of
Stereotactic Body Radiotherapy,
Conventional Single-Fraction
Radiotherapy, and Medical
Management Alone for a Painful
Localized Spine Metastasis
2939
Apar Gupta
Effect of Patient Demographics and
Radiation Timing on PSA Reduction in
Patients Treated With Definitive
Radiation Therapy for Prostate Cancer
2951
Daniel Trifiletti
Reconsidering Adjuvant Versus Salvage
Radiotherapy For Prostate Cancer Using
An Individualized Decision Analysis
With Genomic Classifier Scores
153
2961
Jason Ye
Cost-effective Analysis Of
Hypofractionated Versus Standard
30-fraction Imrt In Patients With Poor
Prognosis Glioblastoma Multiforme
2962
Patrick Richard
Development of a Multi-Parametric
Cost Effectiveness Model for
Comparison of Therapeutic Modalities
in Definitive Radiotherapy for Stage III
Non-Small Cell Lung Cancer (NSCLC)
2963
Dimitri Dimitroyannis
Favorable Cost-Effectiveness is a
Hallmark of Modern Hypofractionated
Radiotherapy: the case of early-stage
Lung Cancer
2964
Shlomo Koyfman
(IMRT) Reduces Late Toxicity Without
Increasing Cost Compared to
Conventional 3D-RT in Patients with
Human Papillomavirus Associated
(HPV+) Oropharyngeal Carcinoma
Treated with Chemoradiotherapy (CRT)
2965
Anthony Wong
Physicians’ Beliefs about the Benefits
and Risks of Adjuvant Therapies for
Stage II and Stage III Colorectal Cancer
2966
Caroline Patton
Choosing Wisely: The American Society
for Radiation Oncology’s Top 5 List
2967
Beant Gill
Quantitative Evaluation of Radiation
Oncologists’ Adaptability to
Cost-Effective Treatment Programs
2968
Clayton Hess
Current Attitudes of Practicing
Physicians Regarding Ethical Dilemmas
in Radiation Oncology: Findings From a
National Survey
2969
Laurie Pilote
Is Radiation Oncology Living Up To The
Standards Of Informed And Shared
Decision Making?
2970
Christine Lauro
Breast Cancer Risk Assessment and
Chemoprevention: Results of a Survey
2971
Bhartesh Shah
Analysis of Decision Making at a
Multidisciplinary Head and Neck Tumor
Board Incorporating Evidence Based
NCCN Guidelines
2972
Tatiana Conrad
Malignant Epidural Spinal Cord
Compression: Prognostic Factors
Predicting Need for Surgery
2983
Steve Braunstein
Tobacco Cessation Perspectives and
Practice Among U.S. Radiation
Oncology Residents
2973
Jose Lopez
Computerized Decision Support System
and NaïVe Bayes Models for Predicting
the Risk of Relapse in Breast Cancer
2984
Audrey Tetreault
Impacts of Software-based
Management of Radiation Treatment
Interruptions
2974
Michael Lock
Identification of Patients with Liver
Cancer that will Not Benefit from
Radiation
2985
Giang Hong
Monitoring Neutron Exposure of
Radiation Therapists on 15 Mv Linear
Accelerators
2975
Mark Mishra
Is Prophylactic Cranial Irradiation (PCI)
with Hippocampal Avoidance (HA)
Justified in Limited Stage Small Cell
Lung Cancer (LS-SCLC)?
2986
Neil Martin
Defining a Standard Set of PatientCentered Outcomes for Men With
2976
Muhammad Qureshi
Preoperative Multiparametric Mri
Accurately Predicts For Extracapsular
Extension In A Diverse Patient
Population Undergoing Prostatectomy
2987
Max Dahele
A Snapshot of the Practice of
Stereotactic Body Radiotherapy from 30
Centers in 6 Countries
HISTORY
2977
Aaron Kusano
Preoperative Short Course Radiation
for Locally Advanced Rectal Cancer: A
National Opinion Survey
2978
Shauna Campbell
Factors Influencing One Year Survival in
Early Stage Non-Small Cell Lung Cancer
(NSCLC) Patients Receiving Stereotactic
Body Radiotherapy (SBRT)
2979
Tangel Chang
Phase II Prospective Trial of Triphasic
PET/CT: Primary Site Inflammation
versus Cancer at 3 Months After
Completion of Radiation for Head and
Neck Squamous Cell Carcinoma
2980
Paul Wallner
Promises and Pitfalls: Development of a
National Brachytherapy Registry
2981
Corey Hobbs
Cancer Mortality Based on Income and
Radiotherapy Availability: a Correlation
Analysis and Implications for
Developing Countries
2982
Harold Agbahiwe
Increased African-American Enrollment
in Breast Cancer Clinical Trials: A Single
2988
Debra Yeboa
Historical Trends of Radiotherapy Use in
Prevalent Malignancies
2989
Ankit Agarwal
A Ten-year Analysis of the American
Society for Radiation Oncology Political
Action Committee
2990
Daniel Golden
Implementation and Evaluation of a
Multi-institutional Radiation Oncology
Clerkship Curriculum: A Report from the
Radiation Oncology Education
Collaborative Study Group
2991
Gurleen Dhami
Mentorship of Radiation Oncology
Residents: An Unmet Need
2992
Nikhil Thaker
Improving the Quality of Radiation
Oncology Education through an
Innovative Medical Student Treatment
Planning Curriculum
2993
Nicholas Zaorsky
A National Assessment of Medical
Student Knowledge in Radiation
Oncology and Comparison to Primary
Care and Radiation Oncology Attending
Physicians
154
2994
Crys Curkendoll
Use of WikiBooks in Radiation Oncology
Education
2995
Aaron Kusano
Integrity of the Radiation Oncology
National Resident Matching Program:
Applicant Perspectives
2996
Shannon Byler
Student Oncology Society: A Radiation
Oncologist Led Approach To
Exploring Careers In Oncology For
Medical Students
2997
Jasbir Jaswal
Evaluating the Impact of a Canadian
Anatomy and Radiology Contouring
(ARC) Bootcamp for Radiation
Oncology Residents
2998
Wilfred Ngwa
Radiation Oncology in Resource-Poor
Settings: Challenges and
Opportunities for Humanitarian or
Collaborative Cancer Care, Research
and Education
2999
Brian Koottappillil
Evaluation of a Radiation Oncologist
Led Dedicated Oncology Block in the
Preclinical Medical School Curriculum
3000
Paris-Ann Ingledew
Caught In The Web: The Quality Of
Online Resources For Cancer Patients
3001
Evan Thomas
Development of a Structured Education
and Evaluation Program to Standardize
and Improve Target and Organ-at-risk
Contouring Ability among Radiation
Oncology Residents
3002
Heather Warkentin
Efficacy and Efficiency of a Tumor
Group Model in Clinical Physics
Instruction of Residents
LUNG CANCER
3003
Tsuyoshi Takanaka
Breath-hold Volumetric Modulated Arc
For Early-stage Lung Cancer Guided By
Real-time Fluoroscopy
3004
Marco Trovo
SBRT for Re-irradiation of Persistent or
Recurrent Locally Advanced NSCLC
3005
Takashi Shintani
Stereotactic Body Radiotherapy As A
Part Of Definitive Treatment For
Synchronous Double Primary Lung
Cancer
3006
Atsushi Motegi
Acute Toxicities and Dose Volume
Histogram Parameters for Organ at Risk
in Proton Beam Therapy for Stage Iii
Non-small Cell Lung Cancer
3007
Katsuyuki Shirai
The Maximum Standardized Uptake
Value (SUVmax) on FDG-PET Predicted
Overall Survival and Progression Free
Survival for Stage I Non-Small-Cell
Lung Cancer Treated with Carbon Ion
Radiotherapy
3008
Aruna Turaka
Correlation of PET/CT Response To The
Mediastinal Down Staging In Operable
NSCLC: Impact Of RT Dose
3009
Lin Zhou
Phase I Trial of Icotinib Combined
With Whole Brain Radiotherapy for
EGFR-mutated Non-Small Cell Lung
Cancer Patients With Brain Metastases
-Updated Results
3010
Kimberley Mak
Patterns of Local Recurrence for
Mesothelioma Patients Treated with
Extra-Pleural Pneumonectomy and
Radiation Therapy Using the
Electron-Photon Technique: The
Dosimetric Challenges of
Electron-Photon Match Lines and
Blocks
3015
Nima Aghdam
Robotic Stereotactic Body Radiation
Therapy (SBRT) with Fiducial Tracking
for Inoperable Peripheral Stage I
Non-small Cell Lung Cancer (NSCLC):
Four-Year Disease Control and Survival
Outcomes
3016
Shigeo Takahashi
The Relationship between Mean Lung
Dose and Pulmonary Complications
after Neoadjuvant Chemoradiotherapy
followed by Surgery for Lung Cancer
3017
Leah Katz
Clinical Outcomes Of Alternative Uses
For Stereotactic Body Radiotherapy In
Non-small Cell Lung Cancer: Thinking
Beyond Definitive Treatment For Early
Disease
3018
Aruna Turaka
Can PET/CT Predict Pathological
Response For Operable NSCLC Patients
Treated With Dose-escalated Radiation
Therapy (DE-RT) In Trimodality Setting
3019
Ben Fischer-Valuck
Correlation Of A Qualitative Visual
Based FDG-PET/CT Scale And The
Semi-quantitative SUVmax in Predicting
Overall Survival In Patients With
Early-stage NSCLC Following SBRT
3020
Connie Yip
A Prospective Study Of Bevacizumab
& Platinum-based Chemotherapy In
NSCLC: Comparison Of The
Prognostic Value Of Early Imaging
Response Assessment Criteria And
Intratumoral Heterogeneity Analysis
3011
Aiko Nagai
Efficacy And Toxicities Of
Intensity-modulated Stereotactic Body
Radiotherapy Using Helical
Tomotherapy For Lung Cancer And
Lung Metastases
3021
Daniel Tandberg
Invasive Sampling of PET Positive
Aortopulmonary Window Lymph
Nodes in Patients with Right-Sided
Non-Small Cell Lung Cancer is Not
Always Necessary to Guide Treatment
3012
Michael Herman
SBRT for Oligometastatic Non-Small Cell
Lung Cancer
3022
Feifei Teng
The Influence Of Response To Initial
Chemotherapy On Optimal Timing
Of Radiotherapy Administration For
Limited-disease Small-cell Lung Cancer
3013
Qi Wang
Can Abnormalities on High-resolution
CT Predict Early radiation Pneumonitis
after Thoracic Radiation Therapy
3014
Adam Olson
Normal Tissue Toxicity Risk Assessment
with Interim 18F-FDG PET-CT in Patients
with Non-Small Cell Lung Cancer
(NSCLC) Undergoing Radiotherapy
3023
Byounghyuck Kim
Role of Postoperative Radiotherapy
After Curative Resection and Adjuvant
Chemotherapy for Patients With
Pathological Stage N2 Non-Small Cell
Lung Cancer: A Propensity Score
Matching Analysis
155
3024
John Heinzerling
Stereotactic Ablative Body Radiosurgery
(SABR) In Early Stage Lung Cancer: Can
Results of Advanced Cancer Care in
an Innovative De-Centralized Cancer
Institute Replicate Favorable Clinical
Trial Results?
3025
Meixiang Zhou
Salvage Concurrent Paclitaxel-based
Chemo-radiotherapy for Post-surgical
Microscopic Residual Tumor At The
Bronchial Stump (R1 Resection) In
3026
Takaya Yamamoto
Impact of Tumor Attachment to the
Pleura Measured by a Pretreatment
CT Image on Outcome of Stage I
NSCLC Treated With Stereotactic Body
Radiotherapy
3027
Nitesh Paryani
Outcomes And Patterns Of Failure With
Stereotactic Body Radiotherapy In The
Treatment Of Primary And Metastatic
Lung Nodules In Elderly Patients
3028
Joe Chang
Clinical Implementation Of
Intensity-modulated Proton Therapy In
Thoracic Malignancies
3029
Chad Tang
Lymphopenia Association With Low
Lung Dose And Its Effects On Non-small
Cell Lung Cancer Patient Outcomes
3030
Chad Tang
Predictors Of Site-specific Distant
Metastasis After Definitive Radiotherapy
In Non-small Cell Lung Cancer, And
The Impact Of Metastatic Location On
Survival
3031
Gregory Videtic
5 Years And Beyond: Characterizing
Long Term Survivors After Stereotactic
Body Radiotherapy (SBRT) For Early
Stage Lung Cancer
3032
Noriyoshi Takahashi
Even Local Control of Metastatic Lung
Tumors is Worse Than That of Primary
Lung Cancer in Patients Treated With
3034
Yili Duan
Comparison Of Primary Target Volumes
Based On Four-dimensional CT And
Fluorodeoxyglucose Positron Emission
Tomography CT Images Of
Non-small-cell Lung Cancer
3043
Nathan Cannon
Neutrophil-lymphocyte And
Platelet-lymphocyte Ratios As
Prognostic Factors Following
Stereotactic Radiation Therapy For
Early-stage Non-small Cell Lung Cancer
3035
Gitte Persson
Deep Inspiration Breath-hold
Radiotherapy For Locally Advanced
Non-small Cell Lung Cancer: Is Dose To
The Mediastinal Structures Reduced?
3044
Brandon Disher
Lateral Electron Disequilibrium (LED)
in Lung Cancer Patients Treated With
Stereotactic Body Radiation Therapy:
Assessing the Potential for Underdosing
3036
Shankar Siva
Feasibility of IMRT Planning to Reduce
Dose to Functional Lung Using
Respiratory Gated (4D) Gallium-68
Perfusion PET/CT
3045
Andrew Barsky
Prophylactic Irradiation of Surgical Tract
Sites in the Era of Radical Pleurectomy
for Malignant Pleural Mesothelioma
3037
Sung-Ja Ahn
Surgical Salvation after Full-dose
Concurrent Chemoradiation in Patients
With Locally Advanced Non-small Cell
Lung Cancer (NSCLC)
3038
Quynh Nguyen
The five-year outcome for patients
diagnosed with Locally Advanced
Non-Small Cell Lung Cancer treated
with definitive concurrent
Chemotherapy and Proton Beam
Therapy
3039
Yukinori Matsuo
Comparison of Long-term Survival
Outcomes between Stereotactic Body
Radiotherapy and Sublobar Resection
for Stage I Non-small Cell Lung Cancer
in High-risk Operable Patients:
Propensity Score Match Analysis
3040
Yoshihiko Manabe
Helical and Static-port Tomotherapy
Using the Newly-developed Dynamic
Jaws Technology for Lung Cancer
3041
Mustafa Adli
Erythrocyte Membrane Na+/K+-Atpase
Activity In Locally Advanced Non-Small
Cell Lung Cancer Patients Treated With
Chemoradiotherapy
3042
Tzung-Chi Huang
Motion Freeze For Respiration Motion
Correction In PET/CT: A Preliminary
Investigation With Lung Cancer Patient
Data
3046
Ritsuko Komaki
Predictors of Brain Metastasis after
Prophylactic Cranial Irradiation for
Limited-Stage Small Cell Lung Cancer
3047
Benjamin Mou
Stereotactic Body Radiotherapy For
Central Lung Tumors: Outcomes And
Toxicity
3048
Xiong Wei
Nadir White Blood Cell, Absolute
Neutrophil And Absolute Lymphocyte
Counts During Concurrent
Chemoradiation Therapy Are
Associated With Worse Outcomes In
Patients With Limited-stage Small Cell
Lung Cancer
3049
Mohammadreza
Negahdar
Non-Invasive Pulmonary Nodule
Elastometry by CT and Deformable
Image Registration
3050
Mohammadreza
Negahdar
First in Human High-Resolution
Imaging of Regional Lung Function by
Single Energy Xenon CT Compared to
Ventilation SPECT
3051
Yyki Takeuchi
45 Gy Versus 54 Gy Of Accelerated
Hyperfractionated Radiotherapy For
Patients With Limited-stage Small-cell
Lung Cancer: A Retrospective Analysis
Of A Seven-year Experience
3033
Qingsong Pang
The Interval Time Between First
Diagnosis and Brain Metastasis for
Limited Small-cell Lung Cancer Without
Prophylactic Cranial Irradiation
156
3052
Marina Heskel
Safety and Efficacy of Stereotactic Body
Radiotherapy (SBRT) Reirradiation for
New or Recurrent Pulmonary
Malignancies Following Previous
In-field Conventionally Fractionated
Thoracic Radiotherapy (CFRT)
3053
Karl Wurstbauer
Dart-bid (differentiated Accelerated
Radiation Therapy- 1.8 Gy Twice Daily)
For Locoregionally Advanced NSCLC:
Mature Results Of A Novel Therapeutic
Approach
3054
Marina Heskel
Oligometastatic Pulmonary Lesions
3055
Kristin Higgins
A Phase I Study Examining a
Stereotactic Boost in Combination with
Chemoradiation for Patients with Stage
III Non-Small Cell Lung Cancer
3056
Damodar Pokhrel
Clinical Evaluation of RTOG 0813
Dosimetric Criteria for Lung SABR Using
XVMC Monte Carlo Algorithm
3057
Adil Akthar
Incidence of Occult N1 Disease in
Patients with Clinical Stage I Non-Small
Cell Lung Cancer: Implications for
Patients Considered for Stereotactic
Body Radiotherapy
3058
Tomoki Kimura
A Prospective Study Of Functional
Image-guided Radiotherapy Planning In
Lung Cancer Patients
3059
Jason Samuelian
Curative Treatment of Stage I
Non-Small-Cell Lung Cancer Using
Robotic Stereotactic Radiation in
Patients with COPD: A VA Population
Study
3060
Derek Bergsma
Temporal Variation in Total Lung
Volume and Lung V20 in Lung Cancer
Patients Treated With Radiotherapy
3061
Stephen Bowen
Negative Correlation Between
Quantitative FDG PET/CT And MAA
SPECT/CT Blood Perfusion Imaging
Parameters In Thoracic Malignancy
Patients
3062
Joanne Zhung
Patterns Of Regional Failure &
Evaluation of LN dose In Early Stage
Nsclc Treated With Sbrt
3063
Jackie Wu
Predictive Models for Assuring Quality
and Consistency of Lung IMRT Plans
Across Institutions in Cooperative
Group Trials
3064
Jiraporn Setakornnukul
Target Volume Delineation for Lung
Stereotactic Body Radiotherapy (SBRT):
Utility of PET/CT for Lesions Centrally
Located or Close to the Chest Wall
3065
Hubert Pan
A Prospective Analysis of Cardiac
Biomarkers and Electrocardiogram
Abnormalities in Patients Receiving
Thoracic Radiation Therapy with
High-Dose Heart Exposure
3066
Wei Jiang
Intensity-modulated Stereotactic Body
Radiotherapy For Medically Inoperable
Stage I non-small Cell Lung Cancer
3067
Anna Maria Ascolese
Concurrent Chemo-radiotherapy In
Patients With Locally Advanced NSCLC:
Toxicity And Clinical Assessment Using
VMAT Tecnique
3072
Neal Bhatt
Evaluation of Prognostic Variables in
Patients With Small Cell Lung Cancer:
The Role of Volumetric Response to
Initial Therapy in Determining the
Benefit of Prophylactic Cranial
Irradiation
3073
Inaya Ahmed
Impact of Metformin Use on Survival
in Non-small Cell Lung Cancer Treated
with Definitive Radiation Therapy
3074
Inaya Ahmed
Survival Benefit with Carboplatin-based
Induction Chemotherapy for Bulky
Stage II & III Inoperable Non-small Cell
Lung Cancer
3075
Ning Liu
Metabolic Tumor Volume Change
During Radiotherapy and Late-course
Adaptive Radiotherapy in Patients With
3076
Ellen Kim
Comparison of Overall and Cause
Specific Survivals of Stage 3 Non-Small
Cell Lung Cancer (NSCLC) Treated With
Carboplatin or Cisplatin Based
Concurrent Chemoradiation Therapy
using SEER-Medicare Data (1992-2007)
3068
Qurrat Mehmood
Predicting Esophagitis During Radical
Lung Radiotherapy Using 18-FDG-PET
3077
Justin Mann
Accelerated Hypofractionated
Radiotherapy with Concurrent
Chemotherapy in Locally Advanced
Non-Small Cell Lung Carcinoma
3069
Kyung Su Kim
Treatment Outcomes Of Limited-stage
Small-cell Lung Cancer Patients Treated
With Concurrent Chemoradiotherapy:
A Comparative Analysis Of Different
Radiation Dose Fractionation Schedules
In A Single Institution
3078
Wen Feng
The Emerging Outcome of
Postoperative Radiotherapy for Stage
IIIA(N2) Non-Small Cell Lung Cancer:
Basing on 3D Conformal Techniques
and Institutional Standard Clinical
Target Volume
3070
Hiromitsu Iwata
A Phase I Study Of Stereotactic Body
Radiotherapy With Real-time Tumor
Tracking Using A Robotic Radiosurgery
System Based On The Monte Carlo
Algorithm For Lung Tumors: The First
Report In Japan
3079
Shankar Siva
Inflammatory Cytokine Expression as
Prognostic Biomarkers of Toxicity
During Radiation Therapy of Patients
with Non-Small Cell Lung Cancer
3071
Kitty Huang
(SABR) and Pulmonary Re-Irradiation: A
Systematic Review of the
Literature Assessing Safety and
Oncologic Outcomes
3080
Mei Ling Yap
Adaptive Dose-escalation Using Serial
4D-PET/CT Scans During Radiotherapy
For Locally Advanced Non-small Cell
Lung Cancer
157
3081
Nami Ueki
Comparison Of Four-dimensional
Doses And Three-dimensional Doses
In Dynamic Tumor Tracking Irradiation
For Lung Tumor Using A Gimbaled
X-ray Head
3082
Fumiya Baba
Analysis of Changes in Dose
Distribution due to Respiration in
Respiratory-Gated Stereotactic Body
Radiotherapy (SBRT) for Lung Tumors
using 4D-CT
3083
Marco Trovo
Extended Pleurectomy/Decortication
or Surgical Biopsy in the Era of High
Doses of Radiation Therapy for
Malignant Pleural Mesothelioma?
3084
Eileen Harder
ACE Inhibitors Decrease the Risk of
Radiation Pneumonitis Following SBRT
3085
Aaron Allen
12Gy*5 is a Safe and Effective Dose for
Centrally Located Lung Tumors
3086
Eileen Harder
The Effect of Diabetes and Antidiabetic
Drugs on Outcomes after Pulmonary
SBRT
3087
Marciana-Nona Duma
SBRT For Lung Metastases: Should We,
Should We Not?
3088
Prashoban Bremjit
Is Overall Treatment Time A Predictive
Factor In Radiation Therapy For
Non-small Cell Lung Cancer?
3089
Matthew Nyflot
Accuracy Of 4D Cone Beam CT And 4D
Fan Beam CT For Thoracic Radiotherapy
Simulation And Verification Imaging
3090
Scott Lester
An Evaluation Of Toxicity Using
Accumulated Total Dose Based On Eqd2
For Thoracic Reirradiation Incorporating
At Least One Course Of Sbrt
3091
H Fazilet Dincbas
Is Deformable PET/CT Registration For
Contouring Target Volume Superior to
Rigid Image Registration in Lung Cancer
Radiotherapy?
3092
Jeremy Kilburn
Which Lung Tumors Shrink During
Fractionated Radiation And How Does
This Influence Outcome? Appropriately
Selecting Tumor And Treatment
Characteristics For Adaptive
Radiotherapy Protocols
3093
Stefan Jeppesen
A comparison of Stereotactic Body
Radiation Therapy (SBRT) vs. No
Treatment in medical inoperable
patients with early-stage Non-Small Cell
Lung Cancer (NSCLC)
3094
Lindsay Rowe
Dosimetry and Survival from an
Adaptive Radiotherapy Clinical Trial for
Limited-stage Small Cell Lung Cancer
3095
Jian Sun
Gross Target Volume as the Predictor for
the Overall Survival for Stage III
Non-Small Cell Lung Cancer
3096
Suchit Patel
Pattern Of Failure In Metastatic
EGFR-mutant NSCLC Treated With
Erlotinib: A Role For Upfront
Radiotherapy?
3097
Hotaka Nonaka
Re-stereotactic Body Radiotherapy
(SBRT) for Local Recurrence of Lung
Cancer Previously Treated With SBRT
3098
Suchit Patel
Risk Of Brain Metastasis In EGFR-mutant
NSCLC Treated With Erlotinib: A Role For
Prophylactic Cranial Irradiation?
3099
Tarun Podder
Is Lack Of Dosimetric Coverage
Responsible For Post-sbrt Tumor
Recurrence?
3100
Andre Dekker
Rapid Learning In Practice: A Lung
Cancer Survival Decision Support
System In Routine Patient Care Data
3101
Gordon Guo
Local Treatment Improves Survival In
NSCLC Patients With Synchronous Brain
Oligometastases
3102
Dandan Zheng
Is PTV Still Appropriate for Prescription
Specification in Monte Carlo SBRT Lung
Planning?
3103
Siddharth Saraiya
Evaluation Of Diffusion Weighted Mri
To Differentiate Atelectasis From Lung
Cancer In Radiotherapy Planning
3104
Masahiro Morimoto
Overall Treatment Time of Accelerated
Hyperfractionated Radiotherapy at 45
Gy in 30 Fractions for Limited Small Cell
Lung Cancer is A Significant Prognostic
Factor
3105
Kevin Kelley
Medically Inoperable Early Stage
Peripheral versus Central Lung Cancer
Treated with Stereotactic Body
Radiation Therapy
3106
Monika Blake
Loco-regional Control and Toxicity After
Treatment With Intensity Modulated
Radiotherapy (IMRT) to The Thoracic
Cavity in Patients With Non-metastatic
Malignant Pleural Mesothelioma (MPM).
A Feasibility Study
3107
Jing Liu
Exploring Spatial Overlap Of High
Uptake Regions Derived From Dual
Tracer PET/CT Imaging Using 18F-FDG
And 18F-FLT In NSCLC Patients
3108
Yoshiyuki Shioyama
90 years or Older Patients with Stage I
Non-small-cell Lung Cancer
3109
Tadamasa Yoshitake
Incidence Of Radiation Pneumonitis
After Multiple Courses Of Stereotactic
Body Radiation Therapy For Lung
Cancer Patients
3110
Lipin Liu
Outcome of Concurrent
Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer
3111
Song Gao
A Pilot Study On Imaging Of Integrin
αvβ3 With Rgd Pet/ct In Suspected
Lung Cancer Patients
3112
Mitsuhiko Oguri
The factors which Influence Acute
Exacerbation on Patients Recieving
Lung Cancers with “Interstitial Change”
3113
Adam Smith
Recurrent or Second Primary Non-Small
Cell Lung Cancer
158
3115
Jason Edwards
Stereotactic Body Radiation Therapy In
Patients With Immune Suppression
3125
George Rodrigues
Is Intermediate Radiation Dose
Escalation with Concurrent
Chemotherapy for Stage III Non-Small
Cell Lung Cancer Beneficial? A
Multi-Institutional Propensity-Score
Matched Analysis
3116
Sanath Kumar
Prognostic Biomarkers In Non-small
Cell Lung Cancer Patients Treated With
Radiotherapy
3126
Angela Mohr
Evaluation Of Automatic Segmentation
Tools For Thoracic Organs In
Radiotherapy Planning
3117
3127
Liyi Xie
SBRT For Lung Cancer Appears To
Provide Superior Local Control To
Wedge Resection: Is This Due To The
Therapeutic Effects Of Low Dose
Peripheral Radiation?
3114
Gerrit Blom
VMAT Planning For Large Volume Stage
III Lung Cancer
WITHDRAWN
3118
Steen Mortensen
Use Of A Novel Liquid Fiducial Marker
Injected With Endoscopic Ultrasound
Equipment, For Use In Image Guided
Radiotherapy Of Thoracic Tumors
(Porcine Model)
3119
Hideomi Yamashita
Stereotactic Body Radiotherapy For
Patients With Pulmonary Interstitial
Change
3120
Judi Van Diessen
Prognostic Parameters For Primary
Tumor And Lymph Node Failure In
Locally Advanced NSCLC Patients
Treated With Concurrent
Chemoradiation Therapy
3121
Richard Cattaneo
After Surgical Resection of Primary
Lung Cancers
3122
Nan Bi
The Potential Predictive Value Of
Urinary Metabolomic Changes In
Locally Advanced Non-small Cell Lung
Cancer Patients Treated With Celecoxib
And Chemoradiotherapy
3128
Luke Miller
Primary Tumor Volume, Bulky
Adenopathy and Number (But Not
Location) of Involved Nodal Stations
Predict Outcome in N2-N3 NSCLC
Treated With Definitive
Chemoradiotherapy
3129
Laura Kollar
Is the Ipsilateral Lung a Superior
Predictor than Total Lung in the
Development of Grade 3 or Greater
Pneumonitis?
3130
Supriya Jain
Monte Carlo-Based Treatment Planning
May Increase Chest Wall Pain and Rib
Fractures in Lung Stereotactic Body
Radiotherapy (SBRT) Patients Treated
According to RTOG 0915 Protocol
3131
Tatiana Rabin
Pre-clinical Studies Of Metformin Reveal
Radiosensitization For Human Small
Cell Lung Cancer In Vitro But Apparent
Antagonism In Vivo
3123
Baosheng Li
Phase III Study Of Concurrent LCAHRT
With Pemtrexed Or Vinorelbine For
Unresectable Stage III NSCLC
3132
Camille Berriochoa
Lung SBRT For Tumors With Chest Wall
Involvement: Safe And Effective
3124
Andreas Rimner
Stage III Non-Small Cell Lung Cancer
Treated Without Concurrent
Chemotherapy: What is the Optimal
Radiation Dose?
3133
Heike Peulen
Prognostic Model For Progression Free
Survival In Patients With Stage III
Non-small Cell Lung Cancer Treated
With Concurrent Chemoradiation
3134
Katsuyuki Karasawa
and Hypofractionated 3-dimensional
Non-coplanar Conformal Radiotherapy
for Solitary Metachronous Second
Primary Non-small Cell Lung Cancer
3135
Matthew Wheatley
Defining a Novel Cardiac
Contouring Atlas for NSCLC Using
Cadaveric Anatomy
3136
Maria Antonia Gomez
Volumetric Modulated Arc Therapy For
Non-Small Cell Lung Cancer Stage III:
Early Results In Our Institution
3137
Samantha Brigotti
The Influence of Hematological
Parameters on Tumor Control and
Survival in Lung SBRT
3138
Stephen Bowen
Impact of Functional Lung Imaging
using Ventilation/Perfusion SPECT/
CT on Planning Objectives in Thoracic
Radiation Therapy
3139
Charles Simone
for Stage I Non-small Cell Lung Cancer
(NSCLC): Outcomes by Fractionation,
Tumor Stage and Location, and Patient
Operability
3140
Ying Hou
Outcomes And Toxicity After Lung
(SBRT) In Patients (Pts) With A History of
Prior Lung Resection or Radiofrequency
Ablation (RFA)
3141
Gurleen Dhami
Anatomic Variations in Pulmonary
Perfusion and Ventilation Per
Quantitative MAA and DTPA SPECT/CT
in Patients Receiving Thoracic Radiation
Therapy
3142
Zhilei Shen
Clinical Evaluation of a Novel
Exponential Weighting Algorithm for
4DCT Reconstruction
3143
Chiara Valentini
Validation Of A Pre Release Commercial
Autosegmentation Software For Sbrt
And 4drt Purposes In Lung Cancer:
Ready (research Program In Auto
Delineation System)-lung-01: Proof Of
Concept
3144
Jason Hayes
Risk of Pneumonitis after Stereotactic
Body Radiation Therapy for Non-Small
Cell Lung Cancer in Patients With Prior
Anatomic Resection
159
3145
Bertram Maidment III
Dosimetric Comparison Of
VMAT-based Lung SBRT Treatments
With And Without A Flattening Filter:
An Inter-institutional Study
3155
Xin Ming
Cardiac Toxicity in Intensity-Modulated
Radiation Therapy, Dynamic Conformal
Arc Therapy and Volumetric Modulated
Arc Therapy of Lung Cancers
3146
Michael Schmuecking
Is Molecular Remission As Detected
By 18F-FDG PET/CT And Regression
Grade After Neoadjuvant Treatment In
The Primary Tumor And The Involved
Mediastinal Lymph Nodes A Prognostic
Factor In Patients With NSCLC Stage III?
3156
Christina Speirs
Comprehensive Analysis Of Dosimetric
Predictors Of Overall Survival For Stage
III Non-Small Lung Cancer (NSCLC)
Treated With Definitive Radiotherapy
3147
Nhu Tram Nguyen
Tracheal Tumours Treated With
Endotracheal Brachytherapy Alone:
Experience From A Single Institution
3148
Eduardo Fernandez
(sabr) For Early Stage Lung Cancer In
The Multi-center Community Setting
3149
Jay Paul Reddy
Influence of Surveillance PET/CT on
Detection of Early Recurrence
Following Chemoradiation in Stage III
3150
Jolinta Lin
Large Tumor Size Increases the Risk
of Developing Symptomatic Pleural
Effusions Following Stereotactic Body
Radiation Therapy for Lung Cancer
3151
Weili Wang
Autoantibodies against p16
Protein-derived Peptides Predict
Radiation Pneumonitis in Patients With
Non-small Cell Lung Cancer Treated
With Definitive Radiotherapy
3152
Yu Chen
Post-induction Inflammatory Status
Predicts Complete Pathologic Response
In Non-small Cell Lung Cancer Patients
Undergoing Induction Chemoradiotherapy
3153
Yankhua Fan
Radiation Dose-Volume Effect in Lung:
A Functional Subunits Based Normal
Tissue Complication Probability Model
and Its Application to 3DCRT and SBRT
3154
Eric Kemmerer
Local Failures After Lung SBRT and
Dosimetric Analysis of Potential Surgical
Resection Lung Volumes
3157
Tithi Biswas
Is There Any Disparity In Treatment
And Outcome Of Stage I Non-small
Cell Lung Cancer (nsclc): A Study From
Single Cancer Registry?
3158
William Chance
Postoperative Hemithoracic Intensity
Modulated Radiation Therapy (IMRT)
with an Optional Integrated Boost for
Malignant Pleural Mesothelioma:
Toxicity, Patterns of Failure, and a
Matched Survival Analysis
3159
Hani Al-Halabi
A Contralateral Esophagus Sparing
Technique To Limit Severe Esophagitis
Associated With Concurrent
Chemoradiotherapy In Lung Cancer
Patients
3160
Julip Jung
Lung Tumor Motion Tracking using
Sequential Inter-phase Deformable
Registration in 4D CT Images for
Radiation Treatment Planning
3161
Yun Hee Lee
Tumor Volume Changes Assessed with
High Quality KVCT in Lung Cancer
Patients Undergoing Concurrent
Chemoradiotherapy
3162
Anshu Jain
A Pilot Study of FLT-PET as an Early
Imaging Biomarker in the Tri-modality
Treatment of Patients with Thoracic
Malignancies
3163
Feng-Ming Kong
Immunomodulating Cytokines May
Improve Overall Survival Prediction
After Radiotherapy In Patients With
Locally Advanced Non-small Cell Lung
Cancer
3164
Ankit Mangla
The Association Of Pre-chemotherpay
Neutrophil-lymphocyte Ratio With
Survival In Non-small Cell Lung Cancer
Patients
LYMPHOMA/LEUKEMIA
3165
Jonathan Farr
Potential Organ Dose Reduction From
For Pediatric Hodgkin’s Disease Patients
Receiving Consolidative Involved-node
Intensity Modulated Photon Therapy
3166
Bouthaina Dabaja
Hodgkin’s Lymphoma Treatment:
Modern Radiation Therapy, Lower
Dose, Smaller Field, But The Risk Of
Lhermitte’s Sign Is Still There
3167
George Mikhaeel
Patterns of Mediastinal Lymph Node
(MLN) Involvement by Lymphoma
Using International Association for the
Study of Lung Cancer (IASLC)
Classification
3168
Carlo Furlan
The German Hodgkin Study Group
Stratification Scheme For Newly
Diagnosed Hodgkin’s Lymphoma Is
Useful For Predicting Outcome Of
Patients Receiving Radiotherapy After
Autologous Self Cell Transplant In
Relapsed/refractory Hodgkin
Lymphoma
3169
Shane Lloyd
Hodgkin Lymphoma With Bulky
Mediastinal Disease: A Comparison of
AP/PA, IMRT, and Volumetric Arc Plans
3170
Maximilian Spickermann
How Reliable Is Cone Beam Computed
Tomography (CBCT)? - A Quality Control
Of Intensity-modulated Radiotherapy
And Intensity-modulated Arc Therapy
For Patients With Hodgkin’s Lymphoma
3171
Jordan Torok
Low-Dose Consolidation Radiation
Therapy for Early-Stage Unfavorable
Hodgkin Lymphoma
3172
Marianne Aznar
Breathing Adapted Radiotherapy In
Hodgkin Lymphoma: Do We Need The
Staging Pet/CT In Deep Inspiration
Breath Hold?
3173
Suzanne Sachsman
Impact on Dose to Abdominal Organs
with the Use of Proton Therapy in the
Management of Diaphragmatic and
Infradiaphragmatic Hodgkin
Lymphoma
160
3174
Ali Mazloom
Survival Benefit of Radiotherapy in
Patients With Stage III Classical Hodgkin
Lymphoma: An Analysis of the
Surveillance, Epidemiology, and End
Results (SEER) Database
3175
Christopher Wilke
Role Of Consolidative Radiotherapy
Following Autologous Stem Cell
Transplantation For Relapsed Or
Refractory Hodgkin’s Lymphoma
3176
Michio Iwabuchi
Treatment of Primary Central Nervous
System Lymphoma (PCNSL):
Comparison between Whole-brain
Radiotherapy and Partial-brain
Radiotherapy
3177
Bouthaina Dabaja
Definitive Radiation Therapy For Stage
I And II (MALT) Mucosa Associated
Lymphoid Tissue Lymphoma: Report Of
A Prospective Study
3178
Bouthaina Dabaja
Follicular Lymphoma of the Skin:
Different Therapies Similar Outcome
3179
Joohwan Lee
The Role of Radiotherapy in Localized
Nongastric and Nonorbital
Mucosa-associated Lymphoid Tissue
Lymphoma
3180
Kotoha Tatekawa
Clinical Outcome of Radiation Therapy
for Ocular Adnexal Mucosa-Associated
Lymphoid Tissue Lymphomas
3181
Saiji Ohga
Treatment Outcome of Primary
Ocular Adnexal Malt Lymphoma by
Radiotherapy - Prognostic Effect of the
Ajcc Tumor-Node-Metastasis Clinical
Staging System for Ocular Adnexal Malt
Lymphoma
3182
Lior Braunstein
Predictive Factors for Ophthalmic
Toxicity in Patients Receiving
Radiotherapy for Ocular Adnexal or
Periorbital Lymphoma
3184
Chelsea Pinnix
The Outcome of Limited Stage
Plasmablastic Lymphoma Treated With
and Without Radiation Therapy: A
Single Institutional Experience
3185
Susan Hiniker
Prognostic Factors, Treatment, And
Outcomes Of Limited-Stage Diffuse
Large B-cell Lymphoma (DLBCL) In The
Rituximab (R) Era
3195
Christopher Kelsey
Cardiopulmonary Exercise Testing
Prior To Myeloablative Allogeneic Stem
Cell Transplantation Using Total Body
Irradiation: A Feasibility Study
3186
Arisa Harada
Primary Radiation Therapy For Localized
Duodenal Follicular Lymphoma
3196
Josef Hammer
Total Body Irradiation (TBI) by
Volumetric Modulated Arc
Therapy - First Experiences and
Perspectives
3187
Kazunari Miyazawa
Low Cataract Incidence Of Electron
Beam Therapy With Hanging Lens Block
For Conjunctival MALT Lymphoma
3188
Jian Zang
Better Outcome In Stage I-II Nasal-type
Of Nk/t Cell Lymphoma Treated With
Radiotherapy Followed By etoposide
and/or L-asparaginase Containing
Chemotherapy Regimen
3189
Bo Chen
Failure Distribution Of Early Stage
Upper Aerodigestive Tract NK/T-cell
Lymphoma After Treatment
3190
Sameer Jhavar
Role of Radiation Therapy in Early Stage
Diffuse Large B-Cell Lymphoma (DLBCL)
in Elderly
3197
John Plastaras
Risk Factors for Radiation Pneumonitis
in Patients With Lymphoma Treated
With Chemotherapy and Photon or
Proton Radiotherapy
3198
Naoya Ishibashi
Prospective Study Of Total Body
Irradiation As Pretreatment For
Hematopoietic Stem Cell
Transplantation
3199
Douglas Kelly
Dosimetric Evaluation of Helical
Tomotherapy Low Dose Total Body
Irradiation (TBI) for Mini Allogeneic
Transplants
NON-MALIGNANT
3191
Ophelie Cassuto
Comparison Between Short Course
(Single Fraction) And Long Course
(Multiple Fractions) On Pain Relief In
Patients With Bone Localization Of
Multiple Myeloma
3200
Steven Sckolnik
Frameless LINAC Image Guided
Radiosurgery for Primary and Recurrent
Trigeminal Neuralgia
3192
Ehsan Balagamwala
Spine Stereotactic Radiosurgery for
the Treatment of Multiple Myeloma, an
Institutional Series
3201
Waleed Mourad
Higher Energy Megavoltage Photon
and Split Beam technique Minimize
the Testicular Dose during Radiation
Prophylaxis of Heterotopic Ossification
3193
Thatcher Heumann
Total Skin Electron Irradiation (TSEI)
Using Rotational Technique For
Cutaneous T- Cell Lymphoma
3202
Zachary Lopater
Treatment of Dupuytren’s
Contracture and Ledderhose’s Disease
with Radiation
3194
Jeffrey Wong
Phase I Dose Escalation Trial of Total
Marrow and Lymphoid Irradiation
(TMLI) Using Helical TomoTherapy
Combined with Etoposide (VP16) and
Cyclophosphamide (CY) in Patients with
Refractory Acute Leukemia
Undergoing Allogeneic Hematopoietic
Cell Transplant
3203
Adriana Blakaj
Metallothioneins in Fibrosis:
Implications for Radiation-induced
Fibrosis
3204
Nisha Ohri
A Renewed Application of Intracoronary
Brachytherapy for In-Stent Restenosis of
Drug-Eluting Stents
161
3205
Divya Arora
Dosimetric Analysis Of Brainstem
Dose Constraints For Linac Based
Radiosurgery For Medical Management
Refractory Trigeminal Neuralgia
3215
Chiaki Fujioka
Optimal Bladder Volume at Treatment
Planning for Prostate Cancer Patients
Receiving Volumetric-modulated Arc
Therapy
3225
Tetsuo Saito
Physicians’ Reluctance to Choose
Radiotherapy over 1 to 2 Weeks for Pain
Relief in Patients With Bone Metastasis
and a Poor Prognosis
3206
Shen Jie
Hypofractionated Electron-Beam
Radiation Therapy for Keloids:
Retrospective Study of 568 cases with
834 lesions
3216
Therese PorzioKwiecinski
Temporary Displacement of the Bowel
during Treatment of Sacral Tumors With
3226
Matthew Cheney
Re-irradiation for Spinal Metastases:
A Single Institution Series Examining
Radiation Myelopathy and Disease
Outcomes
3207
Stella Yoo
Radiation Therapy for Prophylaxis of
Heterotopic Ossification at the Elbow: A
Single-Institution Retrospective Study
3217
Olivier Maisonet
Implementation of a Quality Assurance
Protocol for Patients With an Implanted
Cardiac Device Undergoing Treatment
With Radiation
3227
Christina Henson
Outcomes in Patients Treated with
Whole Brain Radiotherapy Versus
Metastases Secondary to Non-Small Cell
Lung Cancer
PALLIATIVE CARE
3228
Woo Joong Rhee
Vertebral Compression Fractures after
Spine Irradiation Using Conventional
Fractionation in Patients with
Metastatic Colorectal Cancer
3208
Terence Sio
Radiation Toxicity in Patients With
Scleroderma, Discoid and Systemic
Lupus Erythematosus: A Retrospective
26-Year Single-Institutional Study
3209
Nathan Tennyson
Patient Reported Outcome after
Electron Radiation Treatment for
Early-Stage Palmar and Plantar
Fibromatosis
3210
Claudia Carvajal
Postoperative Radiotherapy in the
Management of Keloids
NURSING
3211
Patries Herst
Prophylactic Use Of Soft Silicone Film
Prevents Radiation-induced Moist
Desquamation In Breast Cancer Patients
3212
Colleen Schaidle
The Role of the Non-physician
Practitioner (Advanced Practice Nurse
and Physician Assistant) in Radiation
Oncology
3218
Drew Moghanaki
Availability Of Single-fraction Palliative
Radiotherapy For Cancer Patients
Receiving End-of-life Care Within The
Veterans Healthcare Administration
3219
Shane Lloyd
Radiation Oncologists’ Opinions about
Palliative Radiation Therapy for Patients
on Hospice Care
3220
Ian Poon
A Multi-National Report on
Image-Guided Stereotactic Body
Radiotherapy for Oligometastases Patient Selection and Follow-Up
3221
Shohei Kawashiro
Reirradiation of Spinal Metastases With
3229
Pierfrancesco Franco
Palliative Radiotherapy for Painful Bone
Metastases From Solid Tumors
Delivered With Static Ports of
Tomotherapy
3230
Hidetoshi Kobayashi
Radiation Therapy for
Symptomatic Bone Metastases: The
Effect of Calculated Dose And Dose
Distribution on Intensity of Pain Relief
and Time of Pain Relief
3231
Tetsuo Saito
Painful Diseases Other than Bone
Metastasis are More Frequently Treated
with Radiotherapy than Bone Metastasis
3222
Robert Olson
Impact of Program Wide Dissemination
of the Inconsistent Utilization of Single
Fraction Radiotherapy for Bone
Metastases across a Provincial Program
3232
Mareike Held
A System to Determine Suitable
Candidates for Expeditious On-board
CBCT Dose Planning and Delivery
3213
Diane Serra
Guided Imagery Improves Head and
Neck Cancer Patients’ Satisfaction
and Quality of Life during Definitive
Radiation Therapy with or without
Chemotherapy
3223
Mark Barnes
Radiotherapy Fractionation Schedules
Prescribed are Dependent on the
Distance a Patient Travels to Receive
Treatment
3233
Ken Harada
Factors Influencing upon Pain
Reduction: Bone Metastases from Renal
Cell Carcinoma (RCC) Treated With
Radiation Therapy
3214
Florence Yuen
Management of Moist Desquamation in
Radiation Oncology Patients
3224
Naoki Nakamura
Neuropathic Pain Features In Patients
With Bone Metastases
3234
Layth Mula-Hussain
Palliative Radiotherapy to Metastatic
Breast and Lung Cancers in The Middle
East Region: 5 Years Experience at A
Tertiary Center In Iraq
162
3235
Saif Aljabab
Hemostatic Radiotherapy in Advanced
Bladder Cancer A Single Institution
Review
3236
Omar Mian
Reduced Lymphocytopenia Following
(SBRT) For Spine Metastases Compared
With Conventional Radiation Therapy
(CRT)
3237
Sara Alcorn
Analysis of Factors Complicating
Treatment for Bone Metastases: Why
Are Patients Not Receiving
Single-fraction Radiotherapy?
3238
Yu-Ming Wang
Heart Rate Variability as a Novel
Prognosticator in Patients with Brain
Metastasis - A Pilot Study
3239
Tai Chung Lam
Adverse Outcomes After Palliative
Radiation Therapy For
Uncomplicated Spine Metastases: Role
Of Spinal Instability And Single Fraction
Radiation Therapy
3240
Bevan Ly
Dose Escalation Using Conventional
Versus IMRT Planning for
Hypofractionated Radiation of
Lumbosacral Metastases
3241
Yasushi Hamamoto
Prognoses Of Patients Who Received
Palliative Intent Radiotherapy In Recent
Years
3242
Jason Lee
A Multi-institution Pooled Analysis of
Oligometastatic Patients Treated with
SBRT
3243
Kyle Arneson
Patterns Of End Of Life Care In Patients
With Metastatic Melanoma Requiring
Whole Brain Radiation
3244
Natalie Logie
Dose Fractionation Schedule Correlates
With Survival In Whole Brain
Reirradiation: An International Pooled
Analysis
3245
Benjamin Lok
Palliative Head and Neck Radiotherapy
with the Quad Shot Regimen for
Incurable Primary or Metastatic Cancers
3246
Hiroshi Tanaka
An International Multi-institutional
Planning Study Evaluating Treatment
Planning And Plan Acceptability Metrics
For Spine Stereotactic Body
Radiotherapy (SBRT)
3247
Vladimir Avkshtol
Lacrimal Gland Radiation Dose and
Toxicity After Whole Brain Radiation
3256
Alan Kiang
Long-term Trajectory of Quality of Life
in Nasopharyngeal Cancer Patients
3257
Jennifer Woo
Prostate Cancer: What is the
Appropriate Patient-Reported Outcome
for Clinical Trial Design?
3248
Daniel Tan
Radiosurgery For The Treatment Of
Large Brain Metastases
3258
Shrinivas Rathod
High-precision Conformal Radiotherapy
In Head-neck Cancers: Longitudinal
Changes In Quality-of-life And
Temporal Time-Trends
3249
Heather Curry
Utilization of Hypofractionated
Regimens for the Treatment of Bone
Metastases Before and After Initiation of
ASTRO’s ”Choosing Wisely” Campaign
3259
Adriana Valderrama
Health State Utilities Among Metastatic
Castrate-resistant Prostate Cancer
Patients With and Without
Symptomatic Skeletal Events
3250
Francesco Cellini
Virtual Simulation Procedure’S Difficulty
Level Assessed By New Score System:
Pain Level Affects Duration Of
Procedures Better Than Technical
Complexity
3260
Andra Krauze
Assessment of Ten Years of Quality of
Life Research Presented at Major
American Clinical Oncology Meetings
3251
C.M. Charlie Ma
Quality Assurance for MR Guided
Focused Ultrasound Treatment of Bone
Metastasis - A Clinical Experience
3252
Jessica Schuster
A Compassionate Care Palliative
Radiotherapy Program for Cancer
Patients Enrolled in Hospice - Offering
Reduced-Cost Palliative Radiotherapy in
the Same Day as Evaluation
3253
Amir Zahra
Pain Response and Local Control of
Bone Metastases for Renal Cell
Carcinoma with Conventional
Fractionation Radiation Therapy
3261
Jennifer Woo
Comparing Patient-reported Outcomes
In Patients With And Without Late
Urinary Flare Following Stereotactic
Body Radiation Therapy (SBRT) For
3262
Matthew Mason
Patient Reported Outcomes: Correlation
of MDASI-HN and Clinical Support
Required for Patients Receiving Curative
Head and Neck Chemoradiotherapy
3263
Terence Sio
Baseline Patient-Reported Qualityof-life Is Not Related to Overall Survival
in Patients Receiving Stereotactic Body
Radiation Therapy for Thoracic
Malignancies: A Preliminary Report
3264
Einsley-Marie Janowski
Dysuria Following Stereotactic Body
QUALITY OF LIFE
3254
Hong Ye
Quality Of Life in Patients With Brain
Metastasis Treated With Frame-Based
Stereotactic Radiosurgery Alone Using
the EORTC QLQ-C30 and QLQ-BN20
3255
Daniel Joh
Proctitis Following Stereotactic Body
3265
Jae Lee
Clinically-Relevant Body Composition
Changes in Head and Neck Cancer
Patients Undergoing Chemoradiation
3266
Andrew Rossetti
The Impact Of Music Therapy On
Anxiety and Distress In Patients
Undergoing Simulation For Radiation
Therapy (RT)
163
3267
Marie Gurka
Gross Hematuria after Stereotactic Body
Radiation Therapy (SBRT) for Prostate
Cancer
3268
Isabelle Thibault
Quality of Life in Patients Treated With
Stereotactic Ablative Body
Radiotherapy (SABR) for Liver
Metastases
3269
Leszek Miszczyk
Split-Course Accelerated,
Hyperfractionated Irradiation
(CHA-CHA) as a Sole Treatment for
Advanced Head and Neck (H&N) Cancer
Patients - Randomized Clinical Study.
Quality of Life (QOL) Evaluation
3270
David Elliott
Medical Marijuana Use in Patients with
History of Head and Neck Squamous
Cell Carcinoma Treated with
Radiotherapy
3271
Devarati Mitra
Does Adding Vaginal Brachytherapy
(VB) To External Beam (EB) Increase
Rectal Bleeding? Comparing Results
Of Combined EB+VB To The PORTEC-2
Data For EB Alone And VB Alone
3272
Yu-Hsuan Lai
Analysis of Health-Related Quality of
Life in Breast Cancer Patients Receiving
Adjuvant Radiotherapy
3273
Joost Nuyttens
Quality of Life during 5 Years after
Stereotactic Radiotherapy in Stage I
3274
Anuj Goenka
The Impact of Prostate Size on Patient
Assessed Quality of Life Following
Proton Beam Radiotherapy
3275
Zaker Rana
Improved Irritative Voiding Symptoms
Three Years After Stereotactic Body
Radiation Therapy For Prostate Cancer
3276
Shariq Khwaja
Patient Reported QOL Outcomes From
A Prospective Phase II Trial Of Short
Course Radiotherapy Followed By
FOLFOX Chemotherapy As Preoperative
Treatment For Rectal Cancer
3277
Andrew Lee
The Impact Of Hormone Therapy
On Long-term Quality Of Life In Men
Receiving Proton Therapy For Prostate
Cancer
3278
Jessica Zhou
Patient Reported Outcomes for Quality
of Life (QOL) By Expanded Prostate
Cancer Index (EPIC) 15 Years Post
Treatment
3279
Zaker Rana
Factors Affecting Patient Reported
Outcomes Following Robotic
Radiosurgery Stereotactic Body
Radiotherapy for Prostate Cancer
3280
Amy Leatherwood
What is the Impact of Survivorship
Visits? Preliminary Analysis from a
NCI-Designated Cancer Center
Radiation Oncology Program
3281
Meredith Giuliani
Identification of Unmet Survivorship
Needs in Primary Lung Cancer Patients:
A High Burden for Younger Patients
3282
Andrew Barsky
Radiation-Induced Malignant
Mesothelioma: Frequency and
Prognosis
3283
Sara Samiee
Colorectal Cancer Screening In Cancer
Survivors Treated with Radiation
Therapy
3284
Miriam Knoll
Long Term Urinary and Rectal Tolerance
in Prostate Cancer Survivors Treated
with Definitive Conformal Radiotherapy
3285
Devarati Mitra
Lymphedema: Is It Associated With
Lymph-node Involvement In
Endometrial Cancer?
3286
YoungsSeok Seo
Stereotactic Body Radiotherapy Based
Strategy For Oligo-recurrent Cancer In
The Para-aortic Area
3288
John Groarke
Negative Correlation Between Coronary
Flow Reserve And Mean Radiation Dose
To The Heart
3289
Lisa Kachnic
Perceptions And Practices Regarding
Women’s Vaginal Health Following
Radiation Therapy
3290
Robert Olson
Feasibility of Population Based
Collection of Patient Reported
Outcome Measures in a Provincial
Radiotherapy Program
3291
Arisa Shimizu
Correlation of The Incidence of
Hypothyroidism and the Dose-Volume
Histogram in Head and Neck Cancer
Patients Treated With IntensityModulated Radiotherapy
3292
Luis Larrea
Stereotactic Body Radiation Therapy In
The Elderly
3293
Ashish Patel
Pitfalls and Predictors of Poor Press
Ganey Patient Satisfaction Scores
PATIENT SAFETY
3327
Sarah Gwynne
Prospective Review Of Outlining In The
Uk Neoscope Oesophageal Trial
3328
Hiral Fontanilla
Individual Patient Based Peer-review At
A Proton Center
3329
Wai Wang Lam
Dosimetric Impact of Dose Servo
Control on Long Helical Tomotherapy
Treatment Delivery
3330
Sarah Gwynne
Progress Towards Prospective Real Time
Review Of Outlining In GI Trials At A UK
Radiotherapy Quality Assurance Centre
3287
Christine Hill-Kayser
Patient Reported Outcomes after Chest
Radiation for Hodgkin (HL) and
Non-Hodgkin Lymphoma (NHL)
164
3331
Jialu Yu
Investigation Into A New Quality
Assurance Tool For Radiotherapy
Structure Delineation: Atlas-based
Automatic Segmentation (ABAS) Of
Cardiac Structures For Non-small Cell
Lung Cancer From RTOG 0617
3332
Tomas Dvorak
Assessment Of Radiation 30-Day Mortality Based On ACR Continuous Quality
Improvement Process
3333
Timothy Meier
A Rapid Large Increase in Patient Visits
Can Compromise Quality and Safety in
Radiation Oncology Treatment Delivery
3334
Kelly Kisling
Evaluation of a System for Independent
Treatment Plan and Delivery Verification
3335
Joshua Mathews
A Liquid Ion Chamber For Clinical
Stereotactic Output Measurements
3336
Sarah Hamilton
A National Survey on Peer Review:
Canadian Radiation Oncologists’ Views
Regarding the Benefits, Practical
Workload Implications and Legal
Liability
3337
Lucas Vitzthum
Identifying and Implementing Factors
that will Reduce Treatment Package
Time for Cervical Cancer Patients
Requiring Definitive Radiotherapy:
AQuality Improvement Effort
3338
Yoshiyuki Katsuta
Plan Quality Assurance of VMAT for
prostate cancers in a Digitally
Integrated and Controlled Linear
Accelerator Using Log Files
3339
Charles Able
A Model for Preemptive Maintenance of
Medical Linear Accelerators - Predictive
Maintenance
3340
Kara Leonard
Developing a Process for Radiation
Oncology Specific Apparent and Root
Cause Analyses
3341
Ruijie Yang
Implementation of Incident Learning in
the Safety and Quality Management of
Radiotherapy: the Primary Experience
in a New Established Program with
Advanced Techniques
3342
Yutao Gong
Variation Of Cardiac Contours Using
Different Heart Definitions For NSCLC
Patients Enrolled On Rtog 0617
3343
Lukasz Matulewicz
Evaluation of Transit Dosimetry
Software For Helical Tomotherapy
3344
Yuvaraj Sekar
Evaluation of a Novel 2D Detector Array
for Patient Plan Verification in
Conventional and Flattening Filter
Free (FFF) Photon Beams in Clinical
Conditions
3345
Yu Chen
Tomotherapy Patient Specific Delivery
QA Using Exit Detector Array
3346
Xiaohu Mo
A Delivered Dose Based Record and
Verify System in the Era of IGRT
3347
Brian Liszewski
A National System for Incident
Reporting in Radiation Therapy:
Development of a Taxonomy and
Severity Classification
3354
Samuel Chao
One Year Experience with the Workflow
Enhancement (WE) Team: Does
Continuous Improvement Have to be
Continuous?
3355
Rohan Deraniyagala
Usability Study of the EduMod
eLearning Program: Head and Neck
Nodal Station Contouring
3356
Nataliya Kovalchuk
Optimizing Efficiency and Safety in
Radiation Oncology Department
through the Use of Aria 11 Visual Care
Path (VCP)
3357
Seiichi Ota
Feasible Strategy For Reduction Of
Individual Human Failures In External
Radiation Therapy Workflow
3358
Ryan Jones
The Improvement of a Novel
Radiotherapy Workflow by Failure Mode
and Effects Analysis
3348
Andrea McNiven
Multicenter Collaborative Quality
Assurance Program in Ontario: Second
Year Results
3359
Shalini Moningi
Management of Task Saturation in
a Pancreatic Multidisciplinary Clinic:
Using a Novel Operations Management
Methodology to Increase Efficiency
and Reduce Unnecessary Downstream
Encounters
3349
Gustavo Kertzscher
Fast, Simple And Accurate: In Vivo
Dosimeter Calibration For Hdr/pdr
Brachytherapy
3360
Karl Fritscher
A 3d Patient Specific Collision
Avoidance System for Radiotherapy
Treatment Planning
3350
Raj Varadhan
VMAT Head & Neck Treatment
Delivery-Benchmarking Accuracy of
Patient DVH based QA with Radiological
Physics Center (RPC) Head and Neck
Phantom Results
3361
Chihray Liu
Designing a Patient Treatment
Workflow Management and Analysis
System in a Department of Radiation
Oncology
3351
Shalini Moningi
A Comparison of Incident Learning in
the Academic and Community
Radiation Oncology Setting
3352
Guilherme Pavan
Dosimetric Evaluation Of Treatment
Planing System On High Dose Rate
(hdr) Brachytherapy Using Monte Carlo
Method And Radiochomic Film
3353
Thomas Mullen
What’s the Hold-Up? Late Work Events
in Radiation Oncology Reveal
Opportunities for Improved Patient
Care and Safety
3362
Byong Yong Yi
Determination of Risk-Based Target
Margins: A Failure Mode and Effect
Analysis (FMEA) Proof of Principle
3363
Seth Blacksburg
Operations Management in Radiation
Oncology: Identifying Workflow
Parameters that Portend for Simulation
Delay
3364
Matthew Peter Mumber
Effect of Mindfulness Training on
Mindfulness Level in The Workplace
and Patient Safety Culture as a Part of
Error Prevention in Radiation Oncology
Practice: A Pilot Study
165
3365
Bin Yang
Application of ExpectationMaximization Method in kV X-ray
Spectrum Estimation From
Transmission Measurements
3366
Kyle Delaney
Neutron Activation of Indium Foils
Irradiated During Passively Scattered
Proton Therapy and Implications on the
Treatment of Pacemaker Patients
3368
Jona Hattangadi
A 25-Year Epidemiologic Study of
Medical Malpractice Claims in Radiation
Oncology
3296
Ange Wang
Impact of Molecular Sub-type and
Craniospinal Irradiation (CSI) Dose on
Relapse of Medulloblastoma
3308
Waqar Haque
Radiation Therapy Provides Favorable
Outcomes as Definitive Treatment for
Ewing’s Sarcoma
3297
Joanna Chin
Incidence of Optic Nerve Involvement
in Pediatric Intracranial Germ Cell
Tumors
3309
Jun Liang
Primary Mediastinal and Thoracic
Liposarcomas: Clinical Analysis of 25
Cases
3298
Kristin Redmond
Diffusion Tensor Imaging (DTI) and
Proton MR Spectroscopy (MRS)
Detected Region Specific Injury to
White Matter in Children Treated with
Cranial Irradiation
3310
Barbara Roeper
High-precision Involved-Lesion
Radiation Therapy (IL-RT) to all
Metastatic Sites in Multifocal Pediatric
Sarcoma
3311
3369
Shereef Elnahal
Identifying Predictive Factors for
Treatment Variance Events in Patients
Receiving Radiation Therapy:
Comparative Results from a
Comprehensive Safety Variance
Database
3370
Prithima Mosaly
Objective Assessment of Mental
Workload With Pupillary Monitoring
During Routine Clinical Tasks: The
Impact of Cross Coverage
3371
Kinley Taylor
A Case Study of the Use of A3 Thinking
in Radiation Oncology
3372
Prithima Mosaly
Assessing the Applicability and
Reliability of the Human Factors
Analysis and Classification System
(HFACS) to the Analysis of Good
Catches in Radiation Oncology
3373
Jonathan Grant
Secondary Neutron Production is
Predictive of Implantable Cardiac
Device Reset in Patients Receiving
Radiotherapy
PEDIATRIC CANCER
3294
Anita Mahajan
Neurocognitive Outcomes in
Relationship to Hippocampal and Brain
Doses after Partial Brain Proton
Radiotherapy in Children
3295
Roshan Sethi
Patterns Of Failure Following Proton
Therapy In Medulloblastoma; LET
Distributions And Rbe Associations For
Relapses
3299
I-Chun Lai
Treatment Results and Prognostic
Factors for Intracranial Nongerminomatous Germ Cell tumors:
Single Institute Experience
3300
Melis Gultekin
Reirradiation of Pediatric Tumors with
Robotic Stereotactic Radiosurgery
3301
Jinsoo Uh
Effects of Surgery and Proton Therapy
on Cerebral White Matter of
Craniopharyngioma Patients
3302
Sara Alcorn
Predictors of Setup Accuracy in
Image-Guided CNS Radiotherapy:
Prospective Data from a Multi-national
Pediatrics Consortium
3303
Oren Cahlon
Craniospinal Radiotherapy May Not Be
Necessary for Localized
Nongerminomatous Germ Cell Tumors
(NGGCT)
3304
Geoffrey Ray
Pediatric Central Nervous System
Reirradiation and Tolerance of the
Brainstem to High Cumulative Dose
3305
Susan McGovern
Proton Therapy For Pediatric AT/RT of
the CNS
3306
Rachel Jimenez
Proton Radiotherapy for Pediatric
Craniopharyngioma
3307
Radhika Sreeraman
Mid-Treatment Magnetic Resonance
Imaging in Pediatric Intracranial
Low-Grade Giomas Treated with Proton
Beam Therapy
Ozlem Ozkaya
Akagunduz
The Effect of Radiotherapy in the Local
Control of the non-Extremity Ewing’s
Sarcomas
3312
Eleanor Osborne
Survival And Toxicities Following Whole
Abdominopelvic Radiotherapy As Part
Of Multimodality Treatment For Patients
With Desmoplastic Small Round Cell
Tumor
3313
Robert Kirkland
Stratifying Pulmonary Tumor Burden
in Patients with Stage IV Wilms Tumor
(WT): Implications for Treatment and
Disease Outcome
3314
Ronica Hazariwala
Cardiopulmonary Outcomes for
Concurrent Versus Sequential Lung
and Abdominal Irradiation in Stage IV
Wilms Tumor
3315
Vanessa Salinas
Incidence of Cataracts in Lens Sparing
vs Whole Eye Radiation Therapy
Technique in Retinoblastoma Patients
3316
Nikhil Thaker
Evolution of Proton Therapy and
Advanced Radiation Techniques for
Retinoblastoma
3317
Fauzia Shaikh
Modeling Radiation Induced Vascular
Effects of High Dose Versus Standard
Dose Radiation in an Orthotopic Mouse
Model of High-Risk Neuroblastoma
3318
Brandon Imber
Biomarker Modulations in Children with
Neuroblastoma Following Treatment
with 131I-mIBG
166
3319
Carl DeSelm
Optimum Radiation Treatment for CNS
Recurrent Neuroblastoma
3320
Nikesh Shah
Total Body Radiotherapy Dose
Comparison in Pediatric Patients
with Relapsed Acute Lymphoblastic
Leukemia
3321
Clayton Hess
Outcomes of Pre-Operative Versus
Post-Operative Radiation for
Heterotopic Ossification Prevention
in Pediatric Patients with Cerebral
Palsy Undergoing Proximal Femoral
Resection
3322
Dana Casey
Second Cancer Risk in Childhood
Cancer Survivors Treated with
(IMRT)
3323
Christine Hill-Kayser
Factors Associated With Event
Reporting in the Pediatric Radiation
Oncology Population Using an
Electronic Condition Reporting System
3324
Josefine Stahl Kornerup
The Impact Of Different PTV Margins In
VMAT And IMPT For Adolescents With
3325
Benjamin Farnia
Dosimetric and Toxicity Analyses of
Reirradiation for Recurrent Pediatric
Brain Tumors
3326
David Barron
The Role of Radiotherapy in
Epstein-Barr Virus-Related
Lymphoproliferative Disorder
3550
Dan Ruan
Development of a Clinical Information
Management System With Logical
Organization for Improved Accuracy
and Inheritance
3551
Dan Ruan
Listening To Sinogram: Detecting And
Estimating Actual Discrepancy During
Treatment
3552
Shuai Zheng
Patient Treatment and Prognosis
Information Extraction with Adaptive
Self Learning Medical Form Generating
System
3553
Johannes Kraft
Evaluation and Comparison of
Segmentation Algorithms in Low
Contrast FET-PET Scans for Gross Tumor
Volume Delination
3554
Kevin Albuquerque
Development and Experience With an
EMR Based Radiation Oncology Toxicity
Recording Instrument (ROTOX): Benchmarking and Quality Improvement
3547
Nhu Tram Nguyen
Blinded Evaluation Of Sinogram
Affirmed Iterative Reconstruction In
Radiotherapy Planning Images
3548
Tobias Fechter
Evaluation Of An Integrated Minimall
Interactive Tool For The Segmentation
Of Relevant Oar In Lung Cancer
3549
Anant Gopal
An Electronic Medical Record Search
Engine for Clinical Outcome Research
3562
Shuang Zhao
Identification and Validation of a
Metastasis Signature in Human Breast
Cancer
3563
Florentino Rico
Supervised Learning Methods for the
Prediction of Tumor Radiosensivity to
Preoperative Radiochemotherapy
3564
Russell Rockne
An Evaluation of Multi-institutional
Data-Transfer to Facilitate Personalized
Computational Modeling
3565
Timothy Robinson
Hypoxia Induces mRNA 3’UTR
Truncation in Multiple Cell Types In Vitro
RADIATION AND CANCER
BIOLOGY
3414
Andrew Vaughan
Influence Of Chromatin Structure On
The Induction Of Radiation-induced
Chromosome Aberrations
3555
Weiguo Lu
In-vivo Verification and Adaptive
Evaluation for Every Patient, Every
Treatment
3556
Mark Phillips
Development of a Probabilistic Model
For Therapy Plan Error Checking
3557
Andres Parra
Automatic Detection of the Foci of
Residual or Recurrent Disease in the
Prostate Bed after Prostectomy using
Dynamic Contrast Enhanced-MRI
3558
Kevin Moore
Suboptimal Treatment Planning Adds
Substantial Risk of Normal Tissue
Complication: A Secondary Study on
RTOG 0126
INFORMATICS/
BIOINFORMATICS
3561
Javier Torres-Roca
Correlation Between Tumor Intrinsic
Radiosensitivity and Immune Activation
in Solid Tumors
3415
Brandon Stone
Gene Expression Patterns in Pancreatic
Neuroendocrine Tumors Suggest
Resistance to Radiation Therapy
3416
Kristina Young
TGFβRI Inhibition Prior To Radiation
Enhances Efficacy In A CD8 Dependent
Fashion
3417
Elena Muraro
(SABR) for Oligometastatic Breast Cancer Patients: Investigating the Immune
Profile to Identify Predictive Biomarkers
3418
3559
Javier Torres-Roca
Large-Scale Evaluation of a Molecular
Signature of Tumor Intrinsic Radiosensitivity in Solid Tumors
3560
Christopher Betzing
Identification of Critical Pathways
Altered by Radiation Exposure and Drug
Target Analysis
Azadeh Fahim
Golestaneh
Identifying Molecular Mechanisms
Of Tumor Radio-resistance Via High
Throughput In-vivo Microrna Knock
Down Screen
3419
Chung Man Leung
Ionizing Radiation Exposure Modulates
MicroRNA Expression In Human Cancer
Cells
167
3420
Sophia Bornstein
Role of Non-canonical Wnt5a Signaling
in Metastatic Oral Cavity Squamous Cell
Carcinoma
3421
Jessie Tao
A549 Lung Cancer Cells Up-Regulate
Proto-Oncogene Expression in
Mesenchymal Stem Cells
3422
Aadel Chaudhuri
MicroRNA-125b Represses IRF4 to
Induce Acute Myeloid Leukemia
3423
Michael Koukourakis
Autophago-Lysosomal Flux Following
Exposure of Endothelial Cells And
Fibroblasts to Ionizing Radiation
3424
Mariko Sato
How Can We Overcome Hypoxia- and
Radiation-Induced EMT? - Contribution
of Blockade on HIF-1 and JNK
Phospholyration With LW6
3425
Marjan Rafat
Normal Tissue Irradiation Promotes
Tumor Cell Migration
3426
Catherine Park
Tensional Properties Of Extracellular
Matrix (ecm) Modulate Radiation
Resistance Via Yes Associated Protein
(YAP)
3427
Minsi Zhang
Hif-1α Regulates Radiation Resistance
In Primary Sarcomas In A Tumor-cell
Autonomous Mechanism
3428
Bryan Allen
Assessing Superoxide Levels in Human
NSCLC and Normal Lung Epithelium
3429
Hyun Yoo
Gefitinib Inhibits Radiation-induced
Skin Fibrosis By Inhibition Of Stat1
Expression
3430
Eun-Jung Lee
Radiation-Induced Eosinophil
Recruitment Promotes Th2 response via
IL-33 production in Irradiated Skin
3431
Sibo Tian
The Role Of Fibronectin On Spatial
Organization In 3-d Culture: A Model
For Wound Healing After Radiation
Therapy
3432
Amit Maity
PI3K/Akt Inhibition Decreases Oxygen
Consumption In Tumor Cells By
Phosphorylating And Inactivating
Pyruvate Dehydrogenase (PDH) E1a
Subunit
3442
Michael Epperly
Intraoral GS-Nitroxide JP4-039 In
Novel F15 Emulsion Ameliorates
Irradiation-Induced Mucositis In Tumor
Bearing Fanconi Anemia (FA) (Fancd2-/-)
C57BL/6 Mice
3433
David Dadey
Inhibition of the PERK Arm of the
Endoplasmic Reticulum Stress Response
Attenuates VEGF Production in
Irradiated Glioblastoma Cell Lines
3443
Frank Giordano
Impact of Flattening-Filter-Free (FFF)
Radiation on the Clonogenic Survival of
Astrocytoma Cell Lines
3434
Shyam Rao
Sphingolipid Signaling with High Single
Dose SBRT/SRS
3435
Arta Monjazeb
Radiation Induced Changes In
Chemokine Expression Promote Natural
Killer Cell Homing
3436
Jonathan Schoenfeld
Response of Extra-cranial Lesions After
Treatment of Metastatic Melanoma with
Cranial Radiation and Ipilimumab
3437
Yoshiyuki Suzuki
Carbon-ion Beam And X-ray Irradiation
Increase A Release Of An Immune
Mediator Protein High Mobility Group
Box 1 (HMGB1) In Various Human
Cancer Cell Lines
3438
Marlon Veldwijk
A Potential Role for Non-targeted
Biological Effects in Cellular Inactivation
after Ionizing Irradiation with Large
Single Doses
3439
Timothy Illidge
Radiation Therapy Induces An Adaptive
Upregulation Of PD-L1 On Tumour Cells
Which May Limit The Efficacy Of The
Anti-tumour Immune Response But Can
Be Circumvented By Anti-PD-L1
3440
Vishruth Reddy
BVES Loss is Protective In Radiation
Enteritis
3441
Michael Epperly
Effects of Radiation Mitigators JP4-039
and MMS350 on Gene Transcripts in
Radiosensitive Fanconi Anemia
Fancd2-/- (C57Bl/6) Bone Marrow
Stromal Cells
3444
Takeshi Nishioka
X-ray Irradiation Induces Mitophagy
And Cancer Metabolic Reprogramming
3445
Gerben Borst
Genetically Enigineerd Mouse Models
And High Precision Fractionated
Radiotherapy To Unravel Mechanisms
Of Irradiation Escape
3446
Hiromitsu Iwata
Oxygen Enhancement Ratio Of Proton
Beams: The Precise Report Of The Same
Institution’s Experiments Using The
Clinical Equipments
3447
Trevor Leong
Gamma-H2AX as a Predictive Biomarker
of Individual Radiosensitivity
3448
Katarzyna
Zielinska-Chomej
Alternating Electric Fields (TTFields)
Inhibit Repair Of Dna Damage Induced
By Ionizing Radiation And Sensitize
Glioma And Non-small Cell Lung Cancer
Cells To Radiation
3449
Samuel Bakhoum
Dna Damage Response During Mitosis
Induces Cancer Chromosomal
Instability
3450
Fen Xia
Increasing the Synthetic Lethality of
PARP Inhibition in Glioblastoma Cells by
Depletion of Nuclear BRCA1
3451
Alexander Spektor
Micronuclei-induced DNA Damage And
Mutagenesis In Cancer
3452
Li Yuan Zhang
Minocycline-mediated Improvement Of
Cognitive Impairment Induced By
Irradiation Involves Preventing
Immature Neurons From Apoptosis
168
3453
Piotr Widlak
Radiotherapy-induced Changes In
Serum Lipidome Of Head And Neck
Cancer Patients
3454
Michael Epperly
Radiosensitivity of Human Induced
Pluripotent Stem Cells Compared to
Parental Fibroblasts
3455
Soichi Odawara
Polaprezinc Protects Intestinal
Epithelium from Radiation-induced
Damage in Mice
3456
Fan Xingwen
Electroacupuncture Ameliorates
Irradiation-induced Cognitive
Impairment in Rats via Multiple
Pathways
3457
Diana Yi Zhao
Pharmacological Inhibition And Genetic
Ablation Of The Egr1 Transcription
Factor Radioprotects The Mouse
Hippocampus And Small Intestine
3458
Xiaorong Dong
Nemo Modulates Radiation Induced
Human Umbilical Vein Endothelial Cells
Senescence Via Nf-κB Signal Pathway
3459
Heinz Schmidberger
gamma-H2AX: A Sensitive Biodosimeter
in Radiotherapy?
3460
Ippei Takahashi
KH-3, a Transcriptional Modulator of
p53, Protects Mice from
Radiation-Induced Gastrointestinal
Syndrome
3461
Lisa Abernathy
Soy Isoflavones Inhibit
Radiation-Induced Macrophage and
Neutrophil Activation and Promote
Ly6C+Ly6G- Suppressive Monocytes
Resulting in Lung Radioprotection
3462
Rafi Kabarriti
Co-transplantation Of Liver Sinusoidal
Endothelial Cells Promotes
Repopulation Of Transplanted
Hepatocytes Following Hepatic
Irradiation
3463
Jae Ho Cho
Time, Dose And Volume Response In
The Mouse Pulmonary Injury Model
After Ablative Irradiation
3464
Michael Dominello
Radioprotection of Normal Esophageal
Tissue by Soy Isoflavone Treatment
3476
Gregory Gan
Radiation Dose Uncertainty in a Mouse
Head and Neck Irradiation Model
3465
Jeffrey Buchsbaum
Improving the Delivery and Safety of
Proton Beam Therapy
3477
Jia Yang
Histopathologic Validation of 3’Deoxy-3’-18F-Fluorothymidine PET for
Detecting Tumor Repopulation During
Fractionated Radiotherapy of Human
FaDu Squamous Cell Carcinoma
3466
Napapat Amornwichet
Evaluation Of DNA Damage Response
After Carbon-ion Beam Irradiation In
P53-mutant Cancer Cells
3467
Naoko Okano
In Vitro Determination Of The Relative
Biological Effectiveness Of Carbon-ion
Beam Irradiation In Cells Derived From
Human Normal Lung Tissues
3468
Bin Wang
Pulsed Low Dose Rate External Beam
Radiotherapy: An in vivo Study On
Prostate Cancer
3469
Sei Sai
Effects of Carbon Ion Beam Alone or in
Combination with Gemcitabine and/
or Cisplatin on Cholangiocarcinoma
Stem-Like Cells
3470
Peng Zhang
Local Tumor Control And Normal
Tissue Toxicity Of Pulsed Low Dose Rate
Radiotherapy (plrt) For Recurrent Lung
Cancer: An In Vivo Study
3478
Daniel Spratt
89zr-mstp2109a, A Novel Antibody
Based Radiotracer To Evaluate And
Guide The Clinical Translation Of
Antibody-drug Conjugates Targeting
Steap1
3479
Olga Volotskova
Cerenkov Radiation Energy Transfer
(cret) As Novel Strategy For Tumor
Imaging And Delineation
3480
Masayuki Matsuo
Pulsed Electron Paramagnetic
Resonance Imaging For Evaluation Of
Reoxygenation In Murine Tumors: A
New Reoxygenation Imaging For
Radiation Therapy
3481
Makoto Hosono
Heterogeneity of Intratumoral Hypoxia
on FMISO PET/CT in Association with
Local Control in Radiation Therapy
3471
Pervin Hurmuz
The Effect Of Dose Rate Per Fraction On
Lung Toxicity
3482
Zhenhua Gao
Comparison Of Tumor Volumes As
Determined By Pathologic Examination
And Flt-pet/ct Images Of Non-small-cell
Lung Cancer: A Pilot Study
3472
Sreeja Sarojini
Experimental Radiation (2400 MU/min/
50cGy) In Vitro Achieved Significant
Increase In Apoptosis On Melanoma
Cells With Superior Survival Of Normal
Cells When Compared To 400 MU/min
3483
Martin King
Evaluation Of A Gamma Rejection
Strategy For CCD-based Beta Particle
Imaging
3473
Masatoshi Hasegawa
Changes of Cancer Stem Cell Markers in
Human Ependymoblastoma Following
Carbon Ion Beam Irradiation
3474
Anil Pyakuryal
Radio-biologic Evaluation of
Simultaneously Integrated Boost (SIB)
IMRT Methods in Head and Neck
Cancer: Multi-Institutional Study
3475
Marjan Rafat
Impact of Very Rapid Irradiation on
Clonogenic Survival
3484
Andrea Laruelo
Towards Accurate and Robust MRSI
Quantification to Improve the
Radiotherapy Treatment of GBM
3485
Brian Marples
Evaluating Low-Dose Pulsed Radiotherapy in Murine Model of Neuroblastoma
3486
Vaishali Kapoor
Monoclonal Antibody 2C6F3 Against
Radiation-inducible Cell Surface Tip-1
As A Novel Agent For Imaging And
Targeting Tumors
169
3487
Jessica Perez
Fluorescence Endomicroscopy as a Tool
to Assess Radiation-Induced Lung
Damage, Protection and Regeneration
3488
Keum Sil Lee
Impact of Optimally-Gated PET on
Tumor Localization And Quantification
3489
Kuei Lee
Glucose Metabolism Gene Expression
Patterns and Tumor Uptake of 18F-FDG
Following Radiation Treatment
3490
Moiz Ahmad
X-ray Fluorescence CT As A Novel
Imaging Modality For Improved
Radiation Therapy Target Delineation
3491
Dominik Naczynski
Development Of X-ray Luminescent
Infrared Probes For Tumor Imaging
3492
Shunsuke Furutani
MEK Inhibition by Selumetinib
Enhances the Antitumor and
Anti-Metastatic Effects of
Chemoradiation Therapy in Orthotopic
Human Lung Cancer Models
3493
Shin-ichiro Masunaga
Significance of Administering
Bevacizumab Combined with Boron
Neutron Capture Therapy in terms of
Local Tumor Control and Lung
Metastatic Potential
3494
Noriyuki Okonogi
Therapeutic Impact Of
Intravenous-injection Of Microglia On
Radiotherapy For Malignant Glioma
Arising In S100beta-v-erbB Transgenic
Rat
3495
Satoshi Harada
Tumor Imaging, Antitumor Action, and
Inhibition of Metastasis Using Targeted
Anti-CD47 siRna Nanoparticles and
Radiotherapy
3496
Chi Zhang
Genotype-dependent Tumor Inhibitory
Effects of Metformin in Glioblastoma
Cells
3497
Zhenhuan Zhang
PTIP Down-regulation Enhances
Radiation-induced Tumor Cell
Suppression In Vitro and on CAM
3498
Mohamed Khattab
PSMA-targeted Low Molecular Weight
Urea-siRNA Conjugates for Targeted
Knockdown of DNA-PK and
Radiosensitization of Prostate Cancer
Cell Lines
3499
Peter Huber
Stepwise Combination Of
Multi-pathway Blockade In Addition To
Radio-chemotherapy For Glioblastoma
3500
Nils Nicolay
Multi-pathway Inhibition As A Novel
Strategy To Attenuate
Radiation-induced Pulmonary Fibrosis
3501
Uma Raju
Inhibition of IGF-1R Signaling Enhances
the Head and Neck Tumor
Radioresponse But Fails to Further
Improve Tumor Response to Cetuximab
and Radiation Therapy In Vivo
3502
Ping Li
Photothermal Effect By Rgd-conjugated
Gold Nanorods Enhances The Efficacy
Of Radiotherapy In Melanoma Cancer
Cells
3503
Szu-Yuan Wu
Combination Of Metformin And Statins
Significantly Enhanced The Local
Radio-therapeutic Effect And
Attenuated The Lung Metastasis Of
Lewis Lung Carcinoma (LLC) Animal
Model
3504
Yuji Seo
Systematic Linear-Quadratic Analysis for
Radiosensitization in vitro: Implications
for Hypofractionated Radiotherapy in
the Combined Modality Approaches
3505
Edina Wang
Nanoparticle Formulations of HDAC
Inhibitors as Radiosensitizers
3506
Dong Wook Nathan Kim
Validated Tumor Graft Model Reveals
Delayed Local Recurrence of Renal Cell
Tumors after High Dose Single Fraction
Ablative Radiation Therapy
3507
Darrion Mitchell
Epithelial-to-Mesenchymal Transition as
a Therapeutic Target in Prostate Cancer
3509
Qian Dong
Human Positive Cofactor 4 (PC4) is a
Promising Target to Improve the
Radiotherapy Effect of Esophageal
Squamous Cell Carcinomas
3510
Xi Tian
Preclinical Evaluation Of Promitil, A
Novel Nanoparticle Formulation Of
Mitomycin C, In Chemoradiotherapy
3511
Seong-Yun Jeong
Ibulocydine Sensitizes Human Cancers
to Radiotherapy by Induction of
Mitochondria-Mediated Apoptosis
3512
Seong-Yun Jeong
The Combination Of Hyperthermia,
Radiation And Chemotherapy For
Tumor Suppression Using Hollow Gold
Nanoparticles
3513
Masao Nakayama
Dose Estimation Of Normal Brain Tissue
Tolerance For Microbeam Radiation
Therapy
3514
Manuela Felix
Converting A Standard Micro-CT Into
An IGRT-competent Small Animal
Irradiation Device
3515
Yunguang Sun
Igfbp3 Promotes Cell Death and
Sensitizes Cisplatin and Radiation
Treatments in Lung Cancer Cell Models
3516
Yunguang Sun
Nit1 Is a Novel Therapeutic Target
for the Sensitization of Chemo- and
Radiotherapy in Kras Mutant Lung
Cancer Models
3517
Ana Kiess
Targeted Molecular Auger Radiotherapy
for Micrometastatic Prostate Cancer
3518
Tao Wang
Disruption Of Erk1/2 Sensitizes
Radiation Resistance Prostate Cancer
Cells To Paclitaxel And Ionizing
Radiation
3519
Peter Liu
A Zebrafish Drug Screen Repositions
FDA-Approved Compounds for
Radiochemotherapy
3508
Ligang Xing
Improve The Effect Of Radiotherapy For
Recurrent Esophageal Squamous Cell
Carcinoma With Sodium Glycididazole
170
3520
Thomas Quinn
Immunophenotype of B16-F10
Melanoma After Combination Therapy
With Radiation and Systemic,
RGD-targeted, Adeno-associated Virus
Phage-TNF
3531
Kate Barrett
Genetic Polymorphisms Associated
with Toxicity are Associated with
Overall Survival Following Curative
Radiation for Non-Small Cell Lung
Cancer
3521
Tithi Biswas
Combining Pemetrexed with
Methoxyamine to Enhance the
Radiosensitization of Non-Small-Cell
Lung Cancer (NSCLC): Preclinical Studies
in vivo
3532
Jinyi Lang
Early Changes In Adc Involved In
Mmp-9 Expression Predict The
Response Of Tumor To Irradiation On
Mice Bearing U14 Cervical Cancer
3522
Ralph Vatner
Macrophage-Targeting Agents to
Stimulate Anti-Tumor Immunity Elicited
by Radiotherapy
3523
Arta Monjazeb
Radiation Enhances Innate Immune
Recognition Of Cancer Stem Cells In
Solid Tumors
3524
Tu Dan
The Effect Of Nutrigenomics In
Augmenting Radiation Therapy For
Breast Cancer
3525
Jia Yang
Effect Of Celecoxib On Inhibiting Tumor
Repopulation During Radiotherapy In
Human Fadu Squamous Cell Carcinoma
3533
Maria Teresa Bortolin
Multiplexed Plasma Cytokine
Chemokine and Growth Factor Profiling
in Early-Stage Non-Small Cell Lung
Cancer Patients Undergoing
3534
Leslie Modlin
Circulating Tumor DNA Concentrations
Reflect Metabolic Tumor Volume in
NSCLC
3535
Reza Masoud Rahbari
Enhanced Rad21 Cohesin Expression
Confers Poor Prognosis And Resistance
To Chemotherapy In High Grade
Luminal, Basal And Her2 Breast Cancers
3537
Ting Xu
Nanopore-peptidomics To Predict
Response To Chemoradiotherapy For
Lung Cancer
3527
Meetha Medhora
Mitigation Of Radiation-Induced Injuries
To Multiple Organs In Rats By
Fda-approved Drugs And Supportive
Care
3538
Yipeng Song
Association of Radiation Pneumonitis
Related Single Nucleotide
Polymorphisms and Changes in
Pulmonary Function in Patients with
Non-small Cell Lung Cancer after
Definitive Concurrent Chemoradiation
3529
Thomas Enke
Molecular Radiotherapy In
Experimental Model of Advanced
Prostate Cancer Using Internalizable
Monoclonal Antibody
3530
Michael Epperly
Reduced Radiation Pulmonary Fibrosis
in Toll-Like Receptor-4 (TLR4) Deletion
Recombinant Negative Mice
3542
Jessica Wobb
The Significance of 18FDG PET and
Related Glucose Metabolism Biomarkers
in HPV Positive and Negative Head and
Neck Squamous Cell Carcinomas
3544
Richard Tuli
Correlation of Methylation Patterns
and Gene Expression with Radiation
Response of SMAD4-Characterized
Pancreatic Cancer Xenografts
3545
John Grecula
Dynamic-Contrast Enhanced MR and
Volume Regression rate as a
preoperative predictive assay in
patients with Non Small Cell Lung
Cancer
3546
Evan Osmundson
Circulating Tumor DNA as a Biomarker
for Pancreatic Adenocarcinoma
RADIATION PHYSICS
3536
Ana Ruiz-Alonso
Prognostic Biomarkers in Tongue
3526
Michael Epperly
Disparate Gene Transcript Patterns
Between Radiosensitive Bone Marrow
Stromal and Radioresistant
Hematopoietic Cell Lines From Fanconi
Anemia (FA) (Fancd2-/-) C57BL/6 Mice
3528
Michael Epperly
Organ Specific Levels of MnSOD in
Tet-Inducible Manganese Superoxide
Dismutase Mice
3541
Jonathan Thompson
Toll-like Receptor-9 Expression Does
Not Predict for Breast Cancer Specific
Outcome in African-American
Triple-Negative Breast Cancer Patients
3566
Justin Linam
No Need to Wait: Fiducial Migration in
Immediate Versus Delayed Simulation
for Prostate IGRT
3567
Nzhde Agazaryan
Dosimetric Impact Of Positioning Errors
For Spinal Radiosurgery Patients: A
Planning Tool Proposition
3568
Elisabeth Weiss
Is there a Need for Reassessment of
Internal Target Volumes (ITV) During
Radiotherapy for Locally Advanced
Lung Cancers?
3539
Anwen Liu
Serum CRP Is Predictive Of Survival In
Non-small-cell Lung Cancer Patients
Treated With Definitive
Chemoradiotherapy
3569
Mitsuhiro Nakamura
Improving The Target Estimation
Accuracy In Infrared Marker-based
Dynamic Tumor Tracking With a
Gimbaled Linac
3540
Steve Walston
Papillomavirus E2 Protein As A
Biomarker For Radiation Sensitivity In
HPV Associated Head And Neck
3570
Judit Boda-Heggemann
Breath-Hold Cone Beam Ct (CBCT):
Improved Image Quality With
“Stop-and-go” Breathhold-only
Acquisition Versus Repetitive
Breathhold During Continuous Rotation
3571
Mami Akimoto
Baseline Correction of a Correlation
Model In Infrared Marker-Based
Dynamic Tumor Tracking With a
Gimbaled Linac
3572
Laura Padilla
Patient-Specific Collision Detection
Package Using Surface Imaging
3573
Youngjun Kim
Is Surface Registration Accurate Enough
For Patient Setup In Head-and-neck
Radiation Therapy?
3574
Shingo Oohira
Couch-height Based Patient Set-up For
Abdominal Radiation Therapy
3575
Pengpeng Zhang
Setting Action Levels For Abdominal
Monitored With Frequent KV Imaging
Surveillance
3576
Winky Wing Ki Fung
Effect of Residual Non-Rigid Errors on
Actual Delivered Dose in Prone Breast
Tomotherapy
3577
Manuel Blessing
Image Guided Radiotherapy Using
Ultrafast Kv-mv Cbct: End-to-end Test
Results Of The Finalized
Implementation
3583
Allen Li
A Comparison of Six IGRT Modalities
Used for Soft-Tissue Sarcoma of the
Extremity in RTOG 0630
3594
Yoshihiro Ueda
Setup Evaluation of Two
Immobilization Systems For Stereotactic
Body Radiotherapy
3584
Madeera Kathpal
Margins for Deep Inspiration Breath
Hold (DIBH) With Electromagentic
Surface Transponder Confirmation
of Chest Wall Position for Adjuvant
Therapy of Left Breast Cancer
3595
Bernard Jones
Adaptive Motion Mapping in Pancreatic
SBRT Patients using Fourier Transforms
3585
Kathryn Mittauer
Variation of Controlled Breath Hold
from CT Simulation to Treatment and its
Dosimetric Impact for Left-sided Breast
Radiotherapy with a Real-time Optical
Tracking System
3586
Olivier Gayou
Imaging A Moving Tumor With
Megavoltage CBCT
3587
Niranjan Bhandare
Comparing DVH Parameters of 3D
Inverse Planning Simulated Annealing
(IPSA) with Manual-graphical
Optimization in the Treatment of
Uterine Cervix with HDR Brachytherapy
using a Tandem-and-ring Applicator
3588
Jean Peng
Assessment Of Setup Variability For
Prostate Patients With Rectal Balloon
By 3D CBCT And Real-time Surface
Imaging
3578
Anna Arns
Matching Accuracy of Ultrafast
Kilovoltage-Megavoltage (kV-MV)
Cone-Beam CT for Image Guided
Radiotherapy
3589
Etienne Letourneau
Organ Dose Reduction While Using
In-house CBCT Patient-specific
Protocols Based on OSL Dosimetry
3579
John Park
Clinical Analysis of Patient Setup on
Image-Guided Frameless Stereotactic
Radiosurgery for Acoustic Neuromas
3590
Martin Hojgaard
Deep Inspiration Breath-hold Radiation
Therapy Reduces Heart Radiation Dose
In Gastric Radiotherapy
3580
Karen Mooney
Determining The Internal Margin (IM)
For Lung And gastrointestinal Tumors
Based On Real-time Measurements
3591
You Zhang
Lung 4D-CBCT Reconstruction using
Prior Information and Limited-angle
Projections - Phantom and Patient
Studies
3581
William Plishker
Retrospective Assessment of Image
Mask Box Sizing for Automatic Patient
Positioning
3582
Mirza Ali
Study of Inter Fraction Movements
of Tongue During Radiation Therapy
in Cases of Tongue Malignancy using
Volumetric KV Cone Beam CT (CBCT)
Imaging
3592
Casey Abing
Intra-Fraction Position Management
Post-Cone Beam CT Using Stereoscopic
X-ray Verification for Stereotactic Body
Radiotherapy Lung Treatment
3593
Hui Cheng
Utrecht Intertitial Applicator Shifts And
Organ Movements In 3d Ct-based Hdr
Brachytherapy Of Cervical Cancer
3596
George Noid
Feasibility of Using Ultrasound to
Monitor Intrafraction Motion During
Radiation Therapy for Pancreatic Cancer
3597
Hao Zhang
The Accuracy Of Intra-fraction Tumor
Motion Modeling With Respiratory
Surrogates Using Supervised Learning
3598
Guanzhong Gong
To Study the Feasibility and Potential
Benefit of Defining the Internal Gross
Tumor Volume (ITV) for
Hepatocellular Carcinoma (HCC)
Applying the Contrast-enhanced 4D-CT
Obtained by Deformable Registration
Technology
3599
Benjamin White
Motion Assessment of the Left Anterior
Descending Aorta during Clinical 4DCT
3600
Alon Witztum
Dosimetric Effect Of Setup Errors On
Multiple Isocenter Volumetric
Modulated Arc Radiotherapy For
Craniospinal Axis
3601
Bo Zhao
Comparison Of Deep Inspiration Breath
Hold Left Breast Tangents With Active
Breath Hold And Voluntary Breath Hold
Using 3d Surface Image Guidance
3602
Paul Keall
Clinical Process and Quality Assurance
Practices for the Clinical
Implementation of Kilovoltage
Intrafraction Monitoring (KIM) for
Real-Time Image-Guided Prostate
Cancer VMAT
3603
Dengwang Li
Multi-resolution Liver Segmentation For
CT By Hybrid Method
3604
Clare Suttie
Surgical Clips in Breast Tumor Cavity
Photon Boosts: Impact on CTV Size, and
Utility in Image Verification Using
Non-orthogonal KV Imaging
172
3605
George Chiu
Acute Skin Reaction of Whole Breast
Irradiation in Supine and Prone Position
Using Tomotherapy
3606
Ti-Hao Wang
Margin Assessment and Optimization
in Prostate Irradiation by Quantitative
Analysis of Daily Mega-Voltage
Computed Tomography
3607
Jessica Scholey
Development Of Image Registration
For Novel Megavoltage Topogram For
Patient Localization In Tomotherapy
3617
Martina Hurwitz
Investigation of a Respiratory Motion
Model Based on an External Surrogate
Signal With a Digital Phantom and
Realistic Patient Breathing
3628
Jeho Jeong
Investigation of Temporally Varying
Fractionation in Radiation Therapy
Using a Resource-Conservation Tumor
Response Model
3618
Shane Stecklein
Dosimetric Effects of Respiratory
Motion and Interfraction Setup
Variation on Internal Mammary Node
Irradiation
3629
Ruben Carmona
Longitudinal Study Of Fat
Composition Changes In Bone Marrow
During Chemotherapy And
Radiotherapy For Pelvic Malignancies
3619
William Watkins
Automated Evaluation of Deformable
Image Registration using Physical Tissue
Characteristics
3630
Caspar Van Leeuwen
Meta-Analysis Of Tumor Fractionation
Sensitivities Based On Clinical Data
3631
Piotr Pater
Estimation of DNA Damage Yields Due
to Low Energy Electrons
3608
John Van Sornsen
de Koste
Markerless Tracking Of Lung Tumors On
Continuous Kv Images
3620
Shidong Li
Live Video Imaging Guided
Radiotherapy of Breast Cancer
3609
Susannah Hickling
Feasibility Of X-ray Acoustic Computed
Tomography As A Tool For Non-Invasive
Volumetric In Vivo Dosimetry
3621
Yong Yang
Optimization of Dosimetric Margins
for CBCT-Guided Prostate Volumetric
Modulated Arc Therapy (VMAT)
3632
Norma Ybarra
Impact Of Mesenchymal Stem Cells
Delivery Routes On Recovery From
Radiation-induced Lung Injury Using Ct
Densitometry: Preclinical Investigation
3610
Joshua James
Quantification of PTV Margin When
Using a Robotic Radiosurgery System to
Treat Lung Tumors With Spine Tracking
3622
Caroline Chung
Clinical Evaluation of a Novel
Thermoplastic Mask System with
Intrafraction Motion Monitoring using
IR Tracking and Cone-beam CT for
Dedicated Cobalt Radiosurgery Unit
3633
Scott Merrick
Creation of a More Comprehensive
Target Volume for Esophageal Cancers
by Combining Respiratory Gated
Simulation and Daily Image-Guided
Radiation Therapy (IGRT)
3623
Miranda Risberg
A Prospective Trial Of Kv Stereoscopic
X-rays With Fiducials Versus Ultrasound
For Daily Image Guidance In Prostate
Cancer
3634
Daniel Cho
Predicting Radiotherapy Outcome for
Head and Neck Cancer Patients using
Artificial Neural Network (ANN)
3611
Rojano Kashani
Feasibility of Gating Using a
Magnetic-Resonance Image-Guided
Radiation Therapy (MR-IGRT) System
3612
Mikael Antoine
Geometrical Analysis Of Organs Motion
For Preoperative Helical Tomotherapy
Of Retroperitoneal Liposarcomas
3613
Per Poulsen
Performance Improvement of MLC
Tracking Investigated with an
Experimentally Validated Tracking
Simulator
3614
Jonathan Lischalk
Correlation Of Fiducial Motion In 4D-CT
Planning Scans With Real-time Fiducial
Tracking During Fractionated SBRT Of
Upper Gastrointestinal Malignancies
3615
Louise Fanchon
Spatially Accurate Ground Truth For Pet
Segmentation Verification From Biopsy
Specimens Extracted Under PET/CT
Guidance
3616
Wu Liu
Optimized Prostate Intrafraction Motion
Management IGRT Strategy for 3mm
Margin
3624
Arta Monjazeb
Analysis of Daily Setup Variation with
Image-Guided Treatment of Soft-Tissue
Sarcomas
3625
Angelo Bergamo
Hypofractionated Liver Stereotactic
Body Radiation Therapy: Biological
Effective Dose Correlated Radiation
Induced Liver Disease
3626
Florian Kamp
Predicting the Relative Biological
Effectiveness of Carbon Ion
Radiotherapy Beams using the
Mechanistic Repair-Misrepair-Fixation
(RMF) Model and Nuclear Fragment
Spectra
3627
Daniel Simpson
A Novel Multi-institutional Database for
Tracking and Reporting Dose-Volume
Data and Normal Tissue Effects
3635
Feng Mei
Ct Number Changes Observed During
Ct-guided Radiotherapy For Head And
Neck Cancer, A New Indicator For
Treatment Response
3636
Ke Sheng
Detecting Prostate Focal Lesions In Ct
Images
3637
Phillip Prior
Normal Tissue Complication
Probability Modeling For Chest Wall
Pain In Stereotactic Body Radiaton
Therapy: An Analysis Of Compiled
Clinical Data
3638
Maria Thor
Identifying Groups Of Patient-reported
Gastro-intestinal Symptoms Using
Factor Analysis
173
3639
John Kang
A Free Multi-model Program For
Comparing Linear-quadratic And
Non-linear Quadratic Models In TCP
Prediction Of SABR-treated NSCLC
3640
Victoria Yu
A Dual Compartment Linear-Quadratic
Model of Cell Survival
3641
Tiziana Rancati
An In-Silico Experiment Model to Identify the Best Predictors of Radioinduced
Late Toxicity
3642
Wilfred Ngwa
Radiotherapy Biomaterials For Response
Assessment And Nodal Detection
(brand)
3643
Louise Murray
Risk Of Second Malignancy Following
Prostate Radiotherapy Using
Contemporary Radiotherapy
Techniques
3644
Jagdeep Raince
Integrated Deformable Registration
and Biologic Modeling to Compare
Dose Distributions of High Dose IMRT
and Combination IMRT-Brachytherapy
(combo-RT) in Localized Prostate
Cancer
3645
Omar Ishaq
Dosimetric Comparison between Split
Ring and Tandem & Ovoid HDR
Brachytherapy Applicators in Cervical
Cancer Treatment
3646
Rebecca Howell
Toward Developing Survivorship Care
Plans For Breast Cancer Patients at High
Risk for Radiation-related Cardiac Effects
3647
Eric Paulson
Rapid Evaluation of Radiotherapy
Response using Multi-Parametric Image
Treemaps
3648
Seha Hwang
Study On The Sensitivity Of
Gamma-index Evaluation Methods To
Positioning Errors Of High-definition
MLC Of True Beam STx In VMAT Quality
Assurance For SBRT
3650
Eelco Lens
Dosimetric Benefits Of Using A
Mid-ventilation Or Breath-hold
Approach As An Alternative To Internal
Target Volume For Pancreatic Cancer
Patients
3660
Leonard Kim
Fast, High-Resolution, 3-D Imaging of
Tissue Blocks Using Optical Coherence
Tomography: Visualizing Microscopic
Disease for Clinical Target Volume
Design
3651
Kristofer Kainz
Validation Of A Technique To Derive A
Virtual Phase-specific PET Contour From
Free-Breathing PET
3661
Roxana Draghici
Volumetric Modulated Arc Therapy For
Bilateral Breast Carcinoma: Dosimetric
Analysis and Immediate Tolerance
3652
Michael Altman
Addressing The Issues Limiting Rapid
Contour Evaluation To Facilitate Efficient
On-line Adaptive Radiation Therapy
(OL-ART) With MR-IGRT
3662
Danita Kannarunimi
Dose Analysis of MRI-Based Planning
Techniques Using Volumetric
Modulated Arc Therapy in Brain Tumors
3653
Di Yan
Evaluation of Image Guidance &
Adaptive Radiotherapy Techniques for
H&N Cancer
3654
Kyoung Jun Yoon
Evaluation Of CBCT based Dose
Calculation in an Enhanced CBCT
System
3655
Raj Varadhan
Applicability and Limits of Dose
Warping: Are There Islands of
Deformation that Fail to Depict Dose
Painting?
3656
Lotte Fog
Towards A Criterion For Selective
Adaptive Radiotherapy In Head And
Neck Cancer Patients
3657
Aaron Judith
Impact Of Breathing Motion On Imrt
(intensity Modulated Radiation Therapy)
Of The Chest Wall In Post-mastectomy
Breast Cancer Patients: A
Dosimetric Comparison With 3d
Conformal Radiotherapy
3658
Kwun-Ye Chu
Impact of Weight Change on Dose
Delivery In Pancreatic IntensityModulated Radiotherapy
3659
Jesus Olivera
Localized Prostate Cancer: Volumetric
Modulated Arc Therapy (VMAT) Versus
Intensity Modulate Radiation Therapy
(IMRT): Which one is better?
3649
Yujiro Fujita
Potential Uncertainty as to 3D Image
Registration in Thoracic Image-Guided
Radiotherapy
3663
Guillem Pratx
First Demonstration of Medical
Radiation Treatment Beam Monitoring
via Air Scintillation Imaging
3664
Yuri Jeong
A Dosimetric Comparison of Volumetric
Modulated Arc Therapy (VMAT) and
Non-coplanar Intensity Modulated
Radiotherapy (IMRT) for Nasal Cavity
and Paranasal Sinus Cancer
3665
Ludovic Bedos
CT Number Accuracy Assessment Of A
New Metal Artifact Reduction
Algorithm For CT Simulations In
Radiation Therapy
3666
Suhong Yu
Application Of Cone Beam CT For
Adaptive IMRT Treatment Planning
3667
Peter Balter
A Framework for Dose Based IGRT:
Validation of Dose Cloud Shift
Assumption
3668
Masakuni Kawakami
Development of Error Estimating
Program for IMRT Dose Delivery using
Dynamic MLC Log Files
3669
Kenji Matsumoto
Statistical Process Control For Epid
Dosimetry In The Quality Assurance
Of IMRT
3670
Lisa Tachiki
Deformable Contour Propagation of
Organs-At-Risk in Adaptive Head and
Neck Radiation Therapy
174
3671
Shiv Srivastava
The Effect of Slice Thickness on Target
and Organs at Risk Volumes, Dosimetric
Coverage and Radiobiological Impact In
IMRT Planning
3672
Ahmad Amoush
Potential Systematic Errors in IGRT
When Different Reference Images are
used for Pancreatic Tumors
3673
Fengxiang Li
Quantifying Internal Target Volume
Uncertainties Derived From
Three-Dimensional CT and
Four-Dimensional CT for Radiation
Therapy of Non-Small-Cell Lung Cancer
3674
Fengxiang Li
Evaluation of Movement of Peripheral
Non-small-cell Lung Cancer using
Four-dimensional CT
3675
Wenyang Liu
Four-dimensional CT-based Evaluation
Of Intrafractional And Interfractional
Anastomosis Motion During
Postoperative Radiotherapy in Gastric
Cancer: A Prospective Study
3676
Nicholas Serrano
Correlation Of Three Imaging Modalities
For Pre-treatment Alignment In Head
And Neck Imrt
3677
Jorge Alpuche Aviles
Commissioning Of A Prostate Model
Created Using Knowledge Based
Planning As A Tool To Guide The
Planning Process
3678
Jun Lian
Prostate Deformation from Rectal
Balloon and Dosimetric Effects in
Prostate Brachytherapy
3679
Ben J.M. Heijmen
Fully Automatic IMRT and VMAT
Treatment Planning in Routine Clinical
Practice
3680
Joel Castelli
Impact Of Weekly Re-Planning To Spare
The Parotid Glands In Head And Neck
Cancer Radiotherapy
3681
Takeshi Kamomae
Dosimetric Influence of Dental Crowns
on IMRT and VMAT for Head and Neck
Cancer: Correlation Between Planned
Radiation Doses and Measured Dose
Enhancements
3682
Shirish Jani
On Clinical Utility of Orthopedic Metal
Artifact Reduction (OMAR) Software in
CT Simulation and Treatment Planning
3683
Suk Lee
Development of 3D Dose Evaluation
Solution for Off-line Dose Guided
Adaptive Radiotherapy in
Multi-modality IMRT Techniques
3692
Rob Tijssen
A Combined Breath Hold and Free
Breathing Protocol is not Feasible for
Locoregional Radiation Therapy of
Left-sided Breast Cancer
3693
David Thomson
Automatic Segmentation to Define
Organs at Risk (OARs) for Function
Sparing Head and Neck IMRT
3694
Yong Hum Na
VMAT Treatment Planning Using Cloud
Computing
3684
Kwang Hwan Cho
Dosimetric Evaluation Using MVCT
Images For Adapted Plan-dose
Monitoring In Tomotherapy
3685
Pascal Fenoglietto
Metal Artifact Reduction (mar)
Algorithm For Head And Neck With
Dental Prosthesis
3686
Kenton Thompson
Feasibility of PTV and OAR Overlap as a
Predictive Planning Tool
3687
Suk Lee
Which Is An Optimizing Modality For
Imrt Prostate Case In Linac Step And
Shoot, Tomotherapy, Rapidarc, Vamt,
And Proton Using New Plan Evaluation
Scoring Index And Dosimetric Physical
Index?
3688
Young-nam Kang
The Feasibility Study Of MRI-based
Dose Calculation With Look Up Table In
Radiation Treatment Planning
3689
Stefania Pallotta
Treatment of Moving Lesions with
Helical Intensity-Modulated
Radiotherapy (HIMR): A Phantom Study
3690
Gulay Karagoz
Evaluation of MLC Leaf Position
Accuracy for Static and Dynamic IMRT
treatments Using DAVID In Vivo
Dosimetric System
3691
Akira Sakumi
Impact Of A Low Transmission Multileaf
Collimator on The Parotid Grand
Dose In Head And Neck Volumetric
Modulated Arc Therapy Planning - A
Dose Volume Histogram Comparison
Between Two-step Adaptive And
Simultaneously Integrated Boost
Techniques
3695
Christian Fiandra
Planning Dose Recalculation on Cone
Beam CT Images for Hypo-fractionated
SBRT in Prostate Cancer: Dose Tracking
Comparison with and without the
use of Seed Markers for a daily online
Repositioning Process
3696
Sophia EdwardsBennett
Utilization of a Novel Adaptive Dose
Recalculation Tool in the Delivery of
High Dose Radiation for Intermediate to
High-Risk Prostate Cancer
3697
Neil Kirby
The Potential for Patient-Specific,
Automated Evaluation of Deformable
Image Registration Accuracy
3698
Wensha Yang
Overlap Volume Analysis using 4DCT:
Implications for Gating in SBRT of the
Lung and Pancreas
3699
Evan White
Optimization Index: A Tool for
Quantitative Comparison of Radiation
Treatment Plan Quality
3700
Antonio Damato
Changes in Kidney Position and Dose
Due to Respiratory Motion in
Gynecologic Patients Receiving
Extended Field Intensity Modulated
Radiation Therapy
3701
Guangjun Li
Daily Delivery Accuracy Of Volumetric
Modulated Arc Therapy Treatments
Using Linac Log Files
175
3702
Francisco Clemente
Gutierrez
3D Secondary Verifications for VMAT
Prostate Treatments Based in
DVH-metrics and 3D Gamma Analysis
3703
Eric Paulson
Rapid Evaluation of Radiation Treatment
Plan Quality using Interactive Treemaps
3704
Xiangrong Qi
Assessment of Volumetric and
Dosimetric Variations for Image Guided
Treatment
3705
Andre Vieira
Quality Assessment Of Vmat Plans For A
Linac Unity Using The AAPM-tg119 Tests
3706
Marta Adamczyk
The Influence of Various VMAT
Optimization Strategies on Final Plan
Quality in the Treatment of Prostate
Cancer
3707
Aaron Nelson
Comparison Of Two Atlas-based
Segmentation Methods For Head And
Neck Cancer With Rtog-defined Lymph
Node Levels
3708
Xiangfei Chai
A Web-based Image Processing and
Plan Evaluation Platform (WIPPEP) for
Future Cloud-Based Radiotherapy
3709
Rachel Tuohy
Strategies For Evaluation of Daily
Delivered Dose Using Cone Beam CT
(CBCT)
3714
Ziad Fawaz
Intrafraction Cone Beam Computed
Tomography Imaging Evaluation
During Stereotactic Body Radiation
Therapy For Lung Tumors and
Metastatic Tumors to the Spine
3715
Teh Lin
Comparative Assessment of Adaptive
Radiation Therapy on Partial Bladder
Cancer Treatment between CT-on-Rails
(CTOR) and KV Cone Beam CT (CBCT)
3716
Dewayne Defoor
On The Evaluation Of Patient Specific
IMRT QA Using EPID, Dynalog Files and
Patient Anatomy
3717
Weiguang Yao
Approach to Obtaining Optimal
Combination of MLC Transmission Ratio
and Dynamical Leaf Gap for IMRT/VMAT
Dose Calculation in TPS
3718
Xiaojian Chen
Interfractional Variation Of Cardiac Dose
During Whole Breast Irradiation
3719
Kelly Erickson
A Technique To Quantify And Reduce
Backscatter Due To Metallic Dental
Restoration In Head And Neck
Radiotherapy
3720
Robert Reynolds
Initial Experience with VMAT Plan and
Delivery Verification using a DICOM-RT
Framework and Linac Delivery Log Files
3710
Jason Li
Dose Delivery Accuracy of VMAT with
Frequent Interruptions
3721
Chang Liu
Delivered Target And Organ Dose
Estimation Using Deformable Image
Registration On Cone-beam Computed
Tomography (cbct) Scans For Head And
Neck Radiotherapy
3711
Silvia Chiesa
The Dosimetric Consequences Of A
Rotational Positioning Correction In
IGRT Prostate Volumetric Modulated
Arc Therapy (VMAT) Treatment Using A
6 DOF Robotic Couch
3722
Joong Yeol Woo
Evaluation Of Fast Adaptive Planning
Method Using Deformable Image
Registration And Gpu Based Rtp For
Lung Cancer Patients With Concurrent
Chemoradiotherapy.
3712
Qiong Xu
On-board CBCT Imaging Using 2.5 MV
Beam On A Radiotherapy Linac For
Metal Artifact Reduction
3723
Ralph Vatner
Salvage Radiotherapy (RT) for
Recurrence in the Brain After Surgical
Resection and Involved Field Radiation
Therapy (IFRT) for Single Brain Metastases: VMAT Versus Matched Lateral Fields
3713
James Robar
Compensation for Imaging Dose in
Low-Z Target Volume-of-Interest CBCT
3724
Vangipuram Shankar
Deformable Dose Accumulation on 4-D
CBCT static derived series In Oligofractionated Lung SABR - Trigger Tool For
Adaptive Replanning?
3725
Chunhui Han
Mobile Gross Target Volume Variations
In Computed Tomography Images For
SBRT Treatment Of Early-stage Nonsmall Cell Lung Cancer Patients Using
Abdominal Compression
3726
Rodney Ellis
Comparative Analysis For Renal
Stereotactic Body Radiotherapy (sbrt)
Using Robotic Radiosurgery (RR),
Protons, And Linac Based Treatment
Planning Techniques
3727
Simon Lo
A Multi-National Report on Technical
Factors of Stereotactic Body
Radiotherapy for Oligometastases
3728
Lijun Ma
Clinical Realization of Sector Beam
Intensity Modulation for Gamma-Ray
Based Radiosurgery
3729
Anna Simeonova
Automatically Gated CBCT-controlled
Fast Breath-hold SBRT Is Dosimetrically
Robust and Facilitates Precision
Treatments For Patients With Lung
Cancer
3730
Chuxiong Ding
Multistage Stereotactic Radiosurgery
for Large Intracranial Arteriovenous
Malformations: Focused Cobalt-60
Radiosurgery Versus Robotic
Radiosurgery
3731
Kohei Okawa
Comparison Of 3-d And 4-d Plans In
The Radiotherapy For Lung Cancer
Using Real Time Tumor Tracking System
3732
Jan-Erik Palmgren
Robotic Stereotactic Radiotherapy
Compared To 3d Mr Image Guided Hdr
Brachytherapy In The Treatment Of
Cervical Cancer
3733
Joerg Rottmann
Verification Real-Time Image
Acquisition System (VERITAS)
176
3734
Yutaka Naoi
Accuracy of Hypofractionated
Intracranial Stereotactic Radiotherapy
under Cone-beam Computed
Tomography Image Guidance with a
Six Degrees of Freedom Robotic Couch
and Mask System
3735
Jessica Molinier
Is Tracking Better Than Free Breathing
For Lung Stereotactic Treatments? A
Dosimetric Comparison
3736
WITHDRAWN
3737
Thierry Gevaert
Investigation Of The Optimal
Prescription Isodose For Stereotactic
Radiosurgery Of Vestibular
Schwannomas
3738
Femke Steenbeke
Targeting Accuracy Of A Stereotactic
Frameless Radiosurgery Technique For
Arteriovenous Malformation
3739
Alexander Louie
Dosimetry, Image Guidance And
Clinical Outcome Of Sub-centimeter
Lung Tumors After Stereotactic Ablative
Radiotherapy
3740
Bevan Ly
A Comparative Study of Robotic and
Linac-based Stereotactic Body
Radiation Therapy for Metastatic
Thoracic Spinal Tumors
3741
Alireza Fotouhi Ghiam
Dosimetric Impact of Combined
Rotational and Translational Setup
Errors on Spinal Cord Dose in Patients
Treated With Spine Stereotactic
Body Radiotherapy (SBRT) For Spinal
Metastasis
3742
Winnie Li
Impact of Immobilization on
Intra-Fraction Motion for Dedicated
Cobalt Radiosurgery Unit Using
Cone-Beam Computed Tomography
3743
Randi Cohen
Pre-Treatment SBRT Imaging Correlates
Equally Well with Multi-Phase 4DCT and
Averaging of 4DCT Simulation
3744
Ruggero Ruggieri
Comparison Of Computed 88% TCP
Dose For SBRT Of NSCLC From Different
Models
3745
Murshed Hossain
Respiratory Motion-Encompassing
Planning Target Volume (ME-PTV) for
(SBRT) of Lung Cancer
3746
Ravindra Yaparpalvi
Characterization of Target Dosimetry in
Lung SBRT
3747
Rabia Nergiz Dagoglu
for Pelvic Recurrence from Colorectal
Cancer
3748
Dariusz Michalski
Dynamic System Theory for Lung
Cancer Patient Breathing
3749
Marcus Sonier
Evaluation Of Immobilization On Target
Localization For Image-guided Kidney/
Adrenal SBRT
3750
Jin-Song Ye
Does MLC with Finer Leaf Width
Improve the Treatment Plan Quality in
Stereotactic Body Radiation Therapy of
Lung Cancers
3751
Jianzhou Wu
Duty Cycle Selection of Gating in Lung
SBRT with Flatting-Filter-Free Beams
3752
Thomas Zilli
Urethra-sparing Stereotactic Body
Radiotherapy For Localized Prostate
Cancer: Dosimetric Results From A
Prospective Multicenter Randomized
Phase II Trial
3753
Huan-Huan Wang
Feasibility And Efficacy of Stereotactic
Body Radiation Therapy Using Robotic
Radiosurgery as Curative Treatment for
Metastatic Thyroid Carcinoma
3754
Zsolt Gabos
A Planning Comparison of 3D
Conformal Multiple Static Field,
Conformal Arc and Volumetric
Modulated Arc Therapy for the Delivery
of Stereotactic Body Radiotherapy for
Lung Cancer
3755
Hyun Kim
Dosimetric Comparison of Gamma
Knife and VMAT Radiosurgery for
Vestibular Schwannoma
3756
Joanne Zhung
Evaluation Of Interfraction Changes In
Tumor Volume To Predict Long Term
Outcomes Of Sbrt In Early Stage Nsclc
3757
Benedicte Henriques
Use Of FDG-PET To Guide Dose
Prescription Heterogeneity In
Stereotactic Body Radiation Therapy For
Lung Cancers With Volumetric
Modulated Arc Therapy: A Study Of
Feasibility
3758
Cinzia Talamonti
Novel Epitaxial Silicon Array for Quality
Assurance in Radiotherapy
3759
John Lucas
Safety Assessment, Artifact Reduction
and Description of Geometric
Distortion Associated with
Diffusion Imaging (DWI) with Rigid
Head Frame Immobilization for
3760
Guang Li
Clinical Experience With Two Cranial
Frameless Stereotactic Radiosurgery
(fSRS) Systems
3761
Markus Oechsner
Respiratory-Gated Lung Stereotactic
Body Radiotherapy: a Planning Study of
3D-CRT vs VMAT
3762
Rafael Pineiro Retif
Local Control Evaluation In Bone
Metastases Treated With Stereotactic
Body Radiation Therapy: Initial
Experience
3763
Christopher Estes
Comparative Analysis of Monte Carlo
and Pencil Beam Algorithm-Derived
Dose Distributions for Tumors and
Normal Tissue in Lung Stereotactic
Ablative Radiotherapy
3764
Phuong-Di Dang
Intra-fraction Setup Verification During
Localized Prostate Cancer Using Rectal
Balloons
3765
Rajesh Rajan
Dosimetric Impact Of Intrafraction
Motion In Spine SABR
177
3777
Tomi Ogunleye
Comparison of Linear Accelerator (linac)
and Cobalt-60 Based SRS Dosimetric
Indices in the Radiosurgical Treatment
Of Cerebral AVM Patients
3788
Umar Masood
Development of a Novel Compact
Particle Therapy Facility with Laser
driven Ion Beams via Gantry Systems
based on Pulsed Magnets
3767
Steven Babic
Cone-Beam CT (CBCT) Based Evaluation
of a Non-Invasive Stereotactic Head
Frame Equipped With a Vacuum
Fixation Bite-Block for Radiosurgery
3778
Misbah Gulam
Single Isocenter Lung SBRT for Multiple
PTV Lesions
3768
Johan Cuijpers
A Predictive Model for Radiosurgery
Plan Quality and VMAT Planning
Objectives for Multiple-Brain
Metastases
3779
Enid Choi
Application of a Survival-Predicting
Nomogram Based Primarily on Whole
Brain Radiotherapy-Treated Patients
with Brain Metastases Yields Significant
Underestimates for RadiosurgeryTreated Patients
3789
Paul Romesser
Proton Beam Radiation Therapy (PBRT)
Results in Significantly Reduced Acute
Toxicity Rates Compared with
(IMRT) When Treating the Ipsilateral
Neck for Head and Neck Cancer
3766
Tonghe Wang
Motion Effects on Organ Dose in
Respiratory Gated Stereotactic Body
Radiation Therapy
3769
Pauline Rochefort
Local Control And Role of Fractionation
in Stereotactic Body Radiation Therapy
For Adrenal Gland Metastasis
3770
Qinghui Zhang
Dosimetric Effect of Prescription
Isodose Line Selection on Normal
Tissues in SRS and SRT Treatment
Planning
3771
Joel Broomfield
Stereotactic Ablative Radiotherapy for
Gynaecological Malignancies in the
Oligometastatic Setting
3772
Ricardo Wang
Comparison of Whole Brain Integral
Dose between Whole Brain
Radiotherapy and Stereotactic
Radiosurgery of Multiple Brain
Metastases
3773
Bin Han
Development of a High-Resolution and
High-Efficiency Dosimetry Strategy for
Robotic Radiosurgery QA
3774
Gozde Yazici
The Dosimetric Impact of Implants on
the Spinal Cord Dose in Stereotactic
Body Radiotherapy
3775
Allan Chen
Six-Dimensional Setup Variations and
Intra-Fraction Corrections in
Image-Guided Frameless Stereotactic
Radiosurgery for Trigeminal Neuralgia
3776
Zhong Su
SBRT/SRS Experience Using a Vero Linac
for Oligometastases
3780
Houda Bahig
Quantitative MRI Changes PostStereotactic Ablative Radiotherapy Of
The Spine
3781
Tejas Telivala
Linac with Flattening Filter Free (FFF)
mode based Virtual HDR treatment for
localized Prostate Cancer: A Dosimetric
Feasibility Study
3782
Fiori Alite
Impact of Monte Carlo Treatment
Planning on Local Control in Lung SBRT
3783
Bo Zhao
Lowering Dose Prescription from the
85% to 60% Isodose Lines may Reduce
Radiation Necrosis in Intracranial
Tumors after Linac-based Radiosurgery
3784
Yi Rong
Evaluation of Fiducial Migration in
Lung Patients
3785
Andreea Pennington
using Robotic Radiosurgery for Lung
Cancer - Comparison of Treatment Plans
using Ray Tracing (RT) and Monte Carlo
(MC) Algorithm
3786
John Cuaron
Coverage Of Posterior Supraclavicular
Fossa With Post-mastectomy Proton
Therapy For Breast Cancer: A Dosimetric
Comparison Study And Implications For
Target Definition
3787
John Cuaron
Dosimetric Comparison Of Skin Surface
Dose In Patients Undergoing Proton
And Photon Radiation Therapy For
Breast Cancer
3790
Yuichi Akino
Respiratory Motion Management of
Liver Cancer in Uniform Scanning
Proton Beam Therapy
3791
Jorrit Visser
Robust Proton Versus Photon Dose
Escalated Chemoradiation as Primary
Treatment for Oesophageal Cancer
3792
Dongxu Wang
The Impact of Body Weight Change
on the Dose Distribution of Intensitymodulated Proton Therapy for Cervical
Cancer
3793
Witold Matysiak
Evaluation of the RangeShifter model in
a commercial Proton Therapy Planning
System
3794
Terence Sio
A Dosimetric Planning Feasibility Study
for Spot-scanned Stereotactic Body
Proton Therapy (SBPT) for Unresectable
Pancreatic Tumors
3795
Erik Tryggestad
Aggregated Plan Robustness Analyses
for Spot-Scanned Pancreatic
Stereotactic Body Proton Therapy
3796
Jedediah Johnson
Modeling the Dosimetric Effects of
Repainting in Respiratory-gated Spot
Scanning Proton Treatment Plans
3797
Bruce Faddegon
A Sub-millimeter Experimental
Benchmark Of A 67.5 Mev Proton Depth
Dose Curve In Water
3798
Tony Wong
Evaluation Of Treatment Plan
Robustness With Adaptive Re-planning
For Recurrent Lung Cancer Patients
Treated With Protons
178
3799
Shinichi Shimizu
Realization of the Cone-beam CT by
Fpds that Mounted on the Spotscanning Dedicated Proton Beam
Gantry
3800
Sreekrishna Murty
Goddu
Novel Method for Range Validation of
Proton Beams in Biological Tissues
3801
Aiping Ding
An EPID-based Dosimetric Verification
Tool for Electron Beam Therapy
3802
Vania Batista
Planning Strategies And Inter- And
Intra-fractional Motion Robustness
For Pancreatic Patients Treated With
Scanned Carbon Ion Therapy
3803
Jaeman Son
Development Of Proton Dosimetry
System Using Fiber-optic Array
Including Real-time Analysis Software
Tool
3804
Chuan Zeng
Proton Pencil Beam Scanning for
Mediastinal Lymphoma: Dosimetric
Evaluation and 4-dimensional
Robustness Assessment
3805
Paige Summers
Compilation of Proton Therapy Data
from the Approval Process for
NCI-funded Clinical Trials
3806
Oscar Casares Magaz
Evaluation Of The Stability Of The
Water Equivalent Path Length In Proton
Therapy Of Lung Tumors Using 4D-CT
Images
3807
Li Zhao
Adaptive Re-planning For Proton
Treatment of Lung Cancer Using 4D
Planning
3808
Jerimy Polf
Verifying Proton Treatment Delivery
Using Prompt Gamma Imaging
3809
Patrick Richard
Phantom Analysis of Dental Filling
Materials: Impact on Head and Neck
Tumor Visualization and Proton Beam
Dosimetry
3811
Kwanghyun Jo
A Reusable Proton Range Compensator
And Verification Of Its Functionality
3812
Bryan Ager
Hounsfield Unit Correction for Dental
Implant Materials in Intensity
Modulated Proton Therapy of Head
and Neck Cancer: A Quality Assurance
Benchmark Study
3813
Heng Li
Minimizing Dose Uncertainty For Spot
Scanning Proton Therapy Of Moving
Tumors By Optimization Of The Spot
Delivery Sequence
3814
Bin Cai
Eliminate the Scattering Component
in Smearing Margin with Modern
Treatment Planning System in Proton
Therapy
3815
Aman Anand
Spot Scanned Proton Treatment Could
Potentially Reduce Hemotoxicity In
Patients Being Treated With Radiation
For Endometrial And Cervix Cancer
3823
Ileana Iftimia
Sensitivity Analysis of Rotation Effects
with the Miami Multi-channel HDR
Treatment Technique
3824
David Craft
3D Planning With Low Segment
Multi-criteria IMRT Software
3825
Ergun Ahunbay
Applicability Of An Aperture-morphing
Based Replanning Algorithm For
Flattening-filter-free Beams
3826
Jong In Park
Optimal Design and Evaluation of
Electron Beam Energy Degrader for
Breast Boost Irradiation
3827
Huiting (Christine) Feng
Simultaneously Integrated Boost (SIB)
Improves Sparing of Normal Tissues in
Locally Advanced Cervical Cancer While
Reducing Overall Treatment Time
3828
Dae Yup Han
Direction Modulated Brachytherapy
(DMBT) for Cervical Cancer
3816
Yuanshui Zheng
Minimizing Treatment Planning Errors in
Proton Therapy Using Failure Mode and
Effects Analysis
3829
Nicolas Depauw
A Novel Proton Pencil Beam Scanning
Technique For Post-mastectomy Chest
Wall Irradiation
3817
Juliane Daartz
Technical Aspects Of A Proton
Stereotactic Radiosurgery Program
3830
Deepak Gupta
Real Time Gall Bladder Motion And
Deformation During Fractionated
3818
James Welsh
FFAG Accelerators for Next-Generation
Ion Beam Therapy Systems
3819
Mehran Zaini
Radiation Physics of a New Electronic
Brachytherapy System for Treating Skin
Lesions
3820
Anna Dinkla
Validation of a Novel User-friendly
Approach to Inverse Optimization for
Stepping Source Prostate
Brachytherapy Treatment Planning
3821
Samuel Shin
Use of Simultaneous Integrated Boost
Regimen with Flexible Inflatable
Multi-Channel Versus Single Channel
and Syed Applicator in the
Management of Gynecologic Cancer
3831
Ruijiang Li
Non-isocentric Treatment Strategy For
Breast Radiotherapy
3832
Phillip Prior
Effect Of Electron Density Assignment
On MRI-based Imrt Planning
3833
Bianey Palma
Optimization Of Beam Parameters For
Very High-energy Electron
Radiotherapy: A Lung Cancer Case
3834
Andre-Guy Martin
Robotically Guided Prostatic Fiducial
Marker Insertion Under Direct MRI
Guidance: A Proof Of Concept In A Live
Canine Subject
3835
Guanzhong Gong
Is It Necessary To Inhale Oxygen
3810
Drosoula Giantsoudi
Applying Active Breathing Control In
3822
Juha Korhonen
Symptomatic Treatment Change in
Radiotherapy Of Cancer?
MRI-only Based RTP Workflow for
Medulloblastoma Patients after Proton
Prostate Cancer Patients
RT: LET Distributions and RBE
Associations
179
3836
Jiancheng Li
The Analysis Of Esophageal Tumor
Mobility During Normal Respiration
With Four-Dimensional Computed
Tomography
3848
Uma Goyal
Prone Lead Shield to Reduce Scatter
Radiation to the Contralateral Breast
During Radiotherapy For Breast Cancer:
Physics Results
3859
George Hajdok
Large, Half-Beam, Flattening Filter Free
for Head and Neck Cancer Radiation
Therapy
3837
Tianfang Li
Density Effect on Monte Carlo Dose
Calculation for Lung Robotic
Radiosurgery
3849
Liangzhong Xiang
High Precision Focal Brachytherapy of
Prostate Cancer Guided by Dual-Mode
Photoacoustic and Ultrasound Imaging
3860
Xing Liang
Proton PBS Plan Design and Robustness
Evaluation for Head and Neck Cancer
3838
Daniel Santos
Tangential Volumetric Modulated
Radiotherapy Is Superior To
Brachytherapy For Large Scalp Lesions:
A Case Study In Lentigo Maligna
3850
Jessica Lowenstein Leif
The Credentialing Process for the
NSABP B-51/RTOG 1304 Phase 3
Randomized Clinical Trial
3839
Magdalena Bazalova
Treatment-Planning Study For Very
High-Energy Electron Beam
Radiotherapy: Integral Dose Reduction
For Pediatric Patients
3840
Yu Ra Cho
Dosimetric evaluation of Polymer Gel
Dosimeter using Saccharide in Clinical
Radiotherapy System
3841
Pietro Mancosu
Robustness and In Vivo Dosimetry for
Total Marrow Irradiation With VMAT
3842
Nan Zhao
A Novel Integrated VMAT/IMRT
Technique For the Treatment of
3843
Nan Zhao
A Novel Integrated VMAT/IMRT
Technique for the Treatment of
3844
Panagiotis Tsiamas
A Simplified Craniocaudal Modulated
Arc Technique for Total Body Irradiation
3845
Wilko Verbakel
An Automated Volumetric Modulated
Arc Therapy Optimization Solution for
Head and Neck Treatment Planning
3846
Roohi Gupta
In vivo Pharmacokinetics and
Biodistribution of Drug-Loaded
Nanodroplets for Treating Prostate
Cancer Using Focused-Ultrasound
under MR-Guidance
3847
Danique Barten
Evaluation of Organ at Risk Sparing and
Robustness for Different Proton
Planning Techniques for Head-andNeck Cancer
3851
C.M. Charlie Ma
Pulsed Low Dose Rate Radiotherapy
(PLDR) For Recurrent Cancers:
Treatment Planning Strategies for IMRT
and VMAT
3852
Bill Salter
Hybrid Modulated Arc Therapy (HMAT)
on an Artiste Linac
3853
Katarzyna Balasz
Total Lymphoid Irradiation: A
Comparison of the Dose Distributions
of Four Irradiation Techniques
3854
Maryam Moteabbed
Robustness of Proton Therapy Versus
IMRT to Interfractional Variations for
Prostate Cancer Treatments
3855
Houari Korideck
Intratracheal Delivery of Gold
Nanoparticles for Radiotherapy in
Murine Lung Adenocarcinoma
3856
Evan Thomas
Fast-Awitching Dual Energy Computed
Tomography Mitigates the Effects of
High-Z Streak Artifact in Radiation
Treatment Planning
3857
Baotian Huang
Optimizing Dose Delivery Strategies
in Stereotactic Body Radiotherapy of
Early Stage Non-Small-Cell Lung Cancer
With RapidArc and Flattering Filter Free
Beams
3858
Michael Rutenberg
Dosimetric Advantages of an Adaptive
Strategy Using Dual-Plan Superposition
for Whole Pelvis Radiotherapy in High
Risk Prostate Cancer
3861
Nava Paudel
Free Radical Generation Under the
Conditions of Nanoparticle-aided
Microwave Hyperthermia
3862
Arya Amini
Dose Painting to Treat Single Lobe
Prostate Cancer Using Targeted External
Beam Radiation Therapy: Is It Feasible?
SARCOMA AND CUTENEOUS
TUMORS
3374
Jennifer Pretz
Localized Adult Ewing Sarcoma (ES):
Improved Outcomes With Ifosfamide
and Etoposide (IE) Added to
Cyclophosphamide, Doxorubicin, and
Vincristine (CAV) Chemotherapy (CT)
3375
Dana Casey
Ewing Sarcoma in Adults Treated With
Modern Radiotherapy Techniques
3376
Stephanie Casey
Use of Protoporphyrin Fluorescence to
Determine Clinical Target Volumes for
Non-Melanotic Skin Cancers Treated
With Primary Radiotherapy
3377
Jianyang Wang
Comparison of Postoperative
With Two-dimensional Radiotherapy
in Patients With Soft Tissue Sarcoma of
Extremities and Trunk
3378
Dana Casey
Whole Lung Irradiation for Adults With
Pulmonary Metastases From Ewing
Sarcoma
3379
Matthew Cheney
18F-FMISO PET/CT Visualization of
Tumor Hypoxia in Patients With
Chordoma of the Mobile and
Sacrococcygeal Spine
180
3380
Meritxell Arenas
Hypofractionated High Dose Rate
Brachytherapy in Non-melanoma Skin
Cancer Treatment
3392
Darwin Yip
Review of Experience and Outcome
of Dural Plaque Brachytherapy from
2000-2013
3381
Amar Kishan
Feasibility of MRI-guided Tri-Cobalt-60
IMRT for Preoperative Radiotherapy of
Soft Tissue Sarcomas
3393
Laura Kollar
Does Post-Neoadjuvant Therapy PET
Response Predict Pathologic Outcomes
in the Treatment of Sarcomas?
3382
Michael Cheung
Acute Skin Toxicity using High Dose
Rate Electronic Brachytherapy for
Non-Melanoma Skin Cancer
3394
Franel Le Grange
Late Effects of Radiotherapy in
Extremity Sarcoma
3383
Sanghyuk Song
Effects of Adjuvant Radiotherapy in
Patients With Synovial Sarcoma
3384
Aryavarta Kumar
HDR Brachytherapy for Resected
Retroperitoneal Sarcoma in the Primary
and Recurrent Setting
3385
Haotong Wang
Prognostic Factors in Alveolar Soft-Part
Sarcoma: A Seer Analysis
3386
Ajay Bhatnagar
Electronic Brachytherapy for the
Treatment of Non-Melanoma Skin
Cancer: Results up to 4 Years
3387
Tobias Chapman
Myxoid Liposarcomas Demonstrate a
Profound Response to Neoadjuvant
Radiation Therapy: An MRI Based
Volumetric Analysis and Pathological
Correlation
3388
Anthony Crimaldi
Effects of Radiation Therapy in Adult
Soft Tissue Sarcomas (STS) of the
Extremities (Ext): A 20 Year
Retrospective Review
3389
Pin-I Huang
Outcomes Of Head And Neck
Osteosarcoma: 10-year Experience At A
Single Institution
3390
Silvia Rodriguez Villalba
HDR Valencia Applicator in NonMelanoma Skin Cancer: Clinical
Outcomes
3391
Upendra Parvathaneni
A Novel Single-fraction Radiotherapy
Approach For Metastatic Merkel Cell
Carcinoma Is Well Tolerated And
Demonstrates Strong Efficacy Linked To
Intact Cellular Immunity
3395
Hesham Gayar
Results of Novel Multi-Channel HDR
Brachytherapy Applicators in the
Treatment of Non-Melanoma Skin
Cancer
3396
Julian Johnson
Single Institutional Series of
Intraoperative Radiotherapy (IORT) for
Primary and Recurrent Retroperitoneal
and Pelvic Sarcomas
3397
Christopher Barker
Locally Advanced and Unresectable
Cutaneous Squamous Cell Carcinoma:
Outcomes of Concurrent Cetuximab
and Radiotherapy
3398
Katsuyuki Karasawa
IMRT for Angiosarcoma of the Scalp
Using TomoTherapy: Planning Study
and the Initial Results
3399
Michael Hadsell
Tangential Modulated Arc Therapy: A
Novel Technique for the Treatment of
Superficial Disease
3400
Omeed Moalikyar
Adjuvant Radiation Therapy for
Sarcomas of the Head and Neck: A
Single Institution Experience
3404
Hina Saeed
Impact Of 3dcrtvs Imrt On
Post-operative Wound Complications
3405
Bindu Manyam
Inferior Outcomes in
Immunosuppressed Patients With High
Risk Cutaneous Squamous Cell
Carcinoma of the Head and Neck
Treated With Surgery and Radiation
Therapy
3406
Christopher Tinkle
Oncologic Surgery and Intraoperative
Radiation Therapy (IORT) in
Management of Unplanned Excision of
Extremity Soft Tissue Sarcoma (STS)
3407
Christopher Wilke
Radiologic And Pathologic Response
After Neoadjuvant Radiotherapy For
Myxoid Liposarcoma Of The Extremities
3408
Kenneth Merrell
Outcomes And Prognostic Factors Of
Stereotactic Body Radiotherapy For Soft
Tissue Sarcoma Metastases
3409
Joseph Pennington
Does a Post-operative Boost in Patients
With Low Necrosis Scores Improve
Local Control in High Grade Extremity
Sarcomas?
3410
Oren Cahlon
Hypofractionated Preoperative
Radiation Therapy to a Partial Tumor
Volume in Retroperitoneal Sarcomas
(RPS): A Dosimetric Comparison
Between Intensity Modulated Radiation
Therapy (IMRT) and Uniform Scanning
Proton Therapy (PT)
3411
Aashish Bhatt
High Dose Proton Beam Boosted
Radiation Therapy in the Management
of Non-Skull Base Chondrosarcomas
3401
Masahiro Kenjo
Long Term Results of Postoperative
Three Dimensional High Dose Rate
Brachytherapy for Soft Tissue Sarcomas
3402
Christopher Tinkle
Intraoperative Radiation Therapy
(IORT) in the Management of Recurrent
Extremity Soft Tissue Sarcoma (STS)
3403
Alex Jacobson
Outcomes of Patients With Synovial
Sarcomas Treated With Multimodality
Therapy: A Single Institution Review
3412
James Snider III
Use of “Virtual” High Dose Rate (HDR)
Brachytherapy via Spatially
Fractionated GRID Radiation Therapy
(SFGRT) as Part of Neoadjuvant Therapy
in Poor Prognosis, Bulky Sarcomas
3413
Sean Szeja
Clinical Effects of Ultraviolet Exposure
on Cutaneous Melanoma for White
Americans in SEER
181
prestigious
“Ateaching
faculty
has been assembled to
promote dialogue, provide
multidisciplinary viewpoints
and interact with participants.
–Karen Kelly, MD, Symposium Chair
”
CHICAGO
MULTIDISCIPLINARY SYMPOSIUM in
THORACIC ONCOLOGY
R A D I AT I O N T H E R A P Y
SURGERY
CHEMOTHERAPY
October 30-November 1, 2014
Chicago Marriott Downtown Magnificent Mile | Chicago
• Hear multidisciplinary speakers addressing topics relevant to everyday practice.
• Participate in case-based presentations and post-session discussions on future
directions for cancer treatment.
• NEW IN 2014: Tumor board sessions on early disease and metastatic disease
cases submitted by attendees.
Register by October 1 for advance rates:
www.thoracicsymposium.org
This live activity has been approved for AMA PRA Category 1 Credit™.
CO-SPONSORED BY:
®
INSIDE:
Index by Author
Index by Track
Indexes
ASTRO 2015
Annual Meeting Moves
Deep in the Heart of Texas!
Indexes
October 18-21, 2015 • Henry B. Gonzalez Convention Center • San Antonio
Did you know that San Antonio is:
•
•
•
•
•
•
•
•
The seventh largest city in the United States.
Easy to get to, with direct flights from 34 cities.
A very walkable city, with the famous River Walk, featuring 15 miles of paths
lined with shops, cafes and bistros.
Home to more than 25 museums including the McNay, ranked 4th in the US for
19th and 20th century art.
A place with wonderful family attractions, such as SeaWorld, San Antonio Zoo
and Aquarium, Six Flags and several water parks.
Birthplace of the American Cowboy.
Site of the world famous Alamo.
AND, THE LOCATION FOR ASTRO’S 57TH ANNUAL MEETING!
Want to know more?
Stop by the San Antonio booth in the North Concourse of the Moscone Center,
Sunday and Monday, September 14 and 15, 9:00 a.m. -5:00 p.m. and
Tuesday, September 16, 9:00 a.m. -12:00 p.m.
Index by Author (Abstracts only)
A
Abacioglu, Mehmet Ufuk
Abazeed, Mohamed
Abel, Ryan
Abernathy, Lisa
Abing, Casey
Able, Charles
Abo-Madyan, Yasser
Abraham, Christopher
Abramowitz, Matthew
Abrams, Matthew
Acharya, Sahaja
Adam, Jean-François
Adamczyk, Marta
Adli, Mustafa
Advani, Sunil
Agaoglu, Fulya
Agarwal, Ankit
Agazaryan, Nzhde
Agbahiwe, Harold
Ager, Bryan
Aghdam, Nima
Agoston, Peter
Aguilera, Todd
Ahlawat, Stuti
Ahmad, Moiz
Ahmed, Inaya
Ahmed, Inaya
Ahmed, Kamran
Ahmed, Kamran
Ahmed, Kamran
Ahmed, Merina
Ahmed, Zain
Ahn, Peter
Ahn, Sung-Ja
Ahunbay, Ergun
Aizer, Ayal
Akimoto, Mami
Akino, Yuichi
Akram, Kothwal
Akthar, Adil
Al-Basheer, Ahmad
Albuquerque, Kevin
Alco, Gul
Alcorn, Sara
Alcorn, Sara
Alcorn, Sara
Aleman, Berthe
Al-Halabi, Hani
Ali, Mirza
Alite, Fiori
Alite, Fiori
Alizadeh-Kashani, Moein
Aljabab, Saif
Allen, Aaron
Allen, Bryan
Alpuche Aviles, Jorge
Althaqfi, Saif
Altman, Michael
Altun, Musa
Ambroa Rey, Eva
Amin, Raima
Amini, Arya
Amini, Arya
Amornwichet, Napapat
2721
224
2288
3461
3592
3339
2026
2282
286
2361
2086
26
3706
3041
1038
2640
2989
3567
2982
3812
3015
2578
1008
2131
3490
3073
3074
2237
2241
35
7
2210
2919
3037
3825
2810
3571
3790
1018
3057
2922
3554
2048
177
3237
3302
138
3159
3582
3782
1011
2756
3235
3085
3428
3677
2264
3652
2791
2034
2468
3862
2728
3466
Amoush, Ahmad
Anand, Aman
Anand, Aman
Anderson, Bradley
Anderson, Eric
Anderson, Nigel
Andreassen, Christian
Anker, Christopher
Anne, Pramila, Rani
Antognoni, Paolo
Antoine, Mikael
Anwar, Mekhail
Apisarnthanarax, Smith
Arenas, Meritxell
Ariga, Takuro
Arneson, Kyle
Arneson, Kyle
Arns, Anna
Arora, Divya
Arunsingh, Moses
Asakura, Hirofumi
Ascolese, Anna Maria
Ashamalla, Hani
Asher, David
Ashworth, Allison
Ashworth, Allison
Asuni, Ganiyu
Atsumi, Kazushige
Avkshtol, Vladimir
Ayala-Peacock, Diandra
Aznar, Marianne
Azoulay, Melissa
3672
3815
2460
182
2459
2903
328
2173
90
2872
3612
2185
2394
3380
2307
2277
3243
3578
3205
2623
2561
3067
1127
2620
134
168
31
2306
3247
275
3172
2167
B
Balasz, Katarzyna
Baba, Fumiya
Babic, Steven
Baden, Craig
Badiyan, Shahed
Bagley, Jack
Bagshaw, Hilary
Bahig, Houda
Bahl, Gaurav
Baig, Nimrah
Bair, Ryan
Bakhoum, Samuel
Balagamwala, Ehsan
Baldini, Elizabeth
Baliga, Sujith
Ballas, Leslie
Balter, James
Balter, Peter
Bar Ad, Voichita
Baral, Shweta
Barker, Christopher
Barker, Christopher
Barnes, Mark
Barrett, Kate
Barron, David
Barsky, Andrew
Barsky, Andrew
Barten, Danique
Baschnagel, Andrew
Bates, James
Batista, Vania
3853
3082
3767
2471
2286
2514
2239
3780
2936
71
2744
3449
3192
253
2742
2930
1104
3667
165
1054
2217
3397
3223
3531
3326
3045
3282
3847
2364
2226
3802
Bauer, Nicolas
Baumann, Brian
Baumann, Brian
Bazalova, Magdalena
Bazan, Jose
Beadle, Beth
Beard, Clair
Bedos, Ludovic
Bekelman, Justin
Belcaid, Zineb
Belkacemi, Yazid
Belkacemi, Yazid
Benezery, Karine
Bennion, Nathan
Berbeco, Ross
Bergamo, Angelo
Bergom, Carmen
Bergsma, Derek
Berk, Lawrence
Berman, Abigail
Bernard, Mark
Bernstein, Michael
Berriochoa, Camille
Berriochoa, Camille
Bertke, Matthew
Best, Ryan
Betzing, Christopher
Bhandare, Niranjan
Bhandare, Niranjan
Bhandare, Niranjan
Bhateja, Priyanka
Bhatnagar, Ajay
Bhatt, Aashish
Bhatt, Neal
Bhirud, Abhijeet
Bhooshan, Neha
Bi, Nan
Bilimagga, Ramesh
Bishop, Andrew
Biswas, Tithi
Biswas, Tithi
Bitterman, Danielle
Blacksburg, Seth
Blacksburg, Seth
Blakaj, Adriana
Blake, Monika
Blanchard, Miran
Blas, Kevin
Blay, Christophe
Blessing, Manuel
Block, Alec
Blom, Gerrit
Boda-Heggemann, Judit
Boehling, Nick
Boelke, Edwin
Boggs, Hunter
Bohoudi, Omar
Booth, Jeremy
Bornstein, Sophia
Borst, Gerben
Bortolin, Maria Teresa
Bosnic, Sandi
Bota, Krista
Bourgier, Celine
Bovi, Joseph
2720
260
290.5
3839
2050
2862
2651
3665
132
79
2084
2061
2433
2457
1098
3625
97
3060
CT-07
1117
1110
2372
2381
3132
2905
2694
3560
2800
2870
3587
2838
3386
3411
3072
2456
2413
3122
2799
197
3157
3521
64
3363
2416
3203
3106
118
2612
2574
3577
313
3114
2341
3570
244
152
2296
276
42
3420
3445
3533
2037
2420
2106
2179
Bowen, Stephen
Bowen, Stephen
Boyle, John
Boyle, John
Bradley, Jeffrey
Bradshaw, Tyler
Braunstein, Lior
Braunstein, Lior
Braunstein, Lior
Braunstein, Steve
Braunstein, Steve
Bremjit, Prashoban
Brenneman, Randall
Brigotti, Samantha
Broomfield, Joel
Broomfield, Joel
Brower, Jeffrey
Bryant, Curtis
Buchsbaum, Jeffrey
Burkeen, Jeffrey
Byler, Shannon
3138
3061
2686
170
317
6
3182
2067
1030
2983
32
3088
1045
3137
3771
2274
107
2525
3465
2261
2996
C
Cacicedo, Jon
Cahlon, Oren
Cahlon, Oren
Cai, Bin
Caldas Magalhaes, Joana
Campbell, Shauna
Cannon, Nathan
Cao, Kim
Cao, Lu
Cardenas, Michael
Carlone, Marco
Carlson, Julie
Carlson, Julie
Carmona, Ruben
Carvajal, Claudia
Casares Magaz, Oscar
Cascales Garcia, Maria A.
Casey, Dana
Casey, Dana
Casey, Dana
Casey, Stephanie
Cassidy, Richard
Cassuto, Ophelie
Castelli, Joel
Castelnau-Marchand,
Pauline
Caster, Joseph
Cattaneo, Richard
Caudell, Jimmy
Caudell, Jimmy
Cellini, Francesco
Cellini, Francesco
Chai, Xiangfei
Chalubinska-Fendler,
Justyna
Chan, Annie
Chan, Jason
Chance, William
Chandra, Ravi
Chang, Albert
Chang, Daniel
Chang, Eric
2866
3410
3303
3814
2823
2978
3043
1014
2069
65
2652
2168
2169
3629
3210
3806
2117
3378
3375
3322
3376
2753
3191
3680
2577
2809
2268
3158
2030
2598
2405
2214
185
1066
342
3121
2159
1060
3250
2675
3708
Chang, Jennifer
Chang, Jennifer
Chang, Jennifer
Chang, Joe
Chang, Joseph Tung-Chieh
Chang, Kenneth
Chang, Tangel
Chang-Halpenny, Christine
Chao, Samuel
Chapman, Christina
Chapman, Tobias
Chaudary, Naz
Chaudhary, Ahmed
Chaudhuri, Aadel
Chaudhuri, Aadel
Chen, Aileen
Chen, Allan
Chen, Bo
Chen, Helen
Chen, Jiayi
Chen, Jonathan
Chen, Josephine
Chen, Peter
Chen, Peter
Chen, Susie
Chen, Xiaojian
Chen, Xinfeng
Chen, Yong
Chen, Yu
Chen, Yu
Chen, Yun
Cheney, Matthew
Cheney, Matthew
Cheng, Hui
Cheng, Jessica
Cheng, Jonathan
Cheng, Simon
Chera, Bisham
Cheung, Michael
Cheung, Michael
Cheung, Patrick
Chhabra, Arpit
Chhabra, Arpit
Chiang, Andrew
Chiang, Andrew
Chiang, Yun
Chiesa, Silvia
Chiesa, Silvia
Chilukuri, Srinivas
Chin, Joanna
Chin, Re-I
Chino, Junzo
Chirindel, Alin
Chiu, George
Cho, Daniel
Cho, Eunpi
Cho, Jae Ho
Cho, Kwang Hwan
Cho, Yeona
Cho, Yu Ra
Choe, Kevin
Choflet, Amanda
Choi, Chihwan
Choi, Enid
Choi, Noah
Choi, Seohee
Choudhung, Anaya
Chu, Kwun-Ye
Chua, Melvin Lee Kiang
Chun, Stephen
Chung, Caroline
Chung, Yoonsun
186
2240
2290
2151
3028
2818
221
2979
2711
3354
2722
3387
1072
2918
3422
1007
301
3775
3189
2453
2075
2816
2723
297
2137
2781
3718
210
2784
3152
3345
2332
3379
3226
3593
2342
2524
1139
280
2875
3382
126
12
2500
1005
2555
10
2188
3711
2861
3297
2865
1063
2165
3605
3634
2488
3463
3684
2902
3840
78
2336
103
3779
1133
2244
2516
3658
262
1092
3622
2097
Chuong, Michael
Chuong, Michael
Cifuentes Gaitan, Jidney
Cihoric, Nikola
Citrin, Deborah
Clark, Grant
Clavier, Jean-Baptiste
Clemente Gutierrez,
Francisco
Coates, James
Cohen, Randi
Colaco, Rovel
Colaco, Rovel
Colbert, Lauren
Colbert, Lauren
Colvill, Emma
Comito, Tiziana
Commandeur, Frederic
Conrad, Tatiana
Conway, Jessica
Cooper, Benjamin
Cooper, Samuel
Cordova, Elisa
Corso, Christopher
Corso, Christopher
Counago, Felipe
Counago, Felipe
Counago, Felipe
Cox, Brett
Craft, David
Crawford, David
Creelan, Ben
Crehange, Gilles
Crehange, Gilles
Crimaldi, Anthony
Croke, Jennifer
Croke, Jennifer
Cruz, Misael
Cuaron, John
Cuaron, John
Cuaron, John
Cuaron, John
Cuaron, John
Cui, Taoran
Cuijpers, Johan
Cuneo, Kyle
Curkendoll, Crys
Curry, Heather
Curry, Heather
Cury, Fabio
Cvek, Jakub
Czito, Brian
2414
2419
1080
2942
332
2658
2236
3702
43
3743
2235
2234
100
2348
310
2396
2570
2972
172
1036
2625
2040
2926
1003
2496
2558
2497
2654
3824
2556
163
2590
1125
3388
238
2702
1053
2863
339
3787
3786
2007
316
3768
2346
2994
130
3249
2649
2878
39
D
Daartz, Juliane
Dabaja, Bouthaina
Dabaja, Bouthaina
Dabaja, Bouthaina
Dabaja, Bouthaina
Dabaja, Bouthaina
Dadey, David
Dagoglu, Rabia Nergiz
Dahele, Max
Dai Kubicky, Charlotte
Dalah, Entesar
Damast, Shari
Damato, Antonio
Damato, Antonio
Dan, Tu
Dang, Phuong-Di
De Bari, Berardino
3817
3177
335
3166
140
3178
3433
3747
2987
2102
2353
240
3700
278
3524
3764
2464
De Paula, Ugo
De Rose, Fiorenza
Dean, Mary
Debus, Charlotte
Decker, Roy
Defoor, Dewayne
Dekker, Andre
Del Cerro Penalver, Elia
Delaney, Kyle
Demas, Kristina
Dempsey, Claire
Den, Robert
Depauw, Nicolas
Deraniyagala, Rohan
Desai, Brijal
Desai, Neil
DeSelm, Carl
Dhami, Gurleen
Dhami, Gurleen
Dhanireddy, Bhaswanth
Dhanireddy, Bhaswanth
Dholakia, Avani
Di, Liu
Diaz Pardo, Dayssy
Diaz Pardo, Dayssy
Diletto, Barbara
Dimitroyannis, Dimitri
Dinan, Michaela
Dincbas, H. Fazilet
Ding, Aiping
Ding, Chuxiong
Ding, Yao
Ding, Yun
Dinkla, Anna
Dise, Joseph
Disher, Brandon
Doi, Yoshiko
Doke, Kaleigh
Dolezel, Martin
Doll, Corinne
Dominello, Michael
Dominello, Michael
Dong, Qian
Dong, Xiaorong
Dover, Laura
Dowlatshahi, Morteza
Doyle, Paula
Draghici, Roxana
Du, Shisuo
Duan, Yili
Duelge, Jason
Duma, Marciana-Nona
Duma, Marciana-Nona
Dunlap, Neal
Dunn, Emily
Durkee, Ben
Dvorak, Tomas
Dyer, Brandon
Dyer, Michael
2023
1034
2293
2184
1144
3716
3100
2041
3366
2100
2672
347
3829
3355
2172
2724
3319
3141
2991
2833
2827
1048
2292
2869
2170
2187
2963
2943
3091
3801
3730
160
2021
3820
2729
3044
2294
2921
2547
61
17
3464
3509
3458
1113
2156
2642
3661
116
3034
2033
2011
3087
2880
2687
137
3332
2422
2207
E
Eaton, Bree
Eaton, Bree
Eblan, Michael
Edson, Mark
Edwards, Albert
Edwards, Jason
Edwards-Bennett, Sophia
Eldredge-Hindy, Harriet
Elicin, Olgun
Elliott, David
2271
245
2155
2819
2509
3115
3696
1027
2910
3270
Ellis, Rodney
Elnahal, Shereef
Elshaikh, Mohamed
Elson, Andrew
Eng, Tony
Engelman, Alexander
Engels, Benedikt
Engels, Benedikt
Engineer, Reena
Enke, Thomas
Epperly, Michael
Epperly, Michael
Epperly, Michael
Epperly, Michael
Epperly, Michael
Epperly, Michael
Epperly, Michael
Erho, Nicholas
Erickson, Delnora
Erickson, Kelly
Ernst, Iris
Estabrook, Neil
Estes, Christopher
Evans, Joseph
Evans, Joseph
3726
3369
2718
2163
2692
2609
40
2519
2409
3529
331
3454
3442
3441
3526
3530
3528
348
2010
3719
2400
2283
3763
2494
193
F
Fachal, Laura
114
Faddegon, Bruce
3797
Fahim Golestaneh, Azadeh 3418
Falchook, Aaron
2027
Fan, Yankhua
3153
Fanchon, Louise
3615
Faria, Sergio
2621
Farnia, Benjamin
3325
Farnia, Benjamin
1017
Farnia, Benjamin
1138
Farr, Jonathan
3165
Fasola, Carolina
2154
Fawaz, Ziad
3714
Fechter, Tobias
3548
Felder, Shira
2666
Felix, Manuela
3514
Feng, Felix
CT-02
Feng, Huiting (Christine) 3827
Feng, Mary
2410
Feng, Wen
3078
Fenoglietto, Pascal
3685
Fernandes, Annemarie
2295
Fernandez, Eduardo
3148
Ferraris, Gustavo
2713
Ferrer, Ferran
2560
Fiandra, Christian
3695
Finkelstein, Steven
2490
Fischer-Valuck, Ben
3019
Fog, Lotte
3656
Fogarty, Gerald
2243
Foley, Kimberley
2945
Fontanilla, Hiral
3328
Fotouhi Ghiam, Alireza
3741
Fowble, Barbara
92
Franco, Pierfrancesco
3229
Freilich, Jessica
2351
Freilich, Jessica
2871
Friborg, Jeppe
2831
Fritscher, Karl
3360
Fu, Shen
11
Fujioka, Chiaki
3215
Fujita, Yujiro
3649
Fujitani, Nobumasa
2182
Fuller, Donald
2510
Fuller, Donald
Fung, Winky Wing Ki
Funk, Ryan
Furlan, Carlo
Furlan, Carlo
Furutani, Shunsuke
2627
3576
267
3168
171
3492
G
Gabos, Zsolt
Galalae, Razvan
Galloway, Thomas
Gamez, Mauricio
Gan, Gregory
Gan, Hua
Gao, Ang
Gao, Dexuan
Gao, Lanting
Gao, Song
Gao, Wendy
Gao, Zhenhua
Garg, Rashi
Gayar, Hesham
Gayar, Omar
Gayou, Olivier
Gensheimer, Michael
Gerber, Naamit
Gerngross, Lindsey
Gevaert, Thierry
Ghadjar, Pirus
Ghaly, Maged
Giaddui, Tawfik
Giaddui, Tawfik
Giantsoudi, Drosoula
Gibson, Eli
Giem, Jared
Gilbo, Philip
Gill, Beant
Gillespie, Erin
Giordano, Frank
Giuliani, Meredith
Giuliani, Meredith
Gladwish, Adam
Glaser, Scott
Glick, Daniel
Glick, Daniel
Glide-Hurst, Carri
Goddu, Sreekrishna Murty
Goenka, Anuj
Gogna, Nirdosh
Goh, Lili
Golden, Daniel
Golden, Encouse
Goldsmith, Christy
Gomez, Caitlin
Gomez, Maria Antonia
Gomez-Iturriaga, Alfonso
Gondi, Vinai
Gong, Guanzhong
Gong, Guanzhong
Gong, Yutao
Goodman, Ben
Goodman, Karyn
Gopal, Anant
Gorovets, Daniel
Goyal, Uma
Grant, Jonathan
Gray, Phillip
Gray, Phillip
Grecula, John
Green, Garrett
Green, Olga
3754
2572
263
2766
3476
2371
1079
1039
2883
3111
283
3482
148
3395
2760
3586
9
340
1094
3737
2758
266
324
2329
3810
1122
2273
2874
2967
2059
3443
2879
3281
1067
2776
315
2440
205
3800
3274
2633
2927
2990
1032
2135
2522
3136
174
2254
3598
3835
3342
2403
62
3549
2259
3848
3373
2553
291
3545
2619
204
Greenwalt, Julie
Grew, David
Grew, David
Grimm, Shu-Ya Lisa
Groarke, John
Grossman, Craig
Grover, Surbhi
Guan, Xiyin
Gudur, Madhu Sudhan
Reddy
Guha, Chandan
Guimas, Valentine
Gulam, Misbah
Gultekin, Melis
Gultekin, Melis
Gultekin, Melis
Gunther, Jillian
Guo, Gordon
Guo, Yanluan
Guo, Yanluan
Guo, Yanluan
Guo, Yu
Gupta, Apar
Gupta, Deepak
Gupta, Gaorav
Gupta, Roohi
Gurka, Marie
Gwynne, Sarah
Gwynne, Sarah
281
2467
2907
2585
3288
217
212
2798
156
1041
2688
3778
2745
2130
3300
249
3101
2316
2317
2315
157
2939
3830
147
3846
3267
3330
3327
H
Haasbeek, Cornelis
1006
Haas-Kogan, Daphne Adele 247
Hadsell, Michael
3399
Hadzitheodorou, Christina 274
Hajdok, George
3859
Hajj, Carla
2367
Hall, Matthew
89
Hall, Matthew
2477
Hall, William
2397
Hall, William
173
Hallman, Mark
30
Halthore, Aditya
2418
Hamamoto, Yasushi
3241
Hamilton, Sarah
2536
Hamilton, Sarah
3336
Hamilton, Sarah
96
Hammer, Josef
3196
Han, Bin
3773
Han, Chun
2321
Han, Chunhui
3725
Han, Dae Yup
3828
Han, Dali
2320
Han, James
2853
Han, Kathy
2738
Han, Kathy
191
Hanna, Andrew
1021
Hanna, Nevine
2534
Hanna, Nevine
326
Hansen, Henrik
2691
Hansen, Henrik
2683
Hansen, Tara
2088
Haque, Waqar
3308
Harada, Arisa
3186
Harada, Hideyuki
2233
Harada, Ken
3233
Harada, Satoshi
3495
Hardenbergh, Patricia
304
Harder, Eileen
124
Harder, Eileen
3086
Harder, Eileen
3084
Hardie, John
Harima, Yoko
Harkenrider, Matthew
Harris, David
Harris, Jeremy
Harrison, Amy
Hartsell, William
Hartsell, William
Hasan, Shaakir
Hasan, Yaser
Hasegawa, Masatoshi
Hashimoto, Yaichiro
Hathout, Lara
Hattangadi, Jona
Hayashi, Akihiro
Hayashi, Kazuhiko
Hayes, Jason
Hayman, Thomas
Hazariwala, Ronica
He, Tongming
Healy, Erin
Hearn, Jason
Hedayati, Mohammad
Hegi-Johnson, Fiona
Heijmen, Ben J.M.
Heinzerling, John
Held, Mareike
Helou, Joelle
Helou, Joelle
Hempel, Dominika
Henke, Lauren
Henriques, Benedicte
Henry, Ann
Henson, Christina
Hepel, Jaroslaw
Herman, Lauren
Herman, Michael
Hermann, Gregory
Herskovic, Alex
Herskovic, Alex
Herst, Patries
Heskel, Marina
Heskel, Marina
Hess, Clayton
Hess, Clayton
Heumann, Thatcher
Heumann, Thatcher
Hickling, Susannah
Higgins, Kristin
Hill-Kayser, Christine
Hiniker, Susan
Hirata, Takero
Hitchcock, Kathryn
Hitchcock, Whitney
Ho, Alice
Ho, Clement
Hobbs, Corey
Hoffman, Rex
Hogue, Cory
Hojgaard, Martin
Holcombe, Charles
Hollen, Tyler
Holliday, Emma
Holmes, Jordan
Hong, Cheng
Hong, Giang
Hong, Ji-Hong
Hong, Theodore
Hoover, Andrew
Hoppe, Bradford
Hoppe, Richard
2190
199
237
2589
2938
2935
2624
2139
2914
2267
3473
2482
2569
3368
2231
2681
3144
2366
3314
2954
2044
219
190
159
3679
3024
3232
2511
2513
2540
201
3757
2602
3227
298
2058
3012
1136
307
2706
3211
3054
3052
3321
2968
2731
3193
3609
3055
3287
3323
3185
105
2752
2049
91
198
2981
2876
2571
3590
1081
264
2805
2186
2543
2985
1062
36
2909
179
336
Horowitz, David
2379
Horton, Janet
295
Hosni, Ali
2893
Hosono, Makoto
3481
Hossain, Murshed
3745
Hou, Wei-Hsien
2807
Hou, Ying
3140
Howell, Rebecca
3646
Hsieh, Cheng-En
2850
Hsu, Feng-Ming
2318
Hu, Kenneth Shung
2829
Huang, Andrew
2247
Huang, Baotian
3857
Huang, Chun-Ming
2428
Huang, Jiayi
2191
Huang, Junjian
2920
Huang, Kitty
3071
Huang, Pin-I
3389
Huang, Roger
2528
Huang, Shao Hui
1055
Huang, Tzung-Chi
3042
Huang, Wei
2384
Huang, Yaoru
2386
Huang, Zhibin
2814
Huber, Peter
3499
Huff, Byron
80
Hughes, Michael
2526
Hughes, Ryan
2645
Hui, Zhouguang
1140
Hung, Tsung Min
2786
Hurmuz, Pervin
3471
Hurst, Newton
2824
Hurwitz, Mark
CT-01
Hurwitz, Martina
3617
Husain, Zain
123
Huynh-Le, Minh-Phuong
162
Huynh-Le, Minh-Phuong 2479
Hwang, Seha
3648
Hymas, Richard
2133
I
Iftimia, Ileana
Igaki, Hiroshi
Iganej, Shahrokh
Iizuka, Yusuke
Illidge, Timothy
Imber, Brandon
Ingledew, Paris-Ann
Inokuchi, Haruo
Ishaq, Omar
Ishibashi, Naoya
Ishii, Kentaro
Ishikawa, Hitoshi
Ishikawa, Kazuki
Isohashi, Fumiaki
Ito, Yoshinori
Iuchi, Toshihiko
Ivkov, Robert
Iwabuchi, Michio
Iwata, Hiromitsu
Iwata, Hiromitsu
Izaguirre, Enrique
3823
2171
2825
2388
3439
3318
3000
2520
3645
3198
2538
2325
2323
2678
2305
2161
1037
3176
3446
3070
2777
187
J
Jackson, Matthew
Jackson, William
Jacobson, Alex
Jager, Elise Anne
Jagsi, Reshma
Jain, Anshu
Jain, Prachi
Jain, Supriya
Jairam, Vikram
James, Joshua
James, Nicholas
James, Sarah
Jani, Ashish
Jani, Shirish
Janowski, Einsley-Marie
Jarvis, Lesley
Jastaniyah, Noha
Jaswal, Jasbir
Jawad, Maha
Jayachandran, Priya
Jefferis, Jennifer
Jegadeesh, Naresh
Jensen, Alexandra
Jensen, Lindsay
Jeong, Jeho
Jeong, Seong-Yun
Jeong, Seong-Yun
Jeong, Yuri
Jeongshim, Lee
Jeppesen, Stefan
Jeraj, Robert
Jhavar, Sameer
Jiang, Wei
Jie, Shen
Jimenez, Rachel
Jimenez-Jimenez, Esther
Jin, Jian-Yue
Jing, Hao
JingBo, Wu
Jo, Kwanghyun
Joh, Daniel
Johnson, Jedediah
Johnson, Julian
Johnson, Julian
Johnson, Matthew
Johnson, Matthew
Johnson, Skyler
Jones, Bernard
Jones, Guy
Jones, Guy
Jones, Ryan
Joshi, Nikhil
Ju, Melody
Judith, Aaron
Jung, Julip
Jwa, Eunjin
145
2552
3403
2822
293
3162
2213
3130
2189
3610
18
2330
2262
3682
3264
2081
194
2997
311
2260
2209
143
2851
2512
3628
3512
3511
3664
2454
3093
1090
3190
3066
3206
3306
2435
164
151
1004
3811
3255
3796
3396
2120
2284
180
2630
3595
2022
2929
3358
2200
1093
3657
3160
2113
K
Kabarriti, Rafi
Kabarriti, Rafi
Kachnic, Lisa
Kadoya, Noriyuki
Kahalley, Lisa
Kainz, Kristofer
Kalapurakal, John
Kalbasi, Anusha
Kamomae, Takeshi
Kamp, Florian
188
1
3462
3289
319
248
3651
250
2532
3681
3626
Kamran, Sophia
Kamran, Sophia
Kamrava, Mitchell
Kanakamedala, Madhava
Kanayama, Naoyuki
Kandula, Shravan
Kang, Hyun-Cheol
Kang, John
Kang, Julie Jung
Kang, Julie Jung
Kang, Young-nam
Kannarunimit, Danita
Kapoor, Rishabh
Kapoor, Vaishali
Karagoz, Gulay
Karakaya, Ebru
Karam, Irene
Karan, Tania
Karasawa, Katsuyuki
Karasawa, Katsuyuki
Karasawa, Kumiko
Karlin, Jeremy
Kashani, Rojano
Kashani, Rojano
Kasuya, Goro
Kasuya, Takeo
Kathpal, Madeera
Kathpal, Madeera
Kato, Masako
Katoh, Norio
Katsuta, Yoshiyuki
Kattevilder, Robert
Katz, Leah
Kavanaugh, James
Kawakami, Masakuni
Kawamura, Mariko
Kawamura, Mariko
Kawanaka, Takashi
Kawashiro, Shohei
Kazberuk, Dorota
Keall, Paul
Keane, Florence
Keene, Kimberly
Keiler, Louis
Kelada, Olivia
Kelley, Kevin
Kelly, Douglas
Kemmerer, Eric
Kenjo, Masahiro
Kennedy, William
Kennoki, Norifumi
Keole, Sameer
Kerns, Sarah
Kertzscher, Gustavo
Kesava Ramgopal,
Adavikolanu
Khan, Luluel
Khan, Luluel
Khattab, Mohamed
Khwaja, Shariq
Kiang, Alan
Kidd, Elizabeth
Kidd, Elizabeth
Kierkels, Roel
Kiess, Ana
Kilburn, Jeremy
Kim, Byounghyuck
Kim, Dong Wook Nathan
Kim, Ellen
Kim, Hayeon
Kim, Hyun
2650
2772
2680
2867
2899
2815
149
2504
3639
2192
285
3688
3662
2931
3486
3690
2695
2790
1078
3398
3134
2029
69
1100
3611
2664
2354
2024
3584
2111
2647
3338
2559
3017
2583
3668
2300
2017
2334
3221
2595
3602
2765
2387
2099
49
3105
3199
3154
3401
2205
2350
135
113
3349
2127
176
2253
3498
3276
3256
1070
2667
230
3517
3092
3023
3506
3076
2956
3755
Kim, Jae-Sung
Kim, Jin Ho
Kim, Jin Ho
Kim, Kyung Hwan
Kim, Kyung Su
Kim, Leonard
Kim, Michelle
Kim, Michelle
Kim, Miranda
Kim, Sungjune
Kim, Tae Hyung
Kim, Tae Hyung
Kim, Youn
Kim, Youngjun
Kim, Yusung
Kimura, Tomoki
King, Martin
King, Martin
Kirby, Neil
Kirkland, Robert
Kirsch, David
Kishan, Amar
Kishan, Amar
Kishan, Amar
Kishi, Takahiro
Kisling, Kelly
Kittel, Jeffrey
Klein, Eric
Klein, Jonathan
Knoll, Miriam
Knoll, Miriam
Ko, Huaising
Kobayashi, Hidetoshi
Koc, Mehmet
Kocak, Esengul
Kocak, Esengul
Kodaira, Takeshi
Kohutek, Zachary
Kole, Thomas
Kollar, Laura
Kollar, Laura
Kollmeier, Marisa
Komaki, Ritsuko
Kondaveeti, Satish
Kong, Feng-Ming
Kong, Jie
Koo, Tae Ryool
Koottappillil, Brian
Korhonen, Juha
Korideck, Houari
Kornerup, Josefine
Kortylewicz, Janina
Koshy, Matthew
Kotecha, Rupesh
Kotecha, Rupesh
Koukourakis, Michael
Kountouri, Melpomeni
Kovalchuk, Nataliya
Koyfman, Shlomo
Koyfman, Shlomo
Kozak, Malgorzata
Kozono, David
Kraft, Johannes
Krauss, Daniel
Krauss, Daniel
Krauze, Andra
Kreofsky, Cole
Kriz, Jan
Kropp, Lauren
Kubicek, Gregory
Kubo, Akiko
Kucharczyk, Michael
2436
2847
2848
1026
3069
3660
2162
77
2806
166
1112
2444
334
3573
2665
3058
3483
144
3697
3313
115
2498
2385
3381
2349
3334
2203
1074
2392
3284
2020
2898
3230
1109
2376
2761
2782
22
110
3393
3129
2637
3046
2888
3163
1118
2451
2999
3822
3855
3324
187
1001
2533
2251
3423
2563
3356
2771
2964
2462
220
3553
2501
1132
3260
2837
338
2832
259
2684
2177
Kuczmarska, Aleksandra
Kudithipudi, Vijay
Kumar, Aryavarta
Kumar, Parvesh
Kumar, Rejnish
Kumar, Sanath
Kumarasiri, Akila
Kupelian, Patrick
Kusano, Aaron
Kusano, Aaron
Kusumawidjaja, Grace
Kwok, Young
2855
2393
3384
2622
2901
3116
229
85
2995
2977
2181
2584
L
Lai, I-Chun
3299
Lai, Shihfan
2103
Lai, Stephen
2834
Lai, Yo-Liang
2383
Lalani, Nafisha
294
Lam, Tai Chung
3239
Lam, Wai Wang
3329
Lang, Jinyi
3532
Lanni, Thomas
2958
Lanning, Ryan
2275
LaPlant, Quincey
2160
Lapuz, Carminia
2740
Larrea, Luis
3292
Laruelo, Andrea
3484
Lashkari, Marzieh
2425
Laskar, Siddhartha
246
Latifi, Kujtim
2375
Lauro, Christine
2970
Lautenschlaeger, Tim
2635
Lawrence, Yaacov
2447
Lazow, Stefanie
2227
Le Grange, Franel
3394
Leatherwood, Amy
3280
Lecavalier-Barsoum, Magali 2565
Lecavalier-Barsoum, Magali 2193
Lederman, Ariel
2644
Lee, Andrew
3277
Lee, Andrew
63
Lee, Anna
2121
Lee, Eun-Jung
3430
Lee, Grace
2096
Lee, Jae
3265
Lee, Jason
3242
Lee, Joohwan
3179
Lee, Keum Sil
3488
Lee, Kuei
3489
Lee, Larissa
242
Lee, Larissa
2739
Lee, Percy
54
Lee, Seok Ho
2669
Lee, Suk
3687
Lee, Suk
3683
Lee, Victor
261
Lee, Yongsook
2674
Lee, Yun Hee
3161
Lefresne, Shilo
2426
Lefresne, Shilo
175
Lei, Xin
2449
Leif, Jessica Lowenstein
3850
Leiker, Andrew
1095
Lens, Eelco
3650
Leonard, Charles
2016
Leonard, Kara
3340
Leong, Nelson
299
Leong, Trevor
3447
Lester, Scott
3090
Lester-Coll, Nataniel
300
Letourneau, Etienne
Leung, Chung Man
Levin-Epstein, Rebecca
Li, Allen
Li, BaoQing
Li, Baosheng
Li, Dengwang
Li, Fengxiang
Li, Fengxiang
Li, Guang
Li, Guangjun
Li, Guichao
Li, Heng
Li, Heng
Li, Jason
Li, Jiancheng
Li, Jinluan
Li, Linna
Li, Mei
LI, Minghuan
Li, Ning
Li, Ping
Li, Puyao
Li, Qian
Li, Ruijiang
Li, Ruijiang
Li, Shidong
Li, Shuai
Li, Shuai
Li, Tao
Li, Taoran
Li, Tianfang
Li, Weiwei
Li, Winnie
Li, Xia
Li, Xin
Lian, Jun
Liang, Jieming
Liang, Jun
Liang, Xing
Liang, Yun
Liao, Jay
Liao, Zhongxing
Lim, Hyeon Woo
Lim, Jihoon
Lim, Trevor
Lin, Angela
Lin, Chi
Lin, Chun Chieh
Lin, Jeff
Lin, Jolinta
Lin, Lilie
Lin, Mu-Han
Lin, Teh
Lin, Yu-Wei
Lin, Zhixiong
Linam, Justin
Lindberg, Karin
Ling, Diane
Ling, Ted
Ling, Ted
Lischalk, Jonathan
Liss, Adam
Liszewski, Brian
Liu, Anwen
Liu, Chang
Liu, Chihray
Liu, Feng
Liu, Hui
Liu, Jerry
Liu, Jerry
2953
3589
3419
2250
3583
2634
3123
3603
3673
3674
3760
3701
2343
314
3813
3710
3836
2352
2093
2690
15
2431
3502
2216
1069
3831
4
3620
2098
2077
1119
29
3837
2074
3742
207
2180
3678
309
3309
3860
2370
2845
84
2443
2696
1033
2703
1111
19
243
3150
2689
312
3715
2542
1050
3566
2276
1084
2359
2308
3614
93
3347
3539
3721
3361
1076
2328
2767
2755
Liu, Jianfei
Liu, Jing
Liu, Lipin
Liu, Ning
Liu, Peter
Liu, Qingfeng
Liu, Weixin
Liu, Wenyang
Liu, Wenyang
Liu, Wu
Liu, Yilin
Lloyd, Shane
Lloyd, Shane
Lloyd, Shane
Lo, Andrea
Lo, Simon
Loblaw, Andrew
Lock, Michael
Logie, Natalie
Logie, Natalie
Loiselle, Christopher
Lok, Benjamin
Lok, Benjamin
Longo, John
Lopater, Zachary
Lopez, Jose
Lopresti, Mary
Louie, Alexander
Louie, Alexander
Louie, Alexander
Lovelock, D. Michael
Lu, NingNing
Lu, Sharon
Lu, Weiguo
Lucas, John
Lucas, John
Lucas, John
Ludmir, Ethan
Lukens, John
Lukovic, Jelena
Lutz, Ryan
Ly, Bevan
Ly, Bevan
Lymberiou, Timothy
28
3107
3110
3075
3519
333
2796
3675
41
3616
206
3169
3219
2548
76
3727
2535
2974
3244
2779
1024
2125
3245
2465
3202
2973
2089
3739
2959
303
2582
2344
2717
3555
1051
2248
3759
2331
2603
1134
2368
3740
3240
2094
M
Ma, Charlie
Ma, Charlie
Ma, Faqiang
Ma, Jennifer
Ma, Jinli
Ma, John
Ma, John
Ma, Lijun
Ma, Lin
Ma, Lin
Machiels, Melanie
MacKillop, William
MacKillop, William
Maclean, Jillian
Maghsoudi, Kaveh
Magnan, Sindy
Magnuson, William
Mahajan, Anita
Mahajan, Anita
Mahal, Brandon
Mahal, Brandon
Mahantshetty, Umesh
Mahe, Marc
Mahmood, Usama
Mai, Sabine
3251
3851
2793
2730
153
2659
2757
3728
296
2789
2322
2643
305
2204
2732
2626
2773
3294
251
2591
2596
1064
2661
2944
60
Meister, Moshe
Mellon, Eric
Melotek, James
Mendenhall, William
Meng, Jin
Meng, Mao-Bin
Merrell, Kenneth
Merrell, Kenneth
Merrick, Scott
Meyer, Jeffrey
Meyer, Kurt
Mezera, Megan
Mian, Omar
Mian, Omar
Michalski, Dariusz
Michalski, Jeff
Michaud, Anthony
Mickevicius, Nikolai
Mikell, John
Mikhaeel, George
Mikkelsen, Ross
Milecki, Piotr
Miller, Brett
Miller, Luke
Miller, Robert
Miller, Seth
Ming, Xin
Mirabeau-Beale, Kristina
Mishra, Mark
Mislmani, Mazen
Miszczyk, Leszek
Mitchell, Darrion
Mitin, Timur
Mitra, Devarati
Mitra, Devarati
Mittauer, Kathryn
Miyakawa, Akifumi
Miyawaki, Daisuke
Miyazawa, Kazunari
Mo, Xiaohu
Moalikyar, Omeed
Moding, Everett
Modlin, Leslie
Modlin, Leslie
Moeller, Benjamin
Moghanaki, Drew
Mohamad, Issa
Mohamed, Abdallah
Mohamed, Abdallah
Mohindra, Pranshu
Mohr, Angela
Molinier, Jessica
Moningi, Shalini
Moningi, Shalini
Moningi, Shalini
Moningi, Shalini
Monjazeb, Arta
Monjazeb, Arta
Monjazeb, Arta
Monroe, Alan
Moon, Dominic
Mooney, Karen
Moore, Kevin
Moraes, Fabio Ynoe
Moraes, Paulo
Morillo Macías, Virginia
Morimoto, Masahiro
Morris, Zachary
Mortensen, Steen
Mosaly, Prithima
Mosaly, Prithima
Moteabbed, Maryam
2588
2362
2593
1056
1088
2313
3408
101
3633
104
2198
2741
3236
2369
3748
2579
2699
2272
2476
3167
225
2566
282
3128
184
2539
3155
2085
2975
1071
3269
3507
289
3285
3271
3585
2230
2843
3187
3346
3400
68
3534
2278
2463
3218
2841
2916
2911
1086
3126
3735
3359
2380
3351
2374
3624
3435
3523
2860
218
3580
3558
2605
2255
2424
3104
2458
3118
3370
3372
3854
189
Maidment III, Bertram
Mailhot Vega, Raymond
Maisonet, Olivier
Maity, Amit
Mak, Kimberley
Mak, Kimberley
Mak, Kimberley
Malone, Shawn
Manabe, Yoshihiko
Mancini, Brandon
Mancosu, Pietro
Mangla, Ankit
Mann, Justin
Mannina, Edward
Manon, Rafael
Manoor Maiya, Vikram
Manyam, Bindu
Manzerova, Julia
Manzerova, Julia
Maraldo, Maja
Marciscano, Ariel
Marciscano, Ariel
Marconi, Daniel Grossi
Marcus, David
Marina, Ovidiu
Marina, Ovidiu
Markovina, Stephanie
Maroongroge, Sean
Marples, Brian
Marsh, James
Martin, Andre-Guy
Martin, Jeffrey
Martin, Neil
Marwaha, Gaurav
Masino, Alexander
Mason, Josh
Mason, Mathew
Mason, Matthew
Masood, Umar
Masoud Rahbari, Reza
Massabeau, Carole
Masunaga, Shin-ichiro
Mathew, Prince
Mathews, Joshua
Matsumoto, Kenji
Matsuo, Masayuki
Matsuo, Masayuki
Matsuo, Yukinori
Mattes, Malcolm
Mattes, Malcolm
Matulewicz, Lukasz
Matuszak, Martha
Matysiak, Witold
Maymani, Rebekah
Mazloom, Ali
McClinton, Chris
McCloskey, Susan
McGovern, Susan
McGuffin, Merrylee
McGuffin, Merrylee
McGuire, Sarah
McHaffie, Derek
McKeever, Matthew
McLaughlin, Patrick
McNiven, Andrea
Medhora, Meetha
Mehmood, Qurrat
Mehta, Minesh
Mei, Feng
Mei, Feng
Meier, Timothy
3145
2952
3217
3432
2004
3010
255
346
3040
1012
3841
3164
3077
2415
2792
2892
3405
2122
2727
337
213
2199
2917
2949
2592
308
2483
200
2941
3485
2157
3834
1083
2986
2215
2289
2505
1128
3262
3788
3535
2132
3493
2225
3335
3669
3480
186
3039
1135
2126
3343
279
3793
2735
3174
2708
CT-06
3305
2039
2955
8
2576
2668
111
3348
3527
3068
74
2697
3635
3333
Motegi, Atsushi
Mou, Benjamin
Mourad, Waleed
Mourad, Waleed
Mourad, Waleed
Mourad, Waleed
Moustafa, Mahmoud
Mouw, Kent
Mowery, Yvonne
Mui, Wing Lun
Muirhead, Rebecca
Mula-Hussain, Layth
Mullen, Thomas
Muller, Karin
Mumber, Matthew Peter
Munbodh, Reshma
Murai, Taro
Murai, Taro
Murakami, Ryuji
Murakami, Yuji
Muraro, Elena
Muren, Ludvig
Murofushi, Keiko
Murphy, Colin
Murphy, Colin
Murray, Louise
Musunuru, Hima
Mutic, Sasa
Mutter, Robert
Myojin, Miyako
3006
3047
3201
2530
2527
2849
1042
189
2886
2801
2470
3234
3353
2407
3364
2281
2266
2890
2748
2301
3417
290
2682
1029
2503
3643
2594
202
2065
2311
N
Na, Yong Hum
3694
Nabavizadeh, Nima
2304
Nabhani, Thomas
2546
Nabid, Abdenour
24
Naczynski, Dominik
3491
Nagai, Aiko
3011
Nagai, Aiko
2223
Nagar, Himanshu
2716
Nagar, Himanshu
2710
Naghavi, Arash
2946
Naik, Mihir
344
Nakajima, Naomi
2175
Nakajima, Naomi
2176
Nakajima, Naomi
2174
Nakamura, Mitsuhiro
3569
Nakamura, Naoki
3224
Nakayama, Masao
3513
Naoi, Yutaka
3734
Napieralska, Aleksandra
2896
Narang, Amol
2614
Narang, Amol
2194
Narang, Amol
21
Narayanasamy, Ganesh
2769
Naydich, Boris
2481
Neboori, Hanmanth
2662
Negahdar, Mohammadreza 3050
Negahdar, Mohammadreza 3049
Nelson, Aaron
3707
Nelson, Aaron
2523
Ng, Sweet
150
Ngan, Samuel
38
Nguyen, Dan
235
Nguyen, Nhu Tram
2912
Nguyen, Nhu Tram
3547
Nguyen, Nhu Tram
3147
Nguyen, Paul
2580
Nguyen, Quynh
3038
Ngwa, Wilfred
2998
Ngwa, Wilfred
3642
190
Nichol, Alan
Nicholas, Zachary
Nichols, Elizabeth
Nicolay, Nils
Nishibuchi, Ikuno
Nishimura, Yasumasa
Nishioka, Takeshi
Niska, Joshua
No, Hyunsoo
Noh, Jae Myoung
Noid, George
Nomiya, Takuma
Nonaka, Hotaka
Nonaka, Tetsuo
Nout, Remi
Novak, Avrey
Nowak, Kamila
Nuyttens, Joost
Nyflot, Matthew
273
2749
2118
3500
2326
2303
3444
2398
2112
2104
3596
2492
3097
2337
239
284
1046
3273
3089
O
Obeid, Layal
Odawara, Soichi
Oechsner, Markus
Offor, Onyinye
Ogino, Hiroyuki
Ogita, Mami
Ognibene, Grant
Ogunleye, Tomi
Oguri, Mitsuhiko
Oh, RyoongJin
Oh, Steven
Ohga, Saiji
Ohri, Nisha
Ohri, Nitin
Ohri, Nitin
Ohri, Nitin
Okano, Naoko
Okawa, Kohei
Okonogi, Noriyuki
Okoye, Christian
Oksuz, Didem
Olivera, Gustavo
Olivera, Jesús
Olsen, Jeffrey
Olson, Adam
Olson, Robert
Olson, Robert
Onishi, Hiroshi
Oohira, Shingo
Orman, Amber
Orman, Amber
Osborne, Eleanor
Osmundson, Evan
Osmundson, Evan
Osmundson, Evan
O’Sullivan, Brian
Ota, Seiichi
Owen, Dawn
Ozkaya Akagunduz, Ozlem
Ozsahin, Esat Mahmut
25
3455
3761
1044
2484
2080
2141
3777
3112
2401
2581
3181
3204
106
318
136
3467
3731
3494
1059
2549
277
3659
59
3014
3290
3222
52
3574
2632
2506
3312
2421
3546
2196
215
3357
45
3311
2835
2804
2817
P
Padilla, Laura
Page, Brandi
Paik, Eun Kyung
Pallotta, Stefania
3572
2070
2402
3689
Palma, Bianey
3833
Palmer, Joshua
2377
Palmer, Joshua
2378
Palmgren, Jan-Erik
3732
Palorini, Federica
86
Palta, Manisha
2475
Pan, Hubert
271
Pan, Hubert
3065
Pang, Qingsong
3033
Papineni, Rao
188
Parashar, Bhupesh
1073
Paravati, Anthony
133
Parikh, Rahul
CT-08
Parisi, Elisabetta
322+1143
Park, Catherine
3426
Park, Henry
2491
Park, Henry
53
Park, John
3579
Park, Jong In
3826
Park, Kawngwoo
2663
Park, Sang-June
2734
Park, Sean
119
Parra, Andres
3557
Parvathaneni, Upendra
3391
Paryani, Nitesh
2925
Paryani, Nitesh
3027
Patel, Abhilasha
2473
Patel, Abhilasha
2164
Patel, Abhilasha
2653
Patel, Ashish
3293
Patel, Chirayu
139
Patel, Kirtesh
1091
Patel, Kruti
2114
Patel, Nisha
2148
Patel, Ravi
158
Patel, Ravi
2345
Patel, Sagar
241
Patel, Samir
2839
Patel, Shyamal
2229
Patel, Shyamal
2846
Patel, Suchit
3098
Patel, Suchit
3096
Pater, Piotr
3631
Patton, Caroline
2966
Paudel, Nava
1099
Paudel, Nava
3861
Paulino, Arnold
252
Paulson, Eric
50
Paulson, Eric
3647
Paulson, Eric
3703
Pavan, Guilherme
3352
Peguret, Nicolas
2357
Peng, Jean
3588
Penniment, Michael
CT-03
Pennington, Andreea
3785
Pennington, Joseph
3409
Perez, Bradford
2222
Perez, Jessica
3487
Persson, Gitte
3035
Petereit, Daniel
2143
Petersen, Ivy
2116
Petric, Primoz
2670
Peulen, Heike
3133
Pham, Anthony
122
Pham, Anthony
2280
Pham, Anthony
2774
Pham, Huong
288
Pham, Ngoc
127
Pham, Trang
2095
Pham, Yvonne
2489
Philippens, Marielle
2913
Phillips, John
2480
Phillips, John
Phillips, Mark
Pilones, Karsten
Pilote, Laurie
Pineiro Retif, Rafael
Pinnaro, Paola
Pinnix, Chelsea
Pinnix, Chelsea
Pitroda, Sean
Plastaras, John
Plichta, Kristin
Plishker, William
Podder, Tarun
Pokhrel, Damodar
Polf, Jerimy
Polgar, Csaba
Polishchuk, Alexei
Pollack, Alan
Pollock, Bruce
Pollom, Erqi
Poon, Ian
Poon, Miranda Sze Wing
Poorvu, Philip
Popovtzer, Aron
Porzio-Kwiecinski, Therese
Pos, F.J.
Poulsen, Per
Pratx, Guillem
Press, Robert
Pretz, Jennifer
Price, Samantha
Prieto, Isabel
Prior, Phillip
Prior, Phillip
Pugh, Thomas
Pyakuryal, Anil
343
3556
121
2969
3762
2036
145.5
3184
329
3197
2828
3581
3099
3056
3808
292
2219
2616
2228
102
3220
231
2726
2811
3216
2517
3613
3663
2287
3374
2221
2889
3637
3832
112
3474
Q
Qi, Xiangrong
Qi, Xiangrong
Qi, Xin
Qi, Xin
Qiu, Haoming
Qu, Melody Xuanlu
Quan, Kimmen
Quigley, Matthew
Quinlan-Davidson, Sean
Quinn, Thomas
Quivrin, Magali
Quon, Harry
Qureshi, Muhammad
3704
88
2567
2568
2411
2302
99
1019
2751
2671
3520
2628
2885
2976
R
Raber, Jacob
Rabin, Tatiana
Rackley, Thomas
Rafat, Marjan
Rafat, Marjan
Rahimi, Asal
Rahman, Rifaquat
Raince, Jagdeep
Rajagopalan, Malolan
Rajan, Rajesh
Rajpara, Raj
Raju, Uma
Rakhra, Sunpreet
Raldow, Ann
Raleigh, David
Ram, Ashwin
2249
3131
14
3425
3475
2091
2183
3644
2005
3765
141
3501
2031
2399
2641
2613
Ram, Ashwin
Rana, Zaker
Rana, Zaker
Rana, Zaker
Rancati, Tiziana
Rand, Alexander
Rand, Alexander
Randolph, David
Rangarajan, Ramya
Rao, Min
Rao, Nalini
Rao, Shyam
Rao, Yuan
Rash, Dominique
Rasmussen, Jacob
Rath, Goura Kishor
Rathod, Shrinivas
Ray, Geoffrey
Reddy, Jay Paul
Reddy, Vishruth
Redmond, Kristin
Redmond, Kristin
Refaat, Tamer
Rehman, Sana
Ren, Gang
Ren, Hua
Ren, Lei
Resende Salgado, Lucas
Reynolds, Robert
Rhee, Woo Joong
Rhome, Ryan
Ricchetti, Francesco
Rice, Stephanie
Rice, Stephanie
Richard, Patrick
Richard, Patrick
Rico, Florentino
Rimner, Andreas
Rimner, Andreas
Rimner, Andreas
Rineer, Justin
Ríos Pozo, María
Risberg, Miranda
Rizzo, Anthony
Roach, Michael
Robar, James
Robertson, Scott
Robertson, Scott
Robinson, Clifford
Robinson, Timothy
Rochefort, Pauline
Rockne, Russell
Rodrigues, George
Rodrigues, George
Rodriguez Villalba, Silvia
Roeder, Falk
Roenjom, Marianne Feen
Roeper, Barbara
Roeske, John
Rolfo, Maureen
Romeo, Antonino
Romeo, Antonino
Romesser, Paul
Romesser, Paul
Rong, Yi
Rose, Brent
Rose, Jim
Rose, Jim
Rosenberg, Stephen
Rossetti, Andrew
Rottmann, Joerg
Rovirosa, Angeles
2618
2043
3275
3279
3641
2928
2933
2195
2747
1082
2124
3434
2737
2698
2768
1065
3258
3304
3149
3440
3298
1023
2013
1010
2355
1114
46
2446
3720
3228
2208
2763
2891
108
2962
3809
3563
1142
44
3124
2145
2138
3623
2166
1002
3713
2923
2629
2211
3565
3769
3564
2508
3125
3390
254
2775
3310
1102
2904
1143
2356
345
3789
3784
2142
2499
2736
2770
3266
3733
2712
Rowe, Lindsay
Ruan, Dan
Ruan, Dan
Ruan, Dan
Ruggieri, Ruggero
Ruiz-Alonso, Ana
Russo, Gregory
Rusthoven, Chad
Rutenberg, Michael
Rutter, Charles
Rwigema, Jean-Claude
Ryoo, Joan
3094
228
3550
3551
3744
3536
2202
20
3858
131
2877
2932
S
Sabater, Sebastia
Sabit, Khusraw
Sabolch, Aaron
Sachdev, Sean
Sachdev, Sean
Sachsman, Suzanne
Saeed, Hina
Saeed, Nadia
Safdieh, Joseph
Sahgal, Arjun
Sahgal, Arjun
Sai, Sei
Saito, Tetsuo
Saito, Tetsuo
Saitoh, Jun-ichi
Saksornchai, kitwadee
Sakthivel, Vasanthan
Sakumi, Akira
Saleh, Ziad
Salem, Ahmed
Salinas, Vanessa
Salter, Bill
Samiee, Sara
Samuelian, Jason
Samuels, Stuart
Santanam, Lakshmi
Santhanam, Anand
Santos, Daniel
Sapienza, Lucas
Sapienza, Lucas
Sapienza, Lucas
Saracino, Biancamaria
Saraiya, Siddharth
Sarojini, Sreeja
Sato, Hiroo
Sato, Mariko
Savir, Guy
Schaidle, Colleen
Schaner, Philip
Scher, Eli
Schmidberger, Heinz
Schmuecking, Michael
Schoenfeld, Jonathan
Scholey, Jessica
Schreiber, David
Schreibmann, Eduard
Schuemann, Jan
Schuster, Jessica
Schutzer, Matthew
Sckolnik, Steven
Scorsetti, Marta
Scott, Michael
Scott, Michael
Scroggins, Bradley
Seibert, Tyler
Sekar, Yuvaraj
Sekii, Shuhei
2715
2206
2646
2858
2882
3173
3404
2469
2537
178
2338
3469
3231
3225
2676
2018
2908
3691
82
67
3315
3852
3283
3059
16
233
154
3838
1025
2826
2714
109
3103
3472
2442
3424
2258
3212
2778
2750
3459
3146
3436
3607
2948
2270
48
3252
2957
3200
2406
1123
2836
330
208
3344
2291
Senan, Suresh
Seo, YoungsSeok
Seo, Yuji
Serra, Diane
Serrano, Nicholas
Servagi Vernat, Stephanie
Setakornnukul, Jiraporn
Sethi, Rajni
Sethi, Roshan
Setton, Jermey
Seymour, Zachary
Seymour, Zachary
Sezen, Duygu
Shaffer, Jenny
Shaffer, Jenny
Shah, Anand
Shah, Bhartesh
Shah, Mira
Shah, Nikesh
Shaikh, Fauzia
Shaikh, Fauzia
Shaikh, Talha
Shaikh, Talha
Shaitelman, Simona
Shankar, Vangipuram
Sharabi, Andrew
Sharma, Sonam
Sharp, Hadley
Shasha, Daniel
Shaw, Edward
Shekel, Efrat
Shen, Colette
Shen, Lijun
Shen, Lijun
Shen, Sui
Shen, Xinglei
Shen, Yali
Shen, Zhilei
Sheng, Ke
Shenouda, Mina
Sher, David
Sherr, David
Shi, Xiutao
Shi, Zeliang
Shibamoto, Yuta
Shikama, Naoto
Shimizu, Arisa
Shimizu, Shinichi
Shin, Jacob
Shin, Jacob
Shin, Samuel
Shin, Samuel
Shintani, Takashi
Shioyama, Yoshiyuki
Shirai, Katsuyuki
Shiraishi, Kenshiro
Shiraishi, Yutaka
Shridhar, Ravi
Shukla, Monica
Shulman, Jesse
Shultz, David
Shumway, Dean
Shumway, Dean
Shusharina, Nadya
Sifuentes, Joshua
Silva, Maria Leticia
Simon, Antoine
Simone, Charles
Simontacchi, Gabriele
Simpson, Daniel
Sineshaw, Helmneh
Singh, Hardev
55
3286
3504
3213
3676
2299
3064
2700
3295
146
2493
2242
2474
2417
2404
2960
2971
2279
3320
57
3317
2333
2358
1035
3724
PL-01
2881
2056
2544
1013
2119
2285
2439
2437
2087
341
2452
3142
3636
2028
320
2363
1077
2047
2557
2001
3291
3799
2083
2820
2232
3821
3005
3108
3007
2564
2515
1040
2573
2873
2238
2631
2052
2840
2529
2245
2562
3139
2107
3627
287
2611
Sio, Terence
3263
Sio, Terence
3794
Sio, Terence
2940
Sio, Terence
3208
Sio, Terence
1096
Sioshansi, Shirin
2391
Siva, Shankar
3079
Siva, Shankar
3036
Slade, Alexander
1020
Slotman, Ben
CT-05
Small, William
236
Smith, Adam
3113
Smith, Clayton
222
Smith, Linda
2147
Smith, Tamara
2521
Snider III, James
3412
Snider III, James
2153
Snider III, James
27
Solanki, Abhishek
2601
Son, Christina
2550
Son, Jaeman
3803
Song, Andrew
2263
Song, Sanghyuk
3383
Song, Yipeng
3538
Sonier, Marcus
3749
Soon, Yu Yang
2924
Speers, Corey
70
Speirs, Christina
3156
Spektor, Alexander
3451
Spencer, Christopher
2472
1058
Spickermann, Maximilian 3170
Spieler, Benjamin
2487
Spiotto, Michael
2895
Spiotto, Michael
2894
Spratt, Daniel
1124
Spratt, Daniel
3478
Spratt, Daniel
1126
Sreeraman, Radhika
3307
Srivastava, Shiv
3671
Stalpers, Lukas
2257
Stalpers, Lukas
2220
Stanescu, Teo
203
Stanton, Paul
167
Stauder, Michael
2045
Stecklein, Shane
3618
Steenbeke, Femke
3738
Stegmaier, Petra
2852
Stephans, Kevin
51
Sterzing, Florian
58
Sterzing, Florian
2599
Stessin, Alexander
327
Stewart, Alexandra
2541
Stish, Bradley
258
Stone, Brandon
3415
Straka, Christopher
2531
Strasser, Jon
2134
Strom, Eric
1106
Strom, Tobin
2347
Strom, Tobin
2486
Sturdza, Alina
195
Stuschke, Martin
323
Su, Zhong
3776
Su, Zhong
1107
Sudhyadhom, Atchar
2615
Sugie, Chikao
2012
Suh, Yae-eun
2830
Suh, Yang-Gun
2842
Summers, Paige
3805
Sun, Baozhou
2704
Sun, Jian
3095
Sun, Lova
2158
191
Sun, Yunguang
Sun, Yunguang
Suneja, Gita
Suntharalingam, Mohan
Sura, Karna
Suttie, Clare
Suttie, Clare
Suwinski, Rafal
Suzuki, Yoshiyuki
Sveistrup, Joen
Swanick, Cameron
Syh, Joseph
Symon, Zvi
Szeja, Sean
Szeja, Sean
3516
3515
306
CT-04
321
2101
3604
2432
3437
2485
2685
2733
2597
2218
3413
T
Tachiki, Lisa
3670
Taggar, Amandeep
2265
Tai, An
81
Tait, Lauren
2657
Takagi, Masaru
2864
Takahashi, Ippei
3460
Takahashi, Noriyoshi
3032
Takahashi, Shigeo
3016
Takahashi, Wataru
1141
Takamatsu, Shigeyuki
2390
2389
Takanaka, Tsuyoshi
3003
Takaoka, Taiki
2408
Takeda, Ken
2759
Takeda, Ken
2813
Takehana, Keiichi
2812
Takeuchi, Yuki
3051
Takiar, Vinita
2679
Taku, Nicolette
2746
Talamonti, Cinzia
3758
Tamari, Keisuke
2224
Tan, Daniel
3248
Tan, Jun
2312
Tan, Jun
2310
Tan, Lai
2795
Tan, Vivian
1028
Tanaka, Hiroshi
3246
Tanaka, Nobumichi
1131
Tandberg, Daniel
3021
Tanderup, Kari
196
Tang, Chad
3029
Tang, Chad
3030
Tang, Linglong
1009
Tang, Yu
2450
Tanguturi, Shyam
2461
Tanguturi, Shyam
1022
Tanzler, Emily
2802
Tao, Jessie
3421
Tao, May Lin
2042
Tao, Randa
142
Tatekawa, Kotoha
3180
Taunk, Neil
1121
Taylor, Kinley
3371
Taylor, Robert
1068
Teboh Forbang, Roland
2373
Telivala, Tejas
3781
Tennyson, Nathan
3209
Teng, Feifei
3022
Tetreault, Audrey
2984
Thaker, Nikhil
3316
Thaker, Nikhil
2992
Thammineni, Pratap Reddy 2073
Thariat, Juliette
2859
192
Thau, Matthew
Thibault, Isabelle
Thibault, Isabelle
Thomas, Evan
Thomas, Evan
Thompson, Catherine
Thompson, Jonathan
Thompson, Kenton
Thomson, David
Thomson, David
Thor, Maria
Tian, Sibo
Tian, Xi
Tijssen, Rob
Timmerman, Robert
Tinkle, Christopher
Tinkle, Christopher
Tinkle, Christopher
Todor, Dorin
Tonlaar, Nathan
Torok, Jordan
Torres-Roca, Javier
Torres-Roca, Javier
Torres-Roca, Javier
Toya, Ryo
Toyomasu, Yutaka
Tran, Phuoc
Treharne, Gregory
Trifiletti, Daniel
Trifiletti, Daniel
Troeller, Almut
Trovo, Marco
Trovo, Marco
Trovo, Marco
Truong, Pauline
Tryggestad, Erik
Tsai, Mu-Hung
Tsegmed, Uranchimeg
Tseng, Chia-Lin
Tseng, Yolanda
Tsiamas, Panagiotis
Tuano, Diana
Tuli, Richard
Tuohy, Rachel
Turaka, Aruna
Turaka, Aruna
2335
269
3268
3001
3856
2639
3541
3686
3693
214
3638
3431
3510
3692
56
3406
2648
3402
1103
2149
3171
1031
3561
3559
2788
2887
1047
2693
2123
2951
83
3004
3083
2008
95
3795
2856
2395
270
2068
3844
2109
3544
3709
3008
3018
U
Udayakumar,
Thirupandiyur
Ueda, Yoshihiro
Ueki, Nami
Ugurluer, Gamze
Uh, Jinsoo
Umezawa, Rei
Umezawa, Rei
Ung, Kim Ann
Urbanic, James
Urbanski, Bartosz
Urdaneta, Alfredo
2600
3594
3081
2673
3301
1116
2309
2430
185
2002
2607
V
Vainshtein, Jeffrey
Vainshtein, Jeffrey
Valderrama, Adriana
Valentini, Chiara
Vallieres, Martin
Van de Pol, Sandrine
Van der Heide, Hugo
Van Diessen, Judi
216
2754
3259
3143
3
2502
2868
3120
Van Dijk, Laura
1085
Van Leeuwen, Caspar
3630
Van Sornsen de Koste, John 3608
Vance, Sean
2719
Vanderstraeten, Barbara
232
Vanoni, Valentina
2110
Varadhan, Raj
3655
Varadhan, Raj
3350
Vargo, John
265
Vatner, Ralph
3522
Vatner, Ralph
3723
Vaughan, Andrew
3414
Veldwijk, Marlon
3438
Velec, Michael
155
Velker, Vikram
2725
Vendrely, Veronique
34
Venkat, Puja
2709
Venkat, Puja
2707
Verbakel, Wilko
3845
Verhoeven, Karolien
2108
Verma, Jonathan
2115
Videtic, Gregory
3031
Vieira, Andre
3705
Vigneault, Eric
2554
Villa, Salvador
1015
Vinogradskiy, Yevgeniy
129
Virk, Michael
2212
Visser, Jorrit
3791
Viswanathan, Akila
1061
Vitzthum, Lucas
3337
Volotskova, Olga
3479
Voong, Khinh Ranh
2455
Vujovic, Olga
2019
Vyas, Shilpa
256
W
Waddle, Mark
Wahl, Daniel
Wahl, Michael
Walker, Amanda
Wallace, Harold
Wallach, Jonathan
Wallner, Paul
Walston, Steve
Wang, Ange
Wang, Bin
Wang, Chengtao
Wang, Chunhao
Wang, Dongxu
Wang, Edina
Wang, Haotong
Wang, Huan-Huan
Wang, Jianyang
Wang, Jiazhou
Wang, Jin
Wang, Jin
Wang, Jing
Wang, Jingbo
Wang, Lan
Wang, Lora
Wang, Qi
Wang, Suzhen
Wang, Suzhen
Wang, Tao
Wang, Ti-Hao
Wang, Tonghe
Wang, Tony
Wang, Wei
Wang, Weili
Wang, Xiao Shen
Wang, Xin
2934
2412
75
117
2551
2025
2980
3540
3296
3468
2803
87
3792
3505
3385
3753
3377
1105
2297
2298
1101
169
2319
2360
3013
2071
2072
3518
3606
3766
2252
2046
3151
1049
2201
Wang, Xin
Wang, Xin
Wang, Xin
Wang, Yu-Ming
Wang, Zhi
Ward, Matthew
Ward, Matthew
Warkentin, Heather
Warrell, Gregory
Warren, Laura
Watkins, William
Waxweiler, Timothy
Wazer, David
Wee, Chan Woo
Wei, Randy
Wei, Xiong
Weiner, Ashley
Weiner, Joseph
Weir, Joshua
Weir, Robert
Weiss, Elisabeth
Weller, Michael
Welsh, James
Wen, Ning
Whalley, Deborah
Wheatley, Matthew
White, Benjamin
White, Evan
White, Evan
Widlak, Piotr
Wiedenmann, Nicole
Wilcox, Shea
Wilke, Christopher
Wilke, Christopher
Willers, Henning
Willett, Addison
Williams, Norman
Williams, Terence
Wiltink, Lisette
Witztum, Alon
Wo, Jennifer
Wobb, Jessica
Wobb, Jessica
Wobb, Jessica
Wojcieszynski, Andrzej
Wolfe, Adam
Wong, Andrew
Wong, Anthony
Wong, Jeffrey
Wong, Ru xin
Wong, Tony
Woo, Jennifer
Woo, Jennifer
Woo, Joong Yeol
Woody, Neil
Woolf, David
Wooten, Charles
Wooten, Hasani
Wray, Justin
Wright, Christopher
Wright, Jean
Wright, Jean
Wu, Abraham
Wu, Jianzhou
Wu, Junxin
Wu, Q. Jackie
Wu, Szu-Yuan
Wu, tao
Wu, Vincent
Wurstbauer, Karl
Wzietek, Iwona
2423
1120
2701
3238
1115
2906
2821
3002
2507
2144
3619
2884
2066
2794
2128
3048
2441
2587
2780
2445
3568
1129
3818
1075
2638
3135
3599
3699
3772
3453
5
2900
3175
3407
223
257
2006
2382
183
3600
2466
2140
1087
3542
2003
1043
2057
2965
3194
2197
3798
3261
3257
3722
94
2032
268
209
325
72
2062
2136
128
3751
2327
3063
3503
2105
2783
3053
37
X
Xia, Fen
Xiang, Liangzhong
Xiao, Canhua
Xiao, Qin
Xiao, WeiWei
Xie, Liyi
Xing, Ligang
Xingwen, Fan
Xu, Beibei
Xu, Karen
Xu, Qiong
Xu, Ting
Xu, Ting
3450
3849
2915
2448
2808
3127
3508
3456
2897
2660
3712
226
3537
Y
Yadav, Budhi
Yamada, Yoshiya
Yamamoto, Takaya
Yamashita, Hideomi
Yan, Di
Yang, Bin
Yang, Ching-Chieh
Yang, Ching-Chieh
Yang, Daniel
Yang, Fei
Yang, George
Yang, Jia
Yang, Jia
Yang, Jinsong
Yang, Jinsong
Yang, Ruijie
Yang, Jonathan
Yang, Jonathan
Yang, Jonathan
Yang, Wensha
Yang, Xiaofeng
Yang, Xiaofeng
Yang, Yong
Yang, ZhaoZhi
Yao, Min
Yao, Weiguang
Yap, Mei Ling
Yaparpalvi, Ravindra
Yard, Brian
Yashar, Catheryn
Yassa, Michael
Yathiraj, Prahlad
Yazici, Gozde
Ybarra, Norma
Ye, Fan
Ye, Hong
Ye, Jason
Ye, Jason
Ye, Jin-Song
Yeboa, Debra
Yeung, Daniel
Yeung, Rosanna
Yeung, Rosanna
Yi, Byong Yong
2060
272
3026
3119
3653
3365
2434
2246
2937
2656
2604
3477
3525
2324
2340
3341
2079
2545
1016
3698
2063
2575
3621
2014
1052
3717
3080
3746
66
2129
2053
211
3774
3632
2606
3254
2961
2078
3750
2988
2762
2051
2054
3362
Ying, Hongmei
Ying, James
Yip, Connie
Yip, Darwin
Yip, Darwin
Yip, Stephen
Yoo, Hyun
Yoo, Stella
Yoo, Sua
Yoon, Hong In
Yoon, Kyoung Jun
Yorozu, Atsunori
Yoshitake, Tadamasa
Younan, Lawrence
Young, Kristina
Young, Kristina
Young, Rebekah
Young, Rebekah
Yu, Edward
Yu, Esther
Yu, James
Yu, Jialu
Yu, Naichang
Yu, Suhong
Yu, Victoria
Yu, Wen
Yuan, Lulin
Yue, Yong
Yuen, Florence
2787
2478
3020
2854
3392
47
3429
3207
2055
2677
3654
1130
3109
2844
3416
120
2705
2092
2009
2429
302
3331
2947
3666
3640
13
227
2365
3214
Z
Zahra, Amir
Zaini, Mehran
Zaki, Mark
Zamdborg, Leonid
Zang, Jian
Zaorsky, Nicholas
Zapatero, Almudena
Zarepisheh, Masoud
Zavitsanos, Peter
Zaza, Khaled
Zeitlin, Ross
Zellars, Richard Cedric
Zeng, Chuan
Zhang, Chi
Zhang, Hao
Zhang, Li
Zhang, Li
Zhang, Li Yuan
Zhang, Minsi
Zhang, Ning
Zhang, Peng
Zhang, Peng
Zhang, Peng
Zhang, Pengpeng
Zhang, Qian
Zhang, Qinghui
3253
3819
2339
2082
3188
2993
PL-02
234
2857
2636
2610
2152
2146
3804
3496
3597
2035
2038
3452
3427
2785
3470
2314
192
3575
2090
3770
Zhang, Yan
Zhang, Yibao
Zhang, Ying
Zhang, You
Zhang, Zhenhuan
Zhao, Bo
Zhao, Bo
Zhao, Diana Yi
Zhao, Fen
Zhao, Hanxi
Zhao, Jing
Zhao, Li
Zhao, Nan
Zhao, Nan
Zhao, Shuang
Zhao, Shuang
Zhao, Weizhao
Zheng, Dandan
Zheng, Shuai
Zheng, Yuanshui
Zheng, Zhiyuan
Zhou, Jessica
Zhou, Jessica
Zhou, Jun
Zhou, Lin
Zhou, Meixiang
Zhou, Qichao
Zhou, Xin
Zhuang, Hong-Qing
Zhung, Joanne
Zhung, Joanne
Ziehr, David
Ziehr, David
Zielinska-Chomej,
Katarzyna
Zilli, Thomas
Zlateva, Yana
Zumsteg, Zachary
2438
161
2655
3591
3497
3601
3783
3457
2178
98
125
3807
3842
3843
181
3562
33
3102
3552
3816
2586
2743
3278
2
3009
3025
2797
1057
2269
3756
3062
23
2608
3448
3752
1097
73
193
Index by Track (Abstracts only)
BREAST CANCER
Anne, Pramila
Ho, Alice
Fowble, Barbara
Liss, Adam
Woody, Neil
Truong, Pauline
Hamilton, Sarah
Bergom, Carmen
Setton, Jermey
Gupta, Gaorav
Garg, Rashi
Kandula, Shravan
Ng, Sweet
Jing, Hao
Boelke, Edwinq
Ma, Jinli
Polgar, Csaba
Lalani, Nafisha
Horton, Janet
Ma, Lin
Chen, Peter
Hepel, Jaroslaw
Leong, Nelson
Sapienza, Lucas
Kim, Kyung Hwan
Eldredge-Hindy, Harriet
Tan, Vivian
Murphy, Colin
Braunstein, Lior
Torres-Roca, Javier
Golden, Encouse
Lim, Trevor
De Rose, Fiorenza
Shaitelman, Simona
Cooper, Benjamin
Shikama, Naoto
Urbanski, Bartosz
Wojcieszynski, Andrzej
Mak, Kimberley
Rajagopalan, Malolan
Williams, Norman
Cuaron, John
Trovo, Marco
Yu, Edward
Erickson, Delnora
Duma, Marciana-Nona
Sugie, Chikao
Refaat, Tamer
Yang, ZhaoZhi
Leonard, Charles
Kawamura, Mariko
Saksornchai, Kitwadee
Vujovic, Olga
Knoll, Miriam
Ding, Yun
Jones, Guy
De Paula, Ugo
Kathpal, Madeera
Wallach, Jonathan
194
90
91
92
93
94
95
96
97
146
147
148
149
150
151
152
153
292
294
295
296
297
298
299
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Abo-Madyan, Yasser
Falchook, Aaron
Shenouda, Mina
Karasawa, Kumiko
Chandra, Ravi
Rakhra, Sunpreet
Woolf, David
Duelge, Jason
Ambroa Rey, Eva
Zhang, Li
Pinnaro, Paola
Bosnic, Sandi
Zhang, Li
McGuffin, Merrylee
Cordova, Elisa
Del Cerro Penalver, Elia
Tao, May Lin
Rana, Zaker
Healy, Erin
Stauder, Michael
Wang, Wei
Shi, Zeliang
Alco, Gul
Hitchcock, Whitney
Bazan, Jose
Yeung, Rosanna
Shumway, Dean
Yassa, Michael
Yeung, Rosanna
Yoo, Sua
Sharp, Hadley
Wong, Andrew
Herman, Lauren
Gillespie, Erin
Yadav, Budhi
Belkacemi, Yazid
Wright, Jean
Yang, Xiaofeng
Bekelman, Justin
Mutter, Robert
Wazer, David
Braunstein, Lior
Tseng, Yolanda
Cao, Lu
Page, Brandi
Wang, Suzhen
Wang, Suzhen
Thammineni, Nikhila
Li, Weiwei
Chen, Jiayi
Yang, T. Jonathan
Li, Shuai
Ye, Jason
Yang, T. Jonathan
Ogita, Mami
Jarvis, Lesley
Zamdborg, Leonid
Shin, Jacob
Belkacemi, Yazid
Mirabeau-Beale, Kristina
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
2057
2058
2059
2060
2061
2062
2063
2064
2065
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
2076
2077
2078
2079
2080
2081
2082
2083
2084
2085
Acharya, Sahaja
Shen, Sui
Hansen, Tara
Lopresti, Mary
Zhang, Qian
Rahimi, Asal
Young, Rebekah
Li, Linna
Lymberiou, Timothy
Pham, Trang
Lee, Grace
Chung, Yoonsun
Li, Shuai
Keiler, Louis
Demas, Kristina
Suttie, Clare
Dai Kubicky, Charlotte
Lai, Shihfan
Noh, Jae Myoung
Wu, Tao
Bourgier, Celine
Simontacchi, Gabriele
Verhoeven, Karolien
Tuano, Diana
Vanoni, Valentina
Kato, Masako
No, Hyunsoo
Jwa, Eunjin
Patel, Kruti
Verma, Jonathan
Petersen, Ivy
Cascales Garcia, Maria
Almudena
Nichols, Elizabeth
Shekel, Efrat
Johnson, Julian
Lee, Anna
Manzerova, Julia
Trifiletti, Daniel
Rao, Nalini
Lok, Benjamin
Mattes, Malcolm
Kesava Ramgopal,
Adavikolanu
Wei, Randy
Yashar, Catheryn
Gultekin, Melis
Ahlawat, Stuti
Massabeau, Carole
Hymas, Richard
Strasser, Jon
Goldsmith, Christy
Wright, Jean
Chen, Peter
Ríos Pozo, María
Hartsell, William
Wobb, Jessica
Ognibene, Grant
Rose, Brent
Petereit, Daniel
2086
2087
2088
2089
2090
2091
2092
2093
2094
2095
2096
2097
2098
2099
2100
2101
2102
2103
2104
2105
2106
2107
2108
2109
2110
2111
2112
2113
2114
2115
2116
2117
2118
2119
2120
2121
2122
2123
2124
2125
2126
2127
2128
2129
2130
2131
2132
2133
2134
2135
2136
2137
2138
2139
2140
2141
2142
2143
Warren, Laura
Rineer, Justin
Smith, Linda
Patel, Nisha
Tonlaar, Nathan
Chin, Joanna
Chang, Jennifer
Snider III, James
Fasola, Carolina
Eblan, Michael
Dowlatshahi, Morteza
2144
2145
2146
2147
2148
2149
2150
2151
2152
2153
2154
2155
2156
CENTRAL NERVOUS SYSTEM
Mehta, Minesh
74
Wahl, Michael
75
Lo, Andrea
76
Kim, Michelle
77
Choe, Kevin
78
Belcaid, Zineb
79
Huff, Byron
80
Thibault, Isabelle
269
Tseng, Chia-Lin
270
Pan, Hubert
271
Yamada, Yoshiya
272
Nichol, Alan
273
Hadzitheodorou, Christina 274
Ayala-Peacock, Diandra
275
Bohoudi, Omar
276
Shaw, Edward
1013
Cao, Kim
1014
Villa, Salvador
1015
Yang, T. Jonathan
1016
Farnia, Benjamin
1017
Akram, Kothwal
1018
Quigley, Matthew
1019
Slade, Alexander
1020
Hanna, Andrew
1021
Tanguturi, Shyam
1022
Redmond, Kristin
1023
Loiselle, Christopher
1024
Marsh, James
2157
Sun, Lova
2158
Caudell, Jimmy
2159
LaPlant, Quincey
2160
Luchi, Toshihiko
2161
Kim, Michelle
2162
Elson, Andrew
2163
Patel, Abhilasha
2164
Chirindel, Alin
2165
Rizzo, Anthony
2166
Azoulay, Melissa
2167
Carlson, Julie
2168
Carlson, Julie
2169
Diaz Pardo, Dayssy
2170
Igaki, Hiroshi
2171
Desai, Brijal
2172
Anker, Christopher
2173
Nakajima, Naomi
2174
Nakajima, Naomi
Nakajima, Naomi
Kucharczyk, Michael
Zhao, Fen
Bovi, Joseph
Li, Xin
Kusumawidjaja, Grace
Fujitani, Nobumasa
Rahman, Rifaquat
Debus, Charlotte
Anwar, Mekhail
Holmes, Jordan
Diletto, Barbara
Chiesa, Silvia
Jairam, Vikram
Hardie, John
Huang, Jiayi
Kang, Julie Jung
Lecavalier-Barsoum,
Magali
Narang, Amol
Randolph, David
Osmundson, Evan
Wong, Ru Xin
Meyer, Kurt
Marciscano, Ariel
Joshi, Nikhil
Wang, Xin
Russo, Gregory
Kittel, Jeffrey
Maclean, Jillian
Kennedy, William
Sabit, Khusraw
Dyer, Michael
Rhome, Ryan
Jefferis, Jennifer
Ahmed, Zain
Robinson, Clifford
Virk, Michael
Jain, Prachi
Chang, Eric
Marwaha, Gaurav
Li, Puyao
Barker, Christopher
Szeja, Sean
Polishchuk, Alexei
Stalpers, Lukas
Price, Samantha
Perez, Bradford
Nagai, Aiko
Tamari, Keisuke
Mathew, Prince
Bates, James
Lazow, Stefanie
Pollock, Bruce
Patel, Shyamal
Miyakawa, Akifumi
Hayashi, Akihiro
Shin, Samuel
Harada, Hideyuki
Colaco, Rovel
Colaco, Rovel
Clavier, Jean-Baptiste
Ahmed, Kamran
2175
2176
2177
2178
2179
2180
2181
2182
2183
2184
2185
2186
2187
2188
2189
2190
2191
2192
2193
2194
2195
2196
2197
2198
2199
2200
2201
2202
2203
2204
2205
2206
2207
2208
2209
2210
2211
2212
2213
2214
2215
2216
2217
2218
2219
2220
2221
2222
2223
2224
2225
2226
2227
2228
2229
2230
2231
2232
2233
2234
2235
2236
2237
Shultz, David
Bagshaw, Hilary
Chang, Jennifer
Ahmed, Kamran
Seymour, Zachary
Fogarty, Gerald
Choi, Seohee
Silva, Maria Leticia
Yang, Ching-Chieh
Huang, Andrew
Lucas, John
Raber, Jacob
Levin-Epstein, Rebecca
Kotecha, Rupesh
Wang, Tony
Khan, Luluel
Gondi, Vinai
Moraes, Paulo
Masson-Cote, Laurence
Stalpers, Lukas
Savir, Guy
Gorovets, Daniel
Jayachandran, Priya
Burkeen, Jeffrey
Jani, Ashish
Song, Andrew
Althaqfi, Saif
Taggar, Amandeep
Murai, Taro
Hasan, Yaser
Chan, Jason
Zhuang, Hong-Qing
Schreibmann, Eduard
Eaton, Bree
Mickevicius, Nikolai
Giem, Jared
Broomfield, Joel
Lanning, Ryan
Lindberg, Karin
Arneson, Kyle
Modlin, Leslie
Shah, Mira
Pham, Anthony
Munbodh, Reshma
Abraham, Christopher
Estabrook, Neil
Johnson, Matthew
Shen, Colette
Badiyan, Shahed
Press, Robert
Abel, Ryan
Masino, Alexander
Chang, Jennifer
2238
2239
2240
2241
2242
2243
2244
2245
2246
2247
2248
2249
2250
2251
2252
2253
2254
2255
2256
2257
2258
2259
2260
2261
2262
2263
2264
2265
2266
2267
2268
2269
2270
2271
2272
2273
2274
2275
2276
2277
2278
2279
2280
2281
2282
2283
2284
2285
2286
2287
2288
2289
2290
GASTROINTESTINAL CANCER
Penniment, Michael
CT-03
Suntharalingam, Mohan CT-04
Chiang, Yun
10
Fu, Shen
11
Chhabra, Arpit
12
Yu, Wen
13
Rackley, Thomas
14
Li, Minghuan
15
Samuels, Stuart
16
Dominello, Michael
Vendrely, Veronique
Ahmed, Kamran
Hong, Theodore
Wzietek, Iwona
Ngan, Samuel
Czito, Brian
Engels, Benedikt
Liu, Wenyang
Olsen, Jeffrey
Mai, Sabine
Doll, Corinne
Goodman, Karyn
Lee, Andrew
Bitterman, Danielle
Cardenas, Michael
Quan, Kimmen
Colbert, Lauren
Merrell, Kenneth
Pollom, Erqi
Choi, Chihwan
Meyer, Jeffrey
Hirata, Takero
Ohri, Nitin
Koc, Mehmet
Bernard, Mark
Lin, Chi
Kim, Tae Hyung
Dover, Laura
Ren, Hua
Wang, Zhi
Umezawa, Rei
Berman, Abigail
Kong, Jie
Li, Tao
Wang, Xin
Sekii, Shuhei
Di, Liu
Dean, Mary
Doi, Yoshiko
Fernandes, Annemarie
Boggs, Hunter
Wang, Jin
Wang, Jin
Servagi Vernat, Stephanie
Kawamura, Mariko
Murakami, Yuji
Qu, Melody Xuanlu
Nishimura, Yasumasa
Nabavizadeh, Nima
Ito, Yoshinori
Atsumi, Kazushige
Ariga, Takuro
Ling, Ted
Umezawa, Rei
Tan, Jun
Myojin, Miyako
Tan, Jun
Meng, Mao-Bin
Zhang, Peng
Guo, Yanluan
Guo, Yanluan
Guo, Yanluan
Hsu, Feng-Ming
17
34
35
36
37
38
39
40
41
59
60
61
62
63
64
65
99
100
101
102
103
104
105
106
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
2291
2292
2293
2294
2295
2296
2297
2298
2299
2300
2301
2302
2303
2304
2305
2306
2307
2308
2309
2310
2311
2312
2313
2314
2315
2316
2317
2318
Wang, Lan
Han, Dali
Han, Chun
Machiels, Melanie
Ishikawa, Kazuki
Yang, Jinsong
Ishikawa, Hitoshi
Nishibuchi, Ikuno
Wu, Junxin
Liu, Hui
Giaddui, Tawfik
James, Sarah
Ludmir, Ethan
Chen, Yun
Shaikh, Talha
Kawanaka, Takashi
Thau, Matthew
Choflet, Amanda
Nonaka, Tetsuo
Sahgal, Arjun
Zaki, Mark
Yang, Jinsong
Cheng, Jessica
Li, Guichao
Lu, NingNing
Patel, Ravi
Cuneo, Kyle
Strom, Tobin
Colbert, Lauren
Kishi, Takahiro
Kennoki, Norifumi
Freilich, Jessica
Li, Jinluan
Dalah, Entesar
Kasuya, Takeo
Ren, Gang
Romeo, Antonino
Peguret, Nicolas
Shaikh, Talha
Ling, Ted
Wang, Lora
Abrams, Matthew
Mellon, Eric
Sherr, David
Baschnagel, Andrew
Yue, Yong
Hayman, Thomas
Hajj, Carla
Lutz, Ryan
Mian, Omar
Liang, Yun
Gan, Hua
Bernstein, Michael
Teboh Forbang, Roland
Moningi, Shalini
Latifi, Kujtim
Kocak, Esengul
Palmer, Joshua
Palmer, Joshua
Horowitz, David
Moningi, Shalini
Berriochoa, Camille
Williams, Terence
2319
2320
2321
2322
2323
2324
2325
2326
2327
2328
2329
2330
2331
2332
2333
2334
2335
2336
2337
2338
2339
2340
2341
2342
2343
2344
2345
2346
2347
2348
2349
2350
2351
2352
2353
2354
2355
2356
2357
2358
2359
2360
2361
2362
2363
2364
2365
2366
2367
2368
2369
2370
2371
2372
2373
2374
2375
2376
2377
2378
2379
2380
2381
2382
195
Lai, Yo-Liang
Huang, Wei
Kishan, Amar
Huang, Yaoru
Keene, Kimberly
Iizuka, Yusuke
Sioshansi, Shirin
Klein, Jonathan
Kudithipudi, Vijay
Apisarnthanarax, Smith
Tsegmed, Uranchimeg
Comito, Tiziana
Hall, William
Niska, Joshua
Raldow, Ann
Ernst, Iris
Oh, Ryoong Jin
Paik, Eun Kyung
Goodman, Ben
Shaffer, Jenny
Chang, Daniel
Scorsetti, Marta
Muller, Karin
Takaoka, Taiki
Engineer, Reena
Feng, Mary
Qiu, Haoming
Wahl, Daniel
Bhooshan, Neha
Chuong, Michael
Mannina, Edward
Blacksburg, Seth
Shaffer, Jenny
Halthore, Aditya
Chuong, Michael
Bota, Krista
Osmundson, Evan
Dyer, Brandon
Wang, Xin
Morillo Macías, Virginia
Lashkari, Marzieh
Lefresne, Shilo
Huang, Chun-Ming
Yu, Esther
Ung, Kim Ann
Li, Ning
Suwinski, Rafal
Benezery, Karine
Yang, Ching-Chieh
Jimenez-Jimenez, Esther
Kim, Jae-Sung
Shen, Lijun
Zhang, Yan
Shen, Lijun
Glick, Daniel
Weiner, Ashley
Sato, Hiroo
Lim, Hyeon Woo
Kim, Tae Hyung
Weir, Robert
Resende Salgado, Lucas
Lawrence, Yaacov
196
2383
2384
2385
2386
2387
2388
2389
2390
2391
2392
2393
2394
2395
2396
2397
2398
2399
2400
2401
2402
2403
2404
2405
2406
2407
2408
2409
2410
2411
2412
2413
2414
2415
2416
2417
2418
2419
2420
2421
2422
2423
2424
2425
2426
2428
2429
2430
2431
2432
2433
2434
2435
2436
2437
2438
2439
2440
2441
2442
2443
2444
2445
2446
2447
Xiao, Qin
Lei, Xin
Tang, Yu
Koo, Tae Ryool
Shen, Yali
Chen, Helen
Jeongshim, Lee
Voong, Khinh Ranh
Bhirud, Abhijeet
Bennion, Nathan
Morris, Zachary
Anderson, Eric
Anand, Aman
Tanguturi, Shyam
Kozak, Malgorzata
Moeller, Benjamin
De Bari, Berardino
Longo, John
Wo, Jennifer
Grew, David
Amin, Raima
Saeed, Nadia
Muirhead, Rebecca
Baden, Craig
Patel, Abhilasha
Sezen, Duygu
Palta, Manisha
2448
2449
2450
2451
2452
2453
2454
2455
2456
2457
2458
2459
2460
2461
2462
2463
2464
2465
2466
2467
2468
2469
2470
2471
2472
2473
2474
2475
GENITOURINARY CANCER
Hurwitz, Mark
CT-01
Zapatero, Almudena
PL-02
James, Nicholas
18
Lin, Chun Chieh
19
Rusthoven, Chad
20
Narang, Amol
21
Kohutek, Zachary
22
Ziehr, David
23
Nabid, Abdenour
24
Brower, Jeffrey
107
Rice, Stephanie
108
Saracino, Biamcamaria
109
McLaughlin, Patrick
111
Pugh, Thomas
112
Kerns, Sarah
113
Fachal, Laura
114
Kang, Julie Jung
285
Abramowitz, Matthew
286
Sineshaw, Helmneh
287
Pham, Huong
288
Mitin, Timur
289
Muren, Ludvig
290
Baumann, Brian
290.5
Gray, Phillip
291
Shen, Xinglei
341
Caster, Joseph
342
Phillips, John
343
Naik, Mihir
344
Romesser, Paul
345
Malone, Shawn
346
Den, Robert
347
Erho, Nicholas
348
Taunk, Neil
1121
Gibson, Eli
1122
Scott, Michael
Crehange, Gilles
Spratt, Daniel
Ashamalla, Hani
Mason, Mathew
Weller, Michael
Yorozu, Atsunori
Tanaka, Nobumichi
Krauss, Daniel
Mikell, John
Hall, Matthew
Ying, James
Phillips, John
Naydich, Boris
Hashimoto, Yaichiro
Marina, Ovidiu
Ogino, Hiroyuki
Sveistrup, Joen
Strom, Tobin
Spieler, Benjamin
Cho, Eunpi
Pham, Yvonne
Finkelstein, Steven
Park, Henry
Nomiya, Takuma
Seymour, Zachary
Evans, Joseph
Seymour, Zachary
Counago, Felipe
Counago, Felipe
Kishan, Amar
Rose, Jim
Chhabra, Arpit
Krauss, Daniel
Van de Pol, Sandrine
Murphy, Colin
Kang, Hyun-Cheol
Mason, Josh
Orman, Amber
Warrell, Gregory
Rodrigues, George
Edwards, Albert
Fuller, Donald
Helou, Joelle
Jensen, Lindsay
Helou, Joelle
Bagley, Jack
Shiraishi, Yutaka
Thompson, Catherine
Pos, F.J.
Engels, Benedikt
Inokuchi, Haruo
Smith, Tamara
Gomez, Caitlin
Nelson, Aaron
Cheng, Jonathan
Bryant, Curtis
Hughes, Michael
Mourad, Waleed
Huang, Roger
Sifuentes, Joshua
Mourad, Waleed
Straka, Christopher
1123
1125
1126
1127
1128
1129
1130
1131
1132
2476
2477
2478
2479
2480
2481
2482
2483
2484
2485
2486
2487
2488
2489
2490
2491
2492
2493
2494
2495
2496
2497
2498
2499
2500
2501
2502
2503
2504
2505
2506
2507
2508
2509
2510
2511
2512
2513
2514
2515
2516
2517
2519
2520
2521
2522
2523
2524
2525
2526
2527
2528
2529
2530
2531
Kalbasi, Anusha
Kotecha, Rupesh
Hanna, Nevine
Loblaw, D. Andrew
Hamilton, Sarah
Safdieh, Joseph
Ishii, Kentaro
Miller, Seth
Hempel, Dominika
Stewart, Alexandra
Lin, Yu-Wei
Hong, Cheng
Shasha, Daniel
Yang, T. Jonathan
Nabhani, Thomas
Dolezel, Martin
Lloyd, Shane
Oksuz, Didem
Son, Christina
Wallace, Harold
Jackson, William
Gray, Phillip
Vigneault, Eric
Chiang, Andrew
Crawford, E. David
Yanagi, Takeshi
Counago, Felipe
Kattevilder, Robert
Ferrer, Ferran
Asakura, Hirofumi
Simon, Antoine
Kountouri, Melpomeni
Shiraishi, Kenshiro
Lecavalier-Barsoum,
Magali
Milecki, Piotr
Qi, Xin
Qi, Xin
Hathout, Lara
Commandeur, Frédéric
Hogue, Cory
Galalae, Razvan
Shukla, Monica
Blay, Christophe
Yang, Xiaofeng
McHaffie, Derek
Chalubinska-Fendler,
Justyna
Agoston, Peter
Michalski, Jeff
Nguyen, Paul
Oh, Steven
Lovelock, D. Michael
Kavanaugh, James
Kwok, Young
Grimm, Shu-Ya Lisa
Zheng, Zhiyuan
Weiner, Joseph
Meister, Moshe
Harris, David
Crehange, Gilles
Mahal, Brandon
Marcus, David
Melotek, James
2532
2533
2534
2535
2536
2537
2538
2539
2540
2541
2542
2543
2544
2545
2546
2547
2548
2549
2550
2551
2552
2553
2554
2555
2556
2557
2558
2559
2560
2561
2562
2563
2564
2565
2566
2567
2568
2569
2570
2571
2572
2573
2574
2575
2576
2577
2578
2579
2580
2581
2582
2583
2584
2585
2586
2587
2588
2589
2590
2591
2592
2593
Musunuru, Hima
Kazberuk, Dorota
Mahal, Brandon
Symon, Zvi
Chang, Albert
Sterzing, Florian
Udayakumar,
Thirupandiyur
Solanki, Abhishek
Henry, Ann
Lukens, John
Yang, George
Moraes, Fabio Ynoe
Ye, Fan
Urdaneta, Alfredo
Ziehr, David
Engelman, Alexander
Zeitlin, Ross
Singh, Hardev
Blas, Kevin
Ram, Ashwin
Narang, Amol
Sudhyadhom, Atchar
Pollack, Alan
Syed, A. Nisar
Ram, Ashwin
Green, Garrett
Asher, David
Faria, Sergio
Kumar, Parvesh
Arunsingh, Moses
Hartsell, William
Cooper, Samuel
Magnan, Sindy
Fuller, Donald
Quivrin, Magali
Robertson, Scott
2594
2595
2596
2597
2598
2599
2600
2601
2602
2603
2604
2605
2606
2607
2608
2609
2610
2611
2612
2613
2614
2615
2616
2617
2618
2619
2620
2621
2622
2623
2624
2625
2626
2627
2628
2629
Johnson, Skyler
Shumway, Dean
Orman, Amber
Gogna, Nirdosh
Li, BaoQing
Lautenschlaeger, Tim
Zaza, Khaled
Kollmeier, Marisa
Whalley, Deborah
Thompson, Catherine
Agaoglu, Fulya
Raleigh, David
Doyle, Paula
MacKillop, William
Lederman, Ariel
Hughes, Ryan
Sabolch, Aaron
Katoh, Norio
Tinkle, Christopher
Cury, Fabio
Kamran, Sophia
Beard, Clair
Carlone, Marco
Patel, Abhilasha
Cox, Brett
2630
2631
2632
2633
2634
2635
2636
2637
2638
2639
2640
2641
2642
2643
2644
2645
2646
2647
2648
2649
2650
2651
2652
2653
2654
GYNECOLOGIC CANCER
Jastaniyah, Noha
Sturdza, Alina
Tanderup, Kari
Bishop, Andrew
Ho, Clement
Markovina, Stephanie
Henke, Lauren
Small, William
Harkenrider, Matthew
Croke, Jennifer
Nout, Remi
Damast, Shari
Patel, Sagar
Lee, Larissa
Lin, Jeff
Viswanathan, Akila
Hong, Ji-Hong
Chino, Junzo
Mahantshetty, Umesh
Rath, Goura Kishor
Castelnau-Marchand,
Pauline
Taylor, Robert
Li, Qian
Kidd, Elizabeth
Mislmani, Mazen
Chaudary, Naz
Zhang, Ying
Yang, Fei
Tait, Lauren
Clark, Grant
Ma, John
Xu, Karen
Mahe, Marc
Neboori, Hanmanth
Park, Kawngwoo
1066
1068
1069
1070
1071
1072
2655
2656
2657
2658
2659
2660
2661
2662
2663
Kasuya, Goro
Kim, Yusung
Felder, Shira
Kidd, Elizabeth
McKeever, Matthew
Lee, Seok Ho
Petric, Primoz
Dempsey, Claire
Ugurluer, Gamze
Lee, Yongsook
Cellini, Francesco
Saitoh, Jun-ichi
Yoon, Hong In
Isohashi, Fumiaki
Takiar, Vinita
Kamrava, Mitchell
Hayashi, Kazuhiko
Murofushi, Keiko
Hansen, Henrik
Kubo, Akiko
Swanick, Cameron
Boyle, John
Dunn, Emily
Guimas, Valentine
Lin, Lilie
Li, Mei
2664
2665
2666
2667
2668
2669
2670
2671
2672
2673
2674
2675
2676
2677
2678
2679
2680
2681
2682
2683
2684
2685
2686
2687
2688
2689
2690
194
195
196
197
198
200
201
236
237
238
239
240
241
242
243
1061
1062
1063
1064
1065
Hansen, Henrik
2691
Eng, Tony
2692
Treharne, Gregory
2693
Best, Ryan
2694
Karakaya, Ebru
2695
Lim, Jihoon
2696
Mei, Feng
2697
Rash, Dominique
2698
Michaud, Anthony
2699
Sethi, Rajni
2700
Wang, Xin
2701
Croke, Jennifer
2702
Lin, Angela
2703
Sun, Baozhou
2704
Young, Rebekah
2705
Herskovic, Alex
2706
Venkat, Puja
2707
McClinton, Chris
2708
Venkat, Puja
2709
Nagar, Himanshu
2710
Chang-Halpenny, Christine 2711
Rovirosa, Angeles
2712
Ferraris, Gustavo
2713
Sapienza, Lucas
2714
Sabater, Sebastia
2715
Nagar, Himanshu
2716
Lu, Sharon
2717
Elshaikh, Mohamed
2718
Vance, Sean
2719
Bauer, Nicolas
2720
Abacioglu, Mehmet Ufuk 2721
Chapman, Christina
2722
Chen, Josephine
2723
Desai, Neil
2724
Velker, Vikram
2725
Poorvu, Philip
2726
Manzerova, Julia
2727
HEAD AND NECK CANCER
Berk, Lawrence
CT-07
Yathiraj, Prahlad
211
Grover, Surbhi
212
Marciscano, Ariel
213
Thomson, David
214
O'Sullivan, Brian
215
Vainshtein, Jeffrey
216
Grossman, Craig
217
Moon, Dominic
218
Lee, Victor
261
Chua, Melvin Lee Kiang
262
Galloway, Thomas
263
Hollen, Tyler
264
Vargo, John
265
Ghaly, Maged
266
Funk, Ryan
267
Wooten, Charles
268
Herskovic, Alex
307
Wang, XiaoShen
1049
Lin, Zhixiong
1050
Lucas, John
1051
Yao, Min
1052
Cruz, Misael
1053
Baral, Shweta
1054
Huang, Shao Hui
1055
Mendenhall, William
1056
Zhou, Xin
1057
1058
Okoye, Christian
1059
Caudell, Jimmy
1060
Rangarajan, Ramya
2747
Murakami, Ryuji
2748
Nicholas, Zachary
2749
Scher, Eli
2750
Quinlan-Davidson, Sean 2751
Hitchcock, Kathryn
2752
Amini, Arya
Dise, Joseph
Ma, Jennifer
Heumann, Thatcher
Maghsoudi, Kaveh
Syh, Joseph
Park, Sang-June
Maymani, Rebekah
Rose, Jim
Rao, Yuan
Han, Kathy
Lee, Larissa
Lapuz, Carminia
Mezera, Megan
Baliga, Sujith
Zhou, Jessica
Bair, Ryan
Gultekin, Melis
Taku, Nicolette
Cassidy, Richard
Vainshtein, Jeffrey
Liu, Jerry
Alizadeh-Kashani, Moein
Ma, John
Ghadjar, Pirus
Takeda, Ken
Gayar, Omar
Kocak, Esengul
Yeung, Daniel
Ricchetti, Francesco
Romesser, Paul
Keane, Florence
Gamez, Mauricio
Liu, Jerry
Rasmussen, Jacob
Narayanasamy, Ganesh
Rosenberg, Stephen
Koyfman, Shlomo
Kamran, Sophia
Magnuson, William
Pham, Anthony
Roenjom, Marianne Feen
Glaser, Scott
Izaguirre, Enrique
Schaner, Philip
Logie, Natalie
2728
2729
2730
2731
2732
2733
2734
2735
2736
2737
2738
2739
2740
2741
2742
2743
2744
2745
2746
2753
2754
2755
2756
2757
2758
2759
2760
2761
2762
2763
2764
2765
2766
2767
2768
2769
2770
2771
2772
2773
2774
2775
2776
2777
2778
2779
197
Weir, Joshua
2780
Chen, Susie
2781
Kodaira, Takeshi
2782
Wu, Vincent
2783
Chen, Yong
2784
Zhang, Ning
2785
Hung, Tsung Min
2786
Ying, Hongmei
2787
Toya, Ryo
2788
Ma, Lin
2789
Karam, Irene
2790
Altun, Musa
2791
Manon, Rafael
2792
Ma, Faqiang
2793
Wee, Chan Woo
2794
Tan, Lai
2795
Liu, Weixin
2796
Zhou, Qichao
2797
Guan, Xiyin
2798
Bilimagga, Ramesh
2799
Bhandare, Niranjan
2800
Mui, Wing Lun
2801
Tanzler, Emily
2802
Wang, Chengtao
2803
Ozkaya Akagunduz, Ozlem 2804
Holliday, Emma
2805
Kim, Miranda
2806
Hou, Wei-Hsien
2807
Xiao, WeiWei
2808
Chan, Annie
2809
Aizer, Ayal
2810
Popovtzer, Aron
2811
Takehana, Keiichi
2812
Takeda, Ken
2813
Huang, Zhibin
2814
Kanayama, Naoyuki
2815
Chen, Jonathan
2816
Ozsahin, Esat Mahmut
2817
Chang, Joseph Tung-Chieh 2818
Edson, Mark
2819
Shin, Jacob
2820
Ward, Matthew
2821
Jager, Elise Anne
2822
Caldas Magalhaes, Joana 2823
Hurst, Newton
2824
Iganej, Shahrokh
2825
Sapienza, Lucas
2826
Dhanireddy, Bhaswanth 2827
Plichta, Kristin
2828
Hu, Kenneth Shung
2829
Suh, Yae-eun
2830
Friborg, Jeppe
2831
Kropp, Lauren
2832
Dhanireddy, Bhaswanth 2833
Lai, Stephen
2834
Scott, Michael
2836
Kreofsky, Cole
2837
Bhateja, Priyanka
2838
Patel, Samir
2839
Shusharina, Nadya
2840
Mohamad, Issa
2841
Suh, Yang-Gun
2842
Miyawaki, Daisuke
2843
198
Younan, Lawrence
Liao, Jay
Patel, Shyamal
Kim, Jin Ho
Kim, Jin Ho
Mourad, Waleed
Hsieh, Cheng-En
Jensen, Alexandra
Stegmaier, Petra
Han, James
Yip, Darwin
Kuczmarska, Aleksandra
Tsai, Mu-Hung
Zavitsanos, Peter
Sachdev, Sean
Thariat, Juliette
Monroe, Alan
Chilukuri, Srinivas
Beadle, Beth
Cuaron, John
Takagi, Masaru
Chin, Re-I
Cacicedo, Jon
Van der Heide, Hugo
Diaz Pardo, Dayssy
Bhandare, Niranjan
Freilich, Jessica
Antognoni, Paolo
Shulman, Jesse
Gilbo, Philip
Cheung, Michael
Hoffman, Rex
Rwigema, Jean-Claude
Cvek, Jakub
Giuliani, Meredith
Dunlap, Neal
Sharma, Sonam
Sachdev, Sean
Gao, Lanting
Waxweiler, Timothy
Quon, Harry
Mowery, Yvonne
Toyomasu, Yutaka
Kondaveeti, Satish
Prieto, Isabel
Murai, Taro
Rice, Stephanie
Manoor Maiya, Vikram
Hosni, Ali
Spiotto, Michael
Spiotto, Michael
Napieralska, Aleksandra
Xu, Beibei
Ko, Huaising
Clarke, Sarah
Kumar, Rejnish
Cho, Yeona
Anderson, Nigel
Rolfo, Maureen
Bertke, Matthew
Ward, Matthew
Grew, David
2844
2845
2846
2847
2848
2849
2850
2851
2852
2853
2854
2855
2856
2857
2858
2859
2860
2861
2862
2863
2864
2865
2866
2867
2868
2869
2870
2871
2872
2873
2874
2875
2876
2877
2878
2879
2880
2881
2882
2883
2884
2885
2886
2887
2888
2889
2890
2891
2892
2893
2894
2895
2896
2897
2898
2899
2900
2901
2902
2903
2904
2905
2906
2907
Sakthivel, Vasanthan
Hoover, Andrew
Elicin, Olgun
Mohamed, Abdallah
Nguyen, Nhu Tram
Philippens, Marielle
Hasan, Shaakir
Xiao, Canhua
Mohamed, Abdallah
Chaudhary, Ahmed
Ahn, Peter
Huang, Junjian
Doke, Kaleigh
Al-Basheer, Ahmad
Robertson, Scott
2908
2909
2910
2911
2912
2913
2914
2915
2916
2917
2918
2919
2920
2921
2922
2923
HEALTH SERVICES RESEARCH
Curry, Heather
130
Rutter, Charles
131
Bekelman, Justin
132
Paravati, Anthony
133
Ashworth, Allison
134
Keole, Sameer
135
Ohri, Nitin
136
Durkee, Ben
137
Jagsi, Reshma
293
300
Chen, Aileen
301
Yu, James
302
Louie, Alexander
303
Hardenbergh, Patricia
304
MacKillop, William
305
Suneja, Gita
306
Soon, Yu Yang
2924
Paryani, Nitesh
2925
Corso, Christopher
2926
Goh, Lili
2927
Rand, Alexander
2928
Jones, Guy
2929
Ballas, Leslie
2930
Kapoor, Rishabh
2931
Ryoo, Joan
2932
Rand, Alexander
2933
Waddle, Mark
2934
Harrison, Amy
2935
Bahl, Gaurav
2936
Yang, Daniel
2937
Harris, Jeremy
2938
Gupta, Apar
2939
Sio, Terence
2940
Maroongroge, Sean
2941
Cihoric, Nikola
2942
Dinan, Michaela
2943
Mahmood, Usama
2944
Foley, Kimberley
2945
Naghavi, Arash
2946
Yu, Naichang
2947
Schreiber, David
2948
2949
Lin, Steven
2950
Trifiletti, Daniel
2951
Mailhot Vega, Raymond 2952
2953
He, Tongming
McGuffin, Merrylee
Kim, Hayeon
Schutzer, Matthew
Lanni, Thomas
Louie, Alexander
Shah, Anand
Ye, Jason
Richard, Patrick
Dimitroyannis, Dimitri
Koyfman, Shlomo
Wong, Anthony
Patton, Caroline
Gill, Beant
Hess, Clayton
Pilote, Laurie
Lauro, Christine
Shah, Bhartesh
Conrad, Tatiana
Lopez, Jose
Lock, Michael
Mishra, Mark
Qureshi, Muhammad
Kusano, Aaron
Campbell, Shauna
Chang, Tangel
Wallner, Paul
Hobbs, Corey
Agbahiwe, Harold
Braunstein, Steve
Tetreault, Audrey
Hong, Giang
Martin, Neil
Dahele, Max
2954
2955
2956
2957
2958
2959
2960
2961
2962
2963
2964
2965
2966
2967
2968
2969
2970
2971
2972
2973
2974
2975
2976
2977
2978
2979
2980
2981
2982
2983
2984
2985
2986
2987
HISTORY
Yeboa, Debra
Agarwal, Ankit
Golden, Daniel
Dhami, Gurleen
Thaker, Nikhil
Zaorsky, Nicholas
Curkendoll, Crys
Kusano, Aaron
Byler, Shannon
Jaswal, Jasbir
Ngwa, Wilfred
Koottappillil, Brian
Ingledew, Paris-Ann
Thomas, Evan
Warkentin, Heather
2988
2989
2990
2991
2992
2993
2994
2995
2996
2997
2998
2999
3000
3001
3002
INFORMATICS
Nguyen, Nhu Tram
Fechter, Tobias
Gopal, Anant
Ruan, Dan
Ruan, Dan
Zheng, Shuai
Kraft, Johannes
Albuquerque, Kevin
Lu, Weiguo
Phillips, Mark
Parra, Andres
3547
3548
3549
3550
3551
3552
3553
3554
3555
3556
3557
Moore, Kevin
Torres-Roca, Javier
Betzing, Christopher
Torres-Roca, Javier
Zhao, Shuang
Rico, Florentino
Rockne, Russell
Robinson, Timothy
Feng, Felix
LUNG CANCER
Stephans, Kevin
Onishi, Hiroshi
Park, Henry
Lee, Percy
Senan, Suresh
Timmerman, Robert
Shaikh, Fauzia
Pham, Anthony
Husain, Zain
Harder, Eileen
Zhao, Jing
Cheung, Patrick
Wu, Abraham
Vinogradskiy, Yevgeniy
Creelan, Ben
Jin, Jian-Yue
Bar Ad, Voichita
Kim, Sungjune
Stanton, Paul
Ashworth, Allison
Wang, Jingbo
Boyle, John
Bradley, Jeffrey
Ohri, Nitin
Kadoya, Noriyuki
Sher, David
Sura, Karna
Romeo, Antonino
Stuschke, Martin
Giaddui, Tawfik
Koshy, Matthew
Roach, Michael
Corso, Christopher
JingBo, Wu
Chiang, Andrew
Haasbeek, Cornelis
Chaudhuri, Aadel
Aguilera, Todd
Tang, Linglong
Rehman, Sana
Alite, Fiori
Mancini, Brandon
Choi, Noah
Lukovic, Jelena
Mattes, Malcolm
Hermann, Gregory
Farnia, Benjamin
Cheng, Simon
Hui, Zhouguang
Takahashi, Wataru
Rimner, Andreas
Parisi, Elisabetta
Decker, Roy
3558
3559
3560
3561
3562
3563
3564
3565
CT-02
51
52
53
54
55
56
57
122
123
124
125
126
128
129
163
164
165
166
167
168
169
170
317
318
319
320
321
322
323
324
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1133
1134
1135
1136
1138
1139
1140
1141
1142
1143
1144
Takanaka, Tsuyoshi
Trovo, Marco
Shintani, Takashi
Motegi, Atsushi
Shirai, Katsuyuki
Turaka, Aruna
Zhou, Lin
Mak, Kimberley
Nagai, Aiko
Herman, Michael
Wang, Qi
Olson, Adam
Aghdam, Nima
Takahashi, Shigeo
Katz, Leah
Turaka, Aruna
Fischer-Valuck, Ben
Yip, Connie
Tandberg, Daniel
Teng, Feifei
Kim, Byounghyuck
Heinzerling, John
Zhou, Meixiang
Yamamoto, Takaya
Paryani, Nitesh
Chang, Joe
Tang, Chad
Tang, Chad
Videtic, Gregory
Takahashi, Noriyoshi
Pang, Qingsong
Duan, Yili
Persson, Gitte
Siva, Shankar
Ahn, Sung-Ja
Nguyen, Quynh
Matsuo, Yukinori
3003
3004
3005
3006
3007
3008
3009
3010
3011
3012
3013
3014
3015
3016
3017
3018
3019
3020
3021
3022
3023
3024
3025
3026
3027
3028
3029
3030
3031
3032
3033
3034
3035
3036
3037
3038
3039
Pan, Hubert
Jiang, Wei
Ascolese, Anna Maria
Mehmood, Qurrat
Kim, Kyung Su
Iwata, Hiromitsu
Huang, Kitty
Bhatt, Neal
Ahmed, Inaya
Ahmed, Inaya
Liu, Ning
Kim, Ellen
Mann, Justin
Feng, Wen
Siva, Shankar
Yap, Mei Ling
Ueki, Nami
Baba, Fumiya
Trovo, Marco
Harder, Eileen
Allen, Aaron
Harder, Eileen
Duma, Marciana-Nona
Bremjit, Prashoban
Nyflot, Matthew
Lester, Scott
Dincbas, H. Fazilet
Kilburn, Jeremy
Jeppesen, Stefan
Rowe, Lindsay
Sun, Jian
Patel, Suchit
Nonaka, Hotaka
Patel, Suchit
Podder, Tarun
Dekker, Andre
Guo, Gordon
3065
3066
3067
3068
3069
3070
3071
3072
3073
3074
3075
3076
3077
3078
3079
3080
3081
3082
3083
3084
3085
3086
3087
3088
3089
3090
3091
3092
3093
3094
3095
3096
3097
3098
3099
3100
3101
Kollar, Laura
Jain, Supriya
Rabin, Tatiana
Berriochoa, Camille
Peulen, Heike
Karasawa, Katsuyuki
Wheatley, Matthew
Gomez, Maria Antonia
Brigotti, Samantha
Bowen, Stephen
Simone, Charles
Hou, Ying
Dhami, Gurleen
Shen, Zhilei
Valentini, Chiara
Hayes, Jason
Maidment III, Bertram
Schmuecking, Michael
Nguyen, Nhu Tram
Fernandez, Eduardo
Reddy, Jay Paul
Lin, Jolinta
Wang, Weili
Chen, Yu
Fan, Yankhua
Kemmerer, Eric
Ming, Xin
Speirs, Christina
Biswas, Tithi
Chance, William
Al-Halabi, Hani
Jung, Julip
Lee, Yun Hee
Jain, Anshu
Kong, Feng-Ming
Mangla, Ankit
Slotman, Ben
3129
3130
3131
3132
3133
3134
3135
3136
3137
3138
3139
3140
3141
3142
3143
3144
3145
3146
3147
3148
3149
3150
3151
3152
3153
3154
3155
3156
3157
3158
3159
3160
3161
3162
3163
3164
CT-05
Manabe, Yoshihiko
Adli, Mustafa
Huang, Tzung-Chi
Cannon, Nathan
Disher, Brandon
Barsky, Andrew
Komaki, Ritsuko
Mou, Benjamin
Wei, Xiong
Negahdar,
Mohammadreza
Negahdar,
Mohammadreza
Takeuchi, Yuki
Heskel, Marina
Wurstbauer, Karl
Heskel, Marina
Higgins, Kristin
Pokhrel, Damodar
Akthar, Adil
Kimura, Tomoki
Samuelian, Jason
Bergsma, Derek
Bowen, Stephen
Zhung, Joanne
Wu, Q. Jackie
Setakornnukul, Jiraporn
3040
3041
3042
3043
3044
3045
3046
3047
3048
Zheng, Dandan
Saraiya, Siddharth
Morimoto, Masahiro
Kelley, Kevin
Blake, Monika
Liu, Jing
Shioyama, Yoshiyuki
Yoshitake, Tadamasa
Liu, Lipin
Gao, Song
Oguri, Mitsuhiko
Smith, Adam
Blom, Gerrit
Edwards, Jason
Kumar, Sanath
McGarry, Ronald
Mortensen, Steen
Yamashita, Hideomi
Van Diessen, Judi
Cattaneo, Richard
Bi, Nan
Li, Baosheng
Rimner, Andreas
Rodrigues, George
Mohr, Angela
Xie, Liyi
Miller, Luke
3102
3103
3104
3105
3106
3107
3108
3109
3110
3111
3112
3113
3114
3115
3116
3117
3118
3119
3120
3121
3122
3123
3124
3125
3126
3127
3128
LYMPHOMA
Parikh, Rahul
Aleman, Berthe
Patel, Chirayu
Dabaja, Bouthaina
Rajpara, Raj
Tao, Randa
Jegadeesh, Naresh
King, Martin
Jackson, Matthew
Pinnix, Chelsea
Liu, Qingfeng
Kim, Youn
Dabaja, Bouthaina
Hoppe, Richard
Maraldo, Maja
Kriz, Jan
Cuaron, John
Gerber, Naamit
Farr, Jonathan
Dabaja, Bouthaina
Mikhaeel, George
Furlan, Carlo
Lloyd, Shane
Spickermann, Maximilian
Torok, Jordan
CT-08
138
139
140
141
142
143
144
145
145.5
333
334
335
336
337
338
339
340
3165
3166
3167
3168
3169
3170
3171
199
3049
3050
3051
3052
3053
3054
3055
3056
3057
3058
3059
3060
3061
3062
3063
3064
Aznar, Marianne
Sachsman, Suzanne
Mazloom, Ali
Wilke, Christopher
Iwabuchi, Michio
Dabaja, Bouthaina
Dabaja, Bouthaina
Lee, Joohwan
Tatekawa, Kotoha
Ohga, Saiji
Braunstein, Lior
Pinnix, Chelsea
Hiniker, Susan
Harada, Arisa
Miyazawa, Kazunari
Zang, Jian
Chen, Bo
Jhavar, Sameer
Cassuto, Ophelie
Balagamwala, Ehsan
Heumann, Thatcher
Wong, Jeffrey
Kelsey, Christopher
Hammer, Josef
Plastaras, John
Ishibashi, Naoya
Kelly, Douglas
3172
3173
3174
3175
3176
3177
3178
3179
3180
3181
3182
3184
3185
3186
3187
3188
3189
3190
3191
3192
3193
3194
3195
3196
3197
3198
3199
NONMALIGNANT DISEASE
Sckolnik, Steven
3200
Mourad, Waleed
3201
Lopater, Zachary
3202
Blakaj, Adriana
3203
Ohri, Nisha
3204
Arora, Divya
3205
Jie, Shen
3206
Yoo, Stella
3207
Sio, Terence
3208
Schuster, Jessica
3209
Carvajal, Claudia
3210
NURSES
Herst, Patries
Schaidle, Colleen
Serra, Diane
Yuen, Florence
Fujioka, Chiaki
Porzio-Kwiecinski, Therese
Maisonet, Olivier
3211
3212
3213
3214
3215
3216
3217
PALLIATIVE CARE
Furlan, Carlo
Conway, Jessica
Hall, William
Gomez-Iturriaga, Alfonso
Lefresne, Shilo
Khan, Luluel
Alcorn, Sara
Sahgal, Arjun
Moghanaki, Drew
Lloyd, Shane
Poon, Ian
Kawashiro, Shohei
Olson, Robert
171
172
173
174
175
176
177
178
3218
3219
3220
3221
3222
200
Barnes, Mark
Nakamura, Naoki
Saito, Tetsuo
Cheney, Matthew
Henson, Christina
Rhee, Woo Joong
Franco, Pierfrancesco
Kobayashi, Hidetoshi
Saito, Tetsuo
Held, Mareike
Harada, Ken
Mula-Hussain, Layth
Aljabab, Saif
Mian, Omar
Alcorn, Sara
Wang, Yu-Ming
Lam, Tai Chung
Ly, Bevan
Hamamoto, Yasushi
Lee, Jason
Arneson, Kyle
Logie, Natalie
Lok, Benjamin
Tanaka, Hiroshi
Avkshtol, Vladimir
Tan, Daniel
Curry, Heather
Cellini, Francesco
Ma, C.M. Charlie
Schuster, Jessica
Zahra, Amir
3223
3224
3225
3226
3227
3228
3229
3230
3231
3232
3233
3234
3235
3236
3237
3238
3239
3240
3241
3242
3243
3244
3245
3246
3247
3248
3249
3250
3251
3252
3253
PATIENT-REPORTED
OUTCOMES
Hoppe, Bradford
Johnson, Matthew
Zhao, Shuang
Anderson, Bradley
Wiltink, Lisette
Miller, Robert
Urbanic, James
Ye, Hong
Joh, Daniel
Kiang, Alan
Woo, Jennifer
Rathod, Shrinivas
Valderrama, Adriana
Krauze, Andra
Woo, Jennifer
Mason, Matthew
Sio, Terence
Janowski, Einsley-Marie
Lee, Jae
Rossetti, Andrew
Gurka, Marie
Thibault, Isabelle
Miszczyk, Leszek
Elliott, David
Mitra, Devarati
Lai, Yu-Hsuan
Nuyttens, Joost
Goenka, Anuj
Rana, Zaker
Khwaja, Shariq
179
180
181
182
183
184
185
3254
3255
3256
3257
3258
3259
3260
3261
3262
3263
3264
3265
3266
3267
3268
3269
3270
3271
3272
3273
3274
3275
3276
Lee, Andrew
Zhou, Jessica
Rana, Zaker
Leatherwood, Amy
Giuliani, Meredith
Barsky, Andrew
Samiee, Sara
Knoll, Miriam
Mitra, Devarati
Seo, YoungsSeok
Groarke, John
Kachnic, Lisa
Olson, Robert
Shimizu, Arisa
Larrea, Luis
Patel, Ashish
McCloskey, Susan
3277
3278
3279
3280
3281
3282
3283
3284
3285
3286
3287
3288
3289
3290
3291
3292
3293
CT-06
PATIENT SAFETY
Olivera, Gustavo
Damato, Antonio
Matuszak, Martha
Chera, Bhisham
Greenwalt, Julie
Miller, Brett
Gao, Wendy
Novak, Avrey
Gwynne, Sarah
Fontanilla, Hiral
Lam, Wai Wang
Gwynne, Sarah
Yu, Jialu
Dvorak, Tomas
Meier, Timothy
Kisling, Kelly
Mathews, Joshua
Hamilton, Sarah
Vitzthum, Lucas
Katsuta, Yoshiyuki
Able, Charles
Leonard, Kara
Yang, Ruijie
Gong, Yutao
Matulewicz, Lukasz
Sekar, Yuvaraj
Chen, Yu
Mo, Xiaohu
Liszewski, Brian
McNiven, Andrea
Kertzscher, Gustavo
Varadhan, Raj
Moningi, Shalini
Pavan, Guilherme
Mullen, Thomas
Chao, Samuel
Deraniyagala, Rohan
Kovalchuk, Nataliya
Ota, Seiichi
Jones, Ryan
Moningi, Shalini
Fritscher, Karl
Liu, Chihray
Yi, Byong Yong
277
278
279
280
281
282
283
284
3327
3328
3329
3330
3331
3332
3333
3334
3335
3336
3337
3338
3339
3340
3341
3342
3343
3344
3345
3346
3347
3348
3349
3350
3351
3352
3353
3354
3355
3356
3357
3358
3359
3360
3361
3362
Blacksburg, Seth
Mumber, Matthew Peter
Yang, Bin
Delaney, Kyle
Hattangadi, Jona
Elnahal, Shereef
Mosaly, Prithima
Taylor, Kinley
Mosaly, Prithima
Grant, Jonathan
3363
3364
3365
3366
3368
3369
3370
3371
3372
3373
PEDIATRIC CANCER
Boehling, Nick
244
Eaton, Bree
245
Laskar, Siddhartha
246
Haas-Kogan, Daphne Adele 247
Kahalley, Lisa
248
Gunther, Jillian
249
Kalapurakal, John
250
Mahajan, Anita
251
Paulino, Arnold
252
Mahajan, Anita
3294
Sethi, Roshan
3295
Gibbs, Iris
3296
Chin, Joanna
3297
Redmond, Kristin
3298
Lai, I-Chun
3299
Gultekin, Melis
3300
Uh, Jinsoo
3301
Alcorn, Sara
3302
Cahlon, Oren
3303
Ray, Geoffrey
3304
McGovern, Susan
3305
Jimenez, Rachel
3306
Sreeraman, Radhika
3307
Haque, Waqar
3308
Liang, Jun
3309
Roeper, Barbara
3310
Osborne, Eleanor
3312
Kirkland, Robert
3313
Hazariwala, Ronica
3314
Salinas, Vanessa
3315
Thaker, Nikhil
3316
Shaikh, Fauzia
3317
Imber, Brandon
3318
DeSelm, Carl
3319
Shah, Nikesh
3320
Hess, Clayton
3321
Casey, Dana
3322
3323
Kornerup, Josefine S.
3324
Farnia, Benjamin
3325
Barron, David
3326
BIOLOGY
Sharabi, Andrew
PL-01
Yard, Brian
66
Salem, Ahmed
67
Moding, Everett
68
Karlin, Jeremy
69
Speers, Corey
70
Baig, Nimrah
71
Wright, Christopher
72
Zumsteg, Zachary
73
Zhao, Hanxi
98
Kirsch, David
115
Du, Shisuo
116
Walker, Amanda
117
Blanchard, Miran
118
Park, Sean
119
Young, Kristina
120
Pilones, Karsten
121
Pham, Ngoc
127
Matsuo, Masayuki
186
Kortylewicz, Janina
187
Papineni, Rao
188
Mouw, Kent
189
Hedayati, Mohammad
190
Han, Kathy
191
Zhang, Peng
192
Evans, Joseph
193
Harima, Yoko
199
Hearn, Jason
219
Kozono, David
220
Chang, Kenneth
221
Smith, Clayton
222
Willers, Henning
223
Abazeed, Mohamed
224
Mikkelsen, Ross
225
Xu, Ting
226
Wray, Justin
325
Hanna, Nevine
326
Stessin, Alexander
327
Andreassen, Christian
328
Pitroda, Sean
329
Scroggins, Bradley
330
Epperly, Michael
331
Citrin, Deborah
332
Ivkov, Robert
1037
Advani, Sunil
1038
Gao, Dexuan
1039
Shridhar, Ravi
1040
Guha, Chandan
1041
Moustafa, Mahmoud
1042
Wolfe, Adam
1043
Offor, Onyinye
1044
Brenneman, Randall
1045
Nowak, Kamila
1046
Tran, Phuoc
1047
Dholakia, Avani
1048
Van Dijk, Laura
1085
Mohindra, Pranshu
1086
Wobb, Jessica
1087
Meng, Jin
1088
Higginson, Daniel
1089
Jeraj, Robert
1090
Patel, Kirtesh
1091
Chun, Stephen
1092
Ju, Melody
1093
Gerngross, Lindsey
1094
Leiker, Andrew
1095
Sio, Terence
1096
Spratt, Daniel
1124
Vaughan, Andrew
3414
Stone, Brandon
3415
Young, Kristina
3416
Muraro, Elena
3417
Fahim Golestaneh, Azadeh 3418
Leung, Chung Man
3419
Bornstein, Sophia
3420
Tao, Jessie
3421
Chaudhuri, Aadel
3422
Koukourakis, Michael
3423
Sato, Mariko
3424
Rafat, Marjan
3425
Park, Catherine
3426
Zhang, Minsi
3427
Allen, Bryan
3428
Yoo, Hyun
3429
Lee, Eun-Jung
3430
Tian, Sibo
3431
Maity, Amit
3432
Dadey, David
3433
Rao, Shyam
3434
Monjazeb, Arta
3435
Schoenfeld, Jonathan
3436
Suzuki, Yoshiyuki
3437
Veldwijk, Marlon
3438
Illidge, Timothy
3439
Reddy, Vishruth
3440
Epperly, Michael
3441
Epperly, Michael
3442
Giordano, Frank
3443
Nishioka, Takeshi
3444
Borst, Gerben
3445
Iwata, Hiromitsu
3446
Leong, Trevor
3447
Zielinska-Chomej,
Katarzyna
3448
Bakhoum, Samuel
3449
Sizemore, Steven
3450
Spektor, Alexander
3451
Zhang, Li Yuan
3452
Widlak, Piotr
3453
Epperly, Michael
3454
Odawara, Soichi
3455
Xingwen, Fan
3456
Zhao, Diana Yi
3457
Dong, Xiaorong
3458
Schmidberger, Heinz
3459
Takahashi, Ippei
3460
Abernathy, Lisa
3461
Kabarriti, Rafi
3462
Cho, Jae Ho
3463
Dominello, Michael
3464
Buchsbaum, Jeffrey
3465
Amornwichet, Napapat
3466
Okano, Naoko
3467
Wang, Bin
3468
Sai, Sei
3469
Zhang, Peng
3470
Hurmuz, Pervin
Sarojini, Sreeja
Hasegawa, Masatoshi
Pyakuryal, Anil
Rafat, Marjan
Gan, Gregory
Yang, Jia
Spratt, Daniel
Volotskova, Olga
Matsuo, Masayuki
Hosono, Makoto
Gao, Zhenhua
King, Martin
Laruelo, Andrea
Marples, Brian
Kapoor, Vaishali
Perez, Jessica
Lee, Keum Sil
Lee, Kuei
Ahmad, Moiz
Naczynski, Dominik
Furutani, Shunsuke
Masunaga, Shin-ichiro
Okonogi, Noriyuki
Harada, Satoshi
Zhang, Chi
Zhang, Zhenhuan
Khattab, Mohamed
Huber, Peter
Nicolay, Nils
Raju, Uma
Li, Ping
Wu, Szu-Yuan
Seo, Yuji
Wang, Edina
Kim, Dong Wook Nathan
Mitchell, Darrion
Xing, Ligang
Dong, Qian
Tian, Xi
Jeong, Seong-Yun
Jeong, Seong-Yun
Nakayama, Masao
Felix, Manuela
Sun, Yunguang
Sun, Yunguang
Kiess, Ana
Wang, Tao
Liu, Peter
Quinn, Thomas
Biswas, Tithi
Vatner, Ralph
Monjazeb, Arta
Dan, Tu
Yang, Jia
Epperly, Michael
Medhora, Meetha
Epperly, Michael
Enke, Thomas
Epperly, Michael
Barrett, Kate
Lang, Jinyi
Bortolin, Maria Teresa
Modlin, Leslie
3471
3472
3473
3474
3475
3476
3477
3478
3479
3480
3481
3482
3483
3484
3485
3486
3487
3488
3489
3490
3491
3492
3493
3494
3495
3496
3497
3498
3499
3500
3501
3502
3503
3504
3505
3506
3507
3508
3509
3510
3511
3512
3513
3514
3515
3516
3517
3518
3519
3520
3521
3522
3523
3524
3525
3526
3527
3528
3529
3530
3531
3532
3533
3534
Masoud Rahbari, Reza
Ruiz-Alonso, Ana
Xu, Ting
Song, Yipeng
Liu, Anwen
Walston, Steve
Thompson, Jonathan
Wobb, Jessica
Lin, Steven
Tuli, Richard
Grecula, John
Osmundson, Evan
3535
3536
3537
3538
3539
3540
3541
3542
3543
3544
3545
3546
PHYSICS
Kabarriti, Rafi
Zhou, Jun
Vallieres, Martin
Li, Ruijiang
Wiedenmann, Nicole
Bradshaw, Tyler
Ahmed, Merina
McGuire, Sarah
Gensheimer, Michael
Obeid, Layal
Adam, Jean-François
Snider III, James
Liu, Jianfei
Li, Taoran
Hallman, Mark
Asuni, Ganiyu
Braunstein, Steve
Zhao, Weizhao
Booth, Jeremy
Coates, James
Rimner, Andreas
Owen, Dawn
Ren, Lei
Yip, Stephen
Schuemann, Jan
Kelada, Olivia
Paulson, Eric
Sterzing, Florian
Tai, An
Saleh, Ziad
Troeller, Almut
Liao, Zhongxing
Kupelian, Patrick
Palorini, Federica
Wang, Chunhao
Qi, Xiangrong
Hall, Matthew
Kole, Thomas
Santhanam, Anand
Velec, Michael
Gudur, Madhu Sudhan
Reddy
Guo, Yu
Patel, Ravi
Hegi-Johnson, Fiona
Ding, Yao
Zhang, Yibao
Mutic, Sasa
1
2
3
4
5
6
7
8
9
25
26
27
28
29
30
31
32
33
42
43
44
45
46
47
48
49
50
58
81
82
83
84
85
86
87
88
89
110
154
155
156
157
158
159
160
161
162
202
201
Stanescu, Teo
Green, Olga
Glide-Hurst, Carri
Liu, Yilin
Li, Xia
Seibert, Tyler
Wooten, Hasani
Chen, Xinfeng
Yuan, Lulin
Ruan, Dan
Kumarasiri, Akila
Kierkels, Roel
Poon, Miranda Sze Wing
Vanderstraeten, Barbara
Santanam, Lakshmi
Zarepisheh, Masoud
Nguyen, Dan
Marina, Ovidiu
Liang, Jieming
Colvill, Emma
Jawad, Maha
Lin, Mu-Han
Block, Alec
Li, Heng
Glick, Daniel
Cui, Taoran
Gladwish, Adam
Parashar, Bhupesh
Klein, Eric
Wen, Ning
Liu, Feng
Shi, Xiutao
Karan, Tania
Gao, Ang
Cifuentes Gaitan, Jidney
Holcombe, Charles
Rao, Min
Martin, Jeffrey
Ling, Diane
Zlateva, Yana
Berbeco, Ross
Paudel, Nava
Kashani, Rojano
Wang, Jing
Roeske, John
Todor, Dorin
Balter, James
Wang, Jiazhou
Strom, Eric
Su, Zhong
Lee, HyunSeok
Linam, Justin
Agazaryan, Nzhde
Weiss, Elisabeth
Nakamura, Mitsuhiro
Akimoto, Mami
Padilla, Laura
Kim, Youngjun
Oohira, Shingo
Zhang, Pengpeng
Fung, Winky Wing Ki
Blessing, Manuel
Arns, Anna
202
203
204
205
206
207
208
209
210
227
228
229
230
231
232
233
234
235
308
309
310
311
312
313
314
315
316
1067
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
3566
3567
3568
3569
3570
3571
3572
3573
3574
3575
3576
3577
3578
Park, John
Mooney, Karen
Plishker, William
Ali, Mirza
Li, Allen
Kathpal, Madeera
Mittauer, Kathryn
Gayou, Olivier
Bhandare, Niranjan
Peng, Jean
Letourneau, Etienne
Hojgaard, Martin
Zhang, You
Abing, Casey
Cheng, Hui
Ueda, Yoshihiro
Jones, Bernard
Noid, George
Zhang, Hao
Gong, Guanzhong
White, Benjamin
Witztum, Alon
Zhao, Bo
Keall, Paul
Li, Dengwang
Suttie, Clare
Chiu, George
Wang, Ti-Hao
Scholey, Jessica
Van Sornsen de Koste,
John
Hickling, Susannah
James, Joshua
Kashani, Rojano
Antoine, Mikael
Poulsen, Per
Lischalk, Jonathan
Fanchon, Louise
Liu, Wu
Hurwitz, Martina
Stecklein, Shane
Watkins, William
Li, Shidong
Yang, Yong
Chung, Caroline
Risberg, Miranda
Monjazeb, Arta
Bergamo, Angelo
Kamp, Florian
Simpson, Daniel
Jeong, Jeho
Carmona, Ruben
Van Leeuwen, Caspar
Pater, Piotr
Ybarra, Norma
Merrick, Scott
Cho, Daniel
Mei, Feng
Sheng, Ke
Prior, Phillip
Thor, Maria
Kang, John
Yu, Victoria
Rancati, Tiziana
3579
3580
3581
3582
3583
3584
3585
3586
3587
3588
3589
3590
3591
3592
3593
3594
3595
3596
3597
3598
3599
3600
3601
3602
3603
3604
3605
3606
3607
3608
3609
3610
3611
3612
3613
3614
3615
3616
3617
3618
3619
3620
3621
3622
3623
3624
3625
3626
3627
3628
3629
3630
3631
3632
3633
3634
3635
3636
3637
3638
3639
3640
3641
Ngwa, Wilfred
Murray, Louise
Raince, Jagdeep
Ishaq, Omar
Howell, Rebecca
Paulson, Eric
Hwang, Seha
Fujita, Yujiro
Lens, Eelco
Kainz, Kristofer
Altman, Michael
Yan, Di
Yoon, Kyoung Jun
Varadhan, Raj
Fog, Lotte
Sasidharan, Balu Krishna
Chu, Kwun-Ye
Olivera, Jesús
Kim, Leonard
Draghici, Roxana
Nirunsiriphol, Sawanee
Pratx, Guillem
Jeong, Yuri
Bedos, Ludovic
Yu, Suhong
Balter, Peter
Kawakami, Masakuni
Matsumoto, Kenji
Tachiki, Lisa
Srivastava, Shiv
Amoush, Ahmad
Li, Fengxiang
Li, Fengxiang
Liu, Wenyang
Serrano, Nicholas
Alpuche Aviles, Jorge
Lian, Jun
Heijmen, Ben
Castelli, Joel
Kamomae, Takeshi
Jani, Shirish
Lee, Suk
Cho, Kwang Hwan
Fenoglietto, Pascal
Thompson, Kenton
Lee, Suk
Kang, Young-nam
Pallotta, Stefania
Karagoz, Gulay
Sakumi, Akira
Tijssen, Rob
Thomson, David
Na, Yong Hum
Fiandra, Christian
Edwards-Bennett, Sophia
Kirby, Neil
Yang, Wensha
White, Evan
Damato, Antonio
Li, Guangjun
Clemente Gutierrez,
Francisco
Paulson, Eric
Qi, Xiangrong
3642
3643
3644
3645
3646
3647
3648
3649
3650
3651
3652
3653
3654
3655
3656
3657
3658
3659
3660
3661
3662
3663
3664
3665
3666
3667
3668
3669
3670
3671
3672
3673
3674
3675
3676
3677
3678
3679
3680
3681
3682
3683
3684
3685
3686
3687
3688
3689
3690
3691
3692
3693
3694
3695
3696
3697
3698
3699
3700
3701
3702
3703
3704
Vieira, Andre
Adamczyk, Marta
Nelson, Aaron
Chai, Xiangfei
Tuohy, Rachel
Li, Jason
Chiesa, Silvia
Xu, Qiong
Robar, James
Fawaz, Ziad
Lin, Teh
Defoor, Dewayne
Yao, Weiguang
Chen, Xiaojian
Erickson, Kelly
Reynolds, Robert
Liu, Chang
Woo, Joong Yeol
Vatner, Ralph
Shankar, Vangipuram
Han, Chunhui
Ellis, Rodney
Lo, Simon
Ma, Lijun
Simeonova, Anna
Ding, Chuxiong
Okawa, Kohei
Palmgren, Jan-Erik
Rottmann, Joerg
Naoi, Yutaka
Molinier, Jessica
Simeonova, Anna
Gevaert, Thierry
Steenbeke, Femke
Louie, Alexander
Ly, Bevan
Fotouhi Ghiam, Alireza
Li, Winnie
Cohen, Randi
Ruggieri, Ruggero
Hossain, Murshed
Yaparpalvi, Ravindra
Dagoglu, Rabia Nergiz
Michalski, Dariusz
Sonier, Marcus
Ye, Jin-Song
Wu, Jianzhou
Zilli, Thomas
Wang, Huan-Huan
Gabos, Zsolt
Kim, Hyun
Zhung, Joanne
Henriques, Benedicte
Talamonti, Cinzia
Lucas, John
Li, Guang
Oechsner, Markus
Pineiro Retif, Rafael
Estes, Christopher
Dang, Phuong-Di
Rajan, Rajesh
Wang, Tonghe
Babic, Steven
Cuijpers, Johan
3705
3706
3707
3708
3709
3710
3711
3712
3713
3714
3715
3716
3717
3718
3719
3720
3721
3722
3723
3724
3725
3726
3727
3728
3729
3730
3731
3732
3733
3734
3735
3736
3737
3738
3739
3740
3741
3742
3743
3744
3745
3746
3747
3748
3749
3750
3751
3752
3753
3754
3755
3756
3757
3758
3759
3760
3761
3762
3763
3764
3765
3766
3767
3768
Rochefort, Pauline
Zhang, Qinghui
Broomfield, Joel
Wang, Ricardo
Han, Bin
Yazici, Gozde
Chen, Allan
Su, Zhong
Ogunleye, Tomi
Gulam, Misbah
Choi, Enid
Bahig, Houda
Telivala, Tejas
Alite, Fiori
Zhao, Bo
Rong, Yi
Pennington, Andreea
Cuaron, John
Cuaron, John
Masood, Umar
Romesser, Paul
Akino, Yuichi
Visser, Jorrit
Wang, Dongxu
Matysiak, Witold
Sio, Terence
Tryggestad, Erik
Johnson, Jedediah
Faddegon, Bruce
Wong, Tony
Shimizu, Shinichi
Goddu, Sreekrishna Murty
Ding, Aiping
Batista, Vania
Son, Jaeman
Zeng, Chuan
Summers, Paige
Casares Magaz, Oscar
Zhao, Li
Polf, Jerimy
Richard, Patrick
Giantsoudi, Drosoula
Jo, Kwanghyun
Ager, Bryan
Li, Heng
Cai, Bin
Anand, Aman
Zheng, Yuanshui
Daartz, Juliane
Welsh, James
Zaini, Mehran
Dinkla, Anna
Shin, Samuel
Korhonen, Juha
Iftimia, Ileana
Craft, David
Ahunbay, Ergun
Park, Jong In
Feng, Huiting (Christine)
Han, Dae Yup
Depauw, Nicolas
Gupta, Deepak
Li, Ruijiang
Prior, Phillip
3769
3770
3771
3772
3773
3774
3775
3776
3777
3778
3779
3780
3781
3782
3783
3784
3785
3786
3787
3788
3789
3790
3791
3792
3793
3794
3795
3796
3797
3798
3799
3800
3801
3802
3803
3804
3805
3806
3807
3808
3809
3810
3811
3812
3813
3814
3815
3816
3817
3818
3819
3820
3821
3822
3823
3824
3825
3826
3827
3828
3829
3830
3831
3832
Palma, Bianey
Martin, Andre-Guy
Gong, Guanzhong
Li, Jiancheng
Li, Tianfang
Santos, Daniel
Bazalova, Magdalena
Cho, Yu Ra
Mancosu, Pietro
Zhao, Nan
Zhao, Nan
Tsiamas, Panagiotis
Verbakel, Wilko
Gupta, Roohi
Barten, Danique
Goyal, Uma
Xiang, Liangzhong
Leif, Jessica Lowenstein
Ma, C.M. Charlie
Salter, Bill
Balasz, Katarzyna
Moteabbed, Maryam
Korideck, Houari
Thomas, Evan
Huang, Baotian
Rutenberg, Michael
Hajdok, George
Liang, Xing
Paudel, Nava
Amini, Arya
3833
3834
3835
3836
3837
3838
3839
3840
3841
3842
3843
3844
3845
3846
3847
3848
3849
3850
3851
3852
3853
3854
3855
3856
3857
3858
3859
3860
3861
3862
Barker, Christopher
Karasawa, Katsuyuki
Hadsell, Michael
Moalikyar, Omeed
Kenjo, Masahiro
Tinkle, Christopher
Jacobson, Alex
Saeed, Hina
Manyam, Bindu
Tinkle, Christopher
Wilke, Christopher
Merrell, Kenneth
Pennington, Joseph
Cahlon, Oren
Bhatt, Aashish
Snider III, James
Szeja, Sean
3397
3398
3399
3400
3401
3402
3403
3404
3405
3406
3407
3408
3409
3410
3411
3412
3413
SARCOMA AND CUTANEOUS
TUMORS
Baldini, Elizabeth
253
Roeder, Falk
254
Mak, Kimberley
255
Vyas, Shilpa
256
Willett, Addison
257
Stish, Bradley
258
Kubicek, Gregory
259
Baumann, Brian
260
Pretz, Jennifer
3374
Casey, Dana
3375
Casey, Stephanie
3376
Wang, Jianyang
3377
Casey, Dana
3378
Cheney, Matthew
3379
Arenas, Meritxell
3380
Kishan, Amar
3381
Cheung, Michael
3382
Song, Sanghyuk
3383
Kumar, Aryavarta
3384
Wang, Haotong
3385
Bhatnagar, Ajay
3386
Chapman, Tobias
3387
Crimaldi, Anthony
3388
Huang, Pin-I
3389
Rodriguez Villalba, Silvia 3390
Parvathaneni, Upendra
3391
Yip, Darwin
3392
Kollar, Laura
3393
Le Grange, Franel
3394
Gayar, Hesham
3395
Johnson, Julian
3396
203
2014
Best of
ASTRO
OCTOBER 17-18, 2014
S C I E N C E O F T O D AY
HOPE FOR TOMORROW
| EDEN ROC MIAMI BEACH
| MIAMI BEACH
Join us in Miami Beach!
ATTEND THIS TWO-DAY MEETING FOR A SUMMARY OF THE TOP SCIENCE
FROM THE 2014 ASTRO ANNUAL MEETING.
Register now: www.astro.org/bestofASTRO
This live activity has been approved for AMA PRA Category 1 Credit™.
®
TAR G E T I N G C A N C E R C A R E
Disciplinesof Leadership
D
C
Come
to Miami Beach early and take advantage of the Disciplines of Leadership course taking
p
place October 15-16, at the Eden Roc Miami Beach.
w
www.astro.org/leadershipcourse.
INSIDE:
Industry-Expert Theater Schedule
Exhibitor List
Exhibitor List by Product/Service Category
Exhibit Hall Floor Plan
EXHIBIT HALL HOURS
10:00 a.m. – 5:00 p.m.
10:00 a.m. – 5:00 p.m.
10:00 a.m. – 5:00 p.m.
Exhibitor
ASTRO 2015
technol gy meets
patient care
57TH ANNUAL MEETING
MEETING DATES: OCTOBER 18-21 2015
EXHIBIT DATES: OCTOBER 18-20 , 2015
HENRY B. GONZALEZ CONVENTION CENTER
SAN ANTONIO
Save the Dates!
Call for Abstracts opens:
December 17, 2014
Exhibitor
Deadline for abstract submission:
February 26, 2015
TA R G E T I N G C A N C E R C A R E
INDUSTRY-EXPERT THEATER*
Exhibit Hall, Room 100
This activity allows companies to present their noteworthy products and
services through a live presentation in the Industry-Expert Theater located in
the Exhibit Hall. Seating is available on a first-come, first-served basis.
The Industry-Expert Theater content and views expressed therein are
those of the exhibitor and not of ASTRO.
*Industry-Expert Theaters are not accredited for continuing medical education credits.
Time: 12:15 p.m. – 1:15 p.m.
Precision in Practice: Optimizing
Outcomes and Expanding Applications
with Accuray
Company: Accuray
Contact: Rebecca Byrne
Phone: 408-334-7950
Box lunch provided.
Time: 6:45 a.m. – 7:45 a.m.
Perirectal Spacers: Emerging
Technology and Impact on Future
Prostate RT Utilization
Company: Augmenix
Contact: Eileen Gardner
Phone: 508-944-8015
Time: 12:30 p.m. – 1:30 p.m.
The Therapeutic Application of Xofigo®
(radium Ra 223 dichloride) Injection
Company: Bayer Healthcare Pharmaceuticals Inc.
Contact: Michelle Noyes
Phone: 862-404-5478
Box lunch provided.
Time: 10:15 a.m. – 10:45 a.m.
Exclusive: Pre-release screening
footage from the upcoming series
“Cancer: The Emperor of All Maladies”
by Award-winning Executive Producer
Ken Burns
Company: Siemens
Contact: Jeffrey Bell, Sr. Manager, Media
Relations - Imaging and Therapy Systems
Phone: 484-868-8346
Refreshments provided.
6:45 a.m. – 7:45 a.m.
Clinical Advancements in
Electronic Brachytherapy for
Breast, Skin and Gynecological
Cancers
Company: Xoft Inc.
11:45 a.m. – 12:45 p.m.
Patient QA and Safety in
Modern Radiation Therapy
Company: ScandiDos
Contact: Marni Brown
Phone: 608-630-9415
Box lunch provided.
207
Exhibitor List (as of August 8, 2014)
EXHIBITOR NAME
.decimal
121 Central Park Place
Sanford, FL 32771
Phone: 800-255-1613
Email: contact@dotdecimal.com
Website: www.dotdecimal.com
BOOTH#
1040
EXHIBITOR NAME
BOOTH#
Aktina Medical Corporation
360 North Route 9W
Congers, NY 10920
Phone: 845-268-0101
R
228
ALATRO (Asociacion Iberoamericana De
Terapia Radiante Oncologica)
Av. El Rosario 450 Suite No. 7
San Isidro, Lima, TX Lima 27
Peru
Phone: 51-142-295-94
Email: ccascante@innovativecancer.com
Website: www.alatro.org
241
A2J Healthcare
1145
Parc d’Activité des Vallières, 5 allée des Rousselets
Thorigny sur Marne, 77 77400
France
Phone: 00-331-60-94-22-99
Email: export@a2jlaser.com
Website: www.a2jlaser.com
Alliance Oncology
1801 West End Avenue
Suite 700
Nashville, TN 37203
Phone: 615-263-7888
Email: cmarksdavis@allianceoncology.com
R
504
ABL Medical
705 E. 50 S.
American Fork, UT 84403
Phone: 801-763-8000
Email: sandreasen@ablmed.com
Website: www.ablmedical.com
2537
1601
Acceletronics
602 Gordon Drive
Exton, PA 19341
Phone: 800-543-5144
Email: info@acceletronics.com
Website: www.acceletronics.com
428
AMAC - American Medical Accounting
and Consulting
2864 Johnson Ferry Blvd., Suite 150
Marietta, GA 30062
Phone: 770-693-6031
Email: info.amac@amac-usa.com
Website: www.amac-usa.com
R
202
AccuBoost
1 Industrial Way
Tyngsboro, MA 01879
Phone: 978-649-0007
Email: ryan.flynn@accuboost.com
Website: www.accuboost.com
218
AMAG Pharmaceuticals Inc.
1100 Winter Street
Waltham, MA 02451
Phone: 617-498-3306
Email: jtodd@amagpharma.com
Website: www.amagpharma.com
Accuray Inc.
1310 Chesapeake Terrace
Sunnyvale, CA 94089
Phone: 408-716-4600
Email: sales@accuray.com
Website: www.accuray.com
A
1908
21st Century Oncology
2270 Colonial Boulevard
Fort Myers, FL 33907
Phone: 239-931-7333
Email: Jennifer.Hobaugh@21co.com
Website: www.21stCenturyOncology.com
R
838
AME Publishing Company
206
3/F, 1st Building, Le Su Science Park, 1526, Chunbo
Rd., Binjiang District
Hangzhou, Zhejiang Province 310052
China
Phone: +86-571-28182610
Email: tcr@thepbpc.org
Website: www.thepbpc.org
American Association of Medical
Dosimetrits
2201 Cooperative Way, Suite 600
Herndon, VA 20171
Phone: 703-677-8071
Email: aamd@medicaldosimetry.org
Website: www.medicaldosimetry.org
2732
Advanced Shielding Technologies Inc.
1701
23355 L & N Turnpike, Bldg. F
West Point, KY 40177
Phone: 502-922-3009
Email: svantilburg@advancedshieldingtech.com
Website: www.advancedshieldingtech.com
American Society of Clinical Oncology
2318 Mill Road, Suite 800
Alexandria, VA 22314
Phone: 888-282-2552
Email: membermail@asco.org
Website: www.asco.org
1401
AEP Linac
3870-B Longview Drive
Douglasville, GA 30135
Phone: 678-838-3737
Email: sales@alphatronlinac.com
Website: www.alphatronlinac.com
Anatom-e XRT Information Systems Ltd.
2047 University Blvd
Houston, TX 77030
Phone: 713-382-3638
Email: bill@anatom-e.com
Website: www.anatom-e.com
544
Advanced Accelerator Technologies
1511 Pleasant Street
New Orleans, LA 20115
243
2436
EXHIBITOR NAME
BOOTH#
Ancer Medical
131 Daniel Webster Highway, Box 854
Nashua, NH 03060
Phone: 978-866-0693
107
Anzai Medical Co. Ltd.
3-6-25 Nishi-ShinagawaShinagawa-ku
Tokyo, 141-0033
Japan
Phone: 81-337-791-611
Email: f.sakaguchi@anzai-med.co.jp
Website: www.anzai-med.co.jp
2336
APSHO
37 Main Street
Cold Spring Harbor, NY 11724
Phone: 631-935-7684
Website: www.apsho.org
Email: anthony.cutrone@apsho.org
441
AQUILAB SAS
Parc Eurasante, 250 rue Salvador Allende
Loos Les Lille, France 59120
France
Phone: 00-333-696-1515-1
Email: info@aquilab.com
Website: www.aquilab.com
R
2334
architection
425 W. Market St.
Louisville, KY 40202
Phone: 502-561-1024
Email: ptorp@architection.com
Website: www.architection.com
R
940
Augmenix
204 2nd Avenue, Lower Level
Waltham, MA 02451
Phone: 781-895-3235
Email: egardner@augmenix.com
Website: www.augmenix.com
1943
Bard Medical Division
8195 Industrial Blvd.
Covington, GA 30014
Phone: 770-784-6223
Email: april.wilson@crbard.com
Website: www.crbard.com
1702
Bayer Healthcare Pharmaceuticals Inc.
100 Bayer Blvd
Whippany, NJ 07981
Phone: 862-404-3000
Email: jerry.samuels@bayer.com
Website: www.xofigo-us.com
A
1818
Beekley Medical
1 Prestige Lane
Bristol, CT 06010
Phone: 800-233-5539
Email: info@beekley.com
2634
EXHIBITOR NAME
BOOTH#
Best Medical International, Inc.
7643 Fullerton Road
Springfield, VA 22153
Phone: 419-727-8421, ext. 262
Website: www.teambest.com
R
336, 410, 2901
Bionix Radiation Therapy
5154 Enterprise Boulevard
Toledo, OH 43612
Phone: 419-727-8421, ext. 262
Email: kmclendon@bionix.com
Website: www.bionixrt.com
1627
BK Medical
8 Centennial Drive
Peabody, MA 01960
Phone: 978-326-1300
Email: info@analogicultrasound.com
Website: www.analogicultrasound.com
2601
Bogardus Medical Systems Inc.
3555 N. W. 58th St., Suite 500
Oklahoma City, OK 73112
Phone: 405-917-0500
Email: jcarlin@oncochart.com
Website: www.oncochart.com
R
1801
Boiron
6 Campus Boulevard
Newtown Square, PA 19073-3267
Phone: 610-325-7464
Website: www.boironusa.com
2908
Brainlab
3 Westbrook Corporate Center, Suite 400
Westchester, IL 60154
Phone: 708-409-1343
Email: anna.bliss@brainlab.com
Website: www.brainlab.com
A R
1328
BSD Medical
2188 W. 2200 S.
Salt Lake City, UT 84119
Phone: 801-972-5555
Email: dstancill@bsdmc.com
Website: www.bsdmedical.com
R
1743
Buck Engineering & Consulting GMBH
Gartenstrasse 11
Reutlingen, 72764
Germany
Phone: 49-7121-930721-0
Email: m.gerlich@b-e-c.net
Website: www.b-e-c.net
2709
LEGEND
A
Ambassador
P
Platinum Sponsor
Gold Sponsor
G
S
B
Silver Sponsor
Bronze Sponsor
Copper Sponsor
R Enhanced RO MarketPlace
Corporate
members in bold.
Listing
Corporate members in bold.
C
EXHIBITOR NAME
BOOTH#
C4 Imaging
2160 Bellflower Lane
New Hope, PA 18938
Phone: 609-933-5895
Email: abright@c4imaging.com
Website: www.c4imaging.com
2734
Cancer CarePoint Inc.
17 Executive Park Drive, Suite 520
Atlanta, GA 30329
Phone: 800-998-5859
Email: jlux@cancercarepoint.com
Website: www.cancercarepoint.com
R
704
Cancer Treatment Centers of America
2610 Sheridan Road
Zion, IL 60099
Phone: 847-746-4384
Email: drexa.unverzagt@ctca-hope.com
Website: www.cancercenter.com
2301
Carbon Medical Technologies
1290 Hammond Rd.
St. Paul, MN 55110
Phone: 651-653-8512
Email: info@carbonmed.com
Website: www.carbonmed.com
EXHIBITOR NAME
BOOTH#
CIRS
2428 Almeda Ave., Suite 316
Norfolk, VA 23513
Phone: 757-855-2765
Email: info@cirsinc.com
Website: www.cirsinc.com
R
1644
CivaTech Oncology
P.O. Box 14310
Research Triangle Park, NC 27709
Phone: 919-815-0238
Email: sbabcock@civatechoncology.com
Website: www.civatechoncology.com
R
109
1808
1044
1401 8th St. SE
Orange City, IA 51041
Phone: 712-737-8688
Email: info@civco.com
Website: www.CIVCO.com
B R
1844
Carl Zeiss Meditec Inc.
5160 Hacienda Drive
Dublin, CA 94568
Phone: 925-557-4100
Email: info@meditec.zeiss.com
Website: www.zeiss.com
R
1738
Cleveland Clinic Taussig Cancer Institute
9500 Euclid Avenue, R32
Cleveland, OH 44195
Phone: 216-444-6931
Email: mineffv@ccf.org
Website: www.clevelandclinic.org/cancer
Cold Shot Chillers
14020 Interdrive West
Houston, TX 77032
Phone: 281-227-8400
Email: bcasto@waterchillers.com
website: www.waterchillers.com
2933
CDR Systems Inc.
#33, 235105 Wrangler Drive, SE
Calgary, AB T1X 0K3
Canada
Phone: 403-850-7035
Email: carldenis@cdrsys.ca
Website: www.cdrsys.ca
R
1902
Coumans Care
P.O. Box 84
Hartland, WI 53029
Phone: 262-367-7726
Website: www.coumanscare.com
2739
1346
Cemar Electro Inc.
1370 55th Avenue
Lachine, QC H8T 3J8
Canada
Phone: 514-631-5807
Email: wilson@cemarelectro.com
Website: www.cemarelectro.com
R
2202
C-RAD Inc.
70 SE 4th Ave.
Delray Beach, FL 33483
Phone: 561-742-9260
Email: martin.clay@c-rad.com
Website: www.c-rad.com
R
2934
Churchill Consulting Inc.
384 Route 148
Killingworth, CT 06419
Phone: 860-663-5630
Email: Deb@ChurchillConsulting.com
Website: www.ChurchillConsulting.com
R
1901
CRC Press
3473 Sitio Borde
Carlsbad, CA 92009
Phone: 760-944-9906
Website: www.crcpress.com
Cura Medical Technologies
23 Rancho Circle
Lake Forest, CA 92630
Phone: 858-831-7056
245
Cianna Medical
6 Journey, Suite 125
Aliso Viejo, CA 92656
Phone: 949-360-0059
Email: customercare@ciannamedical.com
Website: www.ciannamedical.com
1838
CYRPA
Avenue Louise, 489
Brussels, 1050
Belgium
Website: www.cyrpa.com
538
209
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
Equicare Health Inc.
1144
201-2020 Yukon St.
Vancouver, BC V5Y 3N8
Canada
Phone: 604-398-2956
Email: rachel.richardson@equicarehealth.com
Website: www.equicarehealth.com
R
Gold Anchor
2907
Vassvagen 21
Huddinge, 14139
Sweden
Phone: 46-706-105-411
Email: samuel.naslund@FineNeedleMarker.com
Website: www.FineNeedleMarker.com
R
Everson Tesla Inc.
615 Daniels Road
Nazareth, PA 18064
Phone: 610-216-6279
Email: tstenulis@eversontesla.com
Website: www.eversontesla.com
238
GuangZhou Raydose Software
2546
Technology LLC
Room 502, Glorious Tower, 850 East Dongfeng Road
GuangZhou, Guang Dong Province 510600
China
Phone: +86-20-87764746
Email: niki@raydose.com
Website: www.raydose.com
2910
2428
Focal Therapeutics
30 Enterprise
Suite 220
Aliso Viejo, CA 92656
Phone: 949-600-5050
Email: bdriscoll@focalrx.com
Website: www.focalrx.com
702
DOSIsoft
45-47 Avenue Carnot
Cachan, 94230
France
Phone: 33-141-242-626
Email: info@dosisoft.com
Website: www.dosisoft.com
2533
Foss Therapy Services Inc.
8794 Avalon St.
Alta Loma, CA 91701
Phone: 909-980-6229
Email: ftsinc@roadrunner.com
Website: www.fosstherapyservices.net
e+CancerCare
104 Woodmont Blvd, Suite 500
Nashville, TN 37205
Phone: 615-467-7407
Email: jjohnson@epluscancercare.com
Website: www.epluscancercare.com
944
e2v
520 White Plains Road
Tarrytown, NY 10591
Phone: 914-592-6050
Email: vijay.patel@e2v.com
Website: www.e2v.com
2438
Eckert & Ziegler BEBIG Inc.
115 Hurley Road, Building 3A
Oxford, CT 06478
Phone: 203-262-0571
Email: lory.bradley@bebig.com
Website: www.bebig.com
1002
Elekta
400 Perimeter Center Terrace, Suite 50
Atlanta, GA 30346
Phone: 770-670-2592
Email: doris.aubuchon@elekta.com
Website: www.elekta.com
A R
1308
Elsevier
1600 JFK Boulevard
Philadelphia, PA 19103
Phone: 404-460-1831
Email: d.liebert@elsevier.com
Website: www.us.elsevierhealth.com
1502
D3 Oncology Solutions
5750 Centre Avenue, Suite 500
Pittsburgh, PA 15206
Phone: 412-365-0719
Email: briggsla2@d3onc.com
Website: www.d3onc.com
R
2242
Dara BioSciences
8601 Six Forks Road, Suite 160
Raleigh, NC 27615
Phone: 919-861-0286
Email: jpena@darabio.com
Website: www.darabio.com
344
Demos Medical Publishing
11 West 42nd Street, 15th Floor
New York, NY 10036
Phone: 212-804-6316
Email: swheeler@demosmedical.com
Website: www.demosmedpub.com
740
DIACOR
2550 Decker Lake Blvd.
West Valley, UT 84119
Phone: 800-342-2679
Email: sales@diacorinc.com
Website: www.diacorinc.com
Full Circle PR
2603
3001 North Rocky Point Drive East, Suite 200
Tampa, FL 33607
Phone: 727-230-9265
Website: www.fullcircle-pr.com
GammaWest Cancer Services
24 South 1100 East
Suite 306
Phone: 801-608-5554
Email: dvincent@gammawest.com
Website: www.gammawest.com
2642
Gammex
7600 Discovery Drive
Middleton, WI 53562
Phone: 608-828-7000
Email: sales@gammex.com
Website: www.gammex.com
1220
GE Healthcare
P.O. Box 414
Milwaukee, WI 53201
Phone: 262-544-3011
Website: www.gehealthcare.com
2228
GenomeDx Biosciences
311 Water Street, Suite 400
Vancouver, BC V6B 1B8
Canada
Phone: 604-558-4777
Website: www.genomedx.com
343
Genomic Health, Inc.
301
301 Penobscot Drive
Redwood City, CA 94063
Phone: 866-662-6897
Email: CustomerService@genomichealth.com
Website: www.OncotypeDX.com
H&H Design-Build
130 East Main St.
New Albany, IN 47150
Phone: 812-206-6178
Email: robert.heinz@hhdesignbuild.com
Website: www.hhdesignbuild.com
R
2904
Hermes Medical Solutions Inc.
710 Cromwell Drive, Suite A
Greenville, NC 27858
Phone: 866-437-6372
Email: info@hermesmedical.com
Website: www.hermesmedical.com
2935
Hitachi
50 Prospect Avenue
Tarrytown, NY 10591
Phone: 914-524-6654
Email: ken.umei@hal.hitachi.com
Website: www.hitachi-america.us
602
Hologic Inc.
35 Crosby Drive
Bedford, MA 01730
Phone: 781-999-7300
Email: info@hologic.com
Website: www.hologic.com
B R
1402
HyperDrive Medical
1110 Sunset Drive
Salt Spring Island, BC V8K 1E6
Canada
Phone: 257-227-0757
Email: info@hyperdrivemed.com
Website: www.hyperdrivemed.com
2903
IBA
Chemin du Cyclotron, 3
Louvain-la-Neuve, 1348
Belgium
Phone: 32-470-048-622
Email: daniel.ernult@iba-group.com
Website: www.iba-worldwide.com
A
1727
Imaging Technology News
3030 West Salt Creek Lane, Suite 201
Arlington Heights, IL 60005
Phone: 847-391-1000
Email: sreilly@sgcmail.com
Website: www.ITNonline.com
1842
EXHIBITOR NAME
BOOTH#
ImpediMed Inc.
5900 Pasteur Court, Suite 125
Carlsbad, CA 92008
Phone: 877-247-0111
Email: info@impedimed.com
Website: www.impedimed.com
R
1042
INSYS Therapeutics Inc.
1333 South Spectrum Blvd., Suite 100
Chandler, AZ 85286
Phone: 602-910-2617
Email: info@insysrx.com
Website: www.insysrx.com
1944
IntraOp Medical Corporation
570 Del Rey Avenue
Sunnyvale, CA 94085
Phone: 408-636-1020, ext. 128
Email: mslavik@intraopmedical.com
Website: www.intraopmedical.com
1703
IOP Publishing
208
150 South Independence Mall West, Suite 929
Phone: 215-627-0880
Email: info@ioppubusa.com
Website: www.ioppublishing.org
Iron Medical Systems Inc.
3104 E. Camelback Rd., #562
Phoenix, AZ 85016
Phone: 602-343-6440
Email: mary@ironmedicalsystems.com
Website: www.ironmedicalsystems.com
2905
IsoAid
7824 Clark Moody Blvd.
Port Richey, FL 34668
Phone: 727-207-5973
Email: jgibson@isoaid.com
Website: www.isoaid.com
R
1201
IsoRay Medical Inc.
350 Hills Street, Suite 106
Richland, WA 99354
Phone: 509-375-1202
Email: dbabcock@isoray.com
Website: www.isoray.com
R
738
James L. Davis
13521 Walsingham Rd.
Largo, FL 33774
Phone: 727-596-0408
Email: sales@jld-radcon.com
Website: www.jld-radcon.com
R
1102
LEGEND
A
Ambassador
P
Platinum Sponsor
Gold Sponsor
Silver Sponsor
G
S
Bronze Sponsor
C Copper Sponsor
Corporate
members in bold.
Listing
B
EXHIBITOR NAME
BOOTH#
Klarity
80 Westgate Drive
Newark, OH 43055
Phone: 740-788-8107
Email: peter@klaritymedical.com
Website: www.klaritymedical.com
R
2416
Kobold, LLC
P.O. Box 1994
Veradale, WA 99037
Phone: 509-703-5090
Email: info@koboldmedical.com
Website: www.koboldmedical.com
R
104
Kunshan GuoLi Vacuum Electric Co. Ltd
Shuixiu Road 1418
Kunshan City, 215316
China
Phone: 86-512-577-3562-1
Website: www.glvac.com
542
Landauer Inc.
2 Science Road
Glenwood, IL 60425
Phone: 877-476-8433
Email: info@landauermp.com
Website: www.landauermp.com
R
608
LAP of America LLC
2002
161 Commerce Rd., Suite 3
Boynton Beach, FL 33426
Phone: 561-416-9250
Email: tava@lap-laser.com
Website: www.lap-laser.com/medical-systems
R
Leoni CIA Cable Systems S.A.S.
2700
5, avenue Victor Hugo, ZAC du Jardin d’Entreprises
Gellainville, 28000
France
Phone: 0033-237333204
Email: samuel.pinault@leoni.com
Website: www.leoni-healthcare.com
Liberty Medical Inc.
22135 Davis Dr. #112
Sterling, VA 20164
Phone: 888-257-2408
Email: rwittmer@libertymedicalinc.com
Website: www.libertymedicalinc.com
R
2544
LifeLine Software Inc.
2407 Pemberton Place
Austin, TX 78703
Phone: 866-592-1343
Email: sales@lifelinesoftware.com
Website: www.lifelinesoftware.com
R
436
LinaTech LLC
1294 Kifer Road, Suite 705
Sunnyvale, CA 94086
Phone: 408-733-2051
Email: corynorris@linatech.com
Website: www.linatech.com
2402
EXHIBITOR NAME
BOOTH#
Linbeck Group LLC
3900 Essex
Suite 120
Houston, TX 77027
Phone: 713-621-2350
2736
Logos Systems Int’l
175 El Pueblo Road
Scotts Valley, CA 95066
Phone: 831-600-6101
Email: brett@logovisionsystem.com
Website: www.logosvisionsystem.com
341
MACROMEDICS BV
Kouwe Hoek 18
Waddinxveen, 2741 PX
Netherlands
Phone: 31-018-238-9777
Website: www.macromedics.com
2636
Math Resolutions
5975 Gales Lane
Columbia, MD 21045
Phone: 410-997-9578
Website: www.MathResolutions.com
244
Max Medical Co. Ltd.
4-5-1, Nishinakajima, Yodogawa-ku
Osaka, 532-0011
Japan
Phone: +81-6-6886-7351
Email: info@maxmedical.com
Website: www.maxmedical.co.jp
101
Maxim Government Services
7227 Lee DeForest Dr.
Columbia, MD 21046
Phone: 866-260-9142
Website: www.maximgov.com
2909
Mayo Clinic
13400 East Shea Boulevard
Scottsdale, AZ 85259
Phone: 507-284-4873
Email: roberts.anne@mayo.edu
Website: www.mayoclinic.org
2640
Medspira LLC
2718 Summer St. NE
Minneapolis, MN 55413
Phone: 612-789-0013
Email: jcarter@medspira.com
Website: www.medspira.com
2036
Mevion Medical Systems
300 Foster Street
Littleton, MA 01460
Phone: 978-540-1500
Email: info@mevion.com
Website: www.mevion.com
G R
728
Miaderm
2412 Calle San Miguel
Encinitas, CA 92024
Phone: 617-461-5959
Email: plinson@post.harvard.edu
Website: www.miaderm.com
837
211
EXHIBITOR NAME
Mick Radio-Nuclear Instruments Inc.,
an Eckert & Ziegler BEBIG Company
521 Homestead Avenue
Mount Vernon, NY 01550
Phone: 203-262-0571
Email: lory.bradley@bebig.com
Website: www.micknuclear.com
R
BOOTH#
902
EXHIBITOR NAME
BOOTH#
MuCheck-Oncology Data Systems
1601 SW 89th Street E-100
Oklahoma City, OK 73159
Phone: 405-680-5222
Email: admin@mucheck.com
Website: www.mucheck.com
R
1139
Myriad Genetic Laboratories
320 Wakara Way
Phone: 801-584-3535
Email: cscomments@myriad.com
Website: www.myriad.com
242
NELCO
2 Burlington Woods Dr., Suite 300
Burlington, MA 01803
Phone: 781-933-1940
Website: www.nelcoworldwide.com
R
627
Novocure
195 Commerce Way
Portsmouth, NH 03801
Phone: 603-436-2809
Email: support@novocure.com
Website: www.novottftherapy.com
2144
Nualine Laser
4333 Belcarra Court
Dublin, CA 94568
Phone: 925-388-6026
Email: sales@nualinelaser.com
Website: www.nualinelaser.com
342
Oncology Services International
400 Rella Boulevard, Suite 123
Montebello, NY 10901
Phone: 845-357-6560
Email: lmann@thinkosi.com
Website: www.thinkosi.com
R
212
1244
Micropos Medical
Stena Center 1
Gothenburg, 41292
Sweden
Phone: +46 31 772 80 99
Email: info@micropos.se
Website: www.micropos.se
R
2643
MIM Software
25800 Science Park Drive, Suite 180
Cleveland, OH 44122
Phone: 216-455-0600
Email: info@mimsoftware.com
Website: www.mimsoftware.com
2127
Mirada Medical
999 18th Street, Ste 2025N
Denver, CO 80202
Phone: 330-379-9228
Email: support@mirada-medical.com
Website: www.mirada-medical.com
308
Mission Search
2203 N. Lois Ave, Suite 1225
Tampa, FL 33607
Phone: 813-870-9500
Email: info@missionsearchusa.com
Website: www.MissionSearch.com
502
Mitsubishi Electric Corporation
503 Keystone Drive
Warrendale, PA 15086-7537
Phone: 742-724-3422
Email: Ryuta.Taniguchi@meppi.com
2602
MM Leadership Management Solutions
4705 Skyway
Paradise, CA 95969
2204
Mobius Medical Systems
5012 Tamarisk Street
Bellaire, Texas 77401
Phone: 888-263-8541
Email: neal@mobiusmed.com
Website: www.mobiusmed.com
2528
Oncology Systems Limited
94 Fernbank Avenue
Delmar, NY 12054
Phone: 518-475-1085
Email: inquiry@osl-usa.com
Website: www.osl-usa.com/rte.asp
2644
Modus Medical Devices Inc.
1570 North Routledge Park
London, ON N6H 5L6
Canada
Phone: 519-438-2409
Email: info@modusmed.com
Website: www.modusmed.com
1937
Oncura Inc.
25 Conventry Avenue
Albertson, NY 11507
Phone: 484-530-3900
Fax: 484-530-3999
Website: www.oncura.com
1438
MPM Medical Inc.
2301 Crown Ct
Irving, TX 75038
Phone: 972-893-4090
Email: mary.jones@mpmmed.com
Website: www.mpmmed.com
R
2303
Orfit Industries America
350 Jericho Turnpike, Suite 302
Jericho, NY 11753
Phone: 516-935-8500
Email: martinj.ratner@orfit.com
Website: www.orfit.com
R
EXHIBITOR NAME
BOOTH#
Oxford Instruments Service LLC
2502
64 Union Way
Vacaville, CA 95687
Phone: 888-673-5151
Email: michaelle.serrano@oxinst.com
Website: www.oxford-instruments.com/ct-mr
Panacea Medical Technologies Pvt. Ltd.
119 Envision Technology Center
EPIP Area Phase1, Whitefield
Bangalore, Karnataka 560 066
India
Phone: +91-9686541355
Email: sales@panaceamedical.com
Website: www.panceamedical.com
443
Paramed Medical Systems Inc.
2341
6204 Oakton Street
Morton Grove, IL 60053-2721
Phone: 847-470-0580
Website: www.paramedmedicalsystems.com
Patient Relationship Management (PRM)
17581 Haralson Drive
Eden Prairie, MN 55347
Phone: 952-239-0411
Website: prmplatform.com
2645
P-Cure Ltd.
500 Lake Cook Rd.
Deerfield, IL 60015
Phone: 847-874-7771
Email: israel.raz@p-cure.com
Website: www.p-cure.com
444
Perioperative Services LLC
111 Continental Drive, Suite 412
Newark, DE 19713
Phone: 302-709-4502
Email: smirande@periop.com
Website: www.periopradonc.com
236
Perkins + Will
10100 North Central Expressway
Dallas, TX 75231
Phone: 214-283-8700
Website: www.perkinswill.com
2931
Phantom Laboratory
P.O. Box 511
Salem, NY 12865
Phone: 518-692-1190
Email: levy@phantomab.com
Website: www.phantomlab.com
1802
Philips Healthcare
3000 Minuteman Road
Andover, MA 01810
Phone: 800-229-6417
Email: marcia.haskell@phillips.com
Website: www.philips.com/healthcare
A
1128
Pitts Little Corp.
2711 Alton Road
Birmingham, AL 35210
Phone: 205-833-5911
Email: sales@pittslittle.com
Website: www.pittslittle.com
1301
EXHIBITOR NAME
BOOTH#
Precision X-Ray
15 Commerce Drive, Unit 1
North Branford, CT 06471
Phone: 203-484-2011
Email: wmclaughlin@pxinc.com
Website: www.pxinc.com
R
2143
Precisis Euromechanics GmbH
Hauptstr. 73
Heidelberg, 69117
Germany
Phone: 49-622-165-5930-0
Email: s.ueltzhoeffer@pe-collimators.com
Website: www.pe-collimators.com
2932
ProNova Solutions
1450 Dowell Springs Blvd.
Suite 230
Knoxville, TN 37909
S
637
ProTom International Inc.
1100 Parker Square, Ste. 230
Flower Mound, TX 75028
Phone: 972-410-3551
Email: jfrank@protominternational.com
Website: www.protominternational.com
R
2508
Prowess Inc.
1844 Clayton Road
Concord, CA 94520
Phone: 925-356-0360
Email: sharon.springorum@prowess.com
Website: www.prowess.com
2628
PTW
140 58th Street Suite 5H3
Brooklyn, NY 11220
Phone: 516-827-3181
Email: mark@ptwny.com
Website: www.ptwny.com
2307
Qfix
440 Church Road
Avondale, PA 19311
Phone: 800-526-5247-713
Email: sales@qfix.com
Website: www.qfix.com
R
1208
QLRAD Inc.
80 South West 8th Street, Suite 2000
Miami, FL 33130
Phone: 770-335-5601
Email: awinkel@qlrad.com
Website: www.QLRAD.com
LEGEND
305
A
P
G
S
Ambassador
Platinum Sponsor
Gold Sponsor
Silver Sponsor
Bronze Sponsor
C Copper Sponsor
Listing
Corporate
members in bold.
B
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
RAD Technology Medical Systems
20801 Biscayne Blvd., Suite 403
Aventura, FL 33180
Phone: 305-898-2544
Email: info@radtechnology.com
Website: www.radtechnology.com
328
RS&C Inc.
465 Forum Parkway
Rural Hall, NC 27045
Phone: 336-969-0583
Email: bginas@rsainc.net
Website: www.rsa-inc.com
1043
RadiaDyne
3801 Kirby Dr., Suite 710
Houston, TX 77098
Phone: 713-807-9100
Website: www.radiadyne.com
302
RT Temps
9 West Front Street
Media, PA 19063
Phone: 800-677-8233
Website: rttemps.com
540
Radiation Business Solutions
1044 Jackson Felts Road
Joelton, TN 37080
Phone: 615-746-4711
Email: dan@radiationbilling.com
Website: www.radiationbusiness.com
1602
S+S Par Scientific
10625 Telge Road
Houston, TX 77095
Phone: 281-815-1300
Email: tj@parscientific.com
Website: www.ParScientific.com
1104
Radiation Products Design Inc.
5218 Barthel Industrial Drive
Albertville, MN 55301
Phone: 763-497-2071
Email: sales@rpdinc.com
Website: www.rpdinc.com
R
1202
Sarah Cannon
3322 West End Avenue
Suite 900
Nashville, TN 37203
Phone: 615-329-7216
Website: www.sarahcannonresearch.com
2742
2738
ScandiDos
2693 Research Park Drive, Suite 202
Madison, WI 53711
Phone: 608-630-9415
Email: matt.douglass@scandidos.com
Website: www.scandidos.com
2536
Radiation Therapy Oncology Group
1818 Market St. Suite 1600
Phone: 215-717-0843
Email: shartson@acr.org
Website: www.rtog.org
320
Sensus Healthcare
851 Broken Sound Pkwy., #215
Boca Raton, FL 33487
Phone: 800-324-9890
Email: info@sensushealthcare.com
Website: www.sensushealthcare.com
R
402
Radiological Imaging Technology - RIT
5065 List Dr
Colorado Springs, CO 80919-3321
Phone: 719-590-1077
Email: mac@radimage.com
Website: www.radimage.com
R
Radiology Oncology Systems Inc.
6725 Mesa Ridge Road, Suite 100
San Diego, CA 92121
Phone: 858-454-8100
Email: info@oncologysystems.com
Website: www.oncologysystems.com
1638
RaySearch Laboratories AB
401 Franklin Ave., Suite 100 A
Garden City, NY 11530
Phone: 877-778-3849
Email: sales@raysearchlabs.com
Website: www.raysearchlabs.com
2315
Revenue Cycle Inc.
1817 West Braker Lane, Bldg. F Ste. 200
Austin, TX 78758
Phone: 512-583-2000
Email: info@revenuecycleinc.com
Website: www.revenuecycleinc.com
R
RK Builders Inc.
1124 Nipomo St., Suite C
San Luis Obispo, CA 93401
Phone: 805-541-2060
Email: admin@rkbuildersinc.com
Website: www.rkbuildersinc.com
Shandong Xinhua Medical
2516
Instruments Co. Ltd
No.7 Taimei Road, Zibo New & Hi - Tech Zone
Shandong, 255086
China
Phone: 86-533-358-7719
Email: xhliping@hotmail.com
Website: www.shinva.com
802
801
Shielding Construction Solutions Inc.
4620 S. Coach Drive
Tucson, AZ 85714
Phone: 520-917-0661
Email: info@shieldingconstruction.com
Website: www.shieldingconstruction.com
R
928
2434
Siemens Medical Solutions USA Inc.
51 Valley Stream Parkway
Malvern, PA 19355
Phone: 914-524-5168
Email: kaiyane.bynoe@siemens.com
Website: www.medical.siemens.com
A
Siris Medical
128 Bonny St.
Mountain View, CA 94043
Phone: 860-214-9284
105
213
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
Sirtex Medical
16 Upton Drive
Suites 2-4
Wilmington, MA 01887
Phone: 888-474-7839
Email: iteigland@sirtex.com
Website: www.sirtex.com
111
Sun Nuclear Corporation
3275 Suntree Blvd.
Melbourne, FL 32940
Phone: 321-259-6862-275
Email: luisrivera@sunnuclear.com
Website: www.sunnuclear.com
C R
1928
Veritas Medical Solutions
2340
5 Great Valley Parkway, Suite 210
Malvern, PA 19355
Phone: 888-242-6760
Email: info@veritas-medicalsolutions.com
Website: www.veritas-medicalsolutions.com
R
SIT USA
14530 Falling Waters Drive
Jacksonville, FL 32258
Phone: 925-768-4034
Email: scott.mestman@soiort.com
Website: www.soiort.com
442
Suremark Company
4645 Industrial Street, 2C
Simi Valley, CA 93063
Phone: 800-406-3399
Email: customerservice@suremark.com
Website: www.suremark.com
2044
2102
Sky Factory
801 N. 18th Street, P.O. 1177
Fairfield, IA 52556
Phone: 641-472-1747
Email: Info@SkyFactory.com
Website: www.SkyFactory.com
839
Synergen Health
3131 McKinney Avenue
Dallas, TX 75204
Phone: 214-952-6602
Website: www.SynergenHealth.com
204
Vertual Ltd.
Logistics Institute
Hull, UK HU6 7RX
United Kingdom
Phone: 44-148-234-7572
Email: sales@vertual.co.uk
Website: www.vertual.co.uk
C
416
2038
Technical Prospects LLC
1000 S. County Road CB
Appleton, WI 54914
Phone: 920-757-6583
Email: parts@technicalprospects.com
Website: www.technicalprospects.com
1745
SpecMed
113 Teal St.
St. Rose, LA 70087
Phone: 504-464-9471
Email: ward@spec-med.com
Website: www.spec-med.com
ViewRay Inc.
2 Thermo Fisher Way
Oakwood Village, OH 44146
Phone: 408-368-2244
Email: mbrandt@viewray.com
Website: www.viewray.com
S R
2408
1302
Theragenics Corporation
5203 Bristol Industrial Way
Buford, GA 30518
Phone: 770-831-5137
Email: roeslerj@theragenics.com
Website: www.theragenics.com
R
2302
Spectrum Pharmaceuticals Inc.
11500 S. Eastern Avenue, #240
Henderson, NV 89052
Phone: 702-835-6300
Email: info@sppirx.com
Website: www.sppirx.com
R
Vision RT Ltd.
8840 Stanford Boulevard, Suite 3200
Columbia, MD 21045
Phone: 866-778-2379
Email: sales@visionrt.com
Website: www.visionrt.com
R
2741
1501
Top Grade Medical Equipment Co. Ltd.
No. 11 Yongchang North Road, BDA
Beijing, P.R.C. 10076,
China
Phone: 86-106-788-5599, ext. 398
Email: mingrui.cao@topgradehc.com
Website: www.topgradehc.com
644
Springer
233 Spring Street
New York, NY 10013
Phone: 212-460-1500
Email: exhibits-ny@springer.com
Website: www.springer.com
VisionTree Software Inc.
8885 Rio San Diego Drive, #220
San Diego, CA 92108
Phone: 619-295-2800
Fax: 619-295-2818
Wolters Kluwer Health
Two Commerce Square, 2001 Market Street
Phone: 215-521-8781
Website: www.lww.com
601
St. Jude Children’s Research Hospital
332 North Lauderdale
Memphis, TN 38105
Phone: 901-495-5294
Fax: 901-495-4011
Website: www.stjude.org
2740
Toshiba Medical Systems
2441 Michelle Drive
Tustin, CA 92780-7043
Phone: 714-669-4190
Email: dkemp@tams.com
Website: www.medical.toshiba.com
2138
Xecan
275 Grove Street, Bldg. 2, Suite 400
Newton, MA 02466
Phone: 617-686-9953
1039
1303
Xoft
101 Nicholson Lane
San Jose, CA 95134
Phone: 408-493-1500
Email: dbreault@icadmed.com
Website: www.xoftinc.com
S R
1938
TRG Oncology Equipment
5318 E. 2nd Street, #682
Long Beach, CA 90803
Phone: 949-622-0022
Website: www.oncologyequipment.com
R
Vantage Oncology
1500 Rosecrans Avenue, Suite 400
Manhattan Beach, CA 90266
Phone: 310-335-4000
Email: info@vantageoncology.com
Website: www.vantageoncology.com
2236
Xstrahl Limited
480 Brogdon Road, Suite 100
Suwanee, GA 30024
Phone: 678-482-6800
Email: support@xstrahl.com
Website: www.xstrahl.com
1338
Standard Imaging
1138
3120 Deming Way
Middleton, WI 53562
Phone: 800-261-4446
Email: standardimaging@standardimaging.com
Website: www.standardimaging.com
R
Sumitomo Heavy Industries Ltd.
1744
Think Park Tower 1-1, Osaki 2-chome, Shinagawa
Tokyo, JAPAN 141-6025
Japan
Phone: 81-3-6737-2566
Email: shn_masui@shi.co.jp
Website: www.shi.co.jp/english/index.html
Varian Medical Systems
3100 Hansen Way
Palo Alto, CA 94304
Phone: 650-424-5927
Email: robert.capuzelo@varian.com
Website: www.varian.com
A R
618, 807
Exhibitor Listing by Product/Service
ACCELERATOR
Acceletronics
Hitachi
IBA
LAP of America LLC
Mevion Medical Sys ms
Pancea Medical Technologies Pvt. Ltd.
RS&A Inc.
Instruments Co. Ltd.
SIT USA
428
602
1727
2002
101
728
2602
212
443
2508
1638
1043
2516
802
442
1744
644
1303
618, 807
BRACHYTHERAPY
838
AccuBoost
218
Best Medical International Inc.
336, 410, 2901
BK Medical
2601
BSD Medical
1743
C4 Imaging
2734
Cianna Medical
1838
CivaTech Oncology
109
1808
1844
DIACOR
2428
1002
Hologic Inc.
1402
IsoAid
1201
IsoRay Medical Inc.
738
Kobold LLC
104
2544
436
Mick Radio-Nuclear Instruments Inc., an Eckert &
Ziegler BEBIG Company
902
MIM Software
2127
1139
443
Prowess Inc.
2628
1202
RK Builders Inc.
2434
Shandong Xinhua Medical Instruments Co. Ltd. 2516
Spec-Med
2038
2302
618, 807
Xoft
1938
DEVICE/EQUIPMENT
Accuray Inc.
Precision Euromechanics GmbH
1908
212
2932
1202
928
2138
DOSIMETRY/DETECTORS
544
336, 410, 2901
DOSIsoft
2533
IBA
1727
341
Micropos Medical
2643
Phantom Laboratory
1802
PTW
2307
QLRAD Inc.
305
320
ScandiDos
2536
Standard Imaging
1138
1928
618, 807
EMR/DATA MANAGEMENT/IT
544
1801
1901
Elekta
1308
1144
GuangZhou Raydose Software Technology LLC 2546
2645
Revenue Cycle Inc.
801
618, 807
Vision Tree Software Inc.
2741
FACILITY CONSTRUCTION/DESIGN
Architection
H&H Design-Build
IBA
James L. Davis
NELCO
Perkins + Will
Pitts Little Corp.
RAD Technology Medical Systems
RK Builders Inc.
Sky Factory
FINANCIAL/INSURANCE
Alliance Oncology
AMAC - American Medical Accounting and
Consulting
Revenue Cycle Inc.
1701
940
2904
1727
1102
627
443
2931
1301
328
2434
802
839
2340
504
1601
1901
236
1602
801
IMAGING/DIAGNOSTICS
Acceletronics
428
544
Acceletronics
428
AQUILAB SAS
2334
336, 410, 2901
BK Medical
2601
C-RAD Inc.
1346
DIACOR
2428
DOSIsoft
2533
Gammex
1220
GE Healthcare
2228
Genomic Health Inc.
301
2935
Logos System Int’l
341
MIM Software
P-Cure Ltd.
Phantom Laboratory
Philips Healthcare
PTW
Vision RT Ltd.
Xoft
Xstrahl Ltd.
INFORMATION/TECHNOLOGY
MIM Software
2127
1244
2502
444
1802
1128
2307
1202
1638
928
1745
644
2138
2408
1938
1338
544
1801
1144
2935
2127
1139
2645
928
618, 807
2741
MEDICAL DEVICE
.decimal
1040
A2J Healthcare
1145
ABL Medical
2537
AccuBoost
218
544
Augmenix
1943
336, 410, 2901
BK Medical
2601
BSD Medical
1743
2709
C4 Imaging
2734
1044
Carl Zeiss Meditec Inc.
1738
CDR Systems Inc.
1902
CivaTech Oncology
109
e2v
2438
1002
Elekta
1308
Focal Therapeutics
2910
702
Gammex
1220
GE Healthcare
2228
Gold Anchor
2907
Hitachi
602
Hologic Inc.
1402
ImpediMed Inc.
1042
1703
IsoRay Medical Inc.
738
Klarity
2416
Kobold LLC
104
2544
LinaTech LLC
2402
Medspira LLC
2036
728
Micropos Medical
2643
MIM Software
2127
2502
215
P-Cure Ltd.
444
Philips Healthcare
1128
Precision Euromechanics GmbH
2932
2508
Qfix
1208
RS&A Inc.
1043
S+S Par Scientific
1104
Sensus Healthcare
402
SIT USA
442
SpecMed
2038
1744
1745
2302
2138
618, 742, 807
ViewRay Inc.
416
Vision RT Ltd.
2408
Xstrahl Ltd.
1338
OTHER
AEP Linac
Anatom-e XRT Information System Ltd.
Boiron
Cold Shot Chillers
Genomic Health Inc.
ImpediMed Inc.
Landauer Inc.
MIM Software
RS&A Inc.
Sky Factory
Vertual Ltd.
1701
2436
544
2908
1808
2933
2242
1144
702
301
1042
2905
608
2127
242
236
1602
2738
1043
839
2102
PATIENT HANDLING/POSITIONING
A2J Healthcare
1145
288
336, 410, 2901
1627
Brainlab
1328
2709
CDR Systems Inc.
1902
Cemar Electro Inc.
2202
1808
C-RAD Inc.
1346
DIACOR
2428
Elekta
1308
Focal Therapeutics
2910
Gold Anchor
2907
Klarity
2416
Kobold LLC
104
LAP of America LLC
2002
2700
Micropos Medical
2643
Nualine Laser
342
Qfix
1208
QLRAD Inc.
305
S+S Par Scientific
1104
Vision RT Ltd.
2408
PHARMACEUTICAL
Bayer Healthcare Pharmaceuticals Inc.
Dara BioSciences
INSYS Therapeutics Inc.
Miaderm
Spectrum Pharmaceuticals Inc.
1818
344
1944
837
1302
PRACTICE MANAGEMENT
Alliance Oncology
AMAC - American Medical Accounting and
Consulting
e+CancerCare
Revenue Cycle Inc.
Vantage Oncology
1601
944
2645
236
1602
801
2236
2741
PROFESSIONAL SOCIETY
ALATRO (Asociacion Iberoamericana De Terapia
Radiante Oncologica)
American Association of Medical Dosimetrists
American Society of Clinical Oncology
APHSO
241
2732
1401
441
PUBLISHER
AME Publishing Company
Demos Medical Publishing
Elsevier
Imaging Technology News
Springer
206
544
740
1502
1842
1501
QUALITY ASSURANCE
AMAC - American Medical Accounting
and Consulting
AQUILAB SAS
C4 Imaging
CIRS
DOSIsoft
Gammex
GuangZhou Raydose Software Technology LLC
IBA
Micropos Medical
Phantom Laboratory
ScandiDos
Standard Imaging
1601
2334
2734
1901
1644
1808
2533
1002
702
1220
2546
2935
1727
436
341
2643
2528
1937
1244
1802
2738
320
2536
1138
1928
RADIATION PROTECTION/SHIELDING
architection
Augmenix
1701
940
1943
838
504
544
James L. Davis
NELCO
1703
1102
101
627
802
2340
RADIATION THERAPY
.decimal
1040
838
A2J Healthcare
1145
Acceletronics
428
AccuBoost
218
Accuray Inc.
1908
228
Alliance Oncology
504
544
Anzai Medical Co. Ltd.
2336
Augmenix
1943
336, 410, 2901
1627
Brainlab
1328
2709
1044
Cianna Medical
1838
CIRS
1644
CivaTech Oncology
109
1808
1844
C-RAD Inc.
1346
DOSIsoft
2533
e2v
2438
1002
Elekta
1308
Focal Therapeutics
2910
702
Gold Anchor
2907
GuangZhou Raydose Software Technology LLC 2546
Hologic Inc.
1402
IBA
1727
1703
IsoAid
1201
IsoRay Medical Inc.
738
Klarity
2416
Landauer Inc.
608
LAP of America LLC
2002
436
101
Medspira LLC
2036
728
Miaderm
837
Micropos Medical
2643
MIM Software
2127
Mirada Medical
308
2602
2528
1937
MPM Medical Inc.
2303
1139
Nualine Laser
342
212
Oncology Systems Ltd.
1244
Orfit Industries America
1438
2502
Panacea Medical Technolgies Pvt. Ltd.
443
P-Cure Ltd.
444
Phantom Laboratory
1802
Precision X-Ray
2143
PTW
2307
Qfix
1208
QLRAD Inc.
305
RadiaDyne
302
2738
320
1638
2315
RS&A Inc.
1043
S+S Par Scientific
1104
ScandiDos
2536
SIT USA
442
Standard Imaging
1138
1744
1928
1745
644
1303
Vantage Oncology
2236
618, 807
Vertual Ltd.
2102
ViewRay Inc.
416
Vision RT Ltd.
2408
Xoft
1938
Xstrahl Ltd.
1338
RADIOISOTOPE SOURCE MANUFACTURER
IBA
IsoAid
RECRUITMENT AND STAFFING
Mission Search
RT Temps
1002
1727
1201
2302
502
540
SEARCH FIRM/STAFFING/RECRUITMENT
Cancer Treatment Centers of America
Landauer Inc.
Mission Search
704
2301
608
502
TREATMENT ACCESSORIES
AEP Linac
2436
288
Beekley Medical
2634
336, 410, 2901
BSD Medical
1743
CDR Systems Inc.
1902
C-RAD Inc.
1346
1002
Hitachi
602
2544
Medspira LLC
2036
Miaderm
837
MIM Software
2127
Mirada Medical
308
RS&A Inc.
1043
S+S Par Scientific
1104
Sky Factory
839
Suremark Company
2044
Vision RT Ltd.
240
TREATMENT PLANNING
ABL Medical Corporation
Accuray Inc.
Anatom-e XRT Information System Ltd.
2537
1908
544
AQUILAB SAS
2334
Beekley Medical
2634
336, 410, 2901
Brainlab
1328
1044
CIRS
1644
1808
1844
2242
DOSIsoft
2533
1002
Elekta
1308
GE Healthcare
2228
Genomic Health Inc.
301
HyperDrive Medical
2903
LinaTech LLC
2402
Medspira LLC
2036
MIM Software
2127
Mirada Medical
308
2602
2528
242
Oncology Systems Ltd.
1244
2502
Phantom Laboratory
1802
Philips Healthcare
1128
Precision X-Ray
2143
Prowess Inc.
2628
2315
ScandiDos
2536
Vantage Oncology
2236
618, 807
ViewRay Inc.
416
2014 ANNUAL MEE TING
Unrestricted Educational
Grant Supporters
Bayer Healthcare
Pharmaceuticals Inc.
Lilly
Merck
Pfizer
217
Meeting Dates: September 14 -17, 2014 • Moscone Center • San Francisco
FOOD
2903 2904 2905
2901
2907 2908 2909 2
245
244
343
344
443
444
540
544
341
342
441
442
538
542
1044 1145
243
242
241
644
742
1144
944
1043
1042
940
1039
1040 1139
1346
1244
238
740
839
738
837
237
637
236
FOOD
CAFE
336
228
838
1138
1338
1128
1328
328
428
627
728
928
H A LL A
218
1438
436
H A LL B
1220
320
618
416
212
410
308
208
111
206
109
204
107
202
105
608
807
602
702
1208
302
402
502
1104
704
504
301
601
801
802
902
1002
1102 1 201
1303
1202 1301
1302 1401
1402 1501
104
ENTRANCE
101
Industry-Expert
Theater
218
1308
305
ENTRANC
FOOD
0 7 2908 2909 2910
2931 293 2 2933 2934
2935
2744
2044 2143
1745
2144 2243
2546 2645
2644 2743
2544 2643
2642 2741
2742
1644 1743
1744
1844 1943
1944
2242 2341
2340
1842
2640 2739
2740
2636 2735
2736
2634
2734
2738
2038
1438
1638
1738
1838 1937
1938
2036
2138
2236
2336
2436 243 8 2537
2334
2434 2533
2536
2732
1627
1727
1928
2228
2127
B
2428
2528
FOOD
CAFE
2628
HALL C
Exhibitor Service
Center
1818
2416
2516
2315
1808
2307
1908
2408
2508
2709
2810
2204 2303
1703
1402 1501
1502 1601
NTRANCE
1602 1701
1702 1801
1802 1901
1902
2002
2102
2202 2301
2603
2302
2402
2502 2601
2808
2602
2804
2700
ENTRANCE
2800
Exhibit
Sales
Office
Office
Exhibitor
L o u ng e
219
NOTES
220
Visit the ASTRO Resource Center to learn about
ASTRO’s newest products and services.
WE ARE LOCATED IN THE NORTH LOWER LOBBY, OUTSIDE HALL D.
2014
Survivor Circle
Stop by the Survivor Circle in
the Resource Center. Meet this
year’s Survivor Circle Award
winner and the Survivor Circle
Grant recipients. Plus, don’t
forget to complete your
Passport for a chance to win
great prizes.*
EXTENDED HOURS FOR 2014:
Saturday, September 13–Tuesday, September 16: 8:00 a.m. – 5:00 p.m.
Wednesday, September 17: 8:00 a.m. – 12:00 p.m.
•
•
Learn more about APEx, ASTRO’s new practice accreditation program.
Ask about RO-ILS: Radiation Oncology Incident Learning System – the only medical specialty
society-sponsored radiation oncology incident learning system.
•
Have your photo taken for your ROhub profile in the ASTRO member directory.
•
Pick up ASTRO’s new Choosing Wisely list of “Five Things Physicians and Patients Should Question.”
•
Pick up new patient brochures and view new patient videos for lung, breast and prostate.
•
Apply for ASTRO membership – new members will receive a special gift for joining on-site.
•
Search for job openings and job seekers on the ASTRO Career Center site.
*Conference and Exhibit Hall Registrants only.
®
TA R G E T I N G C A N C E R C A R E
Thank You
Recognizing ASTRO’s 2014 Corporate Members
.decimal
Acceletronics/Rad Parts
Accuray Incorporated
Advanced Particle Therapy
a-fabco Inc.
Alliance Oncology
AMAC
Amgen Inc.
architection PLLC
Augmenix
Bayer HealthCare
Pharmaceuticals
Boehringer Ingelheim
Pharmaceuticals
Brainlab AG
Bristol-Myers Squibb
BSD Medical
C. R. Bard Inc.
Cianna Medical
CivaTech Oncology Inc.
CompHealth Locum Tenens
Diacor Inc.
e+CancerCare
ELEKTA
eMedical Strategies
Everson Tesla Inc.
Gammex Inc.
GE Healthcare
Genomic Health Inc.
Gold Anchor (Naslund Medical)
Healthcare Administrative
Partners
Hitachi Ltd.
Hologic Inc.
IBA
IsoAid LLC
IsoRay Medical Inc.
James L. Davis Inc.
Klarity Medical Products LLC
Kobold LLC
LAP of America LLC
MedTech Billing Services Inc.
Mick Radio-Nuclear
Instruments Inc.
MIM Software Inc.
Mirada Medical
Mission Search
Mitsubishi
Mobius Medical Systems LP
NELCO
New Bedford Corporation
Oncure Medical Corporation
ORFIT Industries America
Philips Healthcare
ProNova Solutions
Prowess Inc.
PTW-New York
CO R P O R AT E
M E M B E R
222
Qfix
RAD Technology Medical
Systems
Radiological Imaging
Technology (RIT)
RADMAX Ltd.
RC Billing
Revenue Cycle Inc.
RK Builders Inc.
RS&A
ScandiDos AB
Sensus Healthcare
Instruments Co. Ltd.
Shielding Construction
Solutions Inc.
Siemens Healthcare
Sirtex Medical
Spectrum Pharmaceuticals
Standard Imaging
SYNERGEN Health LLC
The Bergendahl Institute LLC
Vantage Oncology
Vertual Ltd.
ViewRay Inc.
Vision RT
Weatherby Healthcare
Xoft Inc.
Xstrahl Ltd.
3URWRQ7KHUDS\LQ
\RXUFRPPXQLW\"
6R(DV\
With
*, you bring proton therapy
to your local community and enhance your
cancer patients’ lives.
is the compact and affordable
IMPT solution from IBA. The most advanced
Proton Therapy solution, available for your clinic.
www.IBA-ProteusONE.com
* ProteusONE is the brand name of a configuration of the Proteus 235 including some new
developments subject to review by competent authorities before marketing.

merrell moc speed streak

Transcription

Similar documents

Program

TexanPlus® HMO Provider Directory Directorio de proveedores

Final Program - American Society for Radiation Oncology

2005 ABS Final Annual Meeting Program, San Francisco, CA

2016 World Congress of Brachytherapy, San Francisco, CA

patients